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ABSTRACT 
 
Alcyonacean octocorals (Order Alcyonacea, amended from Order, Gorgoniidae) are both 
dominant on Caribbean reefs and prolific sources of bioactive natural products. Although 
extensive literature has been published with respect to stony coral-associated bacteria, very little 
is known regarding bacterial populations in healthy octocorals. In this thesis, the octocoral 
Pseudopterogorgia elisabethae was selected as a model organism to investigate owing to its 
commercial significance and its understudied bacterial community. The overall hypothesis of this 
thesis is that the bacterial community of P. elisabethae is diverse and can be cultured to produce 
a valuable and sustainable source of novel natural products. To test this hypothesis, three studies 
were performed. In the first investigation, pyrosequencing was used to examine the culture 
independent bacterial community in P. elisabethae. In the second study, bacteria were isolated 
from P. elisabethae using nine diverse isolation media to maximize the number of isolates. The 
final approach involved assessing the ability of bacterial isolates to produce antimicrobial 
compounds via screening fermentation extracts against five clinically relevant pathogens. 
 
Pyrosequencing results from 14 coral-associated bacterial sequence libraries suggested P. 
elisabethae individuals are a rich source of diverse and novel bacteria. Bacterial communities 
were analyzed at the class and the species level, where a lack of conservation between 
conspecifics within and between reefs in the Bahamas was observed. From the culturing 
approach, 852 bacteria were isolated and were de-replicated by MALDI-TOF MS to 
approximately 78 unique isolates. In addition, sequences generated from de-replicated isolates 
were compared to the pyrosequencing community at 97% sequence similarity, yet very little 
overlap (0.44%) was observed. Regardless, de-replicated isolates were screened for antimicrobial 
activity, where a Streptomyces sp. RKBH-B54 and genetically-related Pseudoalteromonas spp. 
were reproducibly bioactive against yeast and Gram-positive bacteria respectively. Due to the 
potent bioactivity of RKBH-B54, a bioassay guided fractionation was performed in an attempt to 
isolate the antifungal compound produced. Dihydromaltophilin and maltophilin were proposed as 
the most likely compounds responsible for the observed antifungal activity from RKBH-B54 
based on comparison of UPLC/HRMS data to analytical databases; unfortunately, the instability 
of these compounds prevented complete purification and structural elucidation. In conclusion, 
this thesis has demonstrated that P. elisabethae is a rich source of diverse bacteria, yet collecting 
multiple individuals throughout the Bahamas is required to truly evaluate the microbial 
biodiversity in this octocoral. It is also concluded that the potent and reproducible bioactivity of 
selected bacterial extracts from P. elisabethae can be used as a resource for developing 
potentially new therapeutic agents. 
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CHAPTER I 
INTRODUCTION AND BACKGROUND 
CORAL REEFS 
 
 
Coral reefs are an integral part of the well-being of the oceans, and are of major 
economic benefit to many countries (Reshef et al., 2006). Ranging from tropical, subtropical, 
and deep-sea ecosystems, coral reefs cover only 0.2% of the world‘s oceans (Wood, 1998), yet 
their unsurpassed biological diversity have rendered them to be affectionately called ―the 
rainforests of the sea‖ (Connell, 1978; Reaka-Kudla, 1997). As with rainforests, the value of 
reefs results from the millions of species that live primarily or exclusively within these habitats 
(Knowlton, 2001a). Ecologically, coral reefs serve as a physical barrier to protect coastlines and 
communities from wave action and erosion (Wood, 1998). Reefs also assist in nutrient recycling, 
and play a vital role in adding to the marine food chain via their symbiotic algae (Baker, 2003). 
Furthermore, they provide valuable habitats for an estimated nine million marine species 
(Knowlton, 2001b) including fish (Sale, 1993), invertebrates, (Kaplan et al., 1999; Knowlton and 
Rohwer, 2003) and microorganisms (Wood, 1998). Economically, an estimated US$375 billion 
each year is generated directly or indirectly by coral reefs through employment opportunities, 
food, the sale of aquarium fish, and tourism (Costanza et al., 1997). 
 
Corals and other invertebrates have received much attention from academic and industrial 
groups, stemming from the biomedical potential of their chemical extracts. Without physical 
protection or effective escape mechanisms, sessile or slow moving organisms, including corals, 
are likely to be protected through chemical defence (Noyer et al., 2011). These defences, in the 
form of natural products, provide a resource for drug discovery (Harvey, 2000; Noyer et al., 
2011) and can become clinically used drugs or can act as scaffolds for semi-synthetic drugs 
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(Vizcaino, 2011). The biomedical applications of marine-derived extracts are numerous and have 
recently been reviewed (Butler, 2008; Cragg and Newman, 2005; Newman and Cragg, 2004; 
Proksch et al., 2002). Selected examples of marine-derived natural products which have been 
approved by the US Food and Drug Administration (FDA) or are in clinical trials include 
treatments for cancer, inflammation, pathogenic microorganisms, pain, and asthma. 
 
ALCYONACEAN OCTOCORALS 
 
 
The subclass Octocorallia (Order: Alcyonacea; Bayer, 1961) includes over 3000 species 
of soft corals, sea fans, and sea pens (McFadden et al., 2010). By definition, octocorals are 
monophyletic cnidarians with polyps containing eight feather-like tentacles and eight internal 
mesenteries (McFadden et al., 2010; Sánchez et al., 2003), and with only one known exception 
(Fungia sp., Coll, 1992), all octocorals are colonial (McFadden et al., 2010). Previously 
classified as gorgonian octocorals (Order: Gorgonidae) (Bayer, 1961), this terminology has 
recently been discredited by octocoral taxonomists, as the order was defined solely on the basis 
of differences in colony growth morphology (McFadden et al., 2010). Molecular evidence now 
classifies all ―gorgonians‖ under the order Alcyonacea (McFadden et al., 2006; McFadden et al., 
2010). 
 
Abundant on Atlantic and Pacific reefs, octocorals represent almost 40% of the known 
fauna in the Caribbean, with more than 195 species reported (Fenical, 1987; Penn et al., 2006). 
The ability of octocorals to deter predators via chemical defence may in part explain their 
dominance on Caribbean reefs (Whalen et al., 2010).Sessile life styles, slow growth rates and 
soft-bodied morphologies has likely resulted in a selection for a vast arsenal of bioactive 
chemicals with which to defend themselves. In view of their ecological dominance on coral 
reefs, alcyonacean octocoral chemistry has been thoroughly investigated, revealing a wealth of 
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chemically diverse, bioactive metabolites (reviewed in Berrué and Kerr, 2009). Selected coral- 
derived bioactive metabolites are highly significant prospects in clinical trials (Berrué et al., 
2011a); however, the progression of some of these biologically active compounds through 
clinical trials has been hindered by limited supplies (Berrué et al., 2011b). 
 
THE OCTOCORAL PSEUDOPTEROGORGIA ELISABETHAE 
 
 
Members of the genus Pseudopterogorgia are the most abundant octocoral in the 
Caribbean, with over 15 species described (Heckrodt and Mulzer, 2005). As one example, the 
sea plume Pseudopterogorgia elisabethae (Octocorallia; Bayer, 1961, Figure 1.1) has a moderate 
distribution in the West Indies and resides in tropical forereefs at 5 – 35 m (Gutierrez- Rodriguez 
et al., 2009; Heckrodt and Mulzer, 2005). Morphologically, P. elisabethae consists of a cluster of 
feather-like branches, each with a central skeleton with numerous, closely spaced branchlets 
which extend from the central skeleton (Guiterrez-Rodriguez and Lasker, 2004). Colonies of this 
alcyonacean demonstrate significant genetic and morphologic variation within and among 
populations in the Caribbean Sea (Gutiérrez-Rodríguez and Lasker, 2004; Gutiérrez-Rodríguez  
et al., 2009), and demonstrates a higher inter-individual genetic variation than most other corals 
(7.3% compared to up to 3.5%; Gutiérrez-Rodríguez et al., 2009). As with many other shallow 
water octocorals, P. elisabethae contains symbiotic algae called zooxanthellae, with current 
taxonomic resolutions suggesting the coral is exclusively hosting Symbiodinium sp. clade B 
(Santos et al., 2003). P. elisabethae colonies are subject to grazing only by specialized predators, 
most notably by the flamingo tongue snail Cyphoma gibbosum, as well as by the polychaetes 
Hermodice sp. and the four-eyed butterfly fish Chaetodon capistratus (Castanaro and Lasker, 
2003; Thornton and Kerr, 2002). 
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Figure 1.1: The octocoral Pseudopterogorgia elisabethae (Photo credit: R. Kerr). 
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PROKARYOTIC DIVERSITY 
 
 
Prokaryotes constitute the most biologically diverse kingdom on Earth (Rohwer et al., 
2002; Sunagawa et al., 2010), with abundance estimates ranging up to 10
30 
species (Pedros-Alio, 
2006). Although prokaryotes occupy almost every niche on the planet (von Wintzingerode et al., 
1997), only 6000 bacterial species have received a formal description to date, compared with a 
formal description for more than a million plants and animals (Harvey, 2000; Pedros-Alio, 
2006). Traditionally, prokaryotic biodiversity has been measured using conventional approaches, 
including sampling, counting, and cultivation to axenic (pure) cultures (Jones, 2007). In 
microbial cultivation, the general approach is to provide nutrients similar to the natural 
environment with which to grow the target species (Sipkema et al., 2011), yet successful 
cultivation appears to be dependent on specialized techniques (Ben-Dov et al., 2009; Button et 
al., 1993; D‘Onofrio et al., 2010; Kaeberlein et al., 2002; Morris et al., 2008; Sipkema et al., 
2011), including prolonging incubation times (Davis et al.,2005), using alternative gelling agents 
in solid media (Tamaki et al., 2009), co-cultivation of interdependent organisms (Muyzer and 
Smalla, 1998), and sample pre-treatment (Jensen et al., 2005). However, out of over 40 known 
prokaryotic phyla, only half have cultured representatives based on comparison with 16S rRNA 
gene sequences (Connon and Giovannoni, 2002), where estimates suggest only 0.01 – 0.1% of 
cells may be cultured using today‘s technology (Amann et al., 1995; Kogure et al., 1979). 
Consequently, the great majority of bacteria have not been evaluated for their pharmacological 
potential (Manyak and Carlson, 1999), nor have they been described (Staley, 2006). This 
phenomenon is commonly referred to as the ―great plate count anomaly,‖ as coined by Staley 
and Konopka (1985) and describes the difference between the number of organisms cultivated on 
standard agar media plates from those countable by microscopic examination (Connon and 
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Giovanni, 2002). Regardless, cultivation studies are still relevant and vitally important in drug 
discovery today as biomedically active drugs or drug candidates from microbial origin such as 
penicillin are generated by continuous fermentation (Johnson, 1952). As medicines of microbial 
origin have generated worldwide revenues of roughly $83 billion for the pharmaceutical industry 
(Manyak and Carlson, 1999), screening efforts for unique, novel bacteria provide a significant 
and untapped resource for chemical diversity and drug discovery programs (Manyak and 
Carlson, 1999). 
 
Several theories exist to explain the ―great plate count‖ paradigm. For instance, growth of 
microbial species may require oligotrophic conditions to mimic their natural environment; 
oftentimes this is not provided in nutrient rich laboratory media containing complex carbon 
sources (Connon and Giovanonni, 2002). These unnatural growth conditions expose the 
organisms to a variety of potential environmental stressors, often rendering them unable to grow 
on solid media (Olson et al., 2000). Furthermore, many oligotrophic bacteria grow slowly and to 
low cell densities, and thus their presence can be overlooked in culture libraries (Simmons et al., 
2008). As the doubling times of some microorganisms can be up to 100 days (Kaeberlain et al., 
2002), patience in laboratory experiments is necessary, since this time frame is much longer than 
most reported cultivation studies (Sipkema et al., 2011).  In addition, microorganisms with fast 
growth rates are often detected on standard agar (Kirk et al., 2004), which are rarely the most 
dominant species in their habitat (Hugenholtz, 2002). Although cultivation is a requirement to 
officially name and characterize a bacteria (Button et al., 1993; Pedros-Alio, 2006), it is 
important to note that provisional nomenclature of organisms may be granted if their growth is 
not yet possible in the laboratory (Staley, 2006). This is permissible only if sufficient additional 
information is known, including their molecular guanine-cytosine (GC) percent content, their 
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16S rRNA gene sequence, cell size and cell shape, and are thus termed ―Candidatus‖ organisms 
(Staley, 2006). 
 
Since the inception of utilizing the16S rRNA gene (Woese and Fox, 1977) by Pace and 
colleagues in PCR-generated prokaryotic biodiversity analyses (Pace et al., 1985), analysis of 
environmental prokaryotes have more than tripled the number of identifiable bacterial phyla 
(Hugenholtz et al., 1998) and has revolutionized our current understanding of bacterial diversity 
(Kirk et al., 2004). Currently, the 16S rRNA gene sequence constitutes the largest gene-specific 
database for measuring prokaryotic diversity, and the number of entries in easily accessible 
databases is continuously increasing (Dieckmann et al., 2005). This method of determining 
prokaryotic diversity is referred to as a culture-independent approach, which identifies 
prokaryotes on the basis of their nucleic acid sequence. Although bacterial systematics has not 
yet reached a general consensus for describing bacteria at the species level (Cohan, 2002), 
taxonomists have generally agreed to define a species on the basis of a DNA-DNA re-association 
value of greater than 70% (Amann et al., 1995), corresponding to a circa 97% 16S rRNA gene 
sequence similarity (Stackebrandt and Gobel, 1994). Today, culture-independent approaches 
form the backbone of many publications regarding bacterial populations in humans, 
invertebrates, soil, sediment, plants, and microorganisms. 
 
The marine environment represents a relatively unexplored environment for microbial 
cultivation and subsequent drug discovery. Prokaryotes have been evolving over the past 3.5 
billion years, which is presumed to have resulted in exceptionally high levels of genetic and 
phenotypic diversity (Sogin et al., 2006). With the great diversity of bacteria and with genes 
adapted to a wide range of habitats (from deep sea trenches, to hydrothermal vents, to various 
marine invertebrates), a wide variety of unique secondary metabolites may be produced which 
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can significantly increase the diversity of natural product screening libraries (Harvey, 2000). 
Furthermore, by finding a microbial producer of biomedically important compounds, 
fermentation technologies can provide a continuous and sustainable source of supply to meet the 
demands required for human clinical trials. As prokaryotes from unique marine habitats have 
largely been unexplored with respect to their biomedical potential, this demonstrates that marine 
prokaryotes offer a wealth of diversity remaining to be exploited in clinical applications. 
 
THE CORAL HOLOBIONT 
 
 
Stony and alcyonacean corals associate with a wide variety of microorganisms, including 
algae (termed dinoflagellates or zooxanthellae; Cantin et al.,2009; Goulet and Coffroth, 2004; 
Mieog et al., 2009; Voolstra et al., 2009), bacteria (Bourne and Munn, 2005; Brück et al., 2007; 
Rohwer et al., 2001, 2002; Rosenberg et al., 2007), fungi (Bentis et al., 2000; Wang et al., 
2011), and only in the case of stony corals known so far, archae (Wegley et al., 2009) and virus- 
like particles (Marhaver et al., 2008; van Oppen et al., 2009). These associations are generally 
believed to be of symbiotic nature (Shnit-Orland and Kushmaro, 2009), and are collectively 
referred to as the coral holobiont (Rohwer et al., 2002). Owing to their high microbial diversity, 
coral associated microbes are of particular interest to both microbial ecologists and natural 
products chemists by offering a potentially superior source of unique, novel chemistries for 
biotechnological applications (Jackson et al., 2012). Furthermore, so delicate is the balance 
between corals and their associated microbes is that disease and bleaching of both scleractinians 
and octocorals (a term which describes the visible whitening of corals when symbiotic 
dinoflagellates are expulsed; Ben-Haim et al., 1999) has been known to occur when the corals 
are infected by opportunistic fungal (Alker et al., 2001; Rypien et al., 2008) or bacterial (Ben- 
Haim et al., 2003; Kushmaro et al., 2001; Vizcaino et al., 2010) pathogens. 
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CORAL-ASSOCIATED BACTERIAL DIVERSITY 
 
 
Scleractinian-associated bacterial diversity. As mentioned previously, scleractinian 
corals are host to a diverse array of bacteria which may be symbiotic or pathogenic in nature. 
Although prokaryotic diversity has traditionally been measured using cultivation approaches 
(Torsvik and Øvreås, 2002), up to 99.8% of bacteria cannot be cultured by current isolation 
techniques (Koren and Rosenberg, 2006). This paradigm has been offset by targeting the 16S 
rRNA gene, which bypasses cultivation by directly accessing prokaryotic nucleic acids. 
Investigation of scleractinian coral-associated bacterial diversity using the small subunit rRNA 
gene sequence began in 2001, where diversity assessments targeting the 16S rRNA gene 
revealed bacteria form diverse, species-specific associations within the stony coral holobiont 
(Frias-Lopez et al., 2003; Koren and Rosenberg, 2006; Rohwer et al., 2001; 2002; Rosenberg et 
al., 2007). In addition, 16S rRNA gene sequence analysis of the bacterial communities 
associated with the stony corals Montastrea sp., Porites sp., Diploria sp. and Pocillopora sp. 
revealed bacterial communities were unique for each coral species analyzed (Bourne and Munn, 
2005; Rohwer et al., 2002). 
 
Within the scleractinian coral holobiont (Rohwer et al., 2002) bacterial communities 
represent the highest phylogenetic diversity and are one of the most numerically dominant 
microorganisms present (Wegley et al., 2007) with an estimated 10
5 – 106 bacteria per mL 
(Reshef et al., 2006). Although numerous and diverse, the role of most coral-associated bacteria 
within the coral holobiont remains largely unknown, as definitive roles can only be hypothesized 
based on difficulties in bacterial cultivation (Reshef et al., 2006). However, probiotic roles have 
been proposed in hard corals (Reshef et al., 2006), along with providing the host with nutrients 
such as nitrogen (Lema et al., 2012; Lesser et al., 2004) and carbon (Wegley et al., 2007), while 
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sulphur-oxidizing bacteria may remove metabolic waste products generated from the host 
invertebrate (Webster et al., 2001). Furthermore, particular classes of coral-associated bacteria 
provide antibiotic protection from invasive pathogens by producing bioactive metabolites, which 
are believed to aid in host immune defense (Jackson et al., 2012; Ritchie, 2006). Scleractinian 
coral-associated bacteria are found in all layers from the surface mucopolysaccharide layer 
(Ducklow and Mitchell, 1979; Rohwer et al., 2001), to the tissue (Nithyanand and Pandian, 
2009), and to the skeleton (Rosenberg et al., 2007; Sweet et al., 2011), and each of these habitats 
harbour distinct bacterial species (Bourne and Munn, 2005; Koren and Rosenberg, 2006; Sweet 
et al., 2011). In addition, stony coral-associated bacterial communities are shaped by a broad 
variety of biotic and abiotic factors. Abiotic factors which influence biodiversity include 
geographic distance between coral populations (Littman et al., 2009b), seawater pH (Meron et 
al., 2011), rainfall (Chen et al., 2010) and season (Ceh et al., 2011; Chen et al., 2010; Koren and 
Rosenberg, 2006); biotic factors affecting diversity include disease (Bourne et al., 2009) and 
competitive interactions from other microbes (Torsvik and Øvreås, 2002). Although substantial 
evidence suggests bacterial assemblages may be specific in hard corals (Rohwer et al., 2001, 
2002; Rosenberg et al., 2007); contrasting evidence suggests cnidarian microbiology is more 
complex and transient than previously assumed. Microbial communities have been shown to 
differ between sites (Kellogg et al., 2009; Kvennefors et al., 2010), colour morphotypes 
(Neulinger et al., 2009), conspecifics (Chen et al., 2010), life stages of the coral (Littman et al., 
2009a), and spatial locations within the cnidarian holobiont (Bourne and Munn, 2005; Qian et 
al., 2006; Schöttner et al., 2009; Sweet et al., 2011; Wichels et al., 2006). For example, 
acroporids collected in triplicate from two locations in the Great Barrier Reef revealed that 
bacterial communities grouped according to location rather than species (Littman et al., 2009b). 
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Furthermore, bacterial communities of triplicate stony coral libraries not only showed bacterial 
variation within the same environment, but also across locations and by coral colour morph 
(Neulinger et al., 2008). It is generally well-accepted that bacteria present in scleractinian corals 
are distinct from those in the surrounding water column (Bourne and Munn, 2005; Jackson et al., 
2012; Kvennefors et al., 2010; Rohwer et al., 2002; Sunagawa et al., 2010). 
 
Octocoral-associated bacterial diversity. Microorganisms are an integral part of 
contributing to the health of scleractinian corals. However, despite the growing recognition that 
scleractinians live in a symbiotic relationship with a diverse array of bacteria and despite the 
advancement of sequencing technology, studies characterizing the microbial diversity of 
octocorals are rare. To date, only five studies on octocorals exist (Brück et al., 2007; Gray et al., 
2011; Penn et al., 2006; Sunagawa et al., 2010; Webster and Bourne, 2007) and only one study 
has characterized a shallow-water octocoral-associated bacterial diversity using next generation 
pyrosequencing methods (Sunagawa et al., 2010). For example, Webster and Bourne (2007) 
profiled the bacterial community structure associated with the Antarctic alcyonacean octocoral 
Alcyonium antarcticum. Here, bacterial communities were analyzed from corals collected at 
three sites in McMurdo Sound, Antarctica. Both molecular and cultivation approaches revealed 
coral-associated Gammaproteobacteria were conserved within and between sites, while 16S 
rDNA sequences demonstrated low sequence similarity to previously published sequences in the 
GenBank database (Webster and Bourne, 2007). Conclusions drawn from this study supported 
the theory that at least some alcyonacean corals harbor unique bacterial inhabitants (Webster and 
Bourne, 2007). Some studies also suggest octocoral-associated bacteria vary between sites (Gray 
et al., 2011; Penn et al., 2006) and octocoral genera (Brück et al., 2007). Relative proportions of 
the dominant bacterial phyla are variable in some octocorals (Gray et al., 2011; Penn et al., 
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2006). For example, Gray et al. (2011) used clone libraries of 16S rRNA gene sequences to 
reveal deep-sea octocoral-associated bacterial consortia differed between conspecifics collected 
at different sites in the Aleutian Islands, where a variable bacterial community was observed. 
Here, two clone libraries were dominated by the phylum Tenericutes while Alphaproteobacteria 
was the dominant class for the remaining libraries. Furthermore, other clone libraries were more 
similar at the genus level rather than within conspecifics. 
 
Rationale for studying coral-associated bacteria. Understanding coral-associated 
microbial biodiversity is critical for defining ecological networks (Brück et al., 2007), 
characterizing resilience to disease (Bourne and Munn, 2005; Fonseca et al., 2010), providing 
effective reef management (Sharp et al., 2010), and understanding co-evolution of cnidarians 
with their microbial inhabitants (Pedros-Alio, 2006). Interestingly, a growing body of literature 
suggests bacteria have co-evolved with their cnidarians hosts, forming species-specific clades 
which are highly divergent from one another (Jackson et al., 2012; Lee et al., 2009; Webster et 
al., 2010). This fascinating discovery suggests cnidarian-associated bacteria may be uniquely 
adapted to highly specialized niches. In particular, corals can provide a high nutrient niche 
suitable for bacterial colonization within the oligotrophic ocean (Ducklow and Mitchell, 1979; 
Sharon and Rosenberg, 2008). From a microbial point of view, the coral host can be viewed as a 
unique microhabitat to occupy, and therefore, can be a site for highly adapted species (Amann et 
al., 1995). These well-adapted species have evolved under the pressures of natural selection to a 
particular microhabitat (Noyer et al., 2011). Based on preliminary evidence that some natural 
products, previously believed to be of octocoral origin, may be produced by symbiotic bacteria 
(Bunyajetpong et al., 2011; Bunyajetpong, 2011) and owing to the difficulties in harvesting 
marine invertebrates, microorganisms are very attractive to researchers and pharmaceutical 
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companies alike. As alcyonacean octocorals are largely unexplored and unique habitats, this 
microenvironment is ideally suited for exploration of their biomedical potential via their 
associated bacterial community (Singh and Pelaez, 2008). As such, cultivating marine 
invertebrate microbial symbionts represents a pivotal step forward towards generating consistent 
and commercial yields available for supplying invertebrate-derived compounds by continuous 
fermentation (Fortman and Sherman, 2005). By focusing research efforts on novel and unique 
habitats – including the octocoral microhabitat – one can investigate these specialized habitats 
for their potential to provide novel natural products. 
 
METHODS OF ASSESSING CORAL-ASSOCIATED BACTERIAL DIVERSITY 
 
 
Clone libraries. Genetic analysis of microbial communities is often complex and 
daunting due to the great complexity of such systems. As such, a number of PCR-based 
approaches have been developed to characterize microbial diversity, including clone libraries 
(Scharf et al., 1986), automated ribosomal intergenic spacer analysis (ARISA), fluorescence in 
situ hybridization (Ainsworth et al., 2006), temperature gradient gel electrophoresis (TGGE), 
Box-PCR (Lanoot et al., 2004), and denaturing gradient gel electrophoresis (DGGE) (Kirk et al., 
2004; Muyzer et al., 1993). These techniques, called community fingerprinting techniques, all 
provide a ―snapshot‖ of the overall structure and diversity in microbial populations (Rettedal et 
al., 2010). For example, clone libraries using 16S rRNA gene sequences have provided the 
foundation for most coral-associated bacterial community studies following their introduction by 
Scharf and colleagues in 1986 (Scharf et al., 1986). The premise of clone libraries involves 
separation of PCR-amplicons (targeting a particular gene sequence, ex. the 16S rRNA gene) 
from one another by cloning in competent E. coli cells (von Wintzingerode et al., 1997). The 
amplicons are ligated (i.e. inserted) into a plasmid vector, the latter of which often contains a 
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gene sequence which is lethal to E. coli when expressed (yet is disrupted by ligation of a DNA 
insert into the cloning site) and antibiotic resistance genes (Timmis et al., 2010). Cells are plated 
onto a selective medium with antibiotics added; therefore, only cells which have successfully 
been transformed can grow. Furthermore, the need for tedious blue/white screening is eliminated 
with plasmids encoding for a gene lethal to E. coli, as cells which have not been transformed still 
express the lethal gene and subsequently causes death of E. coli when plated. However, due to 
the biases, cost, and labor-intensities of constructing clone libraries (von Wintzingerode et al., 
1997), other techniques to describe microbial communities have been explored. 
 
Denaturing gradient gel electrophoresis. Arguably the most commonly used genetic 
fingerprinting technique (Rettedal et al., 2010), denaturing gradient gel electrophoresis (DGGE) 
was applied to the field of estimating microbial diversity by Muyzer et al. (1993) and has since 
been applied to profiling bacterial communities in hot springs (Ferris et al., 1996), reef-building 
corals (Bourne and Munn, 2005), soil (reviewed in Kirk et al., 2004), and sponges (Webster et 
al., 2004). The basic principle in DGGE is that a mixture of similar sized DNA amplicons, each 
containing different nucleotide sequences, will migrate to unique positions in a polyacrylamide 
gel according to their melting properties (Muyzer et al., 1993; Muyzer and Smalla, 1998; 
Sheffield et al., 1989). Here, double stranded DNA amplicons are electrophoresed through a 
linear gradient of DNA denaturants (formamide and urea) (Muyzer et al., 1993; Sheffield et al., 
1989). Upon reaching a particular denaturing concentration, equal to the melting temperature of 
the nucleotide sequence with the lowest melting point, the double stranded DNA partially 
dissociates, the fragment halts, and discrete bands are formed in the gel at unique positions 
(Ferris et al., 1996; Muyzer and Smalla, 1998; Sheffield et al., 1989). Each band represents one 
gene sequence from a microorganism (Kirk et al., 2004). DNA bands may then be stained 
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(Muyzer and Smalla, 1998), excised, and the nucleotide sequences can be determined (Ferris et 
al., 1993). 
 
The main feature of DGGE is that sequences differing by a single base pair can be 
separated, as single base substitutions alter the melting properties of the DNA sequence strongly 
enough to separate molecules (Myers et al., 1985). Sequence specific strand separation from 
DNA amplicons of identical size is guaranteed by the addition of a 35 – 40 base pair GC-rich 
motif – called a GC clamp – to the 5‘ end of one of the primers during PCR amplification (Ferris 
et al., 1996; Kirk et al., 2004; Muyzer et al., 1993). The GC clamp ensures at least part of the 
DNA remains double stranded during denaturation on the denaturing gel (Ferris et al., 1996; 
Kirk et al., 2004; Muyzer et al., 1993); failure to do so will result in DNA denaturing completely 
into single strands (Kirk et al., 2004). Although DGGE is fast, reliable, reproducible, and cost- 
effective, it is limited in a variety of ways (reviewed in Kirk et al., 2004). For example, only 
sequences constituting higher than 1 – 2% of the population present can be detected (Kirk et al., 
2004; Muyzer et al., 1993). In addition, the GC clamp sequence can cause incomplete strand 
synthesis during PCR amplification leading to multiple bands for one template (von 
Wintzingerode et al., 1997). Furthermore, multiple sequences with minor differences can migrate 
to identical positions in DGGE gels and may not be separated in a mixed sample; therefore, one 
band may not represent one species (Jackson et al., 2000). Due to such limitations of DGGE and 
as reviewed elsewhere (Kirk et al., 2004), other methods of assessing culture-independent 
microbial diversity have been developed, including next generation sequencing methods 
described below. 
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Pyrosequencing. In 1998, a new sequencing technology was introduced (Ronaghi, 1998) 
which would change the nature of bacterial research (Margulies et al., 2005). This second- 
generation sequencing technology, termed pyrosequencing, has allowed for the identification of 
rare and novel microbial phylotypes by unparalleled sequencing depth compared to traditional 
methods (Amend et al., 2010; Sunagawa et al., 2010), which are well understood to 
underestimate diversity by 1 – 2 orders of magnitude (Engelbrektston et al., 2010; Uthicke and 
McGuire, 2007). Pyrosequencing, a term coined from the use of pyrophosphate-based 
sequencing (Margulies et al., 2005) is a fully automated sequencing technology capable of 
generating over 25 million bases in a single 10-hour run, and is performed with ≥99.75% 
accuracy (Huse et al., 2007; Lee et al., 2011; Margulies et al., 2005). This process has been 
scaled up by several laboratories, including 454 Life Sciences and Research and Testing to be 
massively parallel, generating more than 400,000 sequence reads per plate (Quince et al., 2009) 
for roughly 10 – 30 times cheaper than Sanger sequencing (Edwards et al., 2006). In contrast to 
traditional Sanger sequencing, pyrosequencing technology does not require a cloning step, thus 
avoiding potential biases discussed elsewhere (Edwards et al., 2006). In assessing microbial 
communities, DNA is extracted, and in the case of general bacterial sequencing, the 16S rRNA 
gene sequence is amplified by PCR prior to pyrosequencing, although it is possible to directly 
pyrosequence genomic DNA to mitigate potential biases and sequencing errors from multiple 
rounds of PCR. Based on a ―sequencing-by-synthesis‖ technology, pyrosequencing relies on the 
light detection of inorganic pyrophosphate (PPi) released upon every nucleotide incorporation 
during DNA synthesis (Ronaghi et al., 1998). To begin, each of the four nucleotide triphosphates 
are cycled over the plate. If the first unpaired base in a well is complementary to the incoming 
nucleotide, then DNA polymerase (Quince et al., 2009) catalyzes the reaction to ultimately 
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release light (Edwards et al., 2006; Margulies et al., 2005; Ronaghi et al., 1998). The amount of 
light produced in the luciferase-catalyzed reaction is recorded with a CCD (charge - coupled 
device) camera, which captures emitted photons (Margulies et al., 2005). The pattern of light 
intensities emitted can be used to report the order of nucleotide incorporations, and thereby 
reflect the DNA sequence reads in an orderly manner (Huse et al., 2007; Quince et al., 2009; 
Ronaghi et al., 1998). Finally, the genetic variation within the sequence reads can be used to 
assess the phylogenetic diversity of the bacterial community within a sample (Quince et al., 
2009). In prokaryotic analysis, read lengths of ~430 bp allows for sequence resolution to the 
genus level based on pyrosequencing of the hypervariable V1 – V3 region of the 16S rRNA gene 
(Jackson et al., 2012). 
 
Recently, bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP; Dowd et al., 
2008) has been introduced as a powerful molecular tool to rapidly characterize prokaryotic 
bacterial communities in a higher sequencing depth than traditional 16S rDNA clone libraries. In 
2006, the Rohwer laboratory (Edwards et al., 2006) was the first to apply pyrosequencing 
methods to environmental samples, indicating that this technology is still relatively a new 
approach to assessing bacterial diversity in environmental habitats. Furthermore, Lee et al. 
(2011) compared pyrosequencing to traditional clone library methods, where the authors 
discovered six additional bacterial phyla in sponge pyrosequencing 16S libraries which were not 
detected in traditional 16S rDNA clone libraries (Lee et al., 2011). These phylotypes were 
detected in very low numbers and would most likely have gone unrecognized by traditional 
culture-independent analyses. Likewise, pyrosequencing revealed novel sponge phylotypes 
which were not detected in the surrounding seawater (Webster et al., 2010). Presently, bTEFAP 
has been successfully implemented in characterizing bacterial communities in fermented seafood 
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(Roh et al., 2010), cattle feces (Dowd et al., 2008), sponges (Webster et al., 2010), and soil 
(Acosta-Martínez et al., 2008). The large sequence yield generated from pyrosequencing has 
exponentially increased our ability to explore rare and novel phylotypes within environmental 
samples (Kirchman et al., 2010; Sogin et al., 2006). In traditional studies, dominant cultures or 
phylotypes have masked the detection of low abundance sequences (Sogin et al., 2006). 
However, the majority of genetic diversity revealed by second generation sequencing in the 
North Atlantic Sea was represented by thousands of low abundance sequence populations (Sogin 
et al., 2006). This ―rare biosphere‖ (Sogin et al., 2006) has a remarkable source of genomic 
variation, and is a largely underexplored potential reservoir of biological diversity (Sunagawa et 
al., 2010). 
 
DEREPLICATION OF CULTIVABLE BACTERIAL LIBRARIES 
 
 
As mentioned previously, the ideal approach in bacterial cultivation is to provide 
nutrients and a habitat similar to the natural environment with which to grow the target species 
(Sipkema et al., 2011). During the isolation process, several hundreds to several thousands of 
environmental strains can be easily accumulated (Singh and Pelaez, 2008). In order to 
discriminate between potentially interesting, unexplored groups of bacteria, it is essential to 
minimize the number of redundant or previously investigated isolates in a sample library 
(Dieckmann et al., 2005; Singh and Barrett, 2006). In the context of drug discovery, this process 
– the removal of knowns from unknowns at user defined taxonomic levels generally from genera 
to species – is called dereplication, and it is critical to success in reducing labor intensity, time, 
and screening costs (Dieckmann et al., 2005; Ghyselinck et al., 2011). This aids in the focusing 
of efforts on characterizing selected, novel, or rare microorganisms for downstream applications, 
including drug discovery. 
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Molecular methods. Several methods for bacterial dereplication exist, including the use 
of repetitive extragenic palindromic (REP) elements and subsequent PCR amplification (Rep- 
PCR) (Versalovic et al., 1991), enterobacterial repetitive intergenic consensus (ERIC) sequences, 
restriction fragment length polymorphism (RFLP), Box-PCR (Lanoot et al., 2004), randomly 
amplified polymorphic DNA (RAPD) (Lynch and Milligan, 1994), and fatty acid methyl ester 
(FAME) (Haack et al., 1994) analyses. Each of these techniques, including their description, 
advantages, and disadvantages, have been reviewed (Kirk et al., 2004). REP and ERIC sequences 
are invaluable tools for determining genetic variation among Gram-negative bacteria (Versalovic 
et al., 1991), where the former elements act as regulatory elements within the untranslated region 
of the transcriptome (Versalovic et al., 1991). However, REP elements and ERIC sequences do 
not concern Gram-positive bacteria, as probes for REP and ERIC sequences hybridized 
preferentially to genomic DNA from Gram-negative bacteria, but failed to yield hybridization 
signals for Gram-positive bacteria (Versalovic et al., 1991). However, the BOX element has been 
developed as a tool for discriminating between closely related species in Gram- positive bacteria 
(Martin et al., 1992). The BOX elements are composed of three subunits (boxA, boxB, and 
boxC) which are 45 – 59 bases long, and are highly conserved regulatory elements found in 
Gram-positive bacteria (Martin et al., 1992). However, although BOX-PCR has been used to 
discriminate bacteria to the strain level, it is unable to reliably differentiate some bacteria to the 
species level (Kim et al., 2002). Furthermore, none of these technologies can simultaneously 
dereplicate Gram-positive and Gram-negative bacteria. Hence, in those instances where it is vital 
to differentiate to the species level and to differentiate between both Gram- negative and Gram-
negative bacteria, new techniques are required. 
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MALDI-TOF MS. Recently, matrix-assisted laser-desorption ionization (MALDI) time-of- 
flight (TOF) mass spectrometry (MS) has been introduced as a powerful, reliable tool to 
dereplicate a wide variety of microorganisms, with most efforts focusing on clinically relevant 
microbial pathogens (Fenselau and Demirev, 2001), fungi (Neuhof et al., 2007), as well as both 
Gram-positive and Gram-negative bacteria (Vargha et al., 2006). MALDI-TOF MS has been 
routinely demonstrated to differentiate from species to sub-strains in clinical isolates (Bizzini and 
Greub, 2010; Carbonnelle et al., 2011; Mellman et al., 2008; Vanlaere et al., 2008; Vargha et al., 
2006) and more recently, environmental bacteria from marine invertebrates (Dieckmann et al., 
2005). Developed in the 1980s, MALDI-TOF MS uses a ―soft‖ ionization technique, which 
induces only a small amount of molecule fragmentation (Schiller et al., 2007). Briefly, following 
the growth of pure cultures, individual colonies are spotted onto a stainless steel target plate and 
mixed with a photon-absorbing organic matrix, where the sample and the matrix form a co- 
crystallized mixture (Fenselau and Demirev, 2001). Ionization of whole microbial cells 
(Dieckmann et al., 2005; Neuhof et al., 2006), which is particularly valuable in allowing for 
minimal sample preparation, is generated by the addition of a strong acid (generally 
trifluoroacetic acid, TFA) to the MALDI matrix (Liu et al., 2007). A laser converts the  
molecules in the crystallised sample-matrix mixture into gas-phase ions (Fenselau and Demirev, 
2001), which are generally pulsed into a time-of-flight tube (Carbonnelle et al., 2011; Fenselau 
and Demirev, 2001; Vanlaere et al., 2008), where ions are separated by molecular weight after 
migration in an electric field (Carbonnelle et al., 2011). The mass-to-charge ratio (m/z) of an 
analyte is plotted against intensity by the mass spectrometer (Carbonnelle et al., 2011; Vanlaere 
et al., 2008), resulting in a computer-generated spectral output from each sample. In the case of 
bacterial dereplication, the variation between strains is sufficient enough to produce unique 
21  
protein fingerprints for each bacterial isolate, which can be provided by the instrument within a 
few minutes (Mellmann et al., 2008). Spectra typically show a large number of peaks between 
m/z 3,000 and 10,000, representing the ―fingerprint‖ generated (Jackson, 2001). An excellent, in- 
depth summary of MALDI-TOF MS has been published by Gerwick and Dorrestein (Esquenazi 
et al., 2008; Esquenazi et al., 2009). 
 
MALDI is an advanced technology compared to traditional dereplication techniques 
owing to its high sensitivity (Lopez-Legentil et al., 2005), simplicity (Vargha et al., 2006), 
ability to analyze high mass ranges (Liu et al., 2007), low sample requirement (Jackson, 2001), 
reproducibility (Dieckmann et al., 2005; Wunschel et al., 2005), automation (Dieckmann et al., 
2005), and time-saving benefits (Mellmann et al., 2008; Risch et al., 2010). For example, clinical 
diagnostics using MALDI-TOF MS profiling have shown a decrease in the overall analysis cost 
to 22 – 32% of the comparable and conventional bacterial identification methods (Sedo et al., 
2010). Furthermore, the identification of clinical isolates traditionally takes 24 – 48 hours, 
whereas MALDI-TOF MS profiling classifies clinical isolates within a few minutes (Risch et al., 
2010). Resulting from its high degree of sensitivity, MALDI-TOF MS may also serve as an 
alternative to 16S rRNA gene sequencing (Bizzini et al., 2010), as MALDI-TOF MS provides 
finer resolution than 16S rDNA sequences in some environmental bacteria (Dieckmann et al., 
2005; Vargha et al., 2006). In addition, clinical isolates are classified more accurately than 16S 
rRNA gene sequencing (Mellmann et al., 2008). However, bacterial growth conditions – 
including time of growth and media selection – have an effect on the characteristic spectral 
fingerprint; therefore, this factor must be taken into account when analyzing MALDI-TOF MS 
profiles (Jackson, 2001). This can be mitigated by maintaining consistencies with respect to 
growth time and media choice. Furthermore, the use of MALDI-TOF MS for the dereplication of 
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unknown environmental isolates is still in its infancy, with the first study describing its use to 
dereplicate marine environmental isolates published in 2005 (Dieckmann et al., 2005). As 
pointed out by this research group, phylogenetic assessment of unknown bacteria from unknown 
clusters in MALDI-TOF MS analyses will undoubtedly always rely on selective sequencing, 
notably by the use of the 16S rRNA gene (Dieckmann et al., 2005). 
 
Previously, MALDI-TOF MS was applied to de-replicate sponge associated bacterial 
communities in four Norwegian boreal sponges (Dieckmann et al., 2005). Here, the authors 
employed MALDI-TOF MS on whole bacterial cells and discovered that MALDI resolved the 
strains into 11 groups corresponding to various species of Gammaproteobacteria, Firmicutes, and 
Bacteroidetes. This study found a large number of cultivable marine Pseudoalteromonas spp., 
which allowed for the examination of isolate differentiation at the species to strain level. 
Although virtually indistinguishable based on partial to full length 16S rRNA gene sequencing, 
the authors found that the isolated Pseudoalteromonas spp. could be readily distinguished via 
their MALDI-TOF MS patterns. This resolution was deemed significant for microbial drug 
discovery since closely related species may produce different compounds (Dieckmann et al., 
2005). Hence, MALDI screening can provide valuable low level taxonomic resolution and is an 
excellent tool for dereplicating both clinical and environmental isolates. 
 
NATURAL PRODUCTS 
 
 
As Newman and Cragg (2004) eloquently stated, the lack of predation on sessile, soft- 
bodied plants and invertebrates piqued scientific curiosity: why were certain plants and 
invertebrates not attacked by organisms higher in the food chain? Why were some organisms 
susceptible to fouling, while others were not? It is widely agreed that these organisms produce 
compounds which deter potential consumers and spatial competitors by chemical defense 
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(Newman and Cragg, 2004). These compounds, called natural products or secondary 
metabolites, are compounds which are not essential to the sustenance of life yet offer an 
evolutionary advantage in their interactions with the environment (Bialonska and Zjawiony, 
2009). To maintain their evolutionary selection, natural products presumably have increased the 
overall fitness of the host organism (Firn and Jones, 2009) owing to their high metabolic cost 
(Bialonska and Zjawiony, 2009). Isolated from higher plants, invertebrates, and microorganisms 
(Berdy, 2005), secondary metabolites have attracted biomedical interest for their wide range 
biological activities against human ailments, including antimicrobial, anticancer, antiviral, 
antiparasitic, and antiprotozoal activities (reviewed in Berrué and Kerr, 2009; Blunt et al., 2012; 
Cragg and Newman, 2005; Dias et al., 2012; Mayer et al., 2011). In their natural environment, 
biological functions of secondary metabolites are broad and appear to have roles in chemical 
defense (Gil-Turnes et al., 1989; Kelman et al., 2009), predation (Olivera et al., 1985), 
competition for space (Koh and Sweatman, 2000), protection from ultraviolet radiation 
(Thornton and Kerr, 2002), and anti-fouling (Lopez-Legentil et al., 2005). For example, bioassay 
guided fractionation revealed the compound 2,3,4 tribromopyrrole in the mollusc Saccoglossus 
kowalevskii was a chemical deterrent to fishes (Kicklighter et al., 2004). Another popular theory 
adopted by many chemical ecologists is that natural product diversity is the consequence of a 
―chemical arms race‖: the host gained an adaptive advantage by producing a bioactive molecule 
which could reduce the fitness of a competitor (Firn and Jones, 2003). 
 
TERRESTRIAL NATURAL PRODUCTS 
 
 
Although their ecological functions are often unknown, humans have benefited from the 
medicinal potential of secondary metabolites for thousands of years. The earliest suspected 
record in human medical history is based on Paleoanthropological studies of a 60,000 year old 
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Neanderthal burial site in northern Iraq (Solecki, 1975). Buried with the Neanderthals were eight 
different species of flowers, seven of which are recognized today for their herbal and medicinal 
properties. The flowers were not accidentally introduced into the grave – as demonstrated from 
the diverse habitat range from which the flowers were collected – rather, they must have been 
collected and purposely laid down with the burial. Hence, speculation rises as to whether or not 
the Neanderthals were aware of the medicinal values of the various plants used in the burial. 
Traditionally, higher plants have formed the basis of medicine, with an estimated 77% of plant 
derived drugs forming a basis in traditional medicine (Cragg and Newman, 2005) and today at 
least 119 chemical entities, derived from 90 plant species, are used as pharmaceuticals in one or 
more countries (Newman et al., 2000). However, only 5 – 15% of the ~250,000 species of higher 
plants have been assessed for biomedical potential (Cragg et al., 1999). As such, one might 
rationalize that a number of bioactive metabolites are awaiting discovery. The current challenge 
is finding new ways or new sources to access nature‘s chemical diversity (Harvey, 2000). 
 
Economic success of terrestrial natural products. Not only are natural products and 
synthetic drugs based on natural products (termed ―natural product derived drugs‖) successful at 
treating human ailments, they are also significant contributors to the profitability of many 
companies (Butler, 2004). Approximately one half of the 20 best selling drugs are either natural 
products or have been derived from structures provided by nature, with sales totaling roughly 
US$16 billion (Proksch et al., 2003; Tulp and Bohlin, 2002). Probably the most well-known 
example to date is acetylsalicylic acid (aspirin), an anti-inflammatory natural product derived 
from salicin found in the bark of the willow tree Salix alba L. (Dias et al., 2012), which also 
serves as inspiration for many other commonly used anti-inflammatory agents in use today. 
Aspirin alone generates a revenue of approximately US$ 8 billion for Bayer (Jennewein, 2005). 
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Augmentin®, an antibacterial, sold over US $1.5 billion worldwide in 1997, and the patent did 
not expire until 2002 (Newman et al., 2000). Finally, a lovastatin (cholesterol-lowering drug 
from a fungus) derivative, simvastatin (Zocor) had sales in excess of $4.3 billion in 2006 (before 
loss of patent protection) (Li and Vederas, 2009). Thus, natural product drug discovery is a 
profitable endeavor. Several examples below highlight the significance and success of natural 
products isolated from the terrestrial environment. 
 
The “Golden Age” of Antibiotics. Discovered in 1928 by Dr. A. Fleming at St. Mary‘s 
Hospital in London, the observable lysis of pathogenic Gram-positive bacteria caused by 
penicillin began a revolutionary new path for antibiotic discovery and marketing. Although Dr. 
Fleming was not immediately aware of the significance of his own discovery until Florence and 
Chain published its biomedical potential in 1940 (Chain et al., 1940), the drug since went on to 
change health care for the better and led to the understanding of human infectious disease more 
than any other natural product to date (Rishton, 2008; van den Berg, 2008). Furthermore, 
penicillin represented the first drug which was powerfully active against many previously serious 
diseases, including syphilis, meningitis, and diptheria. As such, the ―blossoming‖ of drug 
discovery followed after the large scale production of penicillin for WWII, which encouraged 
pharmaceutical industries to refocus their efforts on the search for new antibiotics (Baker et al., 
2007; Dias et al., 2012). This marked the revolution of ―the Golden Age of Antibiotics‖, which 
refers to the time period from the 1940s to the 1970s and whose name was derived by the sheer 
number of antibiotics discovered during this time (Davies, 2006). It was during this time (1941) 
that the word ―antibiotic‖ was coined by Selman Waksman to describe any small molecule 
produced by a microorganism which inhibited the growth of other microorganisms (Davies, 
2006). Antibiotics discovered in the Golden Age were mainly isolated from fungi and 
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actinomycetes (Pelaez, 2006), which represents one half of the FDA-approved antibiotics still in 
use today (Davies, 2006; Williams, 2009). Notably, a particular actinobacterial genus 
Streptomyces sp. represented 70 – 80% of all the isolated compounds during this time (Berdy, 
2005), which were active against a wide range of bacterial and fungal infections (Berdy, 2005; 
Newman et al., 2000). The high number of microbial natural products discovered in the Golden 
Age of Antibiotics is not surprising, since some bacteria dedicate up to 20% of their genome to 
secondary metabolite biosynthesis (Yang et al., 2009). For example, 50 minor compounds were 
produced in addition to gentimicin in a Micromonospora sp. (Berdy et al., 1977). Owing to the 
success of microbe-derived products in treating serious human ailments, industries were inspired 
to invest time and resources into natural product drug discovery, particularly in the form of 
establishing microbiological and fermentation programs (Baker et al., 2007).  Major 
antimicrobial classes isolated during the Golden Age and beyond are displayed in Figure 1.2. 
 
Actinobacteria as prolific producers of bioactive metabolites. Actinobacteria  
represent a phylum of Gram-positive bacteria recognized for their high guanine-cytosine (GC) 
content (Hopwood, 2007; Stackebrandt et al., 1997). Actinomycetes account for approximately 
7,000 compounds reported (Jensen et al., 2005) and have been the origin of a significant number 
of marketed antibiotics (Pelaez, 2006), accounting for more than half of the bioactive secondary 
metabolites isolated from bacteria so far (Lam, 2006). The genome sequencing project of the first 
marine actinomycete revealed an unprecedented devotion to secondary metabolite biosynthesis 
(Lane and Moore, 2011), and with a genome size of up to 8 megabases, the genomes of 
actinomycetes are much larger than what is necessary for the basic sustenance of life (Hopwood, 
2007). As a result of its extensive genome size, it is widely believed that a significant portion of 
the genome may encode genes for secondary metabolite pathways (Hopwood, 2007). The 
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Figure 1.2: The timeline of major natural products isolated during the ―Golden Age‖ and beyond 
 
(Lewis, 2012). 
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secondary metabolite potential of Actinobacteria is particularly illustrated by the genus 
Streptomyces, which thrive in complex environments such as soil and sediment. Their 
competitive advantage in these complex environments is attributed to their catabolic enzyme 
activity, which enables Streptomyces sp. to exploit complex polymers such as starch, cellulose, 
and chitin; the likes of which many other microorganisms cannot utilize (Hopwood, 2007; 
Williamson et al., 2000). Furthermore, Streptomyces sp. account for 80% of the actinomycete 
derived natural products reported to date, a value beyond rival in the microbial world (Jensen et 
al., 2005). For example, one metabolically talented Streptomyces sp. reportedly synthesizes at 
least 30 different secondary metabolites, many of which were new compounds at the time of 
description (Schiewe and Zeeck, 1999). Currently, an estimated 1 – 3% of all Streptomyces sp. 
antibiotics have been discovered (Clardy et al., 2006), implying the promising biomedical 
potential of natural products from this important group of bacteria is only beginning to be 
understood (Gulder and Moore, 2009; Jensen and Fenical, 1996). The remaining majority of as- 
of-yet undiscovered actinobacteria represent a large, untapped source of chemical diversity 
which may be useful in drug discovery programs (Manyak and Carlson, 1999). 
 
 
 
 
DECLINE OF NATURAL PRODUCTS RESEARCH 
 
 
As highlighted in the examples above, financially and medically successful drugs have 
been isolated from various terrestrial organisms, including higher plants and microorganisms. 
Although industries were considerably involved in finding medicinal cures for common human 
ailments from terrestrial sources in the Golden Age, pharmaceutical companies have since 
terminated or significantly reduced their natural product pipeline (Butler, 2004). For example, in 
the 1970s approximately 60 – 70 new chemical entities (NCEs) were introduced, which dropped 
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to 40 NCEs introduced in the mid-nineties (Manyak and Carlson, 1999). Multiple valid reasons 
can explain this decline. First, antibiotic research declined due to ―solving‖ the perceived 
medical need, as the major causes of death caused by bacterial and fungal infections had 
seemingly been controlled by existing antimicrobials (Peláez, 2006). In addition, the cost of drug 
investment nearly tripled from US$10 billion to US$30 billion from the 1980s to the 2000s, 
while the return output of new drugs had considerably declined (Butler, 2004; Koehn and Carter, 
2005). The lengthy delay – usually 10 years or more – between the discovery and market launch 
of a new drug onto the market also impacted the decision to invest in new medicines (Koehn and 
Carter, 2005). Finally, the terrestrial environment had all been seemingly exhausted as a source 
for new antimicrobial compounds (Davies, 2006). 
 
Today, more than 30,000 diseases have been described, yet less than one-third can be 
treated and only a few cured (Zhang et al., 2005). However, industries are expected to provide 
safe/effective therapeutic agents (the humanitarian goal) and they also are expected to provide 
profitable drugs (the business goal; Baker et al., 2007). However, businesses cannot prosper and 
survive – and thereby cannot produce any drugs at all – if there is no financial return for their 
efforts in this market-based economy; hence, preference is given to those treatments which will 
offer considerable commercial success for their drugs (Baker et al., 2007). Consequently, short 
term cures, including antibiotics, have been grossly under investigated in comparison to drugs 
which are consumed daily for lengthy periods of time such as cholesterol lowering drugs (Baker 
et al., 2007; Li and Vederas, 2009). 
 
Although preference is given to highly profitable drugs, of serious and immediate 
concern is the increasing crisis of new and re-emerging microbial infectious diseases to which no 
effective antimicrobials are available (Cragg, 1997). As the use of an antibiotic invariably selects 
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for resistant microbes, there is a continuous need for discovering new antibiotics (Clardy et al., 
2006). For example, highly resistant strains of the ―superbug‖ methicillin-resistant 
Staphylococcus aureus (MRSA) were originally restricted to hospitals, yet are now widespread 
across the country (Lewis, 2012). Additionally, resistance to the β-lactam class of antibiotics has 
rendered drugs such as penicillin less effective (Baker et al., 2007). From a public health 
standpoint, there is an urgent pressure for researchers to invest in new antimicrobial agents. 
 
MARINE NATURAL PRODUCTS 
 
 
With the need for new antibiotics and medical treatments on the rise, over-mining of the 
terrestrial environment resulted in diminishing returns and the drug discovery platform collapsed 
(Kim, 2012). With regard to drug discovery and development, hope was provided in that the 
oceans began attracting interest from pharmaceutical companies and research institutions 
following the advent of the self-contained underwater breathing apparatus (SCUBA) (1970s), 
manned submersibles (1980s), and remotely operated vehicles (ROVs) (1990s) (Dias et al., 
2012). Now, organisms which were previously unavailable to researchers could be accessed with 
significant ease. 
 
In terms of natural product discovery, the marine environment provides a rational 
ecosystem for identifying new bioactive compounds which may be distinct compared to their 
terrestrial counterparts. With over 300,000 described marine species representing 34 of the 36 
described phyla (Donia and Hamann, 2003), the number of marine phyla surpasses that of the 
terrestrial environment (Sala and Knowlton, 2002), and represents the most biologically and 
chemically diverse habitat on the planet (Burgess, 2012). Furthermore, life began in the sea (Sala 
and Knowlton, 2002), and today the world‘s oceans cover over 70% of our planet‘s surface 
(Esquenazi et al., 2008). A wide variety of unique habitats are found within the world‘s oceans, 
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ranging from tropical, shallow water coral reefs to sub-zero, deep seas which harbour uniquely 
marine plant and invertebrate phyla (Jensen and Fenical, 1996). 
 
Despite offering a wide variety of unique habitats suitable for discovering new taxa, the 
oceans represent a relatively untapped yet rich resource for identifying bioactive natural products 
with applications in the pharmaceutical, cosmetic, agricultural, and nutritional supplements, each 
representing products with a potential multi-billion dollar market value (Ebada et al., 2008; 
Pomponi, 1999). The first marine natural products were identified in the 1950s by Bergman and 
Feeney, who isolated the unusual nucleosides spongothymidine and spongouridine from the 
Caribbean sponge Cryptotethya crypta (Bergman and Feeney, 1951). These structures served as 
lead structures for the discovery of the FDA approved drug for leukemia, Ara-C (1, Figure 1.3) 
and the anti-viral drug Ara-A (2). Since then, more than 20,000 structurally diverse marine 
natural products with unique bioactivities have been identified from marine microbes, algae, and 
invertebrates (Baker et al., 2007; Hu et al., 2011) representing a wide variety of natural product 
classes, including terpenes, acetogenins, alkaloids, and polyphenolics, with notable antifungal, 
antiviral, antibacterial, antiparasitic, anticancer, and antiprotozoal activities (reviewed in Blunt et 
al., 2012; Butler, 2008; Mayer et al., 2011; Newman et al., 2000). To date, the global marine 
pharmaceutical pipeline consists of four US-FDA approved marine-derived drugs (ziconotide, 
eribulin mesylate, cytarabine, vidarabine), one EU registered drug (ET-743), and 13 natural 
products which are in various phases of the clinical or pre-clinical pipeline (Mayer et al., 2010; 
Montaser and Luesch, 2011). 
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Figure 1.3: The sponge derived nucleosides Ara-C (1) and Ara-A (2). 
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As addressed by Jensen and Fenical (1996), it is with little wonder that marine natural 
products show little similarity to those isolated from the terrestrial environment, where 
completely different environmental challenges must be faced. Unlike their terrestrial 
counterparts, marine organisms must adapt to different environmental stressors including high 
pressure (up to ~1,100 atmospheres), salinity, limited light penetration, anaerobic environments 
at temperatures near freezing (0°C on the deep sea floor), high acidity (pH as low as 2.8), 
oligotrophic conditions, and temperatures exceeding 100°C near hydrothermal vents at the mid- 
ocean ridges (Lam, 2006). Furthermore, unlike their terrestrial counterparts, marine organisms 
must compensate for the enormous dilution factor owing to the aqueous nature of their 
environment which causes diffusion of their bioactive metabolites; consequently, marine natural 
products can be incredibly potent (Zhang et al., 2005). Marine organisms must therefore rely on 
unique adaptation strategies to deal with stress which may have resulted in the evolution of 
unique metabolic and physiological pathways (Jensen and Fenical, 1996), resulting in secondary 
metabolites which can differ significantly from those isolated in the terrestrial environment 
(Fenical, 1993). For instance, halogenation is a common phenomenon in marine natural products, 
presumably owing to the ready availability of chlorine in seawater (Lam, 2007; Simmons et al., 
2005) and is vital for bioactivity in some marine secondary metabolites (Jensen et al., 2005). 
This is particularly highlighted by the marine metabolite Salinisporamide A, (3, Figure 1.4; 
Nereus Pharmaceuticals) a γ-lactam-β-lactone which displays potent cytotoxicity against HCT- 
116 human colon carcinoma (IC50 value of 11 ng/mL) (Williams et al., 2005). The growth of the 
producing actinomycete, Salinispora tropica, (Figure 1.4) is dependent on sodium concentration 
(Lam et al., 2006) and the loss of the chloroethyl moiety reduces biological activity by a 500- 
fold reduction as demonstrated previously (Williams et al., 2005). FDA approved drugs from 
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Figure 1.4: The Actinomycete Salinispora tropica and its halogenated natural product, 
 
Salinisporamide A (3). Image from Mayer et al., 2010. 
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marine sources are reviewed by Mayer (2010), and marine natural products with significant 
biomedical and financial value are discussed below and highlighted in Table 1.1. 
 
ET-743. Undoubtedly one of the most successful marine natural products to date is ET- 
743 (Yondelis®, generic trade name trabectedin; PharmaMar/Johnson & Johnson), (4, Scheme 
1.1) which was isolated from the tunicate Ecteinascidia turbinata (Figure 1.5) from mangroves 
in the Caribbean and Mediterranean Sea (Mayer et al., 2010; Rinehart et al., 1990; Zewail-Foote 
and Hurley, 1999). Its impressive in vitro nanomolar potency in preclinical trials against a wide 
variety of human cancer cell lines promoted its rapid progression to Phase I clinical trials in the 
1990s (Izbicka et al., 1998; Rinehart et al., 1990; Zewail-Foote and Hurley, 1999).This 
compound was the first marine anticancer drug to be approved in the EU for patients with soft 
tissue sarcoma and relapsed platinum-sensitive ovarian cancer (Mayer et al., 2010). As of 2002, 
it had been used to treat 1,000 patients in European and American hospitals (Proksh et al., 2002). 
However, its progression through clinical trials was delayed due to a low source of supply 
(Proksch et al., 2002). Although total synthesis had been published, the 44-step procedure 
resulted in a yield of less than 1% (Rinehart, 1999). However, researchers at PharmaMar 
reported a scientific breakthrough by performing a 21-step, semi-synthesis starting with 
cyanosafracin B (5, Scheme 1.1), an antibiotic of bacterial origin which can be produced in a 
cost-effective, multi-kilogram scale by bulk fermentations of the bacterium Pseudomonas 
fluorescens (Cuevas et al., 2000). Interestingly, this bacterial metabolite was a close analog of 
the ecteinascidin, and therefore provided a platform for the generation of this important 
anticancer agent. 
  
Table 1.1: Marine natural products in the clinical pipeline. Adapted from Mayer et al. (2010) and Haefner (2003). 
 
 
Compound 
Name 
Clinical 
Status 
Original Marine 
Source 
Natural 
Product 
Class 
Treatment Molecular 
Target 
Licensing 
Company 
Reference 
Ara-C 
(Cytosar-U®) 
Approved The sponge 
Cryptotethya crypta 
Nucleoside Cancer DNA 
polymerase 
Bedford, Enzon Bergman and Feeney, 1950; 
Furth and Cohen, 1968. 
Ara-A 
(Vira-A®) 
Approved The sponge C. crypta Nucleoside Antiviral Viral DNA 
polymerase 
King 
Pharmaceuticals 
Bergman and Burke, 1955; 
Furth and Cohen, 1968 
Ziconotide 
(Prialt®) 
Approved 
(FDA; EU) 
The cone snail Conus 
magus 
Peptide Analgesic N-type Ca
2+ 
channels 
Elan 
Pharmaceuticals 
Olivera and Cruz, 2001 
ET-743 
(Yondelis™) 
Approved 
(EU only) 
The tunicate 
Ecteinoscidia turbinata 
Alkaloid Cancer Minor groove 
of DNA 
Pharmamar Rinehart et al., 1990; Izbicka 
et al., 1998; Rath et al., 2011 
Eribulin 
Mesylate 
(Halaven™) 
Approved 
(2010) 
The sponge 
Halichondria okadai 
(derivative) 
Macrolide Cancer Microtubules Eisai Inc. Stamos et al., 1997; Molinski 
et al., 2009 (reviewed) 
DMXBA (GTS- 
21) 
Phase II The Nemertine worm 
Paranemertes sp. 
Alkaloid Alzheimers 
Disease; 
Schizophreni
a 
Nicotinic 
acetylcholine 
receptor 
Comentis; Taiho Kem et al., 2006 
Discodermolide Phase I The deep-water sponge 
Discodermia dissoluta 
Polyketide Cancer Microtubules Novartis Gunasekera et al., 1991 
Methopterosin 
(OAS1000) 
Phase II 
complete 
The octocoral 
Pseudopterogorgia 
elisabethae 
(Derivative) 
Diterpene 
glycoside 
Wound 
healing; 
inflammation 
PLA2 OsteoArthritis 
Sciences 
Fenical, 1997 
Pseudopterosins Phase II 
complete 
The octocoral 
Pseudopterogorgia 
elisabethae 
Diterpene 
glycoside 
Inflammation, 
analgesic, 
cosmetic 
applications 
PLA2 NA Look et al., 1986a,b; Mayer 
et al., 1998 
Salinosporamid 
e A 
(Marizomib) 
Phase I The marine bacterium 
Salinisporamide A 
β-lactone-γ- 
lactam 
Cancer 20S 
proteasome 
Nereus 
Pharmaceuticals 
Williams et al., 2005 
Bryostatin 1 Phase I 
complete 
The bryozoan Bugula 
neritina 
Polyketide Cancer Protein kinase 
inhibitor 
GPC Biotech Pettit et al., 1982 
Dolastatin-10 Phase II 
complete 
The sea slug Dolabella 
auricularia 
Peptide Cancer Microtubules NCI/Knoll Haefner, 2003 
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Scheme 1.1: The production of ET-743 (4) is generated semi-synthetically using cyanosafracin B 
 
(5), a metabolite of bacterial origin. 
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Figure 1.5: The sea squirt Ecteinascidia turbinata. Image obtained from Li and Vederas (2009). 
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Eribulin mesylate. A second example of a marine natural product with exceptional 
medical and commercial value is that of the FDA-approved halichondrin B (6, Figure 1.6) 
derivative eribulin mesylate (Halaven™, Eisai) (7). Since their discovery from the sponge 
Halichondria okadai (Figure 1.6) by researchers in Japan in the mid-1980s and subsequently in 
the deep water sponge Lissodendoryx sp. in the 1990s, the halichondrins have been the subject of 
numerous investigations owing to their potent in vivo antitumor activity (Hirata and Uemura, 
1986). Owing to their phenomenal potency, even small quantities of Halichondrin B could be 
commercially valuable (Simmons et al., 2005) and as of 2002, the promising bioactivity of 
Halichondrin B encouraged the US National Cancer Institute to progress the compound to Phase 
I clinical trials (Molinski et al., 2009). However, the supply is extremely limited in the 
invertebrate host, yielding approximately 0.4 mg of halichondrin B per kilogram of 
Lissodendoryx sp. (Proksch et al., 2003). In order to be approved as an FDA drug for cancer 
treatments, an estimated one to five kg per year is required, requiring roughly 3,000 – 16,000 
metric tonnes of sponge biomass annually (Proksch et al., 2003). Although two different sponge 
species contained Halichondrin B – which would thereby mitigate some ecological damage 
caused by overharvesting one species – the supply paradigm prevented full clinical use. 
Although total synthesis was reported in the early 1990s, the procedure took 90 steps to perform 
(Aicher et al., 1992a, b) and still resulted in poor yields. 
 
Ingeniously performed by researchers in Japan, a significant breakthrough was achieved 
by truncating synthetic analogues of halichondrin B. Here, it was demonstrated that only the 
right-hand portion of the molecule was required for nearly equal activity with Halichondrin B 
against tumor cells (Stamos et al., 1997; Wang et al., 2000). The bioactivity was reported to 
reside in the macrocyclic lactone corresponding to the C1 – C38 moiety, and this derivative was 
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Figure 1.6: The sponge Halichondria okadai (image obtained from Mayer et al., 2010), 
 
Halichondrin B (6) and Eribulin mesylate (7). 
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named eribulin mesylate  (Stamos et al., 1997; Wang et al., 2000). This work culminated in the 
scale up of eribulin mesylate (Molinski et al., 2009), which could be generated in quantities 
suitable for clinical investigations (Huyck et al., 2011). Today, eribulin mesylate is approved by 
the European Union for use in patients with advanced breast cancer (Molinski et al., 2009), and 
is in various other clinical trials due to its in vitro activity against a variety of other cancer cell 
lines (McBride and Butler, 2012). 
 
 
 
 
NATURAL PRODUCTS FROM CORALS 
 
 
Natural Products from Scleractinians 
 
 
As highlighted in the examples above, the marine environment offers a unique array of 
secondary metabolites which have significant biomedical applications. Scleractinian corals are 
the primary builders of coral reefs, yet are traditionally not known to produce secondary 
metabolites, presumably due to their physical protection via a calcareous exoskeleton (Coll, 
1992). Notable exceptions of marine natural products isolated from scleractinians include 
alkaloids, primarily the aplysinopsins (Bialonska and Zjawiony, 2009; Koh and Sweatman, 
2000), macrolides (Rashid et al., 1995), and cytotoxic sterols (Guerriero et al., 1996). 
 
Natural Products from Octocorals 
 
 
In contrast to scleractinian corals, chemical investigation of alcyonacean octocorals over 
the past several decades has uncovered a wealth of structurally diverse metabolites which 
possess an equally diverse array of biological activities. The identification of large quantities of 
prostaglandins (which have biomedical applications involved in inflammatory disease, fever, and 
pain) from the alcyonacean Plexaura homomalla by Weinheimer and Spraggins in 1969 has been 
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considered as the ―take-off point‖ for serious efforts of drug discovery from the sea (Proksh et 
al., 2002). Since then, the common structural classes isolated from alcyonacean octocorals 
includes sesqui- and diterpenes (Berrué and Kerr, 2009) and highly functionalized steroids (Coll, 
1992; Fenical, 1987). In particular, diterpenes isolated from octocorals have a range of biological 
activities which can be applied to areas of human health, including anti-cancer (most common), 
anti-inflammatory, antiplasmodial, antibacterial (generally against Gram-positive bacteria), 
antiviral, and antioxidants (Berrué and Kerr, 2009; Berrué et al., 2011a). As a result of the low 
internal source of supply, many octocoral derived natural products have not become FDA 
approved drugs. For example, the encrusting octocorals Eleutherobia sp. and Erythropodium 
caribaeorum are the sources of the cytotoxic diterpene eleutherobin, which shows a similar 
nanomolar potency (IC50 is 10 ± 15 nM) and mechanism of action as paclitaxel against a broad 
range of selective cancer cell lines (Hamel et al., 1999; Lindel, 1998). However, eleutherobin is 
available only in scarce amounts, comprising between 0.01 – 0.03% of the dry weight of 
Eleutherobia sp. (Lindel, 1998). The related diterpene glycoside desmethyleleutherobin 
demonstrates comparable anticancer activity to Taxol with an IC50 of 20 nM (Berrué et al., 
2011a). Similarly, the fuscosides, diterpenes isolated from the alcyonacean Eunicea fusca, 
demonstrate superior anti-inflammatory activity compared with the industry standard 
indomethacin by inhibition of the enzyme 5-lipoxygenase (Berrué et al., 2011a). Again, the 
supply of these important diterpenes in their native environment is low and their progression 
through clinical trials has consequently been hampered. 
 
Natural products from Pseudopterogorgia elisabethae 
 
 
Particular attention on natural products isolated from alcyonaceans has been given to the 
octocoral Pseudopterogorgia elisabethae. Chemical investigation on this important octocoral 
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was initiated by Fenical and co-workers in the mid-1980s following the discovery of the 
pseudopterosins (Look et al., 1986a,b), diterpene glycosides with potent anti-inflammatory and 
analgesic properties comparable to the industry standard indomethicin. Studies have since 
revealed that P. elisabethae is host to a remarkably diverse array of compounds with over 78 
compounds representing 20 distinct terpene skeletons being reported (Ata et al., 2004; Berrué 
and Kerr, 2009; Rodriguez and Shi, 2000). Not only is the chemical diversity particularly 
valuable, the reported biological activities are also incredibly diverse and display notable 
cytotoxic, antibacterial, anti-inflammatory, antiviral, anti-tuberculosis, and analgesic activities 
(reviewed in Berrué and Kerr, 2009). The natural products of P. elisabethae and its associated 
biological activities have been reviewed in detail elsewhere (Berrué et al., 2011a; Flachsmann et 
al., 2010; Rodriguez et al., 2004). 
 
Pseudopterosins. The pseudopterosins (Figure 1.7, general structure, 8) were the first natural 
products to be isolated from Bahamian collections of the octocoral P. elisabethae. These 
diterpene glycosides demonstrated significant anti-inflammatory and analgesic activity (Look et 
al., 1986a, b) which were significantly more potent than indomethicin in blocking topical 
inflammation (K =8.93 x 10
-4 
M for pseudopterosin A and 40 mM for indomethicin) in mouse 
ear models and were potent inhibitors of phospholipase A2 (IC50 = 3.0 µM in vitro) (Look et al., 
1986a, b; Mayer et al., 1998), the key enzyme involved in the biosynthesis of inflammatory 
eicosanoid mediators (Proksch et al., 2002). The most biologically active pseudopterosin 
discovered at the time – pseudopterosin A (PsA, 9) – also displayed analgesic potential several 
times more potent than indomethacin (ED50 of PsA is ca. 3.12 mg/kg versus ca. 10 mg/kg for 
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Figure 1.7: The general structure of the pseudopterosins (8) and pseudopterosin analogues PsA 
 
(9), PsE (10), and methopterosin (11). 
45  
indomethacin) (Look et al., 1986a). Shortly thereafter, pseudopterosin E (PsE, 10) was reported 
from a Bermudian collection of P. elisabethae, which was reportedly less acutely toxic in mice 
(LD50 > 300 mg/kg) than pseudopterosin A (Roussis et al., 1990). The pseudopterosins appear to 
act by a novel mechanism of action distinct from other non-steroidal anti-inflammatory drugs, 
which involves inhibiting eicosanoid biosynthesis in polymorphonuclear leukocytes (Kijoa and 
Sawangwong, 2004; Kohl and Kerr, 2004). A total of 31 pseudopterosins have been described 
which differ structurally in the location and identity of the sugar unit, yet the aglycone skeleton 
is identical (Berrué et al., 2011a). Today, the pseudopterosins are prized both as anti-irritants in 
cosmetic applications (Roussis et al., 1990) and for their progression past Phase II clinical trials 
as anti-inflammatory agents (Mayer et al., 2010). The pseudopterosins have also met with 
unexpected financial success for their use as additives in the Estée Lauder™ Resilience Lift line 
to prevent irritation caused by sun exposure (Kijjoa and Sawangwong, 2004) and for reducing 
skin degeneration (Fenical, 1997). Additionally, a simple derivative of the pseudopterosins, 
methopterosin (11), has been approved by the FDA for clinical trials (Correa et al., 2009) as a 
superior wound healing agent, which enhances wound healing by over 400% and is therefore an 
attractive treatment for burn victims and for disorders involved in the healing process (Fenical, 
1997). However, as the coral is the sole known source of these biomedically important 
diterpenes, an estimated 30 – 45 tons of P. elisabethae have been harvested per year from the 
Bahamas since the mid-1990s (Gutierrez-Rodriguez and Lasker, 2004; Puyana et al., 2004). 
Hence, defining alternative and viable sources for generating suitable supplies is critical 
(Mydlarz et al., 2003). While the pseudopterosins have successfully completed Phase II clinical 
trials as a topical anti-inflammatory agent, further progression of the drug has been hindered by 
supply issues (Berrué et al., 2011a). Owing to the complexity of the structure and based on the 
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fact that the pharmacophore is not yet entirely understood (Berrué et al., 2011a), chemical 
synthesis is not an option; therefore, the pseudopterosins are awaiting further clinical testing until 
a suitable supply can be generated. 
 
 
 
 
NATURAL PRODUCTS FROM MARINE BACTERIA 
 
 
Microorganisms, particularly bacteria and fungi, produce the majority of all described 
clinically useful microbial natural products to date (Baker et al., 2007). Within the kingdom 
Bacteria, the majority of natural products isolated from marine bacteria between 1997 to 2008 
producing all known anti-infective agents parallels the same five bacterial phyla as those 
described from the terrestrial environment: Actinobacteria (n = 256 compounds), Cyanobacteria 
(n = 220), Proteobacteria (n = 78), Firmicutes (n = 35), and Bacteriodetes (n = 34) (Williams, 
2009). The Antibase database (a collection of all published microbial natural products) contains 
approximately 38,843 natural products, with about 1,000 derived specifically from marine 
microbes as of 2005 (Singh and Pelaez, 2008). Currently, the metabolite Salinisporamide A 
produced by the obligate marine bacteria Salinispora tropica is in clinical trials for the treatment 
of cancer (Mayer et al., 2010). 
 
 
 
 
AN ISSUE CONCERNING MARINE NATURAL PRODUCT DRUG DISCOVERY 
 
 
The supply issue. As has been identified above, a serious impediment causing delays in 
many marine natural products currently undergoing clinical or pre-clinical trials is the problem 
of low compound availability. In order to qualify as a drug, however, an adequate supply of the 
metabolite of interest must first be procured (Cragg et al., 1999). Nevertheless, yields of 1 mg of 
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the target compound per 3 kg of organism are not uncommon in many marine invertebrates 
(Newman and Cragg, 2004), often requiring collections of 5 – 50 kg of the host organism (Cragg 
et al., 1999; Proksch et al., 2002). It is easily apparent that invertebrate harvesting to supply the 
biologically promising natural product from nature cannot be performed without risking species 
extinction (Proksch et al., 2002). To mitigate the supply issue and to bridge the gap between 
medical potential and commercial application, numerous methods are generally considered. 
 
 
 
 
MITIGATING THE SUPPLY ISSUE 
 
 
Mariculture. Mariculture of the invertebrate, where the host organism is ―farmed‖ in 
controlled areas, has been tested in some cases. For instance, bryostatin-1 and ET-743 can be 
generated at least partially by mariculture of the bryozoan Bugula neritina and the tunicate E. 
turbinata respectively (Mendola, 2000; Proksch et al., 2002). Prior to mariculture, bryostatins 
were collected by invertebrate harvesting off the southern coast of California where the 
invertebrate is most abundant, yet it took divers employed by the NCI two years to collect 17 
tons of the organism (Haefner, 2003). However, weather events, pests, and infection can often 
render cultured marine invertebrates vulnerable to destruction (Fortman and Sherman, 2005). 
Furthermore, in most cases marine aquaculture still fails to produce sufficient yields of the 
metabolite of interest as required should the drug enter the market (Donia and Haman, 2003; 
Fortman and Sherman, 2005; Proksch et al., 2002). For example, the octocoral derived 
metabolite eleutherobin can be produced by mariculture of Erythropodium caribaeorum, which 
yields 0.0012% (wet weight), a value which cannot sustain clinical trials (Fortman and Sherman, 
2005). Hence, other avenues of generating sufficient quantities of bioactive metabolites are 
needed. 
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Chemical synthesis. It is noteworthy to mention that natural product chemical structures 
can be extremely complex, costly to synthesize, and can still result in small yields (Baker et al., 
2007; Fortman and Shermann, 2005; Proksch et al., 2003); thus, chemical synthesis is not always 
a viable option. Highly complex molecular structures are incredibly difficult to synthesize, and 
therefore, synthesis is not a practical means to commercially supply natural products. For 
example, the microtubule-stabilizing polyketide (+)-Discodermolide was coveted for its 
improved aqueous solubility (Koehn and Carter, 2005) and improved potency compared to 
paclitaxel (ter Haar et al., 1996), qualifying the compound as an exceptional anticancer candidate 
(Koehn and Carter, 2005). As is the case with many other marine invertebrates, discodermolide 
is isolated in low quantities in the host organism (0.002% wet weight) (Fortman and Sherman, 
2005). Although its daunting structure was finally synthesized by the team at Novartis, the yields 
were still less than 1% (reviewed in Fortman and Sherman, 2005). 
 
Heterologous host expression. A third approach to overcoming the supply issue is 
through heterologous host expression. As mentioned previously in this chapter, an estimated 
<1% of microbes are available in pure culture, yet cultivated marine microorganisms have 
yielded a number of promising therapeutics (Williams, 2009). In heterologous host expression, 
natural product biosynthetic genes are expressed in a microbial host which is amenable to 
culturing and production on a large scale (Clardy et al., 2006). By using genetic expression of 
uncultivated bacterial DNA in an easily cultured heterologous host, one can bypass cultivation 
by directly accessing the genes encoding for secondary metabolites (Brady et al., 2001; Clardy et 
al., 2006). The key to successful application lies in selecting a suitable host, which if chosen 
appropriately, should have a proper metabolic and genetic background in a close approximation 
to the native cellular environment (Clardy et al., 2006; Fortman and Sherman, 2005). The first 
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example of successfully cloning a marine natural product biosynthetic gene cluster from a 
bacterial symbiont was performed by Schmidt et al. (2005). Here, the authors reported the 
successful expression the peptides petallamide A and C into the heterologous host, Escherichia 
coli, revealing the practicality of heterologous host expression. Clearly, heterologous host 
expression has important implications for the production of otherwise inaccessible marine drugs. 
However, identifying natural product gene clusters from clone libraries from the presumed 
metabolic producer can be tedious and time consuming (Gulder and Moore, 2009), while 
differences in background metabolism can be challenging barriers rendering genes incompatible 
with the most commonly used hosts (Clardy et al., 2006). 
 
Fermentation. A final method to overcome the problems of supply and sustainability of 
marine derived natural products is through fermentation. Fermentation can be a more cost 
effective alternative compared to chemical synthesis, as copious amounts of starting natural 
product material can be obtained from microbes which are amenable to culturing (Baker et al., 
2007; Koehn and Carter, 2005). Furthermore, cultures can remain viable for many years without 
appearing to undergo degenerative changes (Backus and Stauffer, 1955), and can therefore 
generate a continuous supply using the same starting material. Microbial recovery is simple, 
requiring only aseptic removal of a small quantity of stock on a selected medium (Backus and 
Stauffer, 1955). Furthermore, natural product production via fermentation is rapid, and 
biosynthesis has been documented after only 22 hours of growth (Yang et al., 2009). Examples 
of unmodified marine secondary metabolites produced by bacterial fermentation include 
thiocoraline, salinosporamide A, and curacin A (Fortman and Sherman, 2005). However, it is 
also important to recognize that fermentation of a microbial natural product is only possible 
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when the metabolite of interest can be isolated from a viable microbial culture (Fortman and 
Sherman, 2005). 
 
 
 
 
SYMBIOTIC MICROORGANISMS AS POTENTIAL BIOSYNTHETIC PRODUCERS 
OF NATURAL PRODUCTS 
 
It is important to note that the presence of a secondary metabolite within a particular cell type is 
not indicative of its biosynthetic origin (Simmons et al., 2008). Although localization of natural 
products to a specific cell type may form the basis for some arguments regarding biosynthetic 
origin, in truth, localization does not necessarily correspond to the site of production (Fortman 
and Sherman, 2005). For instance, although a wide variety of biomedically important natural 
products have been isolated from invertebrates, recent theories based on genetic and 
radiolabeling studies have demonstrated that at least some natural products may be produced by 
their associated microbial endosymbionts (Boehnlein et al., 2005; Davidson et al., 2001; 
reviewed in König et al., 2006; Mydlarz et al., 2003; Schmidt et al., 2005; Sharp et al., 2007). 
As marine invertebrates harbor abundant populations of symbiotic microorganisms (Gulder and 
Moore, 2009) and given that many marine invertebrates have existed for hundreds of millions of 
years, it is reasonable to propose that symbiotic bacteria have co-evolved with the invertebrate 
host (Fortman and Sherman, 2005). Hence, it is indeed possible that the host invertebrate may be 
sequestering microbial-produced metabolites. However, such a relationship has yet to be 
conclusively proven (Fortman and Sherman, 2005), as bacterial endosymbionts are highly 
fastidious and have thus far avoided cultivation attempts (Piel et al., 2004). Other examples of 
symbiotic bacteria as possible producers of invertebrate-derived natural products have been 
reviewed elsewhere (König et al., 2006; Proksch et al., 2002) and are summarized in Table 1.2. 
  
Table 1.2: Selected marine natural products from invertebrates suspected to be of microbial origin. 
 
 
Compound Host Invertebrate Microbial Producer/Chemical Similarity Reference 
Taxol The Yew Taxus sp. The fungus Seimatoantlerium tepuiense Tulp and Bohlin, 2002; Strobel et al., 
 
1999 
Mycalamides (including 
 
mycalamides, 
onnamides, and 
theopederins) 
The sponge Mycale; Theonella sp.; and 
 
Discodermia sp.; the ascidian 
 
Polysincraton sp. 
Similar to pederin (see below); suggestive of 
 
microbial origin 
Dyshlovoy et al., 2012 
Pederin The beetle Paederus fuscipes Uncultured Pseudomonas aeruginosa 
 
(bacterium) 
Piel, 2002; Piel et al., 2004; Kellner et 
 
al., 2001, 2002 
Swinholide A The sponge Theonella swinhoei Candidatus Entotheonella palauensis 
 
(bacterium); Cyanobacterial symbiont 
Schmidt et al., 2005; Andrianasolo et 
 
al., 2005 
Bryostatin-1 Bryozoan Bugula neritina Candidatus Endobugula neritina Davidson et al., 2001; Sudek et al., 
 
2007; Sharp et al., 2007 
ET-743 (Yondelis) Tunicate Ecteinoscidia turbinata Pseudomonas fluorescens (bacterium); 
 
Safracin B 
Ikeda et al., 1983; Cuevas et al., 2000 
Pseudopterosin The octocoral Pseudopterogorgia 
 
elisabethae 
The dinoflagellate Symbiodinium sp.; the 
 
bacterium Pseudomonas aeruginosa 
Coleman and Kerr, 2000; Mydlarz et 
 
al., 2003; Newberger et al., 2006; 
Bunyajetpong et al., 2011 
Jasplakinolide Jaspis spp. (sponges) Chondromyces crocatus (myxobacterium); 
 
Chondramide D 
Proksch et al., 2003 
Dolastatin 10 The mollusc Dolabella auricularia Symploca hydnoides (cyanobacterium); 
 
Symplostatin-1 
Luesch et al., 2001 
Okadaic acid The sponge Halichondria sp. Prorocentrum sp. (dinoflagellate) Proksch et al., 2003 
Patellamides A and C Ascidian Lissoclinum patella Cyanobacterial symbiont Schmidt et al., 2005 
Aplysinamisin-1 The sponge Aplysina aerophoba Chloroflexi phylotype (same compound) Sacristán-Soriano et al., 2011 
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Pederin. One such means through which natural products are linked to microbial origin is 
through genetic analysis. For example, pederin (12, Figure 1.8) is a defensive polyketide isolated 
from female (+) beetles of the species Paederus fuscipes (Kellner et al., 2001), where the 
metabolite shows strong cytotoxicity against a panel of human cancer cell lines in vitro and in 
vivo (Proksch et al., 2003). However, 16S rRNA gene sequencing analysis of (+)-pederin 
containing (female) beetles revealed an endosymbiotic strain of the Gammaproteobacteria 
Pseudomonas aeruginosa was implicated as the most likely producer of the defensive polyketide 
(Kellner et al., 2001, 2002; Piel et al., 2002a, b). Cloning of the putative pederin biosynthetic 
gene cluster has been reported from the total DNA of P. fuscipes beetles (Piel et al., 2004). 
Sequence analysis of the ped gene cluster included a typical bacterial architecture consisting of a 
mixed modular polyketide synthase/nonribosomal peptide synthase and tailoring enzymes, 
thereby providing strong evidence of the prokaryotic origin of pederin (Piel, 2002). Using a 
similar approach, the authors discovered the structurally related compound, onnamide A, from 
the metagenome of the sponge Theonella swinhoei, to which putative gene clusters involved in 
natural product biosynthesis was linked to bacterial origin from an as-of-yet uncultivated bacteria 
(Piel et al., 2004). Furthermore, pederin shows a strong structural resemblance to the sponge 
derived cytotoxic metabolite mycalamide A (Figure 1.8, 13), which suggests the latter metabolite 
may also be of bacterial origin (Proksch et al., 2003). This is due to the fact that it is generally 
accepted that isolating similar compounds from disperate regions of the world (including 
chemical conservation between the terrestrial and the marine environment), is indicative of a 
common microbial biosynthetic origin (Proksch et al., 2003). Conclusive experimental evidence 
for the hypothesis that microbial endosymbionts are the true biosynthetic producers has not yet 
been proven, as attempts to isolate the endosymbionts possibly responsible have thus far 
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Figure 1.8: The structural resemblance of mycalamide A (25) and pederin (26). 
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resisted cultivation on standard Zobell media (Proksh et al., 2003). 
 
 
ET-743. Additional evidence supporting the hypothesis that many natural products 
originate from symbiotic (sensu lato) microorganisms is reflected by evidence from the FDA- 
approved anticancer agent ET-743. As described earlier, ET-743 (4) is isolated in low abundance 
from its native tunicate source E. turbinata (Zewail-Foote and Hurley, 1999). The chemical 
similarity of ET-743 to the Pseudomonas fluorescens (bacteria) originating metabolites the 
safracins is so pronounced that commercial production of ET-743 is produced partially 
synthetically using a biotechnologically available cyanosafracin B (Scheme 1.1, 5, Cuevas et al., 
2000; Ikeda et al., 1983). Naturally, one would assume, given that the microbe is the true 
producer, that the biosynthetic microbial producer would be persistently associated with the 
invertebrate host (Perez-Matos et al., 2007). One particular endosymbiont in E. turbinata, 
Candidatus Endoecteinascidia frumentensis, was found via molecular techniques to be 
specifically associated with E. turbinata from the Caribbean and Mediterranean, locations where 
the tunicate harbours ET-743 (Mendola, 2000; Perez-Matos et al., 2007). Furthermore, rigorous 
sequence analysis based on codon usage performed by Rath et al. (2011) suggested that the 
uncultivated bacterium Candidatus E. frumentensis contains the relevant biosynthetic machinery 
to produce ET-743, and the predicted enzyme activity for the tetrahydroisoquinoline core 
assembly was verified in vitro. Hence, based on the examples demonstrated herein and as 
pointed out by Proksch et al. (2002), it is tempting to assume that compounds such as ET-743 are 
introduced to their respective host invertebrate from their symbiotic microbial counterparts, 
rather than reflecting a mere chemical coincidence (Proksch et al., 2002). 
 
Pseudopterosins. As mentioned previously, the octocoral Pseudopterogorgia elisabethae 
 
is the sole known source of the commercially and medically important compounds the 
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pseudopterosins. Initially assumed to be of invertebrate origin (Look et al., 1986a, b), convincing 
evidence from the Kerr lab suggests the true biosynthetic source of the pseudopterosins may be 
of microbial origin (Boehnlein et al., Kerr, 2005; Bunyajetpong et al., 2011; Bunjayetpong, 
2011; Frenz-Ross et al., 2008; Mukherjee, 2003; Mydlarz et al., 2003; Newberger et al., 2006; 
Thornton and Kerr, 2002). For example, radiolabeling studies using 
14
C-labeled inorganic carbon 
and the tritium labeled intermediate geranylgeranyl diphosphate (GGPP) revealed purified 
dinoflagellate symbionts free of P. elisabethae cells were capable of inducing pseudopterosin 
biosynthesis (Mydlarz et al., 2003). Additionally, a positive correlation between the number of 
Symbiodinium sp. cells and pseudopterosin concentration was observed. Finally, algal cells 
maintained in the dark did not produce 
14
C-labeled pseudopterosins while algal cells maintained 
on a dark/light cycle produced pseudopterosins, providing strong evidence that the 
photosymbiotic symbiont was necessary for pseudopterosin biosynthesis. For the first time, these 
results revealed that pseudopterosins were produced independent of the host coral, yet the 
authors noted that zooxanthellae cells were not free of bacteria or fungi. As pseudopterosin 
biosynthesis was inhibited by 100 µM of mevastatin, a known anti-bacterial, this indicated 
pseudopterosin biosynthesis may involve prokaryotic biosynthetic machinery. This is particularly 
supported by the fact that pseudopterosins are present in the gametes of P. elisabethae, which 
themselves are free of symbiotic dinoflagellates (Mukherjee, 2003), while a pure Pseudomonas 
aeruginosa strain Ps137 subsequently was capable of producing pseudopterosins (Bunyajetpong 
et al., 2011). Hence, preliminary evidence suggests a bacterium may be the true producer of the 
pseudopterosins, yet further experiments are required to confirm that P. aeruginosa is truly 
responsible for pseudopterosin production. 
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CORAL-ASSOCIATED BACTERIA AS A UNIQUE NICHE TO INVESTIGATE NOVEL 
NATURAL PRODUCTS 
 
As mentioned previously, the majority of species cannot be cultivated using today‘s 
technology. However, recent pyrosequencing analysis of the 16S rRNA gene sequence 
community of the Sargasso Sea demonstrated that the majority of phylotypes belonged to the 
―rare biosphere.‖ If previously uncultured microorganisms dominate the total community, then 
this represents a significant, novel, and untapped resource for natural product drug discovery 
(Rondon et al., 1999). Interestingly, the previously described ―rare biosphere‖, referring to the 
rare phylotypes uncovered by next generation sequencing, was sampled from marine water 
(Sogin et al., 2006). As coral associated bacterial concentrations on corals are higher than that of 
the surrounding seawater (Herndl and Velimirov, 1986), corals may prove to yield an even 
higher source of rare phylotypes. In drug discovery programs, maximum biological diversity is 
essential for discovering unique, novel chemical diversity (Singh and Pelaez, 2008). As corals 
harbor high levels of biological diversity via their associated bacteria, and given the hypothesis 
that a high biological diversity translates to a high chemical diversity, coral-associated bacteria 
may offer new natural products with unprecedented structural diversity. Interestingly, recent 
compelling evidence has suggested many of the approved drugs or drug leads previously 
assumed to be of invertebrate origin may be produced by their microbial inhabitants (Boehnlein 
et al., 2005; Davidson et al., 2001; Kador et al., 2011; König et al., 2006; Mydlarz et al., 2003; 
Sharp et al., 2007). 
 
Although the scientific understanding of the ecological roles of marine natural products 
in octocorals is limited, the enormous benefit to the health and quality of life to mankind has 
maintained a continuous interest in their discovery and use; furthermore, characterizing the 
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healthy microfauna associated with these important marine invertebrates has general implications 
for reef conservation and management. Not only do coral extracts provide society with cures for 
disease and ailments, they also generates substantial revenue due to the scale-up and sale of 
bioactive compounds in an ecologically sustainable and continuous source of supply. In 
summary, as a result of their global prevalence and valuable economic, humanitarian, and 
ecologic benefits, the study of corals – including their microbial associates – is both a noble and 
worthy pursuit. 
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RESEARCH GOALS, HYPOTHESES, AND SIGNIFICANCE 
 
 
Despite the growing wealth of knowledge regarding scleractinian-associated bacterial 
diversity, little is known regarding bacterial populations in alcyonacean octocorals. In addition, 
the culture-independent methodologies which have enhanced our knowledge regarding 
scleractinian coral-associated bacterial communities have only rarely been applied to studying 
bacterial communities residing within the octocoral holobiont. Not only would understanding 
bacterial communities in octocorals provide a basis for octocoral ecological management, but an 
exploration of their associated bacterial communities can also provide a resource for identifying 
novel secondary metabolites. Such discoveries will contribute to our understanding of octocoral 
associated bacterial communities and provide a resource for natural product discovery. 
 
No study has investigated the bacterial diversity and natural product potential of bacteria 
associated with the octocoral P. elisabethae. This is a model organism to investigate octocoral- 
associated bacteria owing to the coral‘s broad geographic distribution and commercial 
significance (Berrué et al., 2011a). The thesis research goals herein are threefold: 
 
1) To characterize the culture-independent bacterial community associated with P. 
elisabethae, 
 
2) To determine the cultivable bacterial community associated with P. elisabethae, and 
 
 
3) To assess the potential of cultivable bacteria to produce bioactive natural products. 
 
 
Based on findings from scleractinian associated bacteria, this thesis hypothesizes that the 
bacterial community of P. elisabethae will be conserved both within and throughout reefs in the 
Bahamas, yet will be distinct from the bacterial community of the surrounding seawater. Due to 
the unique microhabitat offered by the octocoral P. elisabethae, it is hypothesized that microbial 
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symbionts capable of producing secondary metabolites with unique biological activities will be 
identified. 
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CHAPTER II 
 
 
A CULTURE-INDEPENDENT COMMUNITY AND DIVERSITY ANALYSIS OF 
BACTERIA ASSOCIATED WITH PSEUDOPTEROGORGIA ELISABETHAE 
 
 
 
INTRODUCTION 
 
Both stony corals and octocorals associate with a diverse collection of microorganisms, 
including algae, bacteria, and fungi, where many of these relationships are hypothesized to be 
mutualistic associations (Gray et al., 2011; Goulet and Coffroth, 2004; Rosenberg et al., 2007; 
Wang et al., 2011). Of these, prokaryotes appear to represent one of the richest sources of 
biological diversity within the host (Wegley et al., 2007). Coral-associated bacteria facilitate 
ecological processes, including nitrogen fixation (Lesser et al., 2004), the degradation of chitin 
and aromatic compounds (Rosenberg et al., 2007; Wegley et al., 2007), and aid in defense via 
the production of antimicrobial natural products (Nissimov et al., 2009). Despite the growing 
implications of the importance of such associations, microbiologists have long been restricted in 
their abilities to describe the composition of bacterial communities using traditional plating 
methodologies, a phenomenon known as ―the great plate count anomaly‖ (Staley and Konopka, 
1985). This phenomenon states that less than one percent of bacteria present in environmental 
samples can be cultured on standard agar plates (Amann et al., 1995). 
 
With the discovery and utilization of the 16S rRNA gene for identifying microbes and 
determining phylogenetic relationships, culture-independent techniques have revolutionized our 
understanding of microbiology. Specifically, with the advent of bacterial tag encoded FLX 
amplicon pyrosequencing (bTEFAP) (Jonasson et al., 2002), rare bacterial phylotypes can be 
identified with superior sequencing depth in a cost-effective manner compared to traditional 
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methods (Amend et al., 2010; Sogin et al., 2006; Sunagawa et al., 2010). Investigations of coral 
associated bacteria using 16S rRNA gene sequencing began in 2001 by Rohwer and colleagues, 
and since then numerous publications have revealed scleractinian corals are host to a diverse 
array of associated bacteria (Bourne and Munn, 2005; Nithyanand and Pandian, 2009; Rohwer et 
al., 2001, 2002). In contrast, despite the wealth of information available regarding scleractinian- 
associated bacterial communities, very few investigations have examined bacterial diversity in 
healthy octocorals. The need to understand bacterial communities in healthy octocorals has 
largely been motivated by the notion that disease, coral bleaching, and death can occur when the 
natural microbial fauna is affected by opportunistic bacterial pathogens (Ben-Haim et al., 2003; 
Kushmaro et al., 2001). 
 
The Caribbean octocoral Pseudopterogorgia elisabethae is the sole source of the 
commercially valuable pseudopterosins, diterpene glycosides which have potent anti- 
inflammatory activity and are marketed in the Estée Lauder
® 
Resilience Lift cosmetic line 
(Fenical, 1997; Look et al., 1986). This organism was selected as a model to investigate 
octocoral-associated bacteria owing to its commercial value and the recent link suggesting the 
pseudopterosins may be of bacterial origin (Bunyajetpong et al., 2011; Bunyajetpong, 2011). 
Despite the high level of interest in P. elisabethae, no study has characterized the bacterial 
diversity associated with this octocoral from the Bahamas. The objective of this study was to 
characterize the bacterial microbiome of P. elisabethae and to determine whether the bacterial 
communities are conserved within and between-reefs throughout the Bahamas. Based on 
research suggesting bacteria form species-specific relationships with stony corals (Frias-Lopez et 
al., 2003; Koren and Rosenberg, 2006; Rohwer et al., 2001, 2002), this thesis tested the 
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hypothesis that the bacterial community in P. elisabethae will be conserved within and between 
reefs in the Bahamas. 
 
MATERIALS AND METHODS 
 
 
Coral sampling and collection information 
 
 
 
Fragments of Pseudopterogorgia elisabethae corals (n=15) were collected by SCUBA 
from various locations throughout the Bahamas (Figure 2.1; 2006 collections: Eleuthera Island 
(site 1, n = 3; 24 48.55N, 76 20.58W); Sweetings Cay (site 2, n = 2; 26 36.23N, 77 54.70W), 
 
Victory Reef (site 3, n = 3, 25 29.13N, 79 16.41W), Petersons Reef (site 4,  n= 3; 26 32.93N, 78 
30.99W); all preceding specimens were collected by Dr. N. Ibrahim; 2009 collection: Victory 
reef, site 3, n = 1; 25 29.13N, 79 16.41W); collected by V. Robertson and R. Kerr. All corals 
appeared healthy at the time of collection (―healthy‖ as defined by the absence of coral bleaching 
and obvious tissue lesions) and were collected > 10 m apart. Prior to DNA extraction, all corals 
were washed by gently shaking three times with 50 mL of sterile filtered (0.22 µm) seawater to 
remove loosely associated bacteria. Following collection, corals were immediately frozen on dry 
ice and stored at -80°C until DNA was extracted. Water samples (500 mL, n = 2, W1 and W2, 
Figure 2.1) were collected in Ziploc bags surrounding site 3 in 2009 and were filtered through a 
0.22 µm Nalgene MF575 water filtration device (VWR International, Mississauga, ON). The 
filter was aseptically removed from the filtration device and frozen on dry ice and stored at -80ºC 
until DNA isolation was performed. Microbes were collected from the filter membrane and 
purified using the Ultra Clean Water DNA kit (Mol Bio Laboratories, Carlsbad, CA) by R. Pike. 
Surrounding water was collected from site 3 (2009; Figure 2.1) and was not collected in 2006; 
thus, coral and water bacterial communities are defined herein as ―similar‖ and ―not similar‖ 
based on comparison of site 3, 2009-collected P. elisabethae to water. 
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Figure 2.1: Map of the Bahamas showing reef locations and collection sites. Modified from the 
 
UNEP/IUCN. 
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Extraction of P. elisabethae holobiont genomic DNA 
 
 
Genomic DNA (gDNA) was extracted from P. elisabethae using a phenol-chloroform 
protocol modified from Rowan and Powers (1991; 1992). Approximately 500 mg of P. 
elisabethae was frozen with liquid nitrogen and crushed using a sterile mortar and pestle. To 
avoid cross-contamination of DNA between samples, residual DNA was denatured from the 
mortar and pestles prior to use by soaking in 0.4 N NaOH for 30 minutes, rinsing well with 
MilliQ
® 
water, and autoclaving. Five milliliters of freshly prepared DNA Lysis Buffer (DNAB, 
 
25 mM EDTA, 25 mM Tris, 0.5 M NaCl, pH 8.0) was added to ground coral tissue and was 
transferred to a sterile centrifuge tube via a sterile pipette. Gentle mixing was performed 
throughout the extraction process to minimize shearing of high molecular weight DNA of both 
Gram-negative and Gram-positive bacteria (von Wintzingerode et al., 1997). Following brief 
centrifugation (100 x g, 2 min), the aqueous layer was transferred to a new 50 mL centrifuge 
tube containing 1 L of RNase ONE (Promega, Madison, WI), 1 mg/mL lysozyme (Fischer 
Scientific, Ottawa, ON), 9 g/L polyvinylpyrrolidone, and sodium dodecyl sulfate (SDS) to a final 
concentration of 0.5%. Bacterial gDNA was lysed from the cells by incubating the mixture at 
37°C for 30 min. Proteinase K (Fischer Scientific, Ottawa, ON) was added to a final volume of 1 
mg/mL and incubated at 55ºC for 2.5 hours. Following incubation, fine debris was removed by 
centrifugation (4,500 x g for 15 min). Supernatants were collected and sodium acetate was added 
to a final concentration of 0.3M, and DNA was extracted with an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1). Samples were gently inverted and centrifuged for 
10 minutes at 9,800 x g. The aqueous phase was further extracted with an equal volume of 
chloroform:isoamyl alcohol (24:1) to remove trace phenol. Samples were centrifuged as above 
and the DNA was precipitated from the aqueous solution by the addition of 0.7 volumes of 
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isopropanol. Samples were centrifuged at 15,317 x g for 50 minutes at 4ºC, isopropanol was 
removed, and the DNA pellet washed with 5 mL of 70% ethanol (EtOH) to remove excess salts. 
Ethanol was decanted following storage on ice for five minutes, pellets were briefly dried in a 
laminar flow cabinet, and DNA was dissolved in 10 mM Tris-HCl (pH 8.0). To remove 
substances often co-extracted with genomic DNA from environmental samples which can 
interfere with subsequent PCR amplification, samples were cleaned using the PowerClean
® 
DNA 
 
Clean-Up Kit (Mol Bio Laboratories, Carlsbad, CA) (samples 1A, 1B, 1D, 3E, 4A – 4C) or the 
Difficult Extraction Protocol (DEP, samples 1C, 1E, 2A – 2B, 3A – 3D) (Newman et al., 2010). 
DNA was extracted from agarose plugs in the DEP protocol using a QIAquick Gel Extraction 
Kit following the manufacturer‘s instructions. The integrity of all purified DNA was assessed by 
agarose gel electrophoresis (AGE). 
 
16S rDNA amplification and preparation for bacterial tag encoded FLX amplicon 
pyrosequencing (bTEFAP) 
 
The diversity of bacteria associated with P. elisabethae was investigated by amplifying 
the universal 16S rRNA gene (Neefs et al., 1990). Bacterial 16S RNA gene sequences were 
amplified using the universal primers pA (5‘-AGAGTTTGATCCTGGCTCAG-3‘) and pH (5‘- 
AAGGAGGTGATCCAGCCGCA-3‘), which target ~1,500 bp on the E. coli 16S rRNA gene 
(Edwards et al., 1989). PCR reactions (50 µL) contained 1X EconoTaq® Plus Green Master Mix 
(Lucigen, Middleton, WI, USA), 1 µM of each primer, 2.5% - 5% molecular biology grade 
DMSO (Sigma, Oakville, ON), and 10 – 30 ng template DNA. A hot start technique was used to 
minimize non-specific annealing of the primers to nontarget DNA (Muyzer et al., 1993). 
Thermal cycling parameters involved 1 cycle at 95ºC for 3 min, 34 cycles of 95ºC for 45 sec, 
54ºC for 1 min, and 72ºC for 1.5 min and a final extension cycle at 72ºC for 10 min. Triplicate 
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PCR 16S rDNA amplicons from each coral holobiont gDNA sample were pooled to reduce 
potential amplification bias (Feinstein et al., 2009). PCR products were purified using a DNA 
Clean and Concentrator Kit (Zymo Research, Irvine, CA) or following band excision and 
purification using a Zymoclean Gel DNA Recovery Kit (Zymo Research). Pooled PCR 
amplicons or selected gDNA samples were used as a template for bTEFAP. 
 
16S rDNA amplicon pyrosequencing 
 
 
Bacterial 16S rDNA amplicons from 13 healthy coral specimens representing 15 sample 
libraries in addition to two water libraries were sequenced by bTEFAP by Research and Testing 
Laboratories (RTL; Lubbock, TX). Titanium FLX amplicon pyrosequencing is similar to 
traditional bTEFAP technology, yet uses Titanium reagents, high-fidelity Taq polymerases, and a 
one-step PCR reaction (Wolcott et al., 2009). Binning of sequences from individual samples and 
cleaning of sequence libraries (removal of failed sequence reads, non-bacterial sequences, low 
quality sequences, chimeras, and sequence tags) was performed by RTL (Dowd et al., 2008). 
Failure of any sequence to meet quality control parameters resulted in sequence rejection. 
Approximately 500 bp of the V1 – V3 region on the 16S rRNA gene was amplified using 20 ng 
of template by the primer pair pA and 16S519r (5‘ – GAATTACCGCGGCGGCTG – 3‘) 
according to RTL procedures (Wolcott et al., 2009). This region was targeted for pyrosequencing 
as the information from partial sequencing of this region provides nearly equivalent taxonomic 
data to full-length sequences and also results in more accurate estimates of bacterial diversity, 
species richness, and bacterial community composition compared to other 16S rRNA gene 
variable regions (Huse et al., 2007; Kim et al., 2011). Due to the novelty of bTEFAP for 
inferring bacterial taxonomy in corals, method reproducibility and variability was assessed by A) 
comparison of the same PCR product (amplified in triplicate) amplified from the same coral 
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genomic DNA samples (sequence libraries 1A and 1B), sequenced once each in independent 
sequencing runs, and B) amplification of the V1 – V3 region from gDNA (sample 3A) and its 
respective nearly-full length 16S rDNA amplicon (sample 3B). 
 
Taxonomic classification of bTEFAP sequences 
 
 
Taxonomic classification of 16S rDNA sequence libraries was performed using the 
Ribosomal Database Project‘s pyrosequencing pipeline (RDP-II; Release 10, Cole et al., 2009), 
where PCR primer sequences (pA and 16S519r) and sequences containing ambiguous bases were 
removed. Sequences less than 250 bp were also discarded from the analysis as longer sequences 
result in more accurate taxonomic assignments and to reduce the possibility of obtaining 
artificially high richness estimations from short sequence reads (Engelbrektson et al., 2010; 
Wang et al., 2007). With 1,921,179 16S small-subunit rRNAs, the RDP has a large database 
suitable for taxonomically characterizing pyrosequencing data, and was selected owing to its ease 
of use and superiority in rapidly handling large pyrosequencing datasets. 
 
To provide a compositional overview of the bacterial communities associated with P. 
elisabethae and water samples, the RDP clustering tool was used to cluster OTUs of 16S rRNA 
gene sequences at the ―class‖ level (defined by 90% sequence similarity/10% sequence 
dissimilarity; OTU0.10) (Wang et al., 2007). Similarly, bacterial 16S rDNA sequences were 
defined at the ―species‖ level (97% sequence similarity; OTU0.03) to determine the extent of 
influence individual phylotypes exert on shaping water and coral associated bacterial libraries. 
Confidence was inferred by the RDP using a 50% confidence threshold. This confidence 
threshold has previously been demonstrated to be suitable for accurate taxonomic assignment of 
short sequences and classifies a higher number of sequences than more stringent confidence 
thresholds (Claesson et al., 2009). Trimmed sequences were aligned by the RDP Sequence 
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Aligner, which aligns sequences based on an ―infernal‖ (Interference of RNA Alignment) 
secondary-structure methodology (Nawrocki and Eddy, 2007). Although singletons may 
represent PCR artifacts, they were retained on the basis that they may represent rare taxa present 
in low levels in the sample (Meyer et al., 2009). Next, the RDP Classifier was used to identify 
sequences to the class level to provide the overall bacterial community composition (Cole et al., 
2009). To compare the class-level community composition between samples, a percent 
composition chart based on RDP taxonomic classification was constructed. 
 
Denaturing gradient gel electrophoresis (DGGE) 
 
 
As inherent biases of pyrosequencing (Amend et al., 2010; Berry et al., 2011; Pinto and 
Raskin, 2012) may affect the ability of bTEFAP for assessing coral associated bacterial 
communities, denaturing gradient gel electrophoresis (DGGE) was selected as a complementary 
tool to analyze coral associated bacterial diversity. Following initial amplification of coral 
associated bacterial 16S rRNA genes described above, nested PCR was performed on selected 
corals using the modified primer 27f-GC (5‘- 
CGCCCGCCGCGCGCGGCGGGCGGGGCGGGGGCACGGGGGG-3‘), which contains a 40- 
nucleotide GC rich sequence (GC clamp) and primer P2 (Muyzer et al., 1993), which anneals to 
nucleotide positions 27 – 534 of the E. coli 16S rRNA gene and has an expected amplicon 
product of 507 bp. Amplification of the same nucleotide positions on the V1-V3 region in DGGE 
was chosen to maintain consistency between DGGE and bTEFAP to enable direct taxonomic 
comparison between sequences obtained from each method. Nested PCR reactions (50 µL) 
consisted of 1X EconoTaq
® 
Plus Green Master Mix (Lucigen), 1 µM of each primer, 1µL of 
 
template DNA (16S rDNA amplification products as described previously), and 5% molecular 
biology grade DMSO. A touchdown thermal cycling protocol was used to prevent erroneous 
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sequencing priming during amplification (Don et al., 1991). Amplification consisted of the 
following parameters: 1 cycle at 95ºC for initial denaturing at 5 min, 10 cycles of 95ºC for 1 min, 
66 - 56ºC (-1ºC/cycle) for 1 min, 72ºC for 2 min, 20 cycles of 95ºC for 1 min, 56ºC for 1.5 min, 
72ºC for 2 min and 1 cycle at 72ºC for 7 min. Amplification of nested PCR products was 
confirmed by 1% AGE.  For DGGE, 24 µL of each amplification product was loaded onto an 8% 
polyacrylamide gel containing a 70 – 40% urea-formamide denaturing gradient. Electrophoresis 
was performed using a D-Code system (Bio-Rad, Hercules, CA, USA) in 6.5L of 1 X TAE 
buffer. Gels were run at 60 V for 24 hours, stained with ethidium bromide, and dominant bands 
were excised, re-amplified by PCR using the above-stated primers and conditions, and re-run on 
the D-Code system to ensure purity. Prior to sequencing, DGGE bands were amplified using the 
primers pA and pD (Edwards et al., 1989). Amplicons were assessed for purity by 1% AGE, and 
the reamplified product representing DGGE bands were sequenced by Genome Québec 
(Montreal, QC, Canada) with primers pA and pD. Sequences were checked for chimeras using 
Bellerophon (Huber et al., 2004). Difficulties in PCR amplification prevented amplification for 
DGGE for all corals; hence, only successful nested amplicons were sequenced for samples 1B, 
1C, 2A, and 3D. 
 
Statistical analysis of coral-associated bacterial diversity 
 
 
 
To describe and compare bacterial diversity between coral and water samples, the RDP 
pyrosequencing pipeline was used to calculate observed richness (Sobs), Chao1 richness estimates 
(Sest), Shannon‘s diversity index (H’) and evenness (E) (Cole et al., 2009). To calculate these 
statistics, 16S rDNA sequences were aligned using the RDP sequence Aligner (Cole et al., 
2009). The resulting alignment files were used as the input files for the RDP Complete Linkage 
Clustering tool, which was used to identify OTUs at various sequence dissimilarities (OTU0.10 
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and OTU0.03). The resulting cluster file was used as the input file to calculate the aforementioned 
diversity statistics. To address sampling coverage, rarefaction curves were generated at the class 
and species level using the RDP Rarefaction calculator. 
 
 
The RDP classifies pyrosequencing data to the genus level; however, in order to 
determine if particular bacterial species (defined at the conventional 97% sequence similarity, 
Cohan, 2002) were predominantly responsible for contributing to the variance in coral-associated 
bacterial communities, dominant OTU0.03s were identified by BLAST sequence identities. Based 
on the high number of sequences retrieved, only dominant species-level phylotypes were 
analyzed. ―Dominant phylotypes‖ herein are called ―RKPE phylotypes‖ and defined as any 
OTU0.03 contributing to ≥1% of an individual coral or water associated 16S rDNA sequence 
library. RKPE sequences were published in GenBank under the accession numbers shown in 
Table A1 (Appendix A). To provide the most accurate taxonomic estimation based on 
characterized bacterial cultures, taxonomic identification of RKPE phylotypes at OTU0.03 was 
performed using GenBank‘s BLAST Reference RNA Sequence (RefSeq) database if sequences 
were >95% similar to published 16S rRNA gene sequences. However, RKPE phylotypes 
exhibiting ≤95% similarity to sequences in the RefSeq database in GenBank were identified 
using the BLASTn algorithm. DGGE band sequences were compared to respective coral 
pyrosequencing libraries using the Local BLASTn application in BioEdit (v7.0.9.0) (Hall, 1999). 
 
 
Principal component analysis (PCA) 
 
 
 
PCA was selected as a tool to model which OTU0.03s were responsible for driving the 
separation of coral-associated bacterial libraries within and between reefs in the Bahamas. To 
prepare the data matrix a composite dataset containing sequences from all 16S rDNA sequence 
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libraries was prepared and the sequences aligned and clustered using the RDP as described 
above.  The number of each OTU0.03 present in each sample was tallied and the data was 
normalized by calculating the percent abundance of each OTU0.03 per sample. Due to the high 
number of OTU0.03s generated by pyrosequencing (9,036 OTU0.03s from all samples), only 
dominant phylotypes (OTU0.03s constituting ≥1% of an individual sequence library) were 
included in the PCA analysis. PCA was performed using the Unscrambler X (v10.1; Camo ASA, 
Oslo, Norway) using the single value decomposition algorithm and validated by cross validation. 
 
Phylogenetic tree construction 
 
 
 
To articulate the level of bacterial diversity associated with P. elisabethae, a phylogenetic 
tree of RKPE phylotype sequences was constructed. RKPE phylotypes (including water and 
coral OTU0.03s) were aligned using ClustalW in MEGA 5.05 (Tamura et al., 2011). Aligned 
sequences were assessed to visualize phylogenetic relationships by a neighbour-joining 
phylogenetic tree (gaps treated by complete deletion) in MEGA 5.05, which best delineated 
Synechococcus related phylotypes. Evolutionary distances were computed using the maximum 
composite likelihood method. Aquifex pyrophilus (M83548.2) was used to root the tree. Overall 
tree topologies were validated by reconstructing phylogenies using multiple evolutionary 
distance methods in MEGA 5.05, including maximum likelihood, minimum evolution, and 
unweighted pair group method with arithmetic mean (UPGMA, maximum composite 
likelihood). 
 
RKPE23/Gven_K23 primer design and amplification from P. elisabethae 
 
 
Due to the unusually high number and novelty of the RKPE23 gene sequence in sample 
3E and sample 3A, a specific primer was designed to amplify this unique gene sequence on the 
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16S rRNA gene to screen other coral samples for the presence of these phylotypes. This 
sequence was not detected in any other sequence present in the RDP database except a clone 
from the octocoral Gorgonia ventalina (clone Gven_K23). RKPE23 and its closest GenBank 
match (Gven_K23, GU118339.1) were aligned with E. coli (J01695.2) and an unrelated G. 
ventalina clone (Gven_G10, GU118518.1) by the RDP sequence aligner. The RDP probe check 
was also used to test the specificity of the primer pair, yet only the Gven_K23 sequence could be 
found in the RDP database. Nested amplification on previously amplified 16S rRNA gene 
sequences (using the primers pA and pH) was performed on each P. elisabethae sample in order 
to determine the distribution of the Gven_K23/RKPE23 related phylotype in P. elisabethae 
corals. This novel sequence was used to design a 25 bp reverse primer. Nested amplification was 
performed on previously amplified 16S rRNA gene sequences (amplification described 
previously), and PCR was conducted as described for 16S rRNA gene sequence amplification 
(using the primer pair pA and Gven_K23-R1) with an annealing temperature of 51.1°C. A 203 
bp amplicon was expected from successful amplifications.  E. coli was amplified in conjunction 
with coral samples as a negative control. 
 
PCR amplification of zooxanthellae DNA from selected P. elisabethae samples 
 
 
Zooxanthellae DNA was amplified from coral homogenate gDNA using the primer pair 
D1/D2 (Zardoya et al., 1995), which provides the greatest resolution for zooxanthellae DNA 
(Sampayo et al, 2009). PCR reaction mixtures consisted of the following: 1X EconoTaq master 
mix, 1 µM of each primer (D1: 5‘-CCCGCTGAATTTAAGCATATAAGTAAGCGG-3‘; D2: 
5‘-GTTAGACTCCTTGGTCCGTGTTCAAGA-3‘), 2 µL of DNA, 2.5% of molecular-biology 
grade DMSO, MilliQ
® 
water to 25 µL. Thermal cycling parameters were 94°C for 3 min, 34 
cycles of 94.0°C for 1 min, 65.0°C for 2 min, 72.0°C for 3 min; and a final extension of 72.0°C 
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for 5 min. Amplification was checked by 1% AGE, and sequencing was performed by Genome 
Québec using the primers D1/D2. 
 
 
 
 
 
RESULTS AND DISCUSSION 
 
 
Composition of P. elisabethae and water-associated bacterial communities 
 
 
In this study, bTEFAP was employed as a tool to examine the bacterial community of 13 
healthy specimens representing 15 sample libraries of the alcyonacean octocoral P. elisabethae, 
collected from four locations across the Bahamas. The results from select gDNA and PCR 
amplicons submitted for pyrosequencing are shown in Figure 2.2. In total, 120,550 sequences 
were generated from 15 coral-associated bacterial sequence libraries and 12,416 sequences were 
generated from two water samples. Sequence read lengths ranged from 373 – 454 bp, with an 
average sequence length of 432 bp (Table 2.1). Sequences could be assigned to 16 phyla and 29 
classes, and a total of 9,035 OTU0.03s were identified from the combined data set to describe 
species-level bacterial communities. The class-level bacterial community composition for coral 
and seawater samples is summarized in Figure 2.3.  Although 29 bacterial classes were identified 
in octocoral-associated sequence libraries, the distribution of class-level taxa in individual 
libraries was highly variable; with 10-21 classes represented in individual sequences libraries.  In 
contrast, 18 classes were identified from seawater with 15 and 14 classes being represented in 
W1 and W2 sequence libraries, respectively. As highlighted in Figure 2.3, all libraries were 
dominated by a few taxa, where the nine most abundant bacterial classes are shown while the 
less abundant taxa are grouped together in an arbitrary grouping labeled ―remainder‖. Here, 
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Figure 2.2: DNA extractions and selected PCR amplicons of P. elisabethae individuals. Band 
 
size molecular weights (in base pairs) are relative to the 2-log ladder (New England Biolabs). 
Coral sequence libraries are designated by a number and alphabetical letter as reflected in Table 
2.1 
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Table 2.1: Sample collection information and sequencing and diversity statistics of 16S rDNA 
 
bTEFAP sequence libraries generated from P. elisabethae (PE) and seawater (W) DNA samples. 
 
 
Sequence 
Library 
 
Site
a
 
 
Sample 
 
Location 
Latitude 
Longitude 
Total 
Seq. 
Avg. 
Length
b
 
 
S   c obs 
 
Sest
d
 
 
H′e 
 
Ef 
 
1A
g
 
 
1 
 
PE-A 
 
Eleuthera 
24° 48.55′ N 
76° 20.58′ W 
 
6979 
 
436 
 
659 
 
977 
 
4.2 
 
0.65 
1B
g
 
 
1 
 
PE-A 
 
Eleuthera 
24° 48.55′ N 
76° 20.58′ W 
 
8098 
 
428 
 
653 
 
1072 
 
4.2 
 
0.65 
 
1C 
 
1 
 
PE-C 
 
Eleuthera 
24° 48.55′ N 
76° 20.58′ W 
 
9511 
 
440 
 
508 
 
669 
 
3.9 
 
0.62 
 
1D 
 
1 
 
PE-D 
 
Eleuthera 
24° 48.55′ N 
76° 20.58′ W 
 
9330 
 
373 
 
1558 
 
2510 
 
6.0 
 
0.82 
 
1E 
 
1 
 
PE-E 
 
Eleuthera 
24° 48.55′ N 
76° 20.58′ W 
 
1207 
 
440 
 
15 
 
17 
 
0.9 
 
0.34 
 
2A 
 
2 
 
PE-A 
Grand Bahama 
(Sweetings Cay) 
26° 36.23′ N 
77° 54.70′ W 
 
10707 
 
440 
 
834 
 
1315 
 
4.0 
 
0.60 
 
2B 
 
2 
 
PE-B 
Grand Bahama 
(Sweetings Cay) 
26° 36.23′ N 
77° 54.70′ W 
 
11299 
 
454 
 
780 
 
1169 
 
3.9 
 
0.58 
3A
h
 
 
3a 
 
PE-A 
Bimini 
(Victory Reef) 
25° 29.13′ N 
79° 16.41′ W 
 
868 
 
450 
 
35 
 
40 
 
1.9 
 
0.53 
 
3B 
 
3a 
 
PE-A 
Bimini 
(Victory Reef) 
25° 29.13′ N 
79° 16.41′ W 
 
2387 
 
451 
 
135 
 
244 
 
2.3 
 
0.46 
 
3C 
 
3a 
 
PE-C Bimini, 
(Victory Reef) 
25° 29.13′ N 
79° 16.41′ W 
 
7510 
 
452 
 
635 
 
1124 
 
3.2 
 
0.49 
 
3D 
 
3a 
 
PE-D 
Bimini 
(Victory Reef) 
25° 29.13′ N 
79° 17.95′ W 
 
4195 
 
435 
 
871 
 
1447 
 
5.4 
 
0.80 
 
3E 
 
3b* 
 
PE-E 
Bimini 
(Tuna Alley) 
25° 31.38′ N 
79° 16.41′ W 
 
7793 
 
382 
 
935 
 
1467 
 
4.9 
 
0.72 
 
4A 
 
4 
 
PE-A 
Grand Bahama 
(Peterson Reef) 
26° 32.93′ N 
78° 30.99′ W 
 
8304 
 
429 
 
1344 
 
1947 
 
5.8 
 
0.81 
 
4B 
 
4 
 
PE-B 
Grand Bahama 
(Peterson Reef) 
26° 32.93′ N 
78° 30.99′ W 
 
10176 
 
427 
 
840 
 
1096 
 
4.8 
 
0.71 
 
4C 
 
4 
 
PE-C 
Grand Bahama 
(Peterson Reef) 
26° 32.93′ N 
78° 30.99′ W 
 
9707 
 
447 
 
478 
 
604 
 
3.4 
 
0.55 
 
W1 
 
3a* 
 
W 
Bimini 
(Victory Reef) 
25° 29.13′ N 
79° 17.95′ W 
 
4238 
 
436 
 
329 
 
482 
 
4.8 
 
0.83 
 
W2 
 
3b* 
 
W 
Bimini 
(Tuna Alley) 
25° 31.38′ N 
79° 16.41′ W 
 
8178 
 
432 
 
688 
 
989 
 
5.1 
 
0.78 
a 
Samples were collected in 2006 except for those marked with an asterisk which were collected in 2009 
b 
Length in base pairs 
c 
Richness at species-level distance (D = 0.03) based on observed unique OTUs. 
d 
Chao1 non-parametric richness estimate at species-level distance (D = 0.03). 
e 
Shannon diversity index at species-level distance (D = 0.03); a higher number indicates greater diversity. 
f  
Evenness index; a higher number indicates greater evenness. 
g 
Replicate bTEFAP sequence libraries prepared from the same genomic DNA sample. 
h 
bTEFAP sequence library prepared using holobiont genomic DNA. 
  
 
W2 
 
W1 
Alphaproteobacteria 
4C 
4B Gammaproteobacteria 
 
4A 
Cyanobacteria 
3E 
3D Flavobacteria 
 
3C Unclassified Bacteria 
3B 
3A 
Actinobacteria 
 
2B Planctomycetacia 
2A 
1E 
Clostridia 
 
1D Betaproteobacteria 
1C 
Bacilli 
1B 
 
1A Remainder 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
Figure 2.3: Class-level bacterial community composition of corals and seawater samples. Sequence libraries are represented on the Y- 
 
axis. ―Unclassified Bacteria‖ refers to sequences which could not be classified by the RDP Classifier using a confidence threshold of 
50%.  ―Remainder‖ is an artificial category encompassing relatively rare classes. This category accounts for 0.67-5.77% of each 
bacterial community. 
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results depict that the relative abundance of bacterial classes varies substantially between corals 
collected at a single site (10-20 m separation) and between corals collected at different sites 
throughout the Bahamas (~60-300 km separation). Specifically, the bacterial community in P. 
elisabethae was dominated by Proteobacteria (Alpha and Gamma), Cyanobacteria, and in some 
sequence libraries, Flavobacteria (sample 1C, 3C, and 3E, 20.9 – 57.4%), a trend which is 
consistent with other culture-independent investigations of bacterial diversity from deep and 
shallow water octocorals (Brück et al., 2007, Penn et al., 2006; Sunagawa et al., 2010; Webster 
and Bourne, 2007). All corals contained at least a small percentage of sequences which could not 
be assigned to a bacterial phylum by the RDP Classifier using a 50% confidence threshold 
(―Unclassified Bacteria‖ Figure 2.3).  These phylotypes were detected in the greatest abundance 
in sample 1E (81.5% of library) and 3A (23.0% of library), yet were also detected in samples 1D 
(<1%), 2B (3.3%), 3B (1.8%), 3C (<1%), and 3D (<1%).  Bacterial communities of the water 
samples W1 and W2, which were separated by approximately 5 km, were both dominated by 
Alphaproteobacteria, Gammaproteobacteria and Cyanobacteria, yet W1 contained a greater 
abundance of Bacilli, Actinobacteria, Clostridia and Betaproteobacteria. 
 
Bacterial diversity of P. elisabethae and surrounding water 
 
 
To compare species-level (OTU0.03) diversity between coral and water-associated bTEFAP 
libraries, non-parametric estimates of richness (Chao1) and diversity (Shannon diversity index- 
H′, evenness-E) were calculated (Table 2.1). Rarefaction curves were also prepared to estimate 
sampling coverage. Overall, P. elisabethae-associated bacterial communities were highly 
diverse, and with the exception of samples 1E, 3A, and 3B, most samples exhibited bacterial 
diversity comparable to the water samples. Genomic DNA libraries (sample 1E and 3A) in 
addition to the sample 3B community generated too few sequences to fully characterize bacterial 
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diversity, which may be a function of the low observed diversity (Table 2.1). In terms of 
observed (Sobs) and estimated richness (Sest), coral bacterial communities exhibited greater 
diversity (average: Sobs = 733, Sest =1120) than the water samples (average: Sobs = 509, Sest =535). 
Paradoxically, coral bacterial communities were comparable but somewhat less diverse than 
those of the water samples when considering average Shannon diversity index values (coral = 
4.07, water = 4.95). Furthermore, 16S rRNA gene pyrosequences obtained from the water 
column were more even than corals (Table 2.1), a trend which has been confirmed in stony 
corals (Bourne and Munn 2005; Meron et al., 2011), sponges (Lee et al., 2009), and rock 
surfaces (Penn et al., 2006). The lower Shannon index values for coral bacterial communities can 
be explained by the dominance by a few taxa, a characteristic which is reflected in lower 
evenness (E) values for coral samples compared to water samples.  As the Shannon index is 
sensitive to evenness, lower H′ values can be expected from samples with less equal distribution 
of individual sequences between OTUs (Hill et al., 2003; Stirling and Wilsey, 2001).  While 
most coral bacterial communities were highly diverse, the observed and estimated diversity of 
bacterial communities varied significantly between samples (Table 2.1).  The greatest species- 
level (OTU0.03) bacterial diversity in P. elisabethae in terms of both richness and evenness was 
observed in sequence libraries 1D, 3D, and 4A (5.4, 6.0, and 5.8 respectively), which is reflected 
in the high H′ values for these samples. Conversely, samples 3A and 3B were the least diverse 
sequence libraries analyzed (1.9 and 2.3 respectively). In addition, most rarefaction curves failed 
to reach their asymptotic maxima at both the class and species level (Figure 2.4), indicating that 
deeper sampling is required to avoid underestimating species richness, particularly for samples 
1D, 3D, and 4A. 
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Figure 2.4: Rarefaction curves generated by the RDP-II from coral and water bTEFAP libraries 
 
at A) OTU0.10s and B) OTU0.03s. Refer to Table 2.1 for sequence library descriptions. 
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Dominant bacterial OTU0.03s in P. elisabethae 
 
 
To characterize the dominant species-level phylotypes shaping the overall bacterial 
community at the class level, 121 dominant OTU0.03s (―dominant‖ defined as phylotypes present 
in ≥1% abundance in coral and water individual sequence libraries) from P. elisabethae were 
compared to published 16S rDNA sequences in the GenBank Database using the nucleotide 
BLASTn algorithm (Table A1). To determine the phylogenetic relationships between dominant 
phylotypes, a neighbour-joining phylogenetic tree was constructed (Figure 2.5). In Figure 2.5, 
the distribution of phylotypes throughout all sequence libraries is indicated in brackets after 
―RKPE‖. The presence of a sequence library in brackets indicates that the particular phylotype 
was found in that particular sequence library, yet it does not indicate that the phylotype was 
abundant. Overall, individual coral-associated sequence libraries differed in constitution and 
abundance between individual corals, while the most abundant OTU0.03 varied between 
individuals. Although the overall bacterial community was not conserved, the occurrence and 
abundance of some phylotypes on corals sampled from different geographic locations suggests 
P. elisabethae has some level of host specificity. For example, no one specific OTU0.03 was 
conserved across libraries in this study; however, RKPE3-related phylotypes (Synechococcus 
sp.) were consistently retrieved from all PCR-generated libraries and were conserved between 
corals and water, suggesting the presence in the coral is due to environmental uptake or 
contamination. Additionally, RKPE12 (Ruegeria sp.) was discovered in all PCR-generated coral 
libraries and was absent in the water column. Although the significance of this phylotype is 
unknown, cultured members of this genus have antibiotic activity (Nithya and Pandian, 2010); 
consequently, their ubiquitous presence across coral-associated bacterial libraries could suggest a 
role in defense against microbial pathogens. Additionally, the abundant ―octocoral-specific‖ 
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Figure 2.5:  Neighbour-joining phylogenetic tree of RKPE sequences. Evolutionary distances 
 
were calculated using the maximum composite likelihood method. (A) Alphaproteobacteria; (B) 
Bacteriodetes, Firmicutes, Cyanobacteria, Tenericutes, Deinococcus-Thermus, Actinobacteria 
and Plancotmycetes; (C) other Proteobacteria of dominant phylotypes from P. elisabethae and 
seawater samples. Bootstrapping (n = 1,000) was used to assess overall tree accuracy, and 
aligned nucleotide sequence gaps were treated by complete deletion. Only bootstrap probabilities 
≥50% are shown. The scale bars represent five nucleotide (nt) substitutions per 100 nt positions 
for (A) and (B) and two nt substitutions per 100 nt positions for (C). All trees were rooted with 
Aquifex pyrophilus (NR_029172.1). The sequence libraries in which phylotypes were present 
(but not necessarily abundant) are indicated in brackets following the RKPE number. Numbers 
in brackets which are not followed by a letter indicate that all sequence libraries starting with that 
number contain representatives of that particular phylotype.  GenBank accession numbers for 
reference strains are shown in parentheses. Classes are indicated on side bars; ―SEP‖ refers to 
Spongiobacter-Endozoicomonas phylotypes in the class Gammaproteobacteria. 
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phylotypes RKPE1 (Gammaproteobacteria) and RKPE23 (Unclassified Bacteria) were also 
absent in the water column; the significance of these phylotypes will be discussed in detail 
subsequently. 
 
Different bacterial classes dominated individual coral-associated bacterial libraries at the 
species level. For example, Flavobacteria (Aquimarina sp.) dominated sequence libraries 1C and 
3C, an uncultured Planctomycetacia ―dominated‖ sample 1D (5.6% abundance), and an 
uncultured Alphaproteobacteria ―dominated‖ sample 4A (4.9% abundance; Table 2.2). In coral 
samples 2A, 2B, 3A, 3B, and 4C, Gammaproteobacteria were dominated by RKPE1-related 
phylotypes (Table 2.2; Figure 2.5). These phylotypes were most similar to Endozoicomonas sp. 
(unpublished pseudonym Spongiobacter), which also included a sequence obtained with high 
similarity to an uncultured bacterium from the octocoral Gorgonia ventalina (clone Gven_G10, 
GU118518.1, 98% BLAST sequence identity) and a clone from the Mediterranean octocoral 
Eunicella cavolini (clone B10, JQ691564.1, Table A1, Appendix). Sequences were more similar 
to G. ventalina clone Gven_G10 than Spongiobacter (≤95% sequence identity), and hence all 
RKPE1-related phylotypes in Table 2.2 are compared to the G. ventalina phylotype. RKPE23- 
related phylotypes dominated sequence library 1E (83.8%) and to some extent, sample 3A 
(32.1% of phylotypes contributing to ≥1% of library) while samples 1D, 2A, 2B, and all Victory 
Reef libraries (sample 3A – 3D) contained these phylotypes yet in reduced abundance.  These 
phylotypes were not classified into a bacterial phylum based on the RDP Classifier and shared 
80% sequence identity with Mycoplasma alkalescens in the phylum Tenericutes (NR025984.1). 
However, these phylotypes most closely resembled an uncultured G. ventalina clone Gven_K23 
(GU118339.1; 100% identity), the significance of which will be discussed in detail subsequently. 
120  
Table 2.2: Dominant OTU0.03s from coral and water-associated bacterial sequence libraries. 
 
Site % of 
library 
OTU0.03 Closest GenBank Match (Accession 
number; percent similarity) 
Class 
1A 13.9 RKPE3 Synechococcus sp. KORDI-54 
(FJ497735.1; 99%) 
Cyanobacteria 
1B 13.6 RKPE3 Synechococcus sp. KORDI-54 
(FJ497735.1; 99%) 
Cyanobacteria 
1C 24.5 RKPE2 Aquimarina sp. (HM998909.1; 94%) Flavobacteria 
1D 5.6 RKPE28 Uncultured Planctomycetales 
(FJ516934.1; 92%) 
Planctomycetacia 
1E 83.8 RKPE23, 
RKPE223 
Uncultured Gorgonia ventalina clone 
Gven_K23 (GU118339.1; 98%) 
Unclassified Bacteria 
2A 17.3 RKPE1 Uncultured Gorgonia ventalina clone 
Gven10 (GU118518.1; 98%) 
Gammaproteobacteria 
2B 25.6 RKPE1 Uncultured Gorgonia ventalina clone 
Gven10 (GU118518.1; 98%) 
Gammaproteobacteria 
3A 32.1 RKPE1 Uncultured Gorgonia ventalina clone 
Gven10 (GU118518.1; 98%) 
Gammaproteobacteria 
3B 31 RKPE1 Uncultured Gorgonia ventalina clone 
Gven10 (GU118518.1; 98%) 
Gammaproteobacteria 
3C 37.9 RKPE2 Aquimarina sp. (HM998909.1; 94%) Flavobacteria 
3D 9.5 RKPE25 Uncultured Gammaproteobacterium 
(DQ917904.1; 93%) 
Gammaproteobacteria 
3E 10.8 RKPE13 Uncultured bleached Muricea 
elongata Rhodospirillaceae bacterium 
(DQ917824; 99%) 
Alphaproteobacteria 
4A 4.9 RKPE35 Uncultured Alphaproteobacterium 
(DQ917839.1; 97%) 
Alphaproteobacteria 
4B 7.8 RKPE3 Synechococcus sp. KORDI-54 
(FJ497735.1; 99%) 
Cyanobacteria 
4C 31.3 RKPE1 Uncultured Gorgonia ventalina clone 
Gven10 (GU118518.1; 98%) 
Gammaproteobacteria 
W1 6.5 RKPE56 Rickettsia monacensis (DQ100164.1; 
99%) 
Alphaproteobacteria 
W2 10.6 RKPE9 Prochlorococcus marinus 
(CP000576.1; 96%) 
Cyanobacteria 
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Characterizing dominant phylotypes driving the separation of coral-associated bacterial 
communities by PCA 
 
Principal component analysis (PCA) was performed to visualize relationships between 
coral and water-associated bacterial communities and to determine bacterial phylotypes 
(OTU0.03s) responsible for the variation observed between coral and water-associated bacterial 
communities. The basic premise of PCA is that samples containing similar dominant variables 
(in this case, members of a bacterial community as measured by the abundance of clusters at 
OTU0.03) will migrate along one principal component (PC) while those having different dominant 
variables will separate away from each other. Each principal component represents the line of 
best fit through n-dimensional space (n = number of variables) which explains the most variance 
within the data. Each subsequent principal component is orthogonal to the previous component 
and describes sequentially less variance. 
 
The abundance of the RKPE23/223 phylotypes heavily skewed the data for the main 
PCA biplot when sample 1E was included in the analysis (Figure 2.6A). As a result, sample 1E 
was excluded from the main PCA biplot as an outlier in order to visualize the other factors 
affecting the PCA model (Figure 2.6B, C). An explained variance plot was generated for 
sequence libraries excluding sample 1E, and demonstrated that the model optimized after 4 PCs 
and explained 86% of the model variance (PC1 explains 50%, PC2 explains 23%, PC3 explains 
9%, and PC4 explains 4%).  Further principal components (PCs 5-7) continued to explain 
decreasingly less of the model variance (3%, 3%, and 2% respectively) and did not correspond to 
major differences within the data structure. 
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Figure 2.6: Principal Component Analysis biplots describing dominant bacterial OTU0.03s 
 
responsible for the observed variance between the bacterial communities of corals and water. (A) 
PCA biplot of PCs 1 – 2 including sample 1E. Excluding sample 1E, PC1 and 2 (B) describe 
50% and 23% respectively of the observed variance while PC3 and 4 (C) describes an additional 
9 and 4% of the variance respectively, explaining 86% of the total variance. Blue dots represent 
coral and water samples while blue dots represent dominant 16S rRNA gene sequence 
phylotypes at OTU0.03. 
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The majority of the model variance was explained within the first two principal 
components (PC1 50% and PC2 23%; Figure 2.6B). PC1 and PC2 distinguish bacterial 
communities dominated by Gammaproteobacteria (specifically RKPE1 and RKPE4, visualized 
by positive separation along PC1) and Flavobacteria (RKPE2, visualized by negative separation 
along PC1 and positive separation along PC2).  Strong positive separation along PC1 directly 
correlated with the abundance of the Gammaproteobacteria-related phylotypes RKPE1 and 
RKPE4 within the bacterial communities of libraries from sample 2A, 2B, 3A/B, and 4C. From 
the phylogenetic tree (Figure 2.5), these phylotypes correlated to a clade clustering together with 
several uncultured Gammaproteobacteria phylotypes previously reported from Gorgonia 
ventalina clones Gven_C04 (GU118411.1), Gven_D20 (GU118326.1) and Gven_G10 
(GU118518.1; Sunagawa et al., 2010) and to recently published sequences in GenBank from the 
Mediterranean octocoral Eunicella cavolini (ex. clone B10, JQ691564.1; 98%). Comparison of 
RKPE1-related phylotypes to characterized strains in GenBank returned matches most closely 
related to Spongiobacter nickelotolerans (93% similarity) and Endozoicomonas elysicola (91% 
similarity). The overall similarity of the replicate sequence libraries (1A and 1B) was confirmed 
in the PCA model as both samples demonstrated comparable trends (Figure 2.6B, C).  Water 
libraries W1 and W2 also demonstrated similar trends to each other, as did the Bimini sequence 
libraries generated from gDNA (3A) and the PCR amplicon (3B) bTEFAP templates, with the 
exception of PC4 due to the high abundance of phylotype RKPE23 (unclassified bacterium) in 
3A compared to 3B. RKPE1-related phylotypes were dominant in some corals and were 
generally conserved between P. elisabethae samples in the Bahamas (Table 2.3). 
 
On the PCA biplot, the dominance of Flavobacteria within the coral-associated bacterial 
communities is modeled by the negative separation along PC1 and positive separation along PC2 
  
Table 2.3: Population abundance of ―Gven_G10‖ clade phylotypes as an individual percent abundance, total percent abundance and 
 
relative percent abundance to total Gammaproteobacteria community of individual coral and water samples.  Bold type indicates 
phylotypes that had the most influence on the PCA model. 
 
 
 
PHYLOTYPE 1A 1B 1C 1D 2A 2B 3A 3B 3C 3D 3E 4A 4B 4C W1 W2 
RKPE1 1.4 1.8 0 0 17.3 25.6 32.1 31.0 0 0 0 2.6 1.8 31.3 0 0 
RKPE4 0.7 1.6 0 0 5.9 12.6 11.4 15.0 0 0 0 1.3 0.7 14.3 0 0 
RKPE8 0.1 0.2 0 0 3.5 2.7 1.3 3.6 0 0 0 0.3 0.2 4.0 0 0 
RKPE14 1.0 1.0 0 0.2 0.2 4.0 3.1 5.9 0 0.1 0 0 0 0.3 0 0 
RKPE20 0.8 1.1 0 0.1 0 3.1 1.8 5.3 0 0 0 0 0 0 0 0 
RKPE21 1.1 1.2 0 0.1 0 2.6 2.6 4.6 0 0 0 0 0 0 0 0 
RKPE30 0.6 0.6 0 0.1 0.2 2.2 2.1 3.1 0 0.1 0 0 0 0.3 0 0 
RKPE32 0.1 0.1 0 0 0.8 1.2 0 0.6 0 0 0 0.2 0.1 1.6 0 0 
RKPE63 0.3 0.3 0 0.1 0 1.2 2.1 1.6 0 0 0 0 0 0 0 0 
RKPE91 0.1 0 0 0 0.2 0.4 0.9 1.0 0 0 0 0 0 0.5 0 0 
  RKPE110   0   0   0   0   1.0   0.1   0   0   0   0   0   0   0   0.1   0   0   
Total % Abundance 6.1 7.8 0 0.5 29.0 55.6 57.4 71.7 0 0.2 0 4.4 2.8 52.4 0 0 
Relative % 
Gammaproteobacteria 
  Abundance   
 
45.9 
 
60.9 
 
0 
 
6.5 
 
66.8 
 
72.7 
 
86.7 
 
82.2 
 
0 
 
1.4 
 
0 
 
39.3 
 
22.8 
 
70.3 
 
0 
 
0 
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 for coral samples 3C, 1C, and 3E (Figure 2.6B).  Negative separation along PC1 of samples 
sample 3C, 1C and to lesser extent, sample 3E are due to the absence of SEPs while positive 
separation along PC2 is correlated with the presence of the RKPE2 phylotype within the 
bacterial communities of these corals. The RKPE2 phylotype clustered together in an 
Aquimarina spp. clade within the Flavobacteria along with RKPE49, RKPE40, and RKPE64. 
These phylotypes made up the majority of the abundance of Flavobacteria-related sequences 
observed in samples 1C, 3C, and 3E (71.8%, 69.9% and 50.7% respectively; Table 2.4). 
 
Separation of samples along PC3 (Figure 2.6C) describes the variation in composition of 
dominant Cyanobacteria present in the dominant bacterial communities. Positive separation of 
sequence libraries 1A/B, 1C, 2A, and 4B along PC3 correlated with the relative abundance of 
RKPE3 and RKPE5 phylotypes within those communities.  Phylotype RKPE3 and RKPE5 
formed a clade with phylotypes RKPE15, 17, 31, 36, and 41-43 and Synechococcus sp. KORDI 
54 (FJ497735.1, 99% sequence identity). These closely-related phylotypes represented 
33.7%/30.7%, 15.6%, 21.8% and 19.0% of the total bacterial population and 61.2%/63.4%, 
48.9%, 49.9% and 39.7% of the dominant Cyanobacteria OTU0.03s in samples 1A/1B, 1C, 2A 
and 4B, respectively (Table 2.5). Synechococcus phylotypes were observed in all but one coral 
sequence library (4A) and were present in seawater libraries (0.2 – 1.2% overall abundance; 
Table 2.5). Negative separation along PC3 correlated with the low abundance of RKPE3/5 clade 
phylotypes in corals and a high abundance of phylotypes RKPE9 and RKPE16 in water samples 
(Figure 2.6C).  RKPE9 and RKPE16 formed a unique clade with a Prochlorococcus marinus 
subsp. pastoris strain (NR 028762.1, 98% sequence similarity), which were rare phylotypes 
obtained from corals (detected in <0.04% abundance in samples 1D, 4A, and 4B) yet were 
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Table 2.4: Population abundance of ―Aquimarina spp.‖ clade phylotypes as an individual percent abundance, total percent abundance 
 
and relative percent abundance to total Flavobacteria community of individual coral and water samples. Bold type indicates 
phylotypes that had the most influence on the PCA model. 
 
 
 
PHYLOTYPE 1A 1B 1C 1D 2A 2B 3A 3B 3C 3D 3E 4A 4B 4C W1 W2 
RKPE2 0 0 24.5 0.2 0 0 0 0 37.9 0 9.0 0 0 0 0 0 
RKPE40 0 0 1.8 0 0 0 0 0 2.2 0 0.6 0 0 0 0 0 
RKPE49 0 0 3.1 0 0.2 0 0 0 0 0 0.1 0 0 0 0 0 
RKPE64 0 0 0.8 0 0 0 0 0 1.1 0 0.9 0 0 0 0 0 
Total % 
Abundance 
 
0 
 
0 
 
30.2 
 
0.2 
 
0.2 
 
0 
 
0 
 
0 
 
41.2 
 
0 
 
10.6 
 
0 
 
0 
 
0 
 
0 
 
0 
Relative % 
Flavobacteria 
  Abundance   
 
0 
 
0 
 
69.9 
 
26.3 
 
27.5 
 
0 
 
0 
 
0 
 
71.8 
 
0 
 
50.7 
 
0 
 
0 
 
0 
 
0 
 
0 
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Table 2.5: Population abundance of ―Synechococcus sp. KORDI-54‖ clade phylotypes as an individual percent abundance, total 
 
percent abundance and relative percent abundance to total Cyanobacteria community of individual coral and water samples.  Bold type 
indicates phylotypes that had the most influence on the PCA model. 
 
PHYLOTYPE 1A 1B 1C 1D 2A 2B 3A 3B 3C 3D 3E 4A 4B 4C W1 W2 
RKPE3 13.9 13.6 5.7 0.1 8.9 0.1 0 0.4 0.4 1.1 0.3 0 7.8 0.7 0.6 0.1 
RKPE5 8.5 9.3 4.1 0 6.9 0.2 0 0 0.2 0.6 0.2 0 4.8 0.5 0.3 0.1 
RKPE15 2.6 2.4 1.2 0 1.6 0.1 0 0 0.1 0.1 0 0 0.9 0.1 0 0 
RKPE17 3.6 1.1 0.4 0 0.5 0.1 0 0 0 0 0.1 0 2.0 0.3 0.3 0 
RKPE31 1.6 1.2 0.5 0 0.6 0 0 0 0 0.1 0 0 1.2 0.1 0 0 
RKPE36 1.0 1.2 0.6 0 0.8 0 0 0 0.1 0.1 0 0 0.6 0.1 0 0 
RKPE41 0.3 0.3 2.0 0 1.0 0 0.1 0 0 0.1 0 0 0.2 0.1 0 0 
RKPE42 1.0 0.9 0.5 0 0.8 0 0 0 0 0.1 0 0 0.7 0.2 0 0 
RKPE43 1.2 0.7 0.6 0 0.7 0 0 0 0 0.1 0 0 0.8 0.1 0 0 
Total % 
Abundance 
 
33.7 
 
30.7 
 
15.6 
 
0.1 
 
21.8 
 
0.5 
 
0.1 
 
0.4 
 
0.8 
 
2.3 
 
0.6 
 
0 
 
19.0 
 
2.2 
 
1.2 
 
0.2 
Relative % 
Cyanobacteria 
  Abundance   
 
61.2 
 
63.4 
 
48.9 
 
0.9 
 
49.9 
 
53.3 
 
4.6 
 
45.5 
 
52.7 
 
26.1 
 
15.3 
 
0 
 
39.7 
 
40.4 
 
7.8 
 
0.6 
 abundant in seawater samples at 7.6 and 17.8 % and represented 49.1% and 55.7% of 
Cyanobacteria sequences in samples W1 and W2, respectively (Table 2.6). 
 
After three principal components, the model began to distinguish between individual 
coral samples.  For example, negative separation along PC4 separated sample 3E (collected in 
2009) from the remainder of the coral samples due to differences in Alphaproteobacteria 
composition. Phylotypes RKPE13, 22, 37, and 44 are phylotypes unique to the bacterial 
community of sample 3E and were low in abundance in the other coral communities sampled in 
2006 (each phylotype was found at levels <0.02% in one other coral sequence library). This 
suggests collection year may be an important variable in octocoral-associated bacterial 
communities. The other Victory Reef samples 3A, 3C, and particularly 3D, separate from the 
remaining coral samples in a positive direction along PC4 (Figure 2.6C).  This separation was 
most strongly influenced by the variables RKPE6, 23, and 25.  Phylotype RKPE6 forms a clade 
with RKPE39 and is most proximal to an uncultured sponge associated Alphaproteobacteria with 
low sequence identity (HQ726945.2, 91% sequence similarity). These OTU0.03s represented 21.3 
and 8.0 % of the bacterial communities from corals 3C and 3D respectively.  Phylotype RKPE25 
formed a unique clade with an uncultured Muricea elongata (octocoral)-associated 
Gammaproteobacterium (DQ91704.1, 93% sequence similarity) and contributed to 9.5% of the 
bacterial community of coral sample sample 3D (as well as samples 1C, 1D, 2A, 2B, 3A/B, 3C, 
4A and 4B at an abundance of 1% or less). Phylotype RKPE23 formed a clade with RKPE223, 
RKPE250 and was most closely related to an uncultured G. ventalina clone Gven_K23 
(GU118518.1; 98% sequence similarity) and contributed predominantly to the bacterial 
community of samples 1E and 3A with an abundance of 83.2% and 23% respectively; however it 
was also found at a much lower abundance in coral samples 2B (3.3%), 3B (1.8%), 3C (0.8%) 
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Table 2.6: Population abundance of ―Prochlorococcus marinus‖ clade phylotypes as an individual percent abundance, total percent 
 
abundance and relative percent abundance to total Cyanobacteria community of individual coral and water samples.  Bold type 
indicates phylotypes that had the most influence on the PCA model. 
 
PHYLOTYPE 1A 1B 1C 1D 2A 2B 3A 3B 3C 3D 3E 4A 4B 4C W1 W2 
RKPE9 0 0 0 0.02 0 0 0 0 0 0 0 0 0 0 4.9 10.6 
RKPE16 0 0 0 0 0 0 0.01 0.03 0 0 0 0 0 0 2.7 7.2 
Total % 
Abundance 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
7.6 
 
17.8 
Relative % 
Cyanobacteria 
  Abundance   
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
49.1 
 
55.7 
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and 3D (0.6%).  Taxonomically, this clade may represent a novel phylum as it is most closely 
related to Mycoplasma alkalescens (80% sequence identity, NR025984.1) in the phylum 
Tenericutes. This phylotype was only detected in corals and was not found in surrounding 
seawater. 
 
Ecological significance of RKPE1-related phylotypes 
 
 
RKPE1-related phylotypes share an ancestral lineage with Endozoicimonas elysicola 
(NR_041264.1) and Spongiobacter nickelotolerans (AB205011.1) strains (91 and 93% similarity 
respectively). Based on 16S rRNA gene-based phylogenies (data not shown), it is likely that the 
two names may be synonymous; however, detailed polyphasic taxonomic characterization 
comparing cultured representatives from each genus is necessary to accurately delineate the two 
genera. Spongiobacter/Endozoicomonas-related phylotypes (SEPs) dominated the bacterial 
communities of P. elisabethae-associated bacterial sequence libraries 3A/B, 2B, and 4C (57.5, 
71.9, 55.6, and 52.4%, respectively), were present in all but three coral sequence libraries, and 
were not detected in seawater libraries (Table 2.3). Based on low sequence similarity scores and 
nucleotide substitution distance within the phylogenetic tree to that of the related strains of S. 
nickelotolerans and E. elysicola, it is proposed that the related SEP phylotypes from P. 
elisabethae represent a novel genus of bacteria within the Hahellaceae. Although a functional 
role of bacteria from the Hahellaceae has yet to be determined, the repeated occurrence and 
dominance of related sequences within the bacterial community from healthy P. elisabethae 
specimens suggests a potential probiotic role. 
 
SEP-related sequences have been identified previously from other healthy alcyonaceans, 
including Sinularia sp. (FJ654584.1, unpublished), Cryogorgia koolsae (HM173232.1, Gray et 
al., 2011), Erythropodium caribaeorum (DQ889928.1, unpublished), Muricea elongata 
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(DQ917877.1, unpublished), and the Mediterranean octocoral Eunicella cavolini (JQ691564.1, 
unpublished). Additionally, SEPs have been detected in healthy tissues of marine sponges 
(Kennedy et al., 2008; Webster et al., 2008), reef-building corals (Bourne et al., 2008; Yang et 
al., 2010) and in cultured toxic and nontoxic dinoflagellates (Hold and Moore, 2001). Two 
studies have demonstrated a specific association of SEPs with healthy specimens of the Great 
Barrier Reef coral Acropora millepora. For example, Bourne et al. (2008) observed a decrease in 
SEP prevalence in clone libraries concomitant with a loss of the dinoflagellate Symbiodinium sp. 
during a coral bleaching event and a return to dominance following reacquisition of the 
dinoflagellate after the bleaching event. The delicate balance between bacteria and 
endosymbiotic zooxanthellae may be explained by the fact that while Symbiodinium spp. are 
predominantly responsible for producing dimethylsulfoniopropionate (DMSP), marine bacteria 
are capable of degrading DMSP to dimethyl sulfide (DMS) (Raina et al., 2009). This dynamic 
may explain why some bacterial communities in acroporid corals may disappear from the coral 
community following the expulsion of algal symbionts; furthermore, this suggests SEPs may be 
important indicators of coral health owing to their sensitivity to disturbance. Collectively, these 
observations suggest that utilization of organic sulfur compounds may strongly influence the 
structure of coral-associated bacterial communities. Indeed, all cultured SEPs have been isolated 
from marine invertebrates which have a close association with algal producers of DMSP, either 
in the form of symbiotic relationships (corals – dinoflagellates, sponges – Cyanobacteria) or 
dietary consumption (sea slug – dietary algae; Van Alstyne, 2008). To experimentally establish 
the role of DMSP content as a driver of octocoral bacterial community structure, future efforts 
could focus on determining if a link exists between DMSP content and the presence of specific 
phylotypes. 
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As mentioned previously, the role that RKPE1-related phylotypes play in octocorals is 
unclear, as uncultured phylotypes reveal little about their biological roles in the holobiont. 
Although further research would be required, it is possible that, based on the abundance and 
dominance of these phylotypes in P. elisabethae within and between reefs throughout the 
Bahamas, these bacteria may be involved in natural product (pseudopterosin) biosynthesis as 
hypothesized in other investigations of bacteria associated with marine invertebrates (Pérez- 
Matos et al., 2007). Moreover, the predominance of this phylotype in P. elisabethae bacterial 
communities indicates this phylotype has a selective advantage or predisposition to utilize the 
coral as a substrate to support the growth and overall fitness of the bacterium. Conversely, the 
ubiquitous presence of RKPE1-related Gammaproteobacteria phylotypes may simply be a 
function of abundance, and may not play an ecologically significant role in the host. For 
instance, fluorescence in situ hybridization studies in the gastroderm of branching stony corals 
revealed large ovoid bacterial aggregates were consistently identified as Gammaproteobacteria 
(Ainsworth et al., 2006). Hence, it is possible that the observed abundance of RKPE1-related 
Gammaproteobacteria phylotypes in P. elisabethae may be due to the formation of large 
aggregates consisting of closely related colonies in the coral holobiont. However, the absence of 
RKPE1 phylotypes in the water column indicates these bacteria may be true endosymbionts 
which have specifically co-evolved with their marine invertebrate hosts. 
 
Flavobacteria 
 
 
Representatives of the Aquimarina spp. phylotype clade (e.g. RKPE2, Figure 2.5) were 
found on coral samples from both Eleuthera Island (Sample 1C, 30.3% abundance) and Victory 
Reef (Sample 3C, 41.3% abundance; Sample 3E, 10.5% abundance). Their discovery from 
samples across different geographical locations, as well as demonstrating the ability to establish 
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a dominant bacterial community on at least some coral samples suggests these bacteria may have 
a specific association with P. elisabethae. Aquimarina is a recently established genus within the 
Flavobacteriacea (Nedashkovskaya et al., 2005) representing aerobic, heterotrophic, gliding, 
Gram-negative, marine bacteria that produce flexirubin-type non-diffusible pigments.  The 16S 
rDNA sequence of RKPE2, the dominant representative phylotype of this clade within P. 
elisabethae-associated bacterial communities (Table 2.4), is most similar to the type strain 
Aquimarina muelleri (93%). To date, the genus contains eight taxa: A. muelleri, A. addita, A. 
brevivitae, A. intermedia, A. latercula, A. macrocephali, A. salinaria, and A. spongiae; all are 
widely distributed in various marine environments and isolated from substrates ranging from 
seawater and sediment to a sea urchin and a sponge. The P. elisabethae phylotypes form two 
distinct clusters in the Aquimarina clade suggesting they may represent at least two new 
Aquimarina species (Figure 2.5). Although the role of these organisms in P. elisabethae is 
unknown, A. salinaria has demonstrated algicidal activity in co-culture experiments (Chen et al., 
2012); thus P. elisabethae-associated Aquimarina spp. may play a role in the preventing algal 
fouling or mediating interactions between the coral and its algal photosymbionts. As taxa of this 
genus can readily be cultured, future culturing of RKPE2 may be achievable and would allow for 
the testing of these hypotheses. 
 
Cyanobacteria 
 
 
Closely-related Synechococcus sp. and Prochlorococcus sp. OTU0.03s were consistently 
abundant as members among the Cyanobacterial pyrosequencing libraries and were shared 
between coral and water libraries (Table 2.5, 2.6).  Synechococcus and Prochlorococcus are 
unicellular autotrophs which are ubiquitously distributed throughout the world‘s oceans and 
comprise a diverse group of Cyanobacteria, where phylogenetic and physiological data have 
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been used to subdivide the group into 18 distinct clades. These are hypothesized to represent 
physiologically and ecologically distinct populations or ecotypes and whose distribution varies 
both spatially and temporally (Choi and Noh, 2009; Fuller et al., 2003; Rocap et al., 2002). The 
most abundant phylotype isolated from the coral samples was 99% similar by 16S rRNA gene 
sequencing to Synechococcus sp. strain KORDI-54, which belongs to Synechococcus clade VI 
(Choi and Noh, 2009) and represented a moderate proportion of the overall bacterial community 
from P. elisabethae samples 1A/B, 1C, 2A and 4B (Table 2.5). Similarly, Prochlorococcus sp. 
contributed to the Cyanobacteria community in water sequence libraries, yet were less abundant 
in corals (Table 2.6). Ecologically, Synechococcus sp. appear to form stable, long-term 
associations with a variety of invertebrates and produce amphiphilic siderophores to acquire iron 
from the surrounding environment (Ito and Butler, 2005). Furthermore, Synechococcus sp. and 
Prochlorococcus sp. co-exist with symbiotic dinoflagellates in the Caribbean hard coral 
Montastraea cavernosa and may play a role in nitrogen fixation, as conspecifics lacking these 
endosymbionts cannot fix nitrogen (Lesser et al., 2004, 2007). Since Synechoccocus sp. are 
globally distributed and abundant in seawater (Choi and Noh, 2009; Dinsdale et al., 2008), it is 
likely that P. elisabethae may be ingesting/obtaining these phylotypes from the surrounding 
environment.  In addition, the high abundance of these phylotypes suggests that Synechoccocus 
sp. occupy a niche in the coral holobiont. 
 
Alphaproteobacteria 
 
 
Alphaproteobacteria have an extensive history of forming symbiotic relationships with other 
taxa (Bates et al., 2010; Jackson et al., 2006). Alphaproteobacteria are both diverse and 
ubiquitously distributed in both stony corals and some octocorals (Brück et al., 2007; Meron et 
al., 2011; Rohwer et al., 2001; Sweet et al., 2011). In contrast to the closely-related 
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Cyanobacteria and Gammaproteobacteria phylotypes obtained  in this study, dominant RKPE 
OTU0.03s in the class Alphaproteobacteria were represented by diverse phylotypes (Figure 2.5). 
This is in opposition to an acroporid study by Meron and colleagues, who demonstrated that 
Alphaproteobacteria were dominated by Rhodobacteracea (Meron et al., 2011). Furthermore, 
due to the low sequence identity of RKPE6 to reference sequences in GenBank (91% sequence 
identity to an uncultured sponge-associated bacteria; 85% sequence identity to Terasakiella 
pusilla (NR_024656.1), this suggests RKPE6 is a potentially novel bacterial order or family. 
Furthermore, some Alphaproteobacteria phylotypes from P. elisabethae showed sequence 
similarity to bacteria obtained from bleached corals and from polluted/wastewater (Figure 2.5), 
which may imply that the health of P. elisabethae requires monitoring. 
 
Unclassified bacteria 
 
 
A candidate bacterial phylum based on RKPE23-related phylotypes (RKPE23, 223, and 250) 
was identified from P. elisabethae which were devoid in water-associated bacterial sequence 
libraries. Interestingly, these phylotypes were particularly abundant in gDNA derived 
pyrosequencing libraries (sample 1E, 82.8%; sample 3A, 23.0%) and were less abundant in PCR 
amplicon libraries (sample 3B, 1.2%). These phylotypes were also responsible for driving the 
separation of P. elisabethae associated bacterial libraries along PC1 in the PCA biplot (Figure 
2.6A). Phylogenetic identification of RKPE23 with the nearest type strain revealed RKPE23 was 
most similar to a Mycoplasma alkalescens strain in the phylum Tenericutes (80% sequence 
identity); however, the RKPE23 phylotype matched at 98% sequence similarity to an uncultured 
bacterium clone obtained from the Caribbean octocoral G. ventalina (clone Gven_K23). 
Although this phylotype thus-far appears to be restricted to octocorals based on RDP probe 
matching, it is difficult to define the taxonomic significance of this phylotype due to its highly 
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distant relationship to M. alkalescens. However, the conservation of shared bacteria between 
different octocorals provides evidence which supports the hypothesis that alcyonaceans share 
common bacterial symbionts. 
 
Detection of potentially novel bacterial phylum from P. elisabethae 
 
 
Due to the novelty of the RKPE23 phylotype, a taxa-specific primer was designed and 
amplicons were constructed for each coral library. Alignment of RKPE23 and RKPE223 with G. 
ventalina clones revealed a unique 10 bp sequence insert that was not detected in another G. 
ventalina clone (Gven_G10) or E. coli (Figure 2.7).  Furthermore, despite the fact that the RDP 
database contains almost 2 million 16S rRNA gene sequences, this 10 bp sequence was only 
retrieved from the 16S rRNA gene sequence for RKPE23 and G. ventalina clone Gven_K23. 
Consequently, a 25 bp primer was designed to amplify this unique fragment from corals (Figure 
2.7). Amplification was successful for 10 of 13 corals based on the detection of an approximately 
200 bp band by 1% AGE (Table 2.7; Figure 2.8), indicating that this phylotype was not a 
sequence artifact from bTEFAP library preparations and revealing that this phylotype appears to 
be conserved across P. elisabethae throughout the Bahamas. Furthermore, the absence of 
evidence of this band from the negative control (E. coli) supports that RKPE23-related 
phylotypes are specific to octocorals. 
 
Comparison of P. elisabethae and water-associated bacterial communities 
 
 
To compare coral and water-associated bacterial communities, water sequence libraries (W1 and 
W2) were clustered with coral sequence library 3E. The water sample used to prepare the W2 
sequence library was collected adjacent to sample 3E, while the W1 sequence library was 
prepared from a water sample collected the same day yet from 5 km away. In total, 2,047 
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RKPE223  A-TGTGTAAAGACATATGTTTT-ATTATTAAAGGATCGTTTTGGTCCG-CGCAG--GGAT 
Gven_K23  A-TGTGTAAAGACATATGTTTTTATTATTAAAGGATCGTTTTGGTCCG-CGCAG--GGAT 
RKPE23  A-TGTGTAAAGACATATGTTTTTATTATTAAAGGACCGTTTTGGTCCGGCGCAG--GGAT 
Gven_G10  ACCTTCTAAGGAAGAAAGC----------AGGGGATC-TTCGGACCTTGCGCTATCGGAT 
Ecoli16S 179 AACGTCGCAAGACCAAAGA----------GGGGGACC-TTCGGGCCTCTTGCCATCGGAT 227 
* * * ** * * *** * **  * * ** **** 
 
RKPE23 (Gven_K23) Designed Primer: 
5' – AAAACGATCCTTTAATAATAAAAAC-3‘ 
 
 
 
 
Figure 2.7: DNA alignment of potentially novel RKPE phylotype sequences from P. elisabethae. 
 
Included in the alignment is the closely related clone Gven_K23 (GU118339.1) along with 
Gven_G10 (GU118518.1) and E. coli (J01695.2). The alignment positions are relative to E. coli 
shown from positions 179 – 227.  The designed primer containing the unique 10 bp sequence is 
highlighted below. 
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Table 2.7: RKPE23 phylotypes detected in coral libraries 
 
 
Site Coral sequence library Gven K23/RKPE23 detected 
Eleuthera Reef 1A Yes 
Eleuthera Reef 1B Yes 
Eleuthera Reef 1C No 
Eleuthera Reef 1D Yes 
Eleuthera Reef 1E Yes 
Sweetings Cay 2A Yes 
Sweetings Cay 2B Yes 
Victory Reef 3A/3B Yes/Yes 
Victory Reef 3C Yes 
Victory Reef 3D Yes 
Bimini 3E No 
Petersons Reef 4A Yes 
Petersons Reef 4B No 
Petersons Reef 4C Yes 
  
 
 
 
Figure 2.8: RKPE23/Gven_K23-R1 screening results from P. elisabethae. A) Amplification results of P. elisabethae sample libraries, 
 
B) Amplification results of sample 1E, which contained the greatest abundance of RKPE23 (83.8%). Shown is sample 3E amplified 
using the conditions listed in the legend; ―M‖ refers to molecular marker (2-log ladder). 
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OTU0.03s were present in the three sequence libraries. Phylotypes from sample 3E outnumbered 
both water library phylotypes at OTU0.03, generating an additional 107 OTU0.03s not detected in 
water. Based on a presence/absence matrix (data not shown), 52.0% of OTU0.03s were unique to 
sample 3E, 46.8% were unique to W1/W2, and only 1.1% were conserved between water and 
sample 3E sequence libraries. Dominant coral phylotypes were not found in seawater libraries 
and vice versa. One notable exception to this was observed among Cyanobacteria-affiliated 
sequences in which a variety of related Synechococcus sp. and Prochlorococcus marinus 
phylotypes overlapped between coral and seawater sequence libraries (Table 2.6). Furthermore, 
Alphaproteobacteria (Pelagibacter sp., Figure 2.5) were present in both the water column and 
corals, suggesting that P. elisabethae may be actively selecting (or possibly consuming) a 
minimal number of microbes from the surrounding environment. In general, however, the 
abundance of unique P. elisabethae-associated phylotypes and the lack of conservation between 
coral and water-associated bacterial communities suggest the surrounding water exerts little 
influence on shaping the bacterial community of P. elisabethae and supports previous 
observations that healthy corals maintain a unique microbial community from the surrounding 
water column (Bourne and Munn, 2005; Kvennefors et al., 2010; Rohwer et al., 2001; Sunagawa 
et al., 2010; Sweet et al., 2011). 
 
Evaluation of sequencing methodology 
 
 
As bTEFAP is a relatively novel method for assessing coral-associated bacterial 
taxonomy, the reproducibility, accuracy, and suitability of the method was tested by comparing 
A) replicate 16S rRNA gene pyrosequences (sequence libraries 1A and 1B) as a template for 
bTEFAP which were submitted independently, B) a gDNA sample in conjunction with its PCR- 
derived amplicon (sample 3A/3B) submitted in the same pyrosequencing run, and C) bTEFAP 
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sequences to dominant DGGE band sequences. The class-level community profiles of 1A and 1B 
were strikingly similar with only moderate differences observed in the abundance of 
Alphaproteobacteria and Cyanobacteria (Figure 2.3). Similarly, the class-level community 
structure deduced from sequence libraries 3A and 3B were generally similar, but differed in the 
relative portion of Gammaproteobacteria and unclassified bacterial sequences (Figure 2.3), 
confirming that nested PCR did not introduce significant bias into the analysis. This was also 
reflected in the PCA model, as PCR amplicon replicates (1A and 1B) and gDNA/PCR amplicons 
(3A and 3B) contained a similar overall bacterial community and separated along all principal 
components in spatial proximity to one another respectively based on species-level phylotypes 
(Figure 2.6). These results suggest that the variation between experiments is relatively low and 
that large observed differences in bacterial community structure in P. elisabethae are not likely 
due to methodological variation. However, there were a few notable differences between the 
gDNA and PCR amplicons. Comparison of bacterial communities generated from gDNA and 
PCR amplicon pyrosequences showed that PCR amplicons yielded a greater number of 
pyrosequencing reads (868 for gDNA (3A) and 2387 for PCR amplicon (3B) pyrosequences 
respectively), higher bacterial diversity, and less unclassified bacteria (Table 2.1). In part, the 
differences observed between these samples may be due to the low number of sequences (868) 
obtained using gDNA (3A) as template. The major difference was highlighted at the species 
level based on the PCA model (PC4) due to differences in the relative abundance of the RKPE23 
phlyotype, while sample 1E (gDNA) was removed as an outlier from the PCA biplot due to the 
overrepresentation of this phylotype (Figure 2.6A). It is unclear why these phylotypes were 
detected in much greater abundance in the gDNA sequence libraries compared to PCR amplicon 
libraries. However, the dominance of unclassified bacteria in gDNA libraries suggests that 
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gDNA pyrosequencing is superior in uncovering higher amounts of rare and unclassified taxa 
which may become reduced over sequential rounds of PCR amplification. Consequently, the use 
of gDNA templates for bTEFAP is recommended to assess bacterial diversity in octocorals. This 
conclusion is drawn from one gDNA pyrosequencing dataset and may not be representative in all 
cases. Taken together, the results suggest that bTEFAP is a reproducible and reliable method for 
characterizing bacterial communities and diversity in a healthy alcyonacean octocoral. 
 
Comparison of bacterial communities by pyrosequencing and DGGE 
 
 
Sequences obtained for excised DGGE bands were directly compared to bTEFAP sequences as a 
result of amplifying the same region on the 16S rRNA gene. In total, eight dominant bands were 
sequenced from six representative corals (Figure 2.9). Interestingly, dominant OTU0.03s in 
bTEFAP did not necessarily reflect the most dominant DGGE retrieved band sequence (Table 
2.8) and did not reflect the numerical abundance of Alphaproteobacteria or 
Gammaproteobacteria as seen in bTEFAP sequence libraries. In several cases, however, DGGE 
band sequences matched those of dominant RKPE phylotypes (Table 2.8). The most frequently 
retrieved band (e.g. in five of the eight bands) was most closely related to Synechococcus sp. 
(Bands 3, 5, and 7; Table 2.8), demonstrating that DGGE and bTEFAP are complementary tools 
for identifying the abundance of Cyanobacteria in an octocoral. In addition, DGGE confirmed 
the presence of the bTEFAP-generated RKPE23 related phylotype (Band 1) from sample 3A and 
its PCR equivalent sample 3B (Table 2.8), classified as relating to the uncultured G. ventalina 
Gven_K23 phylotype, which was an abundant OTU0.03 in bTEFAP libraries (17.6% in sample 
3A and 1.2% in sample 3B). DGGE band 2 confirmed the presence of the bTEFAP phylotype 
RKPE6, representing an uncultured alphaproteobacterium (Table 2.8) along with two 
Mycobacterium caprae – related phylotypes from sample 1C and sample 2A (bands 4 and 6). 
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Figure 2.9: DGGE polyacrylamide gel displaying 16S rRNA gene sequence bands sequenced 
 
from representative P. elisabethae corals. Band sequence identities are indicated in Table 2.9. 
Lanes with no band numbers and visible bands without band numbers indicate no sequences 
could be obtained due to ambiguous sequence data. 
  
Table 2.8: Comparison of DGGE band sequences to bTEFAP sequences from selected corals. NA: Band not available on the gel in 
 
Figure 2.9. DGGE band numbers correspond to labels in Figure 2.9. 
 
 
 
 
Sequence 
library 
DGGE 
band 
no. 
Base pair 
similarity to 
bTEFAP 
Closest BLASTn similarity (GenBank Accession 
No.; percent identity of match) 
Sequence 
abundance in 
coral bTEFAP 
library 
Most dominant 
OTU0.03 in bTEFAP 
library? (Table 3) 
1B 7 402/402, 100% Synechococcus sp. KORDI-54 (FJ497735.1; 
100%) (Cyanobacteria) 
13.6% Yes 
1C 6 408/418, 96% Mycobacterium caprae (NR_028879.1; 95%) 
(Actinobacteria) 
<1% of total 
library 
No 
2A 5 402/402, 100% Synechococcus sp. KORDI-54 (FJ497735.1; 
100%) (Cyanobacteria) 
23.7% No (2
nd 
most 
abundant) 
2A 4 386/388, 99% Mycobacterium caprae (NR_028879.1; 98%) 
(Actinobacteria) 
<1% of total 
library 
No 
3A and 
3B 
1 424/425, 99% Uncultured bacterium clone Gven_K23 
(GU118339.1; 99%) (Unknown phylum) 
24.2% No (2
nd 
most 
abundant in Sample 
3A) 
3C NA 402/402, 100% (Synechococcus sp. KORDI-54 (FJ497735.1; 
97%) (Cyanobacteria) 
1.49% No 
3D 2 407/419, 97% Uncultured sponge Alphaproteobacterium 
(HQ726945.1, 92%) (Alphaproteobacteria); 
Uncultured Proteobacterium clone RKPE6 
(JN411722.1; 99%) 
7.7% No (2
nd 
most 
abundant) 
3D 3 405/406, 99% Synechococcus sp. KORDI-54 (FJ497735.1; 
100%) (Cyanobacteria) 
1.14% No 
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Only a few bands were generated from the use of DGGE, which may be a function of 
experimental difficulties. For example, at 507 bp, the modified primer pair 27f-GC and P2 
(Muyzer et al., 1993) exceeded the 500 bp limit of resolution for DGGE (Muyzer and Smalla, 
1998). In addition, fewer bands could be sequenced. In this case, despite numerous attempts at 
purification, more than one band was present on the polyacrylamide gel (data not shown). As a 
consequence, attempts to sequence the excised bands produced highly ambiguous 16S rDNA 
sequences. As a result of the inherent difficulties of DGGE and in combination with the 
simplicity and efficacy of bTEFAP, bTEFAP is recommended as a superior methodology at 
inferring coral-associated bacterial diversity. 
 
Screening P. elisabethae for the presence of associated zooxanthellae 
 
 
Zooxanthellae from five selected P. elisabethae samples were a match to other stony and 
octocoral-associated zooxanthellae based on sequence identity. Here, zooxanthellae band 
sequences exclusively represented Symbiodinium clade B (Table 2.9), a trend which has been 
reported previously for P. elisabethae (Santos et al., 2003; 2004). Interestingly, the octocorals P. 
elisabethae and G. ventalina host phylogenetically similar Symbiodinium sp. (Santos et al., 2004) 
and as mentioned previously, share some dominant bacteria (e.g. RKPE1 and RKPE23-related 
phylotypes). Octocoral taxonomists state that the two genera (Pseudopterogorgia spp. and 
Gorgonia spp.) are more closely related than previously believed based on mitochondrial DNA 
sequencing (McFadden et al., 2006; 2010; Sanchez et al., 2003). Consequently, the genetic 
similarities and the similarity of algal symbionts between G. ventalina and P. elisabethae may be 
one factor which explains why these corals are hosting similar dominant bacteria. Given that 
octocoral cell signalling controls dinoflagellate populations (Koike et al., 2004), it is perhaps not 
implausible to suggest that the dinoflagellate community may be involved in shaping octocoral- 
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Table 2.9: Zooxanthellae band sequence identities from selected P. elisabethae samples. 
 
 
Sequence 
library 
Nearest BLAST sequence identity Sequence 
length 
(bp) 
E Percent 
maximum 
sequence 
identity (%) 
1A Plexaura kuna (octocoral, Panama)-associated 
Symbiodinium sp. clade B1 (JN558057.1) 
614 0 99 
2A Plexaura kuna (octocoral, Panama)-associated 
Symbiodinium sp. clade B1 (JN558059.1) 
458 0 99 
2B Diploria strigosa (stony coral, Bermuda)-associated 
Symbiodinium sp. clade B (AY074972.1) 
602 0 100 
4A Plexaura kuna (octocoral, Panama)-associated 
Symbiodinium sp. Clade B1 (JN558057.1) 
601 0 99 
4C Montastrae annularis (stony coral, Curacao)-associated 
Symbiodinium sp. Clade B1 (DQ200711.1) 
279 0 98 
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associated bacterial communities and thus may play a role in conserving at least some members 
of the bacterial community in P. elisabethae and G. ventalina. 
 
The bacterial community of P. elisabethae is not conserved within and between reefs in the 
Bahamas 
 
Both community analysis at the class level (Figure 2.3) and PCA at the species level 
(Figure 2.6) revealed that the P.elisabethae-associated bacterial community was not highly 
conserved among individuals within a site; rather, specific dominant OTU0.03s within the 
bacterial community were shared by coral samples from different sites (Figure 2.6B – C), 
suggesting that bacterial communities are diverse and distinct both locally and throughout the 
Bahamas. In contrast to the present research, however, many studies report that corals host a 
stable and species-specific relationship with bacteria (Rohwer et al., 2001, 2002; Rosenberg et 
al., 2007). However, debate surrounding the specificity of bacterial relationships to cnidarians 
exists owing to contradictory evidence which suggest bacterial diversity is variable over time 
(Lee et al., 2009), site (Gray et al., 2011; Kellogg et al., 2009; Kvennefors et al., 2010; Penn et 
al., 2006), species (Lee et al., 2011; Neulinger et al., 2009), life stage (Littman et al., 2009a), 
and spatial location within the cnidarian holobiont (Bourne and Munn, 2005; Qian et al., 2006; 
Schöttner et al., 2009; Sweet et al., 2011; Wichels et al., 2006). For example, acroporids 
collected in triplicate from two locations in the Great Barrier Reef revealed that acroporid 
bacterial communities grouped according to location rather than species (Littman et al., 2009b). 
Additionally, bacterial communities of triplicate stony coral libraries not only showed bacterial 
variation within the same environment, but also across locations and by colour morph (Neulinger 
et al., 2008). Furthermore, clone libraries from bacteria associated with deep-sea alcyonaceans 
collected at different locations in the Aleutian Islands showed no clear pattern of a conserved 
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microbial consortium, with two clone libraries dominated by Tenericutes and 
Alphaproteobacteria, while other coral-associated bacterial libraries were more diverse (Gray et 
al., 2011). Furthermore, the authors found that bacteria were more similar between congenera 
than between conspecifics. This trend in bacterial community variation also extends to other 
eukaryotes. For example, the bacterial community in the plant phyllosphere on cottonwood trees 
was highly variable throughout the growing season (Redford and Fierer, 2009). Interestingly, 
each of the samples collected from the same tree on different dates harboured a distinct bacterial 
community; furthermore, the variability in bacterial communities between different trees 
sampled on the same date was less than the variability in a single tree over time. The authors 
suggested that environmental perturbations may prevent the stabilization of the bacterial 
community over time. Therefore, it is possible that local environmental conditions may have 
impacted the bacterial community in P. elisabethae at least in part. 
 
Factors influencing microbial diversity analysis 
 
 
Several factors may affect the determination of microbial communities. For example, the 
quality and completeness of DNA extractions are regarded as the most influential factor in 
shaping the diversity and community of 16S rRNA gene sequences obtained from invertebrate 
hosts (Feinstein et al., 2009, Pan et al., 2010). In particular, alcyonacean octocorals are 
notoriously difficult to obtain high quality DNA which enables PCR amplification, a factor 
which is most likely due to the incomplete lysing of bacterial cells and the co-extraction with 
phenolic compounds (Gray et al., 2011; Sunagawa et al., 2010). These difficulties may explain 
the lack of investigations characterizing octocoral-associated bacteria. In addition, lysis 
efficiency of bacterial cells varies depending on the targeted group. The highly rigorous 
conditions required for lysis of Gram-positive bacteria, including bead beating, causes shearing 
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of nucleic acids in Gram-negative bacteria, leading to problems in downstream PCR 
amplification (Kirk et al., 2004; von Witzingerode et al., 1997). PCR amplification also 
significantly impacts measures of microbiological diversity. For example, Wu et al. (2010) 
showed polymerase choice in PCR amplification had the most significant effect on the analysis 
of microbial diversity with next generation sequencing methods, where a high fidelity 
polymerase generated less PCR artifacts and determined significantly different community 
structures based on efficiency in amplifying abundant sequences. Hence, the results may have 
been negatively impacted by the use of EconoTaq
® 
DNA polymerase in PCR amplification. 
 
Authors have stressed that compounds co-extracted from environmental sources, mainly 
phenolic compounds (including humic substances), strongly inhibit Taq polymerases (von 
Witzingerode et al., 1997) and denatures biological molecules (Young et al., 1993). Furthermore, 
classifying bacterial species at 97% sequence similarity and based on partial sequences (<500  
bp) can be misleading in phylogenetic placement (Hugenholtz et al., 1998). Consequently, it has 
recently been proposed by Kim et al. (2011) that clustering 16S rDNA sequences at the V1 – V3 
region at OTU0.04 provides a more accurate estimate of species diversity. The choice to cluster at 
the conventional species level (97% sequence similarity, Cohan, 2002) in this investigation may 
explain the abundance of closely-related phylotypes obtained and possibly suggests that diversity 
measurements may be overestimated. 
 
Finally, the results demonstrate that P. elisabethae contains an abundance of bacterial 
phylotypes with the likely ability to produce natural products. For example, marine-derived 
Cyanobacteria continue to be an important source of bioactive metabolites and have yielded a 
greater amount of compounds than their terrestrial counterparts (Gulder and Moore, 2009; 
Williams, 2009). In addition, Flavobacteria produce metabolites which have antitumor activity 
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and Bacillales produce compounds with antimicrobial properties (de Carvalho and Fernandes, 
2010), while Actinomycetales account for up to 45% of promising new bioactive compounds 
(Williams, 2009). In the present study, five of six dominant Actinobacteria phylotypes were 
exclusive to P. elisabethae libraries (5% abundance) and were not detected in surrounding water 
samples. These results suggest that P. elisabethae-associated bacteria may be an excellent 
resource to investigate for drug discovery. This will be discussed in detail in subsequent 
chapters. 
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CONCLUSIONS, SIGNIFICANCE, AND FUTURE AIMS 
 
 
 
 
This study represents the first in-depth analysis on the geographic variability of the 
bacterial communities in the octocoral Pseudopterogorgia elisabethae and has demonstrated the 
suitability of bTEFAP for inferring octocoral-associated bacterial taxonomy. This study has also 
identified species-level phylotypes which are the main contributors to the differences among 
coral and water-associated bacterial sequence libraries. This level of detail has not been 
previously addressed to our knowledge. Based on the analysis of the P. elisabethae bacterial 
community, the evidence presented herein suggests the coral exerts little influence on shaping its 
bacterial community. However, the results also suggest that the octocoral provides a specialized 
habitat for bacteria which are distinct from those of the surrounding seawater. Specifically, the 
results demonstrate that Alphaproteobacteria were more diverse than Flavobacteria, 
Gammaproteobacteria, and Cyanobacteria. P. elisabethae also harbours potentially novel species 
and genera, while a new candidate bacterial phylum was also identified. If strains of the 
previously mentioned novel species, genera, or phyla could be isolated, cultivation studies of 
coral-associated bacteria may help to reveal further insight as to why these bacteria were 
predominant within the bacterial community of P. elisabethae. 
 
This study has contributed to the general scientific understanding of bacteria associated 
with octocorals, which still remains a little-studied topic. Future investigations may consider 
studying additional alcyonaceans in order to determine if the lack of bacterial conservation 
between individuals in P. elisabethae can be extended to other octocorals. The impact of this 
research to the scientific community has been in the form of identifying potentially novel 
bacterial species, genera, and a candidate phylum. Given the well-established link between 
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biological diversity and natural product diversity, and based on the novelty of some of its 
associated bacteria, P. elisabethae is an excellent candidate for drug discovery programs. 
However, based on the evidence presented herein, bioprospecting strategies should consider 
sampling multiple individuals from P. elisabethae within and between reefs to fully realize the 
microbial diversity harboured by this commercially important octocoral. Following successful 
cultivation, P. elisabethae-associated bacteria may provide a sustainable source of new and 
useful natural products for biomedical applications. 
 
Another interesting conclusion from this study is that Pseudomonas aeruginosa may not 
be the sole biosynthetic origin of the pseudopterosins as previously hypothesized (Bunyajetpong 
et al., 2011; Bunyajetpong, 2011). One would presume that a true pseudopterosin-producing 
bacterium would be ubiquitously distributed in all P. elisabethae specimens as has been shown 
in other marine invertebrates (Perez-Matos et al., 2007). Given that Pseudomonas spp. were not 
consistently recovered in corals throughout the Bahamas, one might reasonably conclude that 
pseudopterosin production may be the result of the acquisition of a plasmid containing the 
pseudopterosin biosynthetic gene cluster from P. aeruginosa. Although this study indicated there 
is significant variability in the bacterial community, Ruegeria sp. (RKPE12 phylotype) were 
consistently detected across all PCR-generarted coral libraries, while RKPE1 phylotypes (91% 
sequence similarity to Endozoicomonas sp.) were particularly dominant in select sequence 
libraries. Since Ruegeria mobilis  isolated from Symbiodinium sp. within two reef-building corals 
has previously been demonstrated to horizontally transfer genetic material between bacterial taxa 
(Young, 2011), in addition to the ubiquitous distribution across P. elisabethae samples in the 
Caribbean, it is possible that Ruegeria sp. may be an alternative source of the pseudopterosins. 
A future experiment may consider screening coral-associated Ruegeria sp. for the presence of 
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terpene-natural product biosynthetic gene clusters to determine whether Ruegeria sp. play a role 
in pseudopterosin biosynthesis. 
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CHAPTER III 
 
 
INVESTIGATION OF THE CULTIVABLE BACTERIAL COMMUNITY FROM 
 
PSEUDOPTEROGORGIA ELISABETHAE 
 
 
INTRODUCTION 
 
 
Corals are host to a diverse consortium of microorganisms, including zooxanthellae, 
bacteria, and fungi (Goulet and Coffroth, 2004; Sunagawa et al., 2010; Wang et al., 2011). In the 
past, culture-based studies dominated our understanding of coral-associated microbiology 
(Ducklow and Mitchell, 1979; reviewed in Rosenberg et al., 2007), however, owing to the 
limitations associated with cultivation-based techniques (Engelbrekson et al., 2010; Joint et al., 
2010;  reviewed in Uthicke and McGuire, 2007), culture-independent investigations of coral- 
associated bacteria have taken precedence in the literature (Rohwer et al., 2001; Rosenberg et al., 
2007; Sunagawa et al., 2010). While it is important to acknowledge that culture-based studies 
underestimate bacterial diversity (Engelbrekston et al., 2010), Bergey‘s Manual of Systematic 
Bacteriology states that an organism cannot be classified unless its morphological, cultural, 
physiological and pathogenic characteristics have been described via study of pure and viable 
cultures (Breed and Smithh, 1957). Furthermore, cultivation provides a resource to practically 
assess the biomedical capabilities of bacterial metabolites, as cultivation is an essential 
prerequisite for biodiscovery (Galkiewicz et al., 2011). However, although a wealth of literature 
exists reporting culturable bacteria from scleractinian corals (Ben-Dov et al., 2009; Nithyanand 
and Pandian, 2009; Nithyanand et al., 2011), little attention has been focused on the isolation and 
cultivation of bacteria from commercially important octocorals. 
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Previously, pyrosequencing analysis of bacterial communities associated with the 
octocoral P. elisabethae revealed that the coral harbours a diverse bacterial community (refer to 
Chapter II). Given the commercial significance of P. elisabethae (Roussis et al., 1990) and 
evidence that associated bacteria may be the true source natural products previously ascribed to 
the host invertebrate (Bunyajetpong et al., 2011; Bunyajetpong, 2011; Davidson et al., 2001; Piel 
et al., 2002; 2004), characterizing the prokaryotic community associated with this important 
octocoral can provide a resource with which to discover new sources of natural products. 
Additionally, comparing the cultivable community to the culture-independent community will 
contribute to the scientific understanding of alcyonacean-associated bacterial communities and 
will ultimately enhance our ability to design strategies with which to isolate natural product 
producing bacteria. The research goals in this study are: 
 
1) To characterize the cultivable diversity of bacteria from P. elisabethae and to 
maximize the diversity of recovered isolates through the use of a diverse selection of 
isolation media and the particle filtration technique (PFT), 
 
2) To determine the success of the selected isolation strategy at culturing a representative 
selection of the P. elisabethae microbiome via comparison of the metagenomic 16S 
rDNA sequence libraries to cultured isolates, 
 
3) To assess the ability of matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS) as a tool to de-replicate environmental isolates, and 
 
4) To identify the salinity requirements of coral-associated bacteria and to test their 
susceptibility to pseudopterosin G, an antimicrobial diterpene from P. elisabethae. 
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As less than 1% of microorganisms can be cultured using standard plating procedures, 
techniques which favour the detection of rare species have been devised to overcome the limits 
of cultivation (Hawksworth and Rossman, 1997; Kaeberlein et al., 2002). Specifically, the PFT 
has been successfully implemented as a tool to detect slow growing fungi; ultimately, this 
technique has resulted in increasing the number of fungal species by ten times more than other 
methods (Hawksworth and Rossman, 1997). Here, the PFT is introduced in an attempt to isolate 
potential symbiotic bacteria, where it is hypothesized that screen filters will allow access to 
tissue-associated bacteria by enabling bacteria to physically grow in the presence of coral 
fragments. It is hypothesized that the highly diverse media conditions in conjunction with the 
particle filtration technique will result in a highly diverse culturable bacterial community from P. 
elisabethae. The goal in testing for salinity requirements was to add to the scientific 
understanding of those bacteria isolated from marine invertebrates which are dependent on 
seawater for growth. Although evidence suggests clinical Gram-positive bacteria are inhibited by 
pseudopterosins (Ata et al., 2004; Correa et al., 2011), less information is known regarding their 
activity against ecologically relevant bacteria (Correa et al., 2012). Hence, this investigation also 
tested the hypothesis that ecologically relevant bacteria isolated from P. elisabethae would also 
be inhibited by pseudopterosin G (PsG).This analog was selected as it was previously amongst 
the most active pseudopterosin investigated against Staphylococcus aureus and Enterococcus 
faecalis (Correa et al., 2011). 
 
Consistent with the earlier description and to avoid confusion between bacteria isolated 
by cultivation and gene sequences generated from bTEFAP, the term ―isolates‖ herein refers to 
bacteria obtained by cultivation on solid media. The term ‗library‘ is used to represent the 
collection of sequences identified from bTEFAP and ‗phylotypes‘ or ‗operational taxonomic 
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units (OTUs) to represent a group of PCR amplicon sequences considered to be essentially 
identical at the species (OTU0.03; 97% sequence identity) or class level (OTU0.10; 90% sequence 
similarity). 
 
MATERIALS AND METHODS 
 
 
Coral collection and initial processing: San Salvador, Bahamas (BS), 2008 
 
 
Two colonies of P. elisabethae were identified by morphological characteristics and collected by 
 
R. Kerr by SCUBA from San Salvador Island at Runway 10, Bahamas ((BS), geographic 
coordinates:  24 03.898 N; 74 32.635 W), in August 2008. Precautions were taken to avoid 
contaminating coral specimens by the use of sterilized gloves, scissors, and polypropylene tubes 
as described previously (Chapter II). At the surface, the coral was cut into approximately 1 cm 
lengths and was washed three times with sterile filter seawater (SFSW, sterilized by autoclaving) 
to remove loosely associated microbes. Coral fragments were cut into thin sections using a sterile 
scalpel and ground into a homogenate using a microcentrifuge tube and pestle. 
 
Plating methods: San Salvador, BS, 2008 
 
 
For isolates denoted by ‗RKBH‘, ground coral fragments from one coral colony were suspended 
in nine mL of SFSW and diluted to 10
-3 
and 10
-5 
using SFSW. From the 10
-5 
dilution, 100 µL 
was plated in triplicate on individual Bacto Marine Agar 2216 (MA, Difco BD Biosciences, 
Franklin Lakes, NJ) plates, while 100 µL of the 10
-3 
dilution was pipetted on three plates of each 
of the media listed in Table 3.1. For V8 and R2A media, a sterile 0.45 µm nitrocellulose mixed 
ester membrane (GE: E04WP09025) was aseptically placed on the plates prior to inoculation to 
selectively isolate Actinobacteria (Hirsch and Christensen, 1983). Plates were wrapped in 
parafilm and shipped from San Salvador (SS) to the University of Prince Edward Island (UPEI) 
175  
between August 16 – 25, 2009. Once plates arrived at UPEI, emerging colonies were initially 
subcultured to the same medium as the isolation plates while further subculturing was performed 
on MA.  ―RKBH‖ cultures were plated on media indicated by an asterisk in Table 3.1. For ‗SS‘ 
isolates, coral fragments from the second colony were finely chopped using a sterile razor and 
were homogenized using a microcentrifuge tube and pestle, adding 75% ASW (prepared at 35 
g/L) to aid homogenization. Homogenate was placed in a sterile Nalgene cryovial, and sterile 
glycerol was added to coral homogenates to a concentration of 25% (v/v). Samples were mixed 
well and flash frozen in a liquid nitrogen dry shipper for transport back to UPEI, storing samples 
at -80°C upon arrival. Samples were thawed and were diluted from up to 10
-3 
using 75% ASW 
 
(at 35 g/L) and 25% MilliQ
® 
water. For all three dilutions, 100 µL was plated in triplicate on 
media shown in Table 3.1 (n = 120 plates), yet were not plated on V8 agar or No Nal R2A 
(indicated by a ‗+‘ in Table 3.1). 
 
Coral collection and initial processing: Bimini, BS, 2009 
 
 
Three specimens of visibly healthy P. elisabethae colonies (replicates A, B, and C) were 
collected by SCUBA by R. Kerr at a collection depth of 50 – 60 ft from two reefs surrounding 
Bimini, the Bahamas (Victory Reef = Site 1 – 25 29.13′ N 79 16.41′ W; Tuna Alley = Site 2 –25 
31.38′ N 79 16.41′ W) in February 2009. Corals were identified by morphological characteristics 
and were collected 33 ft apart to ensure clonal propagates were not re-sampled. Multiple 
branches of the same individual corals were collected by inverting a sterile 50 mL polypropylene 
tube underwater and cutting specimens with pre-sterilized scissors, being careful to avoid 
touching the coral section to be analyzed. At the surface, corals were aseptically cut into ~0.5 – 1 
cm lengths using sterilized scalpels and were transferred to new sterile 50 mL tubes, filling the 
tubes halfway with coral fragments. To remove loosely associated microorganisms, coral 
  
Table 3.1: Media ingredients for the isolation of bacteria from P. elisabethae from San Salvador, BS (2008). Media was sterilized by 
 
autoclaving and antimicrobials were filter-sterilized and added post-autoclaving. Purification agar for all agars except MA (prepared 
in MilliQ
® 
water) was prepared using 75% ASW (Instant Ocean, 18 g/L). 
 
Isolation 
Media 
Description/Reference Composition/supplier 
Marine agar 
(MA)* 
Medium for the enumeration of salt-requiring or salt tolerant bacteria BD Difco™, 0.66 µg/mL cyclosporine A and 50 µg/mL 
Nystatin, MilliQ® water to 1 L. 
Dilute MA Diluted 100 fold as previous studies have demonstrated that the number 
of morphologically distinct bacteria increased by 20% when dilute MA 
was selected over full strength media (Bruck et al., 2007) 
BD Difco™ premix, diluted 1/100; 10 g/L agar, 50% 
ASW to 1 L; 50 µg/mL cyclohexamide. 
R2A* Used for the isolation of slow-growing, chlorine-tolerant bacteria. 
Nalidixic acid used at a low concentration to act as a bacteriostatic agent 
(Deitz et al., 1966) 
BD Difco™, 10 µg/mL nalidixic acid, 50 µg/mL 
cyclohexamide, 50 µg/mL nystatin; 1 L ASW 
No Nal 
R2A*
+
 
As above, no nalidixic acid added BD Difco™, 50 µg/mL cyclohexamide, 50 µg/mL 
nystatin; 1 L ASW 
dR2A Solidified with an alternative gelling agent as a means to increase the 
number of colony formations (Tamaki et al., 2009). 
As above for R2A, BD Difco™, diluted 1/100; 15 g/L 
gellan gum; 1 L ASW. 
V8 Agar*
+
 A medium used to stimulate the production of fungal sexual spores 
(Kent et al., 2008; Campbell soup Co.) 
20 g/L agar, 4 g/L CaCO3, 20 mL V8 juice, ASW to 
1L, 10 µg/mL nalidixic acid, 50 µg/mL cyclohexamide, 
50 µg/mL nystatin, to 1 L ASW, pH 7.3 
ISP-4 International Streptomyces project medium, a selective isolation media BD Difco™, ASW to 1 L 
M3 M3 was selected owing to its ability to increase the recovery of 
Actinobacteria from three sponge species based on colony morphotypes 
50 µg/mL cyclohexamide; 10 g/L agar; 1 L ASW 
C media Selected owing to its ability to produce the highest cultivable diversity 
from bacterial communities associated with a South China Sea sponge 
(Li et al., 2007) 
50 µg/mL nalidixic acid 
dNA A high nutrient non-selective medium diluted to enhance the 
cultivability of bacterial isolates (Janssen et al., 2002) 
BD Difco™ premix diluted 1/1000; 10 g/L agar 
An asterisk (*) represents culture media for RKBH isolates; ‗+‘ refers to isolation media not used for the isolation of ‗SS‘ bacteria. 
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 fragments were shaken vigorously three times with SFSW. Coral pieces were homogenized 
using a sterilized homogenizer, where the homogenizer was sterilized after each sample by 10% 
bleach, followed by 70% EtOH, and rinsed using SFSW. Coral homogenates were stored at 4°C 
for 3 – 6 hours prior to plating. 
 
Isolation media and plating methods: Bimini, BS, 2009 
 
 
As metagenomic analysis of a stony coral previously revealed associated bacteria were 
generally heterotrophic (Wegley et al., 2007), media which generally targeted such bacteria were 
selected. The ultimate goal of the research project was to maximize the culturable diversity to 
provide a platform for analyzing the biomedical potential of P. elisabethae-associated bacteria 
by analysis of fermentation extracts. Consequently, the bacterial diversity was maximized by 
incorporating a variety of isolation media with distinct nutrients (Table 3.2). Bacteria were plated 
on isolation media following application of the PFT (described below). BG-11 plates were 
stacked layer-deep on the window side and stored at room temperature (~20°C) to expose 
photosynthetic Cyanobacteria to a source of light. Plates were individually wrapped in Parafilm 
and were transported back to UPEI and incubated at room temperature (~23°C) for up to four 
months to enable the growth of slow growing colonies (Ben-Dov et al., 2009) and checked 
periodically for the emergence of new colonies. Isolates were subcultured two to three times to 
ensure purity, and re-streaking of isolates was performed on MA. To archive isolates, cultures 
were grown in sterilized Marine Broth (MB, BD Difco™) for 24 – 48 hours, and 25% glycerol 
(v/v) was added to 500 µL of cultures in MB which were archived at -80°C. 
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Table 3.2: Media ingredients for the isolation of bacteria from P. elisabethae from Bimini, BS (2009). Media was sterilized by 
 
autoclaving and antimicrobial agents were filter-sterilized and added post-autoclaving. Purification agar for all agars except MA 
(prepared in MilliQ® water) was prepared using half strength Instant Ocean (ASW, 18 g/L). 
 
Isolation Media Rationale Supplier/Composition 
MA Refer to Table 3.1 BD Difco™, Franklin Lakes, NJ, USA; 50 µg/mL cyclohexamide 
Dilute R2A Refer to Table 3.1 BD Difco™ Diluted 1/100, 15 g/L gellan gum, 10 mM filter-sterilized (0.22 
µm) MgSO4·7H2O, 50 µg/mL cyclohexamide; pH 7.2. 
C media Refer to Table 3.1 Refer to table 3.1 
M3 Refer to Table 3.1 10 g/L agar, 50 µg/mL nalidixic acid 
Pseudomonas 
specific media 
(Ps) 
A selective medium for the enumeration of 
Pseudomonas sp., an isolate potentially 
responsible for pseudopterosin production in 
P. elisabethae (Bunyajetpong, 2011). 
10 g K2SO4, 1.4 g MgCl2∙6H20, 20 g peptone, ASW (to 1 L), 50 µg/mL 
cyclohexamide, 50 µg/mL nystatin, 25 µg/mL Irgasan, 10 µg/mL nalidixic acid, 
13.6 g agar, pH 7.0 
PE (Invertebrate 
specific media) 
Used with the rationale that uncultivable 
microbes may grow in pure culture if 
provided with cues from the natural 
environment (Webster and Hill, 2001) 
Top layer: 10 g of finely ground P. elisabethae, 5 g agar, 750 mL 35% ASW, 
250 mL MilliQ
® 
water. Bottom layer: 750 mL ASW, 250 mL MilliQ
® 
water, 15 
g/L agar, and 50 µg/mL cyclohexamide. 
Artificial 
seawater (ASW) 
To enable the growth of potentially 
oligotrophic bacteria 
750 mL ASW, 250 mL MilliQ
® 
water, 15 g/L agar, and 50 µg/mL 
cyclohexamide, pH 7.6. 
BG-11 A selective medium targeting Cyanobacteria, 
which are excellent producers of bioactive 
metabolites (Williams, 2009) 
1.5 g NaNO3, 40 mg K2HPO4, MgSO4∙7 H20, 36 mg CaCl2∙2 H20, 6 mg Citric 
acid, 6 mg Ferric ammonium citrate, 1 mg EDTA (disodium salt), 20 mg 
Na2CO3, 1mL trace metal mix, 100 mL vitamin mix, 1 L ASW, 10 g agar, 50 
µg/mL cyclohexamide. Trace metals mix: 2.86 g H3BO3, 1.81 g MnCl2∙4H20, 
0.222 g ZnSO4∙7H20, 0.39 g NaMoO4∙2 H20, 79 mg CuSO4∙5H20, 49.4 mg 
Co(NO3)2∙6H20, sterile MilliQ
® 
water (to 1L); Vitamin mix: 0.1 g Thiamine 
HCl, 0.025 mg Biotin, 0.015 mg Cyanocobalamin prepared in 1 L MilliQ
®
 
water, filter sterilized, added post-autoclave. pH 7.1 
 
 
 
178 
179  
Isolation strategy: Particle filtration technique (PFT, Bimini, BS, 2009) 
 
 
Briefly, the PFT involves subjecting coral homogenates to vacuum filtration through mesh of 
different sizes and plating filtrates from selected screens on agar. The filtration apparatus 
(minisieve set, Scienceware®) was assembled with mesh screens placed in descending order 
(500 µm, 213 µm, 104 µm, and 51 µm; Figure 3.1). Theoretically, large sized tissue particles 
(including coral fragments) will be trapped on the uppermost screens while small tissue particles 
and free bacterial cells will flow through each screen culminating in the particle filtrate. 
Homogenized coral samples were poured onto the uppermost brass pre-screen, and the apparatus 
was covered with a lid. Vacuum was applied using a vacuum pump to pull particles through the 
screens, where the particle filtrate collected from the filter flask was poured into a 50 mL tube 
and placed on ice. The particles retained on the 104 µm and 51 µm screens were removed using 
sterile forceps and were placed in sterile 50 mL centrifuge tubes containing 30 mL sterile filter 
seawater (SFSW), which was prepared by filtering seawater collected on location using a 0.22 
µm Nalgene MF575 water filtration device (VWR International, Mississauga, ON). Samples 
were vortexed to remove particles from screens, and particles were carefully scraped from the 
screens using sterile forceps. 
 
To increase the bacterial diversity of P. elisabethae, the dilution-to-extinction protocol 
was used (Button et al., 1993). This procedure has distinct advantages by enabling the isolation 
of oligotrophic bacteria, which otherwise become overshadowed by quickly-growing isolates 
(Button et al., 1993). Particle suspensions were poured into a sterile Petri dish containing a 
sterile stir bar, situated on a stir plate to keep particles in suspension. Dilutions from the different 
mesh screens were vortexed in an appropriate amount of SFSW prior to plating (Appendix Table 
B1). Either 10 or 20 µl (Table B1) of the dilutions of each particle size was pipetted per well by a 
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Figure 3.1: The particle filtration device employed in the isolation of P. elisabethae-associated 
 
bacteria. 
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multichannel pipettor onto one plate of each isolation media (contained in 48-well polystyrene 
microtiter plates (Becton Dickinson, Franklin Lakes, NJ). A control of 20 µL per well of SFSW 
was pipetted into well A1 of each plate. 
 
Designation of isolates 
 
 
Isolates obtained from San Salvador in 2008 were denoted by the prefix ‗SS‘ if cultured by V. 
Robertson, or by ‗RKBH‘ if purified by B. Haltli.  Isolates obtained from fresh coral homogenate 
(2009 collections) and cultured by V. Robertson are labeled as ―RKVR‖ isolates or are 
represented by a single alphabetical letter followed by a number. ‗SS‘ isolates were prepared 
from frozen coral fragments, while ‗RKBH‘ and isolates designated by ‗RKVR‘ or a single 
alphabetical letter were prepared from fresh coral homogenate. 
 
Bacterial genomic DNA extraction protocol: San Salvador, BS, 2008 
 
 
Genomic DNA (gDNA) from 2008-collected coral isolates were extracted using a similar 
approach. However, 2009-collected coral isolates were first dereplicated by MALDI-TOF MS 
prior to DNA extraction; the DNA extraction procedure is as described for San Salvador isolates. 
Isolates were grown on MA overnight, and single colonies were picked with a toothpick and 
dispersed in 25 µL of DMSO as a rapid method of lysing bacterial cells. DMSO cell suspensions 
were used as a template in PCR reactions. However, if PCR reactions were unsuccessful using 
this method, DNA was isolated from bacterial cultures using a generic phenol:chloroform 
extraction protocol. Briefly, cells grown on MA were cultured in 5 mL of MB broth at 30°C until 
confluent growth was observed. A portion (500 µL) of each culture was pipetted into a 1.5 mL 
microcentrifuge tube. Cells were pelleted at 10,000 rpm using a desktop centrifuge (Sorvall 
Biofuge pico Thermo Scientific) for 5 minutes, the supernatant was removed, and cells were 
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resuspended using 1 mL of sterile MilliQ
® 
water. Water was removed following cell pelleting as 
above, and cells were suspended in 300 µL 50/20 TE (50 mM Tris, 20 mM EDTA, pH 8.0). 
Cells were incubated with 5 mg/mL lysozyme (Sigma-Aldrich, St. Louis, MO, USA) and 1 µL 
RNase ONE™ (Promega, Madison, WI) for 30 minutes at 37°C. Following incubation, 50 µL of 
10% sodium dodecyl sulfate (SDS) and 85 µL of 5 M NaCl was added and the sample was 
mixed well. A 500 µL volume of phenol/chloroform:isoamyl alcohol (25:24:1) was added to 
each tube and vortexed for 30 seconds. The aqueous layer was transferred to a new tube, where 
DNA was precipitated using 500 µL of isopropanol. Samples were mixed by inversion and 
incubated at room temperature for five minutes. DNA was pelleted at 10,000 rpm using a 
desktop centrifuge (Sorvall Biofuge pico) and isopropanol was removed. DNA pellets were 
washed with 500 µL of ice-cold EtOH to remove excess salt. EtOH was removed following 
centrifugation as above and DNA was dried in a laminar flow cabinet for 10 minutes at room 
temperature. DNA was re-suspended in Tris-HCl (pH 8.0) and stored at -20°C. 
 
PCR amplification of 16S rDNA sequences from isolate gDNA: San Salvador, BS, 2008 
 
 
 
Bacterial 16S rRNA gene sequences were amplified from 2008-collected coral isolates genomic 
DNA using the universal primers pA and pH (Edwards et al., 1989). PCR reactions contained 1X 
EconoTaq
® 
Plus Green Master Mix (Lucigen, Middleton, WI, USA) supplemented with 2.5 - 5% 
molecular biology grade DMSO (Sigma, Oakville, ON), 1 µM of each primer, 20 ng of template 
DNA, and sterile MilliQ
® 
water to 25 µL. Thermal cycling parameters were as follows: 1 cycle 
at 95ºC for 3 min; 34 cycles of 95ºC for 45 sec, 54ºC for 1 min, and 72ºC for 1.5 min, followed 
by a final extension cycle at 72ºC for 5 min. PCR amplification was assessed by 1% agarose gel 
electrophoresis (AGE, 1X TAE, 1% agarose w/v). PCR products were purified following band 
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excision at ~1,500 bp if non-specific banding was detected by 1% AGE. Bands were purified 
from the agarose using the Zymoclean Gel DNA Recovery Kit (Zymo Research, Irvine, CA). 
 
RFLP dereplication of isolates obtained from P. elisabethae: San Salvador, BS, 2008 
 
 
 
PCR amplicons of 16S rDNA sequences from ‗RKBH‘ and ‗SS‘ isolates were digested with 
HhaI and HaeIII separately according to the manufacturer‘s recommendations (New England 
Biolabs, Ipswich, MA, USA). RKBH isolates were dereplicated by B. Haltli. Restriction 
fragments were analyzed by AGE, where gels were prepared with 1.5% agarose (w/v). Gels were 
electrophoresed at 110V for 1hr30 min. Ten microliters of each digest was loaded with 2 µL of 
6X loading dye (Fermentas) and loaded into the gel. A 2-log ladder (NEB) was used as a 
molecular weight standard. Isolates exhibiting the same restriction fragment patterns with both 
enzymes were considered to be identical. 
 
Whole-cell MALDI-TOF MS dereplication of coral-associated bacteria: Bimini, BS, 2009 
 
 
 
Prior to gDNA extraction and PCR amplification, isolates from 2009-collected corals were first 
dereplicated to eliminate isolate redundancy and select for novelty from coral-associated bacteria 
using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF 
MS). Although morphological characteristics are a poor method of bacterial dereplication 
(Dieckmann et al., 2005), the initial dereplication relied upon differences in colony morphology 
and pigmentation as a means to reduce the number of morphologically similar isolates. Isolates 
were prepared by scraping a small amount of archived bacterial cells with a sterile toothpick 
from glycerol stocks onto a 96-well plate filled with 250 – 300 µL of MA. Since the growth 
stage of bacteria can influence the MALDI-TOF MS spectral output (Vargha et al., 2006), 
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experimental conditions were standardized by growing bacteria at 48 ± 2 hours at room 
temperature (~22°C). The matrix, consisting of 500 µL acetonitrile, 475 µL sterile MilliQ
® 
water, 25 µL trifluoroacetic acid (TFA), and α-cyano-4-hydroxycinnamic acid (CHCA) to 
saturation, was prepared fresh in a sterile 1.5 mL microcentrifuge tube. A TFA concentration of 
2.5% (v/v) was selected as previous studies demonstrated this improves ionization and spectrum 
quality for whole cell MALDI of both Gram-positive and Gram-negative bacteria (Vargha et al., 
2006). The matrix was vortexed for 30 seconds, centrifuged for 2 minutes at 10,000 rpm, and 
stored at 4°C until needed. Using a sterile wooden applicator, a thin smear of bacteria was 
stamped from isolates growing on marine agar to a Brüker stainless steel MSP 96 target plate, 
taking care to avoid oversaturation of the target spot. MALDI matrix (1.2 µL) was added to the 
top of the bacterial smear, and isolates were air dried at room temperature. The air dry method 
has previously been demonstrated to generate the best quality MALDI spectra in terms of 
number of detected signals and signal-to-noise ratio (Vaidyanathan et al., 2002). Duplicates of 
selected colonies were analyzed A) on different days and B) the same plate to ensure quality 
monitoring. E. coli was added as a control to each target plate. The use of MALDI-TOF MS was 
kindly provided by Dr. J. Lewis and technical assistance was provided by B. Despres. 
 
Bacterial protein fingerprints were generated from isolates using a Microflex LT 
MALDI-TOF MS (Brüker Daltonics) equipped with a 50-Hz N2 laser. MS analyses were 
performed in linear, positive ionization mode with a m/z charge selection in the range of 2,000 – 
20,000 and an acceleration voltage of 20 kV. FlexControl software (Brüker Daltonics) was used 
to generate MALDI-TOF MS peak profiles. Optimal instrument settings were empirically 
determined. Briefly, the laser intensity was adjusted to a minimum of 50%, and the total number 
of laser shots per spot was adjusted to a minimum of 200. A minimum ―summation‖ intensity of 
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500 – 1,000 was ensured for each sample, with the laser intensity adjusted to 60% if necessary. 
Cluster analysis from MALDI-generated spectra was constructed selecting Unweighted Paired 
Group Method with Arithmetic mean (UPGMA) using Biotyper software (version 2.0, Brüker 
Daltonics), since clustering by UPGMA has been previously demonstrated to suitably group 
similar isolates at the species-to-strain level (Ghyselinck et al., 2011). Dereplication parameters 
for environmental isolates have not been defined by Biotyper bacterial identification software 
(Brüker Daltonics). Furthermore, as the distance level for defining ―unique‖ (species-level) 
bacteria is unknown, sequencing effort was prioritized by sequencing representative isolates 
from clusters in the dendrogram with a similarity cutoff of ≥ 20. The flow-through procedure for 
MALDI-TOF MS dereplication is summarized in Figure 3.2. 
 
Genomic DNA extraction and PCR amplification: Bimini, BS, 2009 isolates 
 
 
 
Genomic DNA extraction and subsequent PCR amplification for MALDI-TOF MS de-replicated 
isolates was performed as described previously for 2008-collected San Salvador isolates. 
 
Sequencing of 16S rDNA amplicons: Bimini; San Salvador, BS 
 
 
 
Sequencing of all isolates was performed by Genome Québec (Montréal, QC) or the Princess 
Margaret Hospital (Toronto, ON) using the 16SR530 primer (5‘-GTA TTA CCG CGG CTG 
CTG-3‘), which provides a comparative region on the 16S rRNA gene to that sequenced from 
bTEFAP data generated from P. elisabethae associated bacteria (Chapter II). Only high quality 
sequences with less than five ambiguous nucleotides (‗N‘) and sequences ≥250 bp were kept in 
the analysis. Chimeras were checked using Bellerophon using default program parameters 
(Huber et al., 2004). Full length sequences were obtained for isolates with less than 96% identity 
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Figure 3.2: MALDI-TOF MS library dereplication procedure. 
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to published sequences. Isolates were submitted to GenBank under the accession numbers 
JX317679 – JX317743 and JX407110 – JX407263 (Table B2). 
 
Taxonomic identification of 16S rDNA sequences: Bimini and San Salvador, BS 
 
 
 
All bacterial isolates from P. elisabethae were identified by comparison of partial 16S rRNA 
gene sequences to published sequences in GenBank, using either the Reference RNA sequences 
(refseq_rna) or nucleotide collection (nr/nt) database. Isolates from both collection years (2008 
and 2009) and from both preparation methods (plating fresh versus frozen coral homogenate) 
were combined together for the analysis. 
 
Phylogenetic analysis of P. elisabethae-associated bacteria 
 
 
 
In order to articulate the level of bacterial diversity associated with P. elisabethae-associated 
isolates, a phylogenetic tree of 16S rDNA sequences was constructed. 16S rRNA gene sequence 
amplicons were aligned using ClustalW in MEGA 5.05 (Tamura et al., 2011). Aligned sequences 
were assessed for evolutionary similarity using a neighbour-joining phylogenetic tree in MEGA 
5.05. Bootstrapping (n = 1,000) was used to assess overall tree accuracy and aligned nucleotide 
sequence gaps were treated by complete deletion. Trees were rooted using different 16S rDNA 
sequences from representative organisms. Overall tree topologies were validated by 
reconstructing phylogenies using multiple evolutionary distance methods including neighbour- 
joining (gaps treated by complete deletion), maximum likelihood, minimum evolution, and 
UPGMA. 
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Comparison of 16S rDNA sequences from the culturable library to the culture-independent 
library of P. elisabethae 
 
Partial 16S rDNA sequences of cultured isolates were compared to 13 PCR-generated bTEFAP 
sequence libraries (1A – 1D, 2A – 2B, and 3B – 3E, refer to Table 2.1 (Chapter II) for 
descriptions) by clustering sequences to the species level (97% sequence identity) in the 
Ribosomal Database Project II (RDP-II, Cole et al., 2009). Cultures were taxonomically assigned 
using a 50% confidence threshold, which is suitable for accurate taxonomic assignment of short 
sequences and classifies a higher number of sequences than more stringent confidence thresholds 
(Claesson et al., 2009). When comparison to a single bTEFAP sequence library was necessary, 
sample 3E was selected as a representative since this individual was collected in the same 
year/site (site 2 in culture studies) as many of the cultured isolates. The combined cluster file was 
assessed for overlapping OTU0.03s between cultures to pyrosequences in Excel (data not shown). 
Any sequence present in both culture and culture-independent sequencing libraries were 
considered to be ‗overlapping‘ OTU0.03s. To determine the number of unique OTU0.03s, sample 
3E was de-replicated to 97% sequence similarity using Fast-Group-II (FG-II; Seguritan and 
Rohwer, 2001). 
 
Sensitivity and inhibition of coral-associated bacterial isolates to pseudopterosin G 
 
 
 
Agar plates were prepared by adding 0, 5, or 50 mg/L of purified PsG prepared in 50% EtOH to 
MA aseptically following autoclaving. Previously growing cultures were transferred onto 
pseudopterosin-containing agar, and growth rates were recorded. Isolates were considered as 
‗sensitive‘ or ‗restricted‘ to PsG if their growth was compromised, but not completely inhibited, 
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while isolates unable to grow in the presence of PsG were termed ‗inhibited. Pseudopterosin 
sensitivity tests were performed by N. Duncan. 
 
Salinity requirements of P. elisabethae-associated bacteria 
 
 
 
Selected isolates were also assessed for their salinity requirements. To verify purity and viability 
and to determine the salt requirement of each isolate, cultures were streaked initially on MA, 
which contains 19.45 g/L sodium chloride to simulate natural sea water concentrations. Plates 
were incubated at 30°C, and cultures were transferred using a sterile flat-tip toothpick to Salt 
Free Marine Agar (SFMA, 5 g/L peptone, 1 g/L yeast extract, 0.1 g/L ferric citrate, 15 g/L agar). 
Isolates were also transferred to fresh MA plates to ensure cultures remained viable. Isolates 
unable to grow on SFMA were considered marine (Jensen and Fenical, 1994). Salinity tests were 
performed by N. Duncan. 
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RESULTS AND DISCUSSION 
 
 
 
The culturable bacterial community of P. elisabethae 
 
 
 
The aim of this study was to explore the cultivable bacterial diversity from the octocoral P. 
elisabethae. To accomplish this goal, bacteria were isolated from P. elisabethae from two 
collection years (2008 and 2009), three collection sites (San Salvador (2008), site 1 and site 2, 
Bimini (2009), refer to Chapter II, Figure 2.1), and from two homogenate types (fresh and frozen 
coral homogenate). Since one of the goals in this research was to maximize the diversity of 
cultures from homogenized P. elisabethae tissue, all isolates obtained from each collection year 
and site were included in the analysis. Although one might argue that combining bacterial 
isolates from different collection years may provide erroneous measures of diversity, previous 
studies examining samples collected at the same time and from the same colony in stony corals 
has demonstrated bacterial communities differ dramatically between cultures and molecular 
techniques regardless (Lampert et al., 2008; Rohwer et al., 2001), therefore, it is rationalized that 
combining isolates will not significantly affect measures of diversity and could increase the 
overlap of bacteria obtained from each methodology. Innovative culturing techniques (diverse 
isolation media and the PFT) were also applied to 2009 collected samples to determine if the 
diversity of bacterial isolates obtained from P. elisabethae could be increased. From the entire 
cultivable bacterial community, phylogenetic investigation of MALDI-TOF MS and RFLP- 
dereplicated bacterial isolates (n = 222) revealed the P. elisabethae community represented four 
bacterial phyla and five classes (Figure 3.3). Specifically, the most abundant bacteria at the class 
level were Gammaproteobacteria, Alphaproteobacteria, Bacilli, Actinobacteria, and 
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Figure 3.3: Evolutionary relationship of P. elisabethae-associated bacterial cultures. Phylogeny 
 
was inferred using 16S rRNA gene sequences ≥400 bp by a neighbour-joining phylogenetic tree 
in MEGA 5.05 (Tamura et al., 2011) where evolutionary distances were calculated using 
maximum composite likelihood. A) Alphaproteobacteria (Rhodobacterales; Rhizobiales; 
Sphingomonadales; Rhodospirillales); B) Gammaproteobacteria (Vibrionales; 
Enterobacteriales); C) Gammaproteobacteria (Alteromonadales; Pseudomonadales; 
Oceanospirillales); D) Bacteroidetes (Bacillales; Lactobacillales), tree continued to E) 
Actinobacteria (Actinomycetales), and Flavobacteria (Flavobacteriales). Alphaproteobacteria 
were rooted with Bacillus weihenstephanensis; Gammaproteobacteria were rooted with 
Aquimarina latercula; and Bacteroidetes, Actinobacteria, and Flavobacteria were rooted with 
Vibrio parahaemolyticus. Bootstrapping (n = 1000) was used to assess overall tree accuracy, and 
aligned nucleotide sequence gaps were treated by complete deletion. Bootstrap probabilities 
>50% are indicated at branch nodes. Sequences were compared against those published in the 
GenBank database. Phylogenies were reconstructed using various methods to confirm the overall 
tree topology. The scale bar represents two nucleotide (nt) substitutions per 100 nt positions, for 
A) and five substitutions per 100 nt positions for B), C), D), and E). GenBank accession numbers 
for reference strains are shown in parentheses, and site and corresponding particle filtrate 
information for P. elisabethae-associated isolates is included on the tree.  MALDI-dereplicated 
isolates (2009 collections) are denoted by a single alphabetical letter and isolates selected for 
fermentation and natural product screening are denoted by the prefix RKVR (refer to Chapter 
IV). San Salvador isolates (2008) are denoted with an ―SS‖ prefix or an ―RKBH‖ prefix if 
cultivated by B. Haltli. 
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Flavobacteria (Figure 3.3). The most abundant genera were Vibrio (Gammaproteobacteria, 56 
cultures), Pseudoalteromonas (Gammaproteobacteria, 33 cultures), Ruegeria 
(Alphaproteobacteria, 21 cultures), Alteromonas (Gammaproteobacteria, 17 cultures), Bacillus 
(Bacilli, 11 cultures), and a more diverse array of Actinobacteria (Figure 3.3). 
 
San Salvador (2008) 
 
 
 
In this investigation, isolation efforts to examine the cultivable bacterial community from P. 
elisabethae were more focused towards the isolation of Actinobacteria (for RKBH isolates) and 
the bacterial community from frozen coral homogenate (SS isolates). Collection efforts from 
frozen coral homogenate (SS isolates) resulted in a total of 17 isolates, which were dereplicated 
by RFLP to nine unique bacteria. Similarly, 31 bacteria were identified by RFLP dereplication of 
isolates obtained from fresh coral homogenate (RKBH isolates). With the exception of six 
isolates (SS9, SS17, RKBH-B001, RKBH-B103, RKBH-B005, RKBH-B110), all remaining 
isolates (n = 25) from the 2008 San Salvador collections were classified as Gram-positive. More 
specifically, these isolates represented a diverse array of Actinobacteria and Bacilli (Figure 3.3). 
It is well-known that Actinobacteria are prolific producers of secondary metabolites (Bérdy, 
2005); yet little is known regarding the cultivable Actinobacterial communities from corals 
(Nithyanand and Pandian, 2009; Webster and Bourne, 2007; Zhang et al., 2008). Actinobacteria 
from the tissue of stony corals produce antibiotics (Nithyanand and Pandian, 2009) which target 
both Gram-negative and Gram-positive bacteria (Nithyanand et al., 2011). More recently, 
Streptomyces spp. from a black coral demonstrated moderate antimicrobial activity against 
marine bacteria and fungi (Zhang et al., 2012). Owing to the extensive reports on the biological 
activity of Actinobacteria and their recent discovery in corals, Actinobacteria isolated from P. 
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elisabethae may be a source of antimicrobial compounds. Similarly, members of the genus 
Bacillus are also common producers of antibiotic compounds, where approximately 800 
antibiotic metabolites have been isolated (Wiese et al., 2009). Furthermore, Bacillus spp. have 
been implicated to play a role in coral protection, as marine-isolated Bacillus spp. exhibited 
antibacterial activity against several clinical pathogens and other marine bacteria (Shnit-Orland 
& Kushmaro, 2009). Therefore, Bacillus spp. may have roles in coral pathogen protection as 
producers of antibacterial compounds. 
 
With respect to measures of culturable bacterial diversity for P. elisabethae, it is also 
important to note that the cultivation of bacteria from fresh coral homogenates gave rise to a 
greater diversity than bacteria isolated from frozen coral homogenate. This highlights the 
significance of inoculating microorganisms from fresh invertebrate homogenates and will be 
discussed subsequently. However, RKBH bacteria were isolated as the result of a more focused 
cultivation effort towards Actinobacteria. Actinobacteria were targeted as a consequence of the 
remarkable biological activities reported from natural products produced by this group (Bérdy, 
2005). Consequently, homogenates of freshly collected coral and more diverse cultivation 
conditions were employed in subsequent investigations to obtain a more complete understanding 
of the culturable bacterial diversity in P. elisabethae. 
 
Bimini (2009) 
 
 
 
As a result of the low numbers of bacteria isolated from frozen P. elisabethae homogenate, a 
subsequent trial used fresh coral homogenate. In addition, diverse media conditions and the PFT 
were also employed in an attempt to increase the phylogenetic diversity of coral-associated 
bacterial isolates. A total of 686 bacteria were cultured from fresh P. elisabethae homogenate on 
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eight solid isolation media, where 16S rRNA gene sequences from 183 representative bacterial 
cultures were sequenced following MALDI-TOF MS dereplication. In this case, 
Gammaproteobacteria represented the largest group in the P. elisabethae culturable bacterial 
community and was dominated by Vibrio spp. (most abundant), Alteromonas spp., and 
Pseudoalteromonas spp. The abundance of these microbes may be indicative of their potential 
symbiotic roles within the coral holobiont. For example, both Pseudoalteromonas sp. and 
Alteromonas sp. appear to be probiotic bacteria in other invertebrates, including stony corals 
(Gil-Turnes et al., 1989; Kesarcodi-Watson et al., 2010; Tebben et al., 2011). Additionally, 
members of the genus Pseudoalteromonas are often associated with higher eukaryotes in marine 
environments and often produce natural products as reviewed elsewhere (Holmström and 
Kjelleberg, 1999). Conversely, bacteria of the genus Vibrio have been implicated as causative 
agents of coral disease (Ben-Haim et al., 1999). However, the abundance of Vibrio sp. from the 
P. elisabethae-associated culturable bacterial community should not be mistaken as a sign of 
compromised coral health, as literature has not defined a standard criterion for comparing Vibrio 
counts in healthy versus diseased corals (Daniels et al., 2011). Furthermore, abundant 
populations of Vibrio sp. have also been reported in other coral-associated bacterial cultivation 
studies (Brück et al., 2007; Koren and Rosenberg, 2006). 
 
Alphaproteobacteria were also numerically dominant in these P. elisabethae samples and 
was dominated by Ruegeria sp. (21 cultures sequenced, Figure 3.3) and were most closely 
related to the type strain Ruegeria mobilis (NR_041454.1). Recently, Ruegeria mobilis was 
isolated from an endosymbiotic zooxanthellae Symbiodinium sp. within a reef-building coral. 
This isolate received attention for its possible role in coral larval metamorphosis by a mechanism 
not yet completely understood (Young, 2011). In addition to their potential roles in larval 
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development, Ruegeria sp. may also have biotechnological applications. For example, cyclic 
peptides have been isolated from sponge-associated Ruegeria sp., where moderate (25 – 50 
µg/mL) and selective Gram-positive antimicrobial activity towards Bacillus subtilis was 
observed (Mitova et al., 2004). Therefore, Ruegeria sp. isolated from P. elisabethae may also be 
responsible for protecting the coral holobiont via the production of antimicrobial metabolites. 
Considering that Ruegeria mobilis was cultured in the present investigation in addition the the 
theory that Ruegeria sp. may be an alternative biosynthetic origin of the pseudopterosins, future 
screening of natural product gene clusters from cultured Ruegeria sp. associated with P. 
elisabethae may result in moving the scientific community one step further in solving the 
biosynthetic origin of the pseudopterosins. 
 
Finally, Flavobacteria comprised a small yet significant portion of the P. elisabethae 
culturable community from fresh coral homogenate, dominated entirely by related Aquimarina 
sp. Specifically, these isolates were most closely related to the acroporid-derived 
Flavobacteriaceae sp. strain 04OKA-17-12 (MBIC08260). This coral was collected from the 
Okinawa prefecture in Japan, where the associated bacterium produced the carotenoids (3R)- 
saproxanthin and (3R, 3‘R)-zeaxanthin. The former compound is rarely found in nature yet 
exhibited significant biological activity, including antioxidant and  neuro-protective effects 
(Shindo et al., 2007). The antioxidative properties of carotenoids have attracted considerable 
interest due to their beneficial effects on human health (Berg et al., 2000). Within the coral 
holobiont, however, carotenoids may function to protect the coral from excessive solar radiation 
and provide antioxidant effects against free radicals (Britton, 1995; Vershinin, 1999). Hence, it is 
likely that the associated Aquimarina sp. within P. elisabethae also plays a symbiotic role within 
the coral holobiont. 
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The effect of the PFT on bacterial cultivation: Bimini (2009) 
 
 
 
In general, the type and number of cultures were comparable between the two collection sites 
described in the previous section. However, Vibrio nigripulchritudo, Sphingopyxis sp., 
Amphritea sp., Aquimarina sp., and Macrococcus sp. were only cultured from Tuna Alley; 
conversely, Arthrobacter sp. and Bacillus anthracis were only cultured from Victory Reef. A 
higher number of yellow and maroon pigmented Pseudoalteromonas spp. were also cultured 
from Victory Reef (Table 3.3). Additionally, of seven potentially novel isolates, six were isolated 
from Tuna Alley (Table 3.4). This signifies that collection location may be an important variable 
in microbial cultivation.  Furthermore, five of the seven potentially novel isolates were cultured 
from plating bacteria in the close physical presence of coral fragments as indicated by their 
cultivation on 51F and 104F screen filters, suggesting that the PFT is an effective tool to 
cultivate potentially novel bacteria. Although the PFT has been successfully implemented as a 
tool to detect slow-growing fungi (Hawksworth and Rossman, 1997), the PFT (refer to Figure 
3.1) was employed here as a tool to cultivate bacteria which require the physical presence of 
coral tissue in an attempt to isolate tissue-associated bacteria. The majority of isolates were 
obtained from the particle filtrate (n = 324), followed by the 51 µm screen (n = 314), and the 104 
µm screen (n = 48, Table 3.3). 
 
 
 
To compare the species-level (OTU0.03) diversity of the P. elisabethae-associated 
cultivable bacterial community between sites and from different particle sizes from the PFT, 
non-parametric estimates of richness (Chao1) and diversity (Shannon diversity index- H′, 
evenness-E) were calculated (Table 3.5).  Overall, bacterial diversity as determined by the 
Shannon-Weiner index (H’) was slightly higher in Tuna Alley (average = 1.9) than Victory Reef 
202  
Table 3.3: The P. elisabethae-associated cultivable bacterial community representing sites, 
 
media, and the PFT. When more than one OTU0.03 for a particular genus was obtained, isolates 
were recorded to the species level to clarify between congenera.  ―PF‖ refers to particle filtrate. 
 
 
Taxa 
Victory Reef Tuna Alley  
Isolation Media PF 51F 104F PF 51F 104F 
Sphingopyxis sp. - - - 2 1 - MA 
Vibrio nigripulchritudo - - - 10 2 - C, ASW, M3, MA 
Vibrio sp. 1 2 - 1 - - MA, R2A 
Bacillus aerophilus 1 - - 1 - - C, MA 
Micrococcus sp. - 1 - 2 5 1 M3, C, R2A, MA 
Ruegeria sp. 1 - - - - - C 
Janibacter terrae 1 - - 1 - - MA, R2A 
Pseudoalteromonas sp. - - - - - 1 R2A 
Pseudoalteromonas piscicidia 
(maroon) 
 
- 
 
3 
 
- 
 
- 
 
1 
 
- 
 
MA 
Photobacterium rosenbergii 2 - - 5 1 1 PE, MA, ASW, R2A 
Vibrio fortis/pelagia 3 1 - 19 2 4 Ps, MA, PE, C, R2A, ASW 
Vibrio tubiashii 21 34 - 23 18 5 MA, M3, C, Ps, R2A, C, PE 
Vibrio parahaemolyticus 49 60 - 39 37 11 MA, C, M3, R2A, PE, Ps, ASW 
Amphritea sp. - - - 1 1 - M3 
Pseudoidiomarina homiensis - 1 - - - - MA 
Janibacter anophelis - 1 - 2 - - C, MA 
Pseudoalteromonas piscicidia 
(yellow) 
 
14 
 
16 
 
1 
 
4 
 
2 
 
1 
 
MA, M3, BG-11, C, ASW, Ps 
Pseudomonas sp. - 1 - - - - M3 
Pseudoalteromonas phenolica 5 2 - 15 20 5 M3, C, R2A, MA, ASW 
Pseudoalteromonas prydzensis 15 13 3 3 2 2 MA, C, R2A, BG-11, PE, ASW, Ps, M3 
Bacillus weihenstephanensis - - - 4 1 - MA, M3, ASW, R2A, C 
Ruegeria sp. - - - 1 - - MA 
Arthrobacter sp. - 1 - - - - Ps 
Bacillus anthracis - 1 - - - - MA 
Aquimarina sp. - - - 2 3 - ASW, MA, M3, C 
Macrococcus sp. - - - 3 2 - C 
Lysobacter sp. - - - - 1 1 C 
Bacillus sp. 1 1 1 4 4 - MA, M3, PE, ASW, C, BG-11 
Ruegeria mobilis 20 26 1 15 5 1 M3, C, MA, BG-11, PE, R2A 
Alteromonas sp. 15 16 1 12 21 8 M3, R2A, MA, BG-11, C, ASW, PE 
Shewanella sp. - 1 - - 1 - MA, M3 
Paraliobacillus sp. - - - 1 - - C 
Kytococcus sp. - - - - 1 - C 
Marinilactibacillus sp. - - - - 1 - R2A 
Paracoccus sp. - - - - 1 - ASW 
Labrenzia sp. - - - 4 - - M3, MA 
Acinetobacter sp. - - - 1 - - C 
Total 149 181 7 175 133 41  
 Total site 1 cultures: 337 Total site 2 cultures: 349 Total number of isolates: 686 
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Table 3.4: Potentially novel isolates cultured from P. elisabethae. Site 1: Victory Reef, Site 2: 
 
Tuna Alley. ―PF‖ refers to particle filtrate, 104F refers to isolates obtained from 104 µm screens, 
and 51F refers to isolates obtained from 51 µm screens. 
 
 
 
 
Isolate 
 
 
 
Nearest GenBank ID (% sequence identity) 
No. of 
base 
pairs 
Site and 
screen 
filter/PF 
 
Isolation 
media 
 
D10 
Pseudoalteromonas agarivorans (NR_025509.1, 
94%) 
 
484 
Site 2, 
104F 
 
R2A 
V10 Ruegeria pomeroyi (NR_028727.1, 96%) 408 Site 2, PF MA 
G25 Lysobacter daejeonensis (NR_043624.1, 95%) 484 Site 2, 51F C 
E1 Aquimarina intermedia (NR_042444.1, 96%) 1504 Site 2, 51F SW 
RKVR22 Shewanella algae (NR_028673.1, 96%) 1530 Site 2, 51F MA 
RKVR31 Paraliobacillus quinghaiensis (NR_044411.1, 96%) 1511 Site 2, PF C 
RKVR32 Janibacter anophelis (NR_043218.1, 96%) 432 Site 1, 51F C 
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Sequence 
library 
 
Total 
Seq. 
  
 
Sobs
a
 
  
 
Sest
b
 
  
 
H’c 
 
 
Ed 
Site 1 PF 150 10  10 1.9 0.81 
Site 1 51F 182 13  41 1.5 0.59 
Site 1 104F  7  5  11 1.5 0.92 
Site 2 PF 175 18 18.6 2.1 0.72 
Site 2 51F 129 17 27.5 2.1 0.75 
Site 2 104F 40  7  13 1.4 0.72 
 
Table 3.5: Diversity statistics of 16S rDNA sequence libraries generated from P. elisabethae- 
 
associated bacterial cultures. ―PF‖ refers to particle filtrate, ―51F‖ refers to bacteria isolated from 
the 51 µm screen, and ―104F‖ refers to isolates obtained from the 104 µm screen from the PFT. 
Site 1: Victory Reef, Site 2: Tuna Alley. 
 
 
 
 
 
 
 
 
 
 
 
 
a 
Richness at species-level distance (D = 0.03) based on observed unique OTUs. 
b 
Chao1 non-parametric richness estimate at species-level distance (D = 0.03). 
c 
Shannon diversity index at species-level distance (D = 0.03); a higher number indicates greater diversity. 
d 
Evenness index; a higher number indicates greater evenness. 
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(average = 1.6, Table 3.5).  More specifically, Tuna Alley (particle filtrate) and Tuna Alley (51F) 
exhibited the greatest species level-bacterial diversity (OTU0.03, 2.1 respectively), while the 
affiliation of bacteria with the particle filtrate suggests these bacteria are only loosely attached to 
the coral. In contrast, representatives of Pseudoalteromonas sp., Vibrio/Photobacterium sp., 
Alteromonas sp., Bacillus sp., Ruegeria sp., Lysobacter sp., and Micrococcus sp. were the only 
isolates retrieved from 104 µm screens (Table 3.3) and consequently (alongside Victory Reef 
(51F)) represented the lowest bacterial diversity (Table 3.5). However, the affiliation of these 
bacteria with larger mesh screens suggests these bacteria may have been tissue-associated. 
 
Effect of media on bacterial cultivation: Bimini (2009) 
 
 
 
As selection of isolation media is a key factor in influencing the cultivability and diversity of 
microorganisms (Zhang et al., 2012), this study used a wide variety of media containing different 
types and constitutions of nutrients. Three general isolation media were used, including MA, C 
media, and R2A, while a variety of specific media were used, including those which targeted 
Actinobacteria (M3), Cyanobacteria (BG-11), and Pseudomonas spp. (Ps media). In addition, PE 
medium was used with the rationale that uncultivable microbes may grow in pure culture if 
provided with cues from the natural environment (Webster and Hill, 2001) while ASW was used 
to enable the growth of potentially oligotrophic bacteria. Only 2009-plated coral homogenates 
were compared in a media examination owing to the success of cultivation and the diversity of 
the isolation media selected. As expected, isolation media affected the diversity and cultivability 
of P. elisabethae-associated bacteria. In particular, the highest numbers of morphologically 
unique colonies were obtained from the general isolation media MA and C, with the former 
isolation media also having been successful in retrieving large numbers of diverse culturable 
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bacteria from sponges (Nithyanand and Pandian, 2009; Webster et al., 2001) and octocorals 
(Brück et al., 2007). In contrast, despite the high number of bacteria isolated from R2A and M3 
media, in general, only the most commonly obtained cultures (e.g. Vibrio sp. and 
Pseudoalteromonas sp.) were retrieved. Although Cyanobacteria phylotypes were abundant 
based on bTEFAP analyses (refer to Chapter II), no Cyanobacteria were cultivated despite the 
use of the selective medium BG-11. However, the inability to cultivate Cyanobacteria may be a 
methodological limitation. For example, although Cyanobacteria are photosynthetic organisms, 
plates were maintained in the dark for approximately one week during shipping back to Prince 
Edward Island. Additionally, precedence in the literature also suggests their cultivation may only 
be after specific criteria have been met, including light, enrichment, and reduction of oxidative 
stress in agar media (Choi and Noh, 2009; Morris et al., 2008; Webster and Hill, 2001). 
 
In contrast to other investigators (Li et al., 2007; Olson et al., 2000), the addition of P. 
elisabethae extract to low nutrient media did not significantly increase the observed bacterial 
diversity, rather, fewer isolates were recovered on PE medium. However, P. elisabethae is the 
sole source of pseudopterosins, diterpene glycosides which have selective activity against Gram- 
positive pathogens (Ata et al., 2004; Correa et al., 2011). Consequently, it is likely that the 
addition of P. elisabethae extract to the medium negatively affected the isolation of Gram- 
positive bacteria. Consistent with Sipkema et al. (2011), however, fewer isolates were obtained 
from the oligotrophic medium ASW yet this medium was successful in isolating the potentially 
novel, slow-growing Aquimarina spp., which were rare isolates recovered in this investigation. 
The ability to cultivate Aquimarina spp. under oligotrophic conditions implies these bacteria 
have little nutritional requirements and may not be dependent on the host for providing nutrients. 
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Very few Vibrio spp. were cultured on ASW, which suggests these bacteria may be dependent on 
nutrients provided by the host for survival. 
 
Unfortunately, this investigation was unsuccessful in obtaining the Spongiobacter- 
Endozoicomonas phylotypes or the candidate octocoral-specific bacterial phylum in pure culture 
(i.e. RKPE1 and RKPE23-related phylotypes respectively, refer to Chapter II). RKPE1 
phylotypes were the most abundant phylotypes retrieved from our culture independent analysis 
of P. elisabethae-associated bacteria, while RKPE23-related phylotypes appeared to be exclusive 
to octocorals and may represent a novel phylum of bacteria. However, the nutritional 
requirements for the RKPE23-related phylotypes are unknown owing to their highly distant 
relationship (80% sequence identity to Mycoplasma sp.) to cultured representatives.  Taken 
together, the results suggest that combining low and high nutrient media in addition to using 
fresh coral homogenate is essential for generating a higher cultivable bacterial diversity. 
 
Many diverse factors influence the cultivability of marine microorganisms, including 
salinity, nutrient constituents, nutrient dilution, incubation conditions, and the presence of 
reactive oxygen species in agar media (Gray et al., 2011; Morris et al., 2008; Sharon and 
Rosenberg, 2008). More specifically, an inability to cultivate a higher amount of coral-associated 
bacteria may be explained by the following reasons: (1) cell damage caused by oxidative stress 
from cultivation media, (2) a lack of signaling molecules in microbiological media required for 
culture growth, and (3) an exhaustion of substrates during latter stages of the growth cycle 
(Bruns et al., 2002). Perhaps the most fascinating observation regarding the ―uncultured‖ 
phenomenon is that many uncultured organisms, with the exception of the elusive Candidatus 
TM7 division for example (Hugenholtz et al., 2001), have very high 16S rRNA gene sequence 
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identities to well-studied cultured representatives.  Strikingly, the 16S rRNA gene sequence of 
the proposed beetle-associated bacterium producing the antitumor polyketide pederin (Kellner et 
al., 2002a, b; Piel et al., 2004; Zimmerman et al., 2009) is 95% identical to the cultured 
reference strain Pseudomonas otitidis (NR_043289.1). Based on the cultivability of other 
Pseudomonas sp., this raises the question as to why a closely related bacterium can fail to grow 
in vivo equally well. What genetic or environmental factors prevent their cultivation? Scientists 
today require a total paradigm shift in order to understand how to successfully isolate 
environmental strains. 
 
MALDI-TOF MS dereplication: Bimini (2009) isolates 
 
 
 
To eliminate isolate redundancy in the bacterial library, MALDI-TOF MS was used as a tool to 
dereplicate coral-associated bacterial isolates. Representatives from each clade (‗clade‘ defined 
here by a unique colour segment on the MALDI dendrogram) were sequenced in an attempt to 
determine an appropriate dendrogram distance-level cutoff. However, an appropriate 
dendrogram cutoff for UPGMA-clustered MALDI spectra to taxonomically distinguish between 
isolates has not been reported in the literature. Using this approach, 29 MALDI clades were 
obtained (Figure 3.4), representing 21 genera. Isolates were recorded to the species level to 
clarify between congenera (Figure 3.4). In general, there was good agreement between each 
member of the clade with corresponding 16S rRNA sequences. For example, Ruegeria spp. were 
conserved within the same clade on the dendrogram. Similarly, Alteromonas macleodii 
(NR_037127.1)-related isolates (n = 14 isolates sequenced) grouped at the base of the 
dendrogram, which were easily distinguished from the genetically related Pseudoalteromonas sp. 
The smallest sections on the dendrogram represented Sphingopyxis sp., Janibacter sp., and 
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Amphritea sp., and coincided with a smaller number of isolates sequenced. However, 
Pseudoalteromonas spp. and Vibrio spp. were not conserved within the same clade on the 
dendrogram respectively; rather, they were dispersed throughout (Figure 3.4). For example, 
sequences from isolates representing the largest clade of the dendrogram (yellow, Figure 3.4) 
demonstrated this clade contained a variety of Vibrio spp., including the closely related 
Photobacterium rosenbergii, V. fortis/pelagia, V. shilonii, V. parahaemolyticus, V. harveyii, and 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: MALDI dendrogram of bacterial isolates from P. elisabethae clustered by UPGMA. ‗M‘ refers to maroon pigmented 
 
isolate; ‗Y‘ refers to yellow-pigmented isolate of P. piscicida. Phylogeny was inferred to the species level when necessary to 
distinguish between congenera. 
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V. natriegens. Similarly, phylogenetically related Pseudoalteromonas sp. did not cluster together 
in similar clades on the dendrogram. For example, the yellow and maroon-pigmented 
Pseudoalteromonas piscicida were closely related on the basis of 16S rDNA sequences, yet these 
grouped in entirely different clades on the dendrogram (Figure 3.4). Furthermore, as noted 
previously, difficulties in species differentiation of Pseudoalteromonas sp. by 16S rRNA gene 
sequencing necessitated nearly full length (~1,400 bp) sequencing in sponge associated 
Pseudoalteromonas; however, MALDI-TOF MS readily differentiated these species (Dieckmann 
et al., 2005). 
 
MALDI-TOF MS will likely rely on sequencing to establish within-clade dendrogram 
cutoff values 
 
Similar to Dieckmann et al. (2005), no clear dendrogram cutoff value could be established for 
cultivable bacterial isolates, as each clade was unique with respect to a dendrogram cutoff value. 
For example, isolate sequences were obtained for the uppermost and lowermost section of the 
Alteromonas clade (Figure 3.4). Sequencing results demonstrated that all sequences were related 
to Alteromonas macleodii, which corresponds to a distance cutoff of 300 – 400. Similarly, the 
dendrogram ‗cutoff‘ for Ruegeria sp. could be defined at approximately 350, signifying that all 
isolates within the clade at a cutoff of 350 were similar when sequenced. In contrast, the 
Pseudoalteromonas clade (blue) was subdivided into two species based on 16S rRNA gene 
sequences, with the uppermost section of the clade more similar to P. phenolica while the 
lowermost section was most similar to a sediment-isolated Pseudoalteromonas sp. (FJ170036.1). 
As a consequence of these differences, it is likely that MALDI-TOF MS dereplication will 
continue to require isolate sequencing (Dieckmann et al., 2005). However, an in-house MALDI- 
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TOF MS spectral library complete with taxonomic information from isolate gene sequences has 
been established in the Kerr lab. This information can be used to guide future investigations in 
the Kerr lab to reduce sequencing effort. 
 
Spatial and temporal comparison of P. elisabethae-associated bacterial isolates 
 
 
 
Conserved between year (2008 and 2009), site (San Salvador, Victory Reef, and Tuna 
Alley) and homogenate type (fresh and frozen) were isolates closely related to Bacillus sp., and 
Micrococcus sp., while Pseudomonas sp. was conserved between collection year and between 
San Salvador and Victory Reef. Their consistent presence at different times and from different 
locations in the Bahamas suggests that these phylotypes may be key symbiotic members in P. 
elisabethae. Pseudomonas spp. have also been detected in other healthy coral-associated 
bacterial libraries (Koren and Rosenberg, 2006), and thus may form a natural part of the normal 
microbial fauna in corals.  However, all Vibrio spp., Ruegeria spp., Pseudoalteromonas spp., 
Alteromonas spp., Macrococcus spp., Photobacterium spp., Amphritea spp., Labrenzia spp., 
Shewanella spp., and Sphingopyxis spp. were only retrieved from fresh (2009-collected) coral 
homogenates. Isolates belonging to the genera Staphylococcus spp., Nocardiodes spp., and 
Streptomyces spp. were unique to frozen coral homogenates. 
 
It is likely that the consistent presence or abundance of select bacteria is attributed to 
their ease of cultivation on standard laboratory media, while the poor viability of bacteria from 
long-term stored, frozen coral homogenates may have reduced the types of bacteria which could 
be isolated on laboratory media. Not surprisingly, bacteria vary in their susceptibility to freezing 
(Haines, 1938), where Gram-positive bacteria are more resistant to freezing than Gram-negative 
bacteria, which may be attributed to the thinner peptidoglycan layer associated with the latter 
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(Miyamoto-Shinohara et al., 2008). Furthermore, spore-forming bacteria can withstand sub-zero 
temperatures, while more sensitive isolates can experience up to an 80% mortality rate upon 
rapid freezing (Haines, 1938). It is possible that the abundance of most Gram-negative bacteria 
was not reflected in isolation efforts from frozen coral homogenate as a consequence of storage 
at -80°C. For example, a significant reduction in the population of the foodborne pathogen V. 
parahaemolyticus was detected following five days of storage at -18°C (Vasudevan et al., 2002), 
which may explain the lack of Vibrio sp. from frozen coral homogenates despite their prevalence 
from isolation efforts using fresh coral homogenates. In the natural environment, P. elisabethae- 
associated bacteria are obviously not accustomed to freezing; therefore, it is likely that P. 
elisabethae-associated bacteria may not have evolved adaptations to survive freezing conditions. 
Although the importance of fresh coral homogenate is advocated in cultivation studies, it is also 
concluded that freezing coral homogenate prior to plating adds a unique benefit by increasing the 
phylogenetic diversity of bacteria, as rapidly-growing Gram-negative bacteria appear to be 
eliminated, permitting the isolation of low GC and Gram-positive bacteria on solid media. 
 
It is acknowledged that bacteria from frozen coral homogenates were also collected a 
year prior and at a different collection site and may not be representative in all cases. However, 
the discrepancy in total numbers of cultures between fresh and frozen coral homogenates is not 
suspected to be a consequence of isolating bacteria from different collection sites or collection 
years and is believed to simply be a function of the cultivation procedures employed. 
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Comparison of the culturable and culture-independent bacterial community from P. 
elisabethae 
 
It is beneficial to use a combination of culture-based and culture-independent methodologies to 
circumvent the limitations associated with each technique (Càrdenas et al., 2012) and thus 
provides a more complete understanding of the true bacterial diversity associated with samples. 
All isolate sequences from both collection years (2008 and 2009) were compared to P. 
elisabethae pyrosequencing libraries to provide an overview of the overlap of bacteria obtained 
between each method. When comparison of isolates to one pyrosequencing library was 
necessary, the sample 3E bTEFAP community was used as it was collected from the same site 
and collection year as 2009-isolated cultures, thus providing the most relevant comparison of the 
culture-independent to the culturable bacterial community. One would assume that bacteria 
identified by culture-independent techniques should overlap with bacterial isolates, yet cross- 
correlation of bTEFAP sequences to bacterial isolate sequences from P. elisabethae clearly 
demonstrates bacterial diversity is underrepresented by cultivation-based approaches (Table 3.6). 
 
In total, 13 P. elisabethae pyrosequencing libraries were clustered with isolate sequences, 
resulting in 8,219 OTU0.03s including singletons (4,985 OTU0.03s excluding singletons, which 
may represent sequencing errors (Tedersoo et al., 2010)). From the combined dataset, 36 
OTU0.03s were common to both pyrosequences and isolate sequences, 32 OTU0.03s were unique 
to cultures, and 8,150 pyrosequences were not represented by an isolate sequence, representing a 
0.44% overlap (0.72% excluding pyrosequencing singletons) of cultures to pyrosequences from 
the P. elisabethae-associated bacterial library. A comparative overview of the cultivable 
community to the culture-independent bacterial community is presented in Figure 3.5. 
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Table 3.6: Comparison of the overlap of 16S rRNA gene sequences obtained from cultivation 
 
and from the sample 3E culture-independent (bTEFAP) data. 
 
 
 bTEFAP Cultures 
No. of sequences 3781 dereplicated to 
292 (at 97% sequence similarity) 
685, de-replicated by MALDI and 
206 sequenced 
No. of bacterial 
phyla represented 
11 4 
Number of 
bacterial classes 
22 5 
Classes Alphaproteobacteria (68%) 
Flavobacteria (21%) 
Cyanobacteria (4%) 
Gammaproteobacteria (4%) 
Gammaproteobacteria (55%) 
Alphaproteobacteria (15%) 
Bacilli (15%) 
Actinobacteria (13%) 
Most abundant 
genera 
Aquimarina 
Pelagibius 
Brevundimona
s 
GP-IIa (Synechococcus) 
Vibrio 
Pseudoalteromonas 
Ruegeria 
Bacillus 
Total number of 
genera 
90 37 
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Figure 3.5: Composition of the culture-independent and cultivable P. elisabethae bacterial 
 
community. A) Culture independent community composition at the class level of coral sample 
3E. B) Culture-dependent community composition at the class level of bacteria isolated from two 
P. elisabethae colonies. C) Culture-independent composition of P. elisabethae sample 3E at the 
genus level, and D) Culture-dependent composition of P. elisabethae isolates at the genus level. 
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Briefly, culture-independent analysis of sample 3E showed a predominance of 
Alphaproteobacteria, Flavobacteria, Cyanobacteria, and Gammaproteobacteria at the class level 
(Figure 3.5A). In particular, the sample 3E community was dominated by Aquimarina sp. and 
Pelagibius sp. phylotypes (Figure 3.5B). Among the culturable bacterial community; however, 
Gammaproteobacteria (55% of library), Alphaproteobacteria (15.3%), Bacilli (14.9%), and 
Actinobacteria (13.1%) were the most abundant classes (Table 3.6, Figure 3.5C), consisting of 
the genera Vibrio, Pseudoalteromonas, and Alteromonas (Figure 3.5D).  In addition, highly 
abundant 16S rRNA gene sequences in culture libraries were often low in abundance or absent in 
all pyrosequencing libraries (Table 3.7). For example, only four isolate sequences overlapped 
with dominant phylotypes in the pyrosequencing library (―dominant‖ defined as OTU0.03s in 
abundance of ≥1% in individual coral-associated bacterial libraries, classified as ‗RKPE‘ 
phylotypes). This included the bTEFAP-generated phylotypes RKPE02, RKPE47, RKPE48, and 
RKPE168, which corresponded to the isolate sequences RKVR24 (Aquimarina sp.), RKVR10 
(Labrenzia sp.), RKVR42 (Pseudomonas sp.), and RKVR35 (Sphingopyxis sp.) respectively 
(Table 3.7). Furthermore, the abundance of Vibrio sp. in culture collections was not represented 
in equal abundance by bTEFAP sequencing libraries. For example, of the 53 Vibrio spp. 
sequenced from cultures, only nine sequences were also found in all 13 PCR-generated P. 
elisabethae bTEFAP pyrosequencing libraries examined (refer to Table 2.1, Chapter II for 
descriptions). Ruegeria spp., Pseudoalteromonas spp., Alteromonas spp., and Bacillus spp. were 
also rarely observed in culture-independent sequence libraries (Table 3.7). For example, the most 
abundant Pseudoalteromonas sp. cultured (e.g. RKVR02-related isolates) did not have any 
representative OTU0.03 when 13 representative pyrosequencing libraries were compared. 
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Table 3.7: Overlap of cultured bacteria to 13 P. elisabethae-associated bTEFAP libraries. 
 
Sequences were clustered at OTU0.03 and taxonomy was inferred by nearest GenBank identities. 
 
 
No. of 
sequences in 
cluster 
 
Representative 
Culture 
 
No. of 
isolates 
No. of bTEFAP 
sequences 
(OTU0.03) 
 
 
Genus 
Representative 
bTEFAP sequence 
(≥1% of library) 
6159 RKVR24 2 6157 Aquimarina sp. RKPE02 
346 RKVR10 3 343 Labrenzia sp. RKPE47 
333 RKVR42 2 331 Pseudomonas sp. RKPE48 
88 RKVR35 3 85 Sphingopyxis sp. RKPE168 
76 SS1 2 74 Staphylococcus sp.  
72 RKVR28 1 71 Acinetobacter sp.  
54 RKBH-B107 1 53 Enterobacter sp.  
49 D52 1 48 Labrenzia sp.  
38 V10 1 37 Ruegeria sp.  
28 RKVR37 3 25 Bacillus sp.  
24 RKVR18 11 13 Bacillus sp.  
16 RKVR15 3 13 Photobacterium sp.  
12 SS15 1 11 Staphylococcus sp.  
12 SS9 1 11 Silicibacter sp.  
18 RKVR03 8 10 Pseudoalteromonas sp.  
10 RKBH-B58 1 9 Brevibacterium sp.  
10 SS17 1 9 Cohaesibacter sp.  
10 RKVR22 2 8 Shewanella sp.  
26 RKVR16 20 6 Ruegeria sp.  
21 RKVR08 15 6 Alteromonas sp.  
14 RKVR17 8 6 Micrococcus sp.  
7 RKVR14 2 5 Alteromonas sp.  
6 RKBH-B56 1 5 Staphylococcus sp.  
20 RKVR21 16 4 Vibrio sp.  
24 RKVR19 21 3 Vibrio sp.  
12 RKVR05 9 3 Pseudoalteromonas sp.  
5 E3 2 3 Flavobacteria  
5 RKBH-B54 2 3 Streptomyces sp.  
18 RKVR01 16 2 Vibrio sp.  
3 F3 2 1 Bacillus sp.  
3 RKBH-B65 2 1 Staphylococcus sp.  
3 SS2 2 1 Nocardioides sp.  
2 RKBH-B114 1 1 Bacillus sp.  
2 RKBH-B103 1 1 Roseomonas sp.  
2 RKBH-B55 1 1 Bacillus sp.  
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Consequently, the data presented herein confirms the power of complementing techniques to 
uncover the true bacterial diversity associated with marine invertebrates. 
 
Literature precedence supports a lack of congruence between culture-dependent and 
culture-independent bacterial diversity 
 
Although some isolate 16S rDNA sequences overlapped with the bTEFAP sequence community 
(Table 3.7), our results demonstrated <1% of bacteria from the P. elisabethae community were 
amenable to culturing. It is acknowledged that the sample size of cultivated isolates is smaller 
than the number of sequences generated by pyrosequencing, yet it is intriguing to question why 
some isolates did not have a culture-independent sequence representative. This lack of 
congruence between culture-dependent and culture-independent techniques is a trend which has 
been repeatedly documented in the literature (Galkiewicz et al., 2011; Gray et al., 2011; Jackson 
et al., 2012; Kellogg et al 2009; Kvennefors et al., 2012; Meron et al., 2011; Neulinger et al., 
2008; Rohwer et al., 2001). For example, comparison of clone libraries to cultured isolates in the 
cold water deep-sea coral Lophelia pertusa reported no overlap between clone libraries and 
cultured isolates (Galkiewicz et al., 2011; Kellogg et al., 2009; Neulinger et al., 2008). 
Furthermore, Gray et al. (2011) found that Vibrionaceae were undetected in clone libraries of six 
deep sea alcyonacean octocorals yet were dominant in cultures. While it is well known that 
cultivation underestimates microbial diversity (Engelbrektston et al., 2010; Uthicke and 
McGuire, 2007), next generation sequencing technology is also not free from biases (Lee et al., 
2012; Pinto and Raskin, 2012), which may also explain why some cultures in the P. elisabethae 
community were poorly represented by pyrosequencing when sequences were clustered at 97% 
sequence similarity (Table 3.7). For example, it is possible that some bacteria were present at 
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levels below the limit of bTEFAP detection, and increasing the coverage of bTEFAP may 
increase the likelihood of detecting these groups. Taken together, the results highlight the 
importance of complementing next generation sequencing with cultivation to obtain a more 
complete understanding of the true bacterial diversity associated with such samples as the 
alcyonacean octocoral examined in this study. 
 
Inhibition of P. elisabethae-associated bacterial isolates by pseudopterosin G 
 
 
 
Isolates were tested for their sensitivity to PsG with the objective of determining the 
antimicrobial effect of this natural product on the cultivability and growth of potential bacterial 
symbionts in P. elisabethae and to shed light on its plausible ecological role. The hypothesis 
which was tested was that Gram-positive bacteria would be more susceptible to PsG than Gram- 
negative bacteria based on prior evidence of PsG against clinically relevant microorganisms from 
Caribbean and Colombian-collected P. elisabethae (Ata et al., 2004; Correa et al., 2011). In this 
study, isolates growing on agar media were transferred to media containing either 0 µg/mL PsG, 
5 µg/mL PsG, or 50 µg/mL PsG. Viability of isolates was checked and isolates were defined as 
‗sensitive‘ to PsG if their growth was compromised, but not completely inhibited, while isolates 
unable to grow in the presence of PsG were termed ‗inhibited.‘ The addition of purified PsG to 
the media was capable of inhibiting or restricting the growth of several isolates. All isolates grew 
at 0 µg/mL PsG (Table 3.8). As expected, the majority of isolates affected by the addition of PsG 
to the media were Gram-positive, with 17 of 38 (44.7%) Gram-positive bacteria inhibited and 
seven sensitive (18.4%; indicated by a perispomeni in Table 3.8) at 50 µg/mL PsG. Additionally, 
nine isolates were inhibited and 14 were sensitive at 5 µg/mL PsG, revealing that PsG has broad 
spectrum activity against potential Gram-positive coral-associated bacteria.  In contrast, only two 
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Gram-negative bacteria were inhibited and one Gram-negative bacterium was sensitive to the 
addition of 50 µg/mL PsG (7.9%). One Gram-negative isolate was sensitive and one Gram- 
negative isolate was inhibited by the addition of 5 µg/mL PsG. The bioactivity of PsG against 
Gram-positive bacteria may also be a factor in explaining why the majority of isolates and 
representative pyrosequences from P. elisabethae were Gram-negative. 
 
The susceptibility of Gram-positive bacteria to PsG may be a consequence of their cell 
wall composition. For example, Gram-negative bacteria have an additional cell wall layer 
surrounding their membranes which is absent in Gram-positive bacteria, a feature which enables 
Gram-negative bacteria to prevent some antibiotics from crossing the membrane (Hopwood, 
2007). The possible biological role of PsG in P. elisabethae may involve regulating the internal 
microbial community by preventing the overgrowth of potentially pathogenic Gram-positive 
bacteria as has recently been addressed elsewhere (Correa et al., 2012). Caution is advised when 
interpreting these results, as the localization of pseudopterosins in the host is not yet known. In 
addition, the visibly declined growth of some of the bacteria in the presence of pseudopterosins 
may imply that pseudopterosins may serve to regulate and reduce, not eliminate, bacteria 
residing within the host. 
 
Salinity requirements of P. elisabethae-associated isolates 
 
 
 
Although no clear term has been used for defining bacteria as ―marine‖, the general consensus 
for using this definition is based on their requirement for sodium (Jensen and Fenical, 1994). For 
the purpose of this experiment, the goal in testing for salinity requirements was to add to the 
scientific understanding of those bacteria isolated from marine invertebrates which are dependent 
on seawater for growth (Jensen and Fenical, 1994). In the present study, isolates which required 
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or could grow with salt are indicated by a ―yes‖ while isolates capable of growth without salt are 
indicated by a ―no‖ (Table 3.8). As expected, the majority of isolates (57.1%) from P. 
elisabethae were considered ―marine‖. Interestingly, ―marine‖ bacteria defined here were far 
more likely to be Gram-negative bacteria, where 33/38 Gram-negative isolates (86.8%) were 
dependent on the addition of salt to the isolation media for growth in comparison to only 11/38 
(28.9%) of Gram-positive bacteria (Table 3.8). This interesting trend, where Gram-positive 
organisms isolated from the marine environment are not dependent on salt (specifically sodium 
chloride) for growth has been reported previously (Jensen and Fenical, 1994). This may be 
explained by the fact that cellular respiration is dependent on Na
+ 
in some marine-isolated Gram- 
 
negative bacteria, while some marine-isolated Gram-positive bacteria lacking the respiration- 
driven Na
+ 
pump did not require sodium for the respiration (Ventosa et al., 1998). Salt tolerant 
bacteria have interesting industrial applications, particularly in providing the genetic machinery 
for salt and drought tolerance in agricultural crops, ultimately promoting crop growth in more 
saline soil (Ventosa et al., 1998). In addition, moderately halophilic bacteria provide an excellent 
model for the molecular study of the regulatory mechanisms which provides these bacteria with 
an ability to survive in a wide range of saline environments (Ventosa et al., 1998). However, it is 
important to note that the original isolation media (Table 3.1 and 3.2) all contained salt; 
therefore, it is difficult to comment on whether any exclusively ―terrestrial‖ bacteria (isolates 
unable to grow in the presence of sodium chloride) were associated with the cultivable 
community of P. elisabethae. 
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Table 3.8: Salinity requirements and pseudopterosin G inhibition for P. elisabethae-associated 
 
isolates. A perispomeni (~) under ‗salt required‘ refers to reduced visible growth of the isolate. 
ND: no data. 
 
 
 
 
ID 
 
 
 
Taxonomy 
 
Salt 
required? 
PsG 0 
µg/mL 
growth 
PsG 5 
µg/mL 
growth 
PsG 50 
µg/mL 
growth 
RKVR01 Vibrio sp. Yes   
RKVR02 Pseudoalteromonas sp. Yes   
RKVR03 Pseudoalteromonas sp. Yes   
RKVR04 Pseudoalteromonas sp. Yes   
RKVR05 Pseudoalteromonas sp. Yes   
RKVR06 Vibrio sp. Yes   
RKVR07 Pseudoalteromonas sp. Yes   
RKVR08 Alteromonas sp. Yes   
RKVR09 Alteromonas sp. Yes   
RKVR010 Alteromonas sp. Yes   
RKVR011 Janibacter sp. No   X 
RKVR012 Pseudoalteromonas sp. Yes   
RKVR013 Pseudoalteromonas sp. Yes   
RKVR014 Pseudoalteromonas sp. Yes   
RKVR015 Photobacterium sp. Yes   
RKVR016 Ruegeria sp. Yes   
RKVR017 Micrococcus sp. Yes   
RKVR018 Bacillus sp. No  X X 
RKVR019 Vibrio sp. Yes   
RKVR020 Pseudoalteromonas sp. Yes   
RKVR021 Vibrio sp. Yes   
RKVR022 Shewanella sp. Yes   
RKVR023 Alteromonas sp. Yes   
RKVR024 Flavobacteriaceae Yes   X 
RKVR025 Flavobacteriaceae Yes   
RKVR026 Macrococcus sp. Yes   
RKVR027 Paracoccus sp. Yes   
RKVR028 Marinilactibacillus sp. No   
RKVR029 Micrococcus sp. No   
RKVR030 Ruegeria sp. Yes   
RKVR031 Paraliobacillus sp. ~  ~ X 
224  
 
RKVR032 Janibacter sp. ~   
RKVR033 Ruegeria sp. Yes   
RKVR034 Pseudoalteromonas sp. Yes   
RKVR035 Sphingopyxis sp. Yes   
RKVR036 Bacillus sp. Yes   
RKVR037 Bacillus sp. Yes   
RKVR038 Bacillus sp. Yes   
RKVR039 Vibrio sp. Yes   
RKVR040 Pseudoalteromonas sp. Yes   
RKVR041 Pseudoidiomarina sp. Yes   
RKVR042 Microbacterium sp. Yes   
RKVR043 Vibrio sp. Yes   
RKBH B1 Paracoccus sp. Yes   
RKBH B54 Streptomyces sp. No  X X 
RKBH B55 Bacillus sp. No  ~ ~ 
RKBH B56 Staphylococcus sp. No  ~ ~ 
RKBH B57 Micrococcus sp. No   
RKBH B58 Brevibacterium sp. Yes   
RKBH B62 Nocardiopsis sp. No  ~ ~ 
RKBH B65 Staphylococcus sp. No   
RKBH B74 Staphylococcus sp. ~  ~ X 
RKBH B75 Microbacterium sp. No  X X 
RKBH B80 Exiguobacterium sp. Yes  ~ ~ 
RKBH B86 Pseudonocardia sp. Yes  ~ ~ 
RKBH B100 Microbacterium sp. No  ~ X 
RKBH B101 Alphaproteobacteria Yes   X 
RKBH B102 Rhodococcus sp. No  ~ X 
RKBH B103 Roseomonas sp. No   
RKBH B104 Rhodococcus sp. No  X X 
RKBH B105 Salinicola sp. Yes   
RKBH B106 Bacillus sp. No  X X 
RKBH B107 Enterobacter sp. No   
RKBH B108 Planococcus sp. Yes   
RKBH B109 Micrococcus sp. No  ~ ~ 
RKBH B110 Pseudomonas sp. Yes   
RKBH-B111 Alphaproteobacteria No  ~ ~ 
RKBH B113 Gordonia sp. No  ~ X 
RKBH B114 Bacillus sp. ~  X X 
RKBH B115 Kytococcus sp. No  X X 
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RKBH B116 Bacillus sp. No  ~ X 
RKBH B150 Terribacillus sp. ~  ~ X 
RKBH B152 Streptomyces sp. No  X X 
RKBH B153 Bacillus sp. No  X X 
RKBH B154 ND Yes   
RKBH B155 Micrococcus sp. No  ~ ~ 
RKBH B156 Staphylococcus sp. No   
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CONCLUSIONS AND PERSPECTIVES 
 
 
The present study provided the first analysis of the cultivable bacterial community of P. 
elisabethae collected from the Bahamas. The use of unique isolation efforts in this investigation 
(PFT, selective media, dilution-to-extinction culturing, and plating bacteria from fresh and frozen 
coral homogenates) generated a diverse array of culturable bacteria. Although most of the 
isolates were closely related (≥ 97% sequence identity) to previously cultured bacteria, seven 
potentially novel bacteria were cultured. In light of the discovery of potentially novel isolates, it 
is suspected that the isolation conditions and the use of the PFT were significant factors in 
enhancing bacterial cultivation, therefore, PFT and select media specified in this investigation  
are recommended for future investigations of microbial cultivation from invertebrates. It is also 
concluded that plating fresh and frozen coral homogenates can shift the predominant microbial 
community from Gram-negative to Gram-positive bacteria respectively. This information can be 
used to guide future studies as a means to increase the biological diversity of cultivable 
prokaryotes. Additionally, this thesis showed the ecological significance of PsG (in addition to a 
recent report, Correa et al., 2012) which inhibits mainly Gram-positive bacteria associated with 
P. elisabethae. 
 
 
 
Based on the notion that a high biological diversity directly translates to a high chemical 
diversity, the high cultivable bacterial diversity from P. elisabethae signifies that coral- 
associated bacteria are excellent targets to investigate for the production of bioactive natural 
products in subsequent analyses. Consistent with the great challenge facing microbiology today, 
however, less than one percent of P. elisabethae-associated cultures were amenable to culturing, 
a result which is in congruence with other investigations. Co-cultivation of P. elisabethae- 
associated bacterial isolates with other microorganisms may have increased the cultivability of 
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bacteria as has been suggested by other investigators (D‘Onofrino et al., 2010; Pettit, 2009); 
other methods which can enhance microbial cultivation have been discussed elsewhere (Ben- 
Dov et al., 2009; Kaeberlein et al., 2002; Sipkema et al., 2011). Furthermore, future efforts will 
focus on culturing and biochemically characterizing isolates of intriguing groups of coral- 
associated bacteria, such as RKPE23-related phylotypes discussed previously, which share 80% 
sequence homology to Mycoplasma sp., to determine their metabolic capabilities and potential 
role(s) within their octocoral hosts. Regardless, the challenge facing microbiology today, which 
states that up to 99.8% of bacteria cannot be cultured on standard isolation media (Koren and 
Rosenberg, 2006) would benefit from a focused effort on A) understanding the factors which 
prevent cultivation and B) the development of novel culturing approaches. As a result, this may 
open new avenues for natural product drug discovery (Nithyanand and Pandian, 2009). Once the 
elusive factors which to-date prevent the cultivation of many microorganisms becomes available, 
this information can be used to increase our understanding of the microbiological world around 
us. 
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CHAPTER IV 
 
INVESTIGATION OF PSEUDOPTEROGORGIA ELISABETHAE-ASSOCIATED 
BACTERIAL ISOLATES FOR FERMENTATION, ANTIMICROBIAL SCREENING, AND 
CHEMICAL PROFILING 
 
 
 
INTRODUCTION 
 
With a large number of antibiotics targeting a variety of clinically devastating 
pathogens during the Golden Age, the world celebrated ―the end of infectious disease.‖ 
However, the process of natural selection desired to maintain the microbial world, and 
consequently microorganisms became progressively resistant to therapeutic treatments (Saleem 
et al., 2010). For example, highly resistant strains of the ―superbug‖ methicillin-resistant 
Staphylococcus aureus (MRSA) were originally restricted to hospitals, yet are now widespread 
in the community (Lewis, 2012). In addition, more than 70% of hospital-acquired infections have 
become resistant to many antimicrobial agents, and today resistant bacteria exist in every country 
in the world (Coates et al., 2002). 
Although the global market value for antimicrobial agents is approximately US $25 
billion per year (Coates et al., 2002), knowledge that the use of an antimicrobial invariably 
selects for resistant microbes (Clardy et al., 2006) is discouraging to pharmaceutical companies, 
who are drawn towards treatments which can offer considerable commercial success, such as 
drugs consumed daily for lengthy periods of time (Baker et al., 2007; Li and Vederas, 2009). 
However, of serious and immediate concern is the increasing crisis of microbial infectious 
diseases to which few effective antimicrobials are available (Zhang et al., 2005). Marine natural 
products provide a virtually untapped resource of structural diversity and diverse biological 
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activity, and therefore offer exceptional potential for the discovery of new antimicrobial agents 
(Baker et al., 2007). 
Recent evidence suggests bacteria associated with marine invertebrates may be the true 
biosynthetic source of many promising marine natural products (Bunyajetpong et al., 2011; 
Bunyajetpong, 2011; Davidson et al., 2001; Gerwick et al., 2008; Kador et al., 2011; König et 
al., 2006; Sharp et al., 2007). Specifically, the octocoral P. elisabethae is a well-characterized 
source of antibacterial diterpenes (McCulloch et al., 2011). However, despite the growing body 
of literature suggesting bacteria are the true sources of many invertebrate-derived natural 
products as discussed above, P. elisabethae-associated bacteria have not been rigorously 
analyzed for natural product production. Given the well-established correlations between 
biological diversity and chemical diversity, it is rationalized that the associated bacterial 
community of P. elisabethae are a promising and sustainable source of novel natural products. 
The third aim of this research was to identify bacteria associated with P. elisabethae which are 
capable of producing novel secondary metabolites. As pointed out by Jensen and Fenical (1996), 
it is rationalized that bacteria will have become more adapted to the resources associated within 
the specific coral, and therefore it is unlikely that the same microorganisms or natural products 
will be discovered in other hosts (Jensen and Fenical, 1996). 
Therefore, the ability of coral-associated bacteria to produce natural products was 
assessed by liquid chromatography/mass spectrometry following antimicrobial screening of 
bacterial extracts against a panel of clinically relevant pathogens. It is acknowledged that testing 
coral-associated bacteria against clinically relevant microorganisms may not be a true reflection 
of their antimicrobial or probiotic activity in their natural environment. However, studies have 
shown that clinically relevant biological activities are often translated into ecologically relevant 
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activities; for example, bacteria which demonstrate Gram positive activity in clinical isolates also 
act against Gram positive bacteria from within the host invertebrate (Hentschel et al., 2001). 
 
 
 
 
MATERIALS AND METHODS 
 
 
Small scale fermentation of P. elisabethae-associated bacteria 
 
 
Bacterial isolates (n = 77) identified with the prefix ―RKVR‖ or ―RKBH‖ (refer to Table 
B2) were selected for fermentation and screening of fermentation extracts for antimicrobial 
activity. Isolates were chosen based on taxonomic affiliation via 16S rRNA gene sequences 
based on low gene sequence identity with published sequences and the likelihood that the genus 
could produce natural products based on literature precedence. Fermentation of all 77 bacteria 
were originally performed by J. MacAuley, N. Duncan, and N. McCarville. Reproducibility was 
assessed by V. Robertson where experiments were conducted in triplicate on two separate 
occasions. Although many of the selected Pseudoalteromonas spp. were genetically related, 
these isolates were selected because previous studies have indicated strains which were closely 
related exhibit different biochemical profiles and antibiotic sensitivity (Lampert et al., 2006); 
therefore, it is not implausible to suggest closely related bacteria may produce different natural 
products. 
 
Bacteria selected for fermentation were obtained from 50% glycerol stocks stored at 
 
-80 °C and were plated immediately on Marine Agar 2216 (MA, BD Difco™) plates for two to 
seven days, until significant growth was observed. Any isolate which was visibly contaminated 
was subcultured to purity on fresh MA plates. To generate a sufficient biomass for small scale 
extraction, pure cultures were transferred using a sterile applicator in a laminar flow hood to 7 
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mL of seed media (Marine Broth, MB, BD Difco™) contained in 25 mm x 150 mm borosilicate 
glass culture tubes (VWR International, Mississauga, ON). Seed media was prepared according 
to the manufacturer‘s instructions. Three to five glass beads were added to each tube when 
filamentous bacteria were cultured to improve broth mixing and aeration. All tubes were capped 
with a plastic enclosure, autoclaved (121°C for 20 min), and cooled to room temperature. Tubes 
were incubated at 30°C and cultures were shaken at 200 rpm on a rotary shaker (Innova, New 
Brunswick Scientific) for two to seven days depending on growth in seed media. Bacteria were 
grown in seed media until confluent growth was observed. Following confluent growth, 100 µL 
(or 1 mL for mF/2 media) of cultures in seed media was used to inoculate 10 mL of 10 sterile 
fermentation media chosen for the induction of secondary metabolite production (Table 4.1). 
Media blanks (absence of bacterial inoculates) were incubated and extracted as a control. In the 
case of filamentous bacteria, wide bore pipette tips were used to ensure a sufficient biomass was 
transferred. Cells were harvested following three to seven days of growth, again depending on 
the observable growth of bacteria during fermentation. Following inoculation, 50% glycerol 
stocks were prepared from seed media in a sterile cryovial, mixed well, and stored at -80°C. 
Fermentations were assessed for purity by streaking 20 µL at each step on sterile MA plates and 
were incubated at 30°C. Following initial bioactivity screening of bacterial fermentation extracts, 
fermentations for 18 of the most active bacteria (defined by ≥80% inhibition against any of the 
tested clinical isolates) were performed in duplicate to ensure reproducibility. 
  
Table 4.1: Fermentation media used in the cultivation of P. elisabethae-associated bacteria. 
 
Medium Medium Name Rationale Ingredients 
 
 
M1 
 
 
modified MB (mMB) 
A general fermentation medium modified from 
MB through the addition of Instant Ocean as a 
salt source. 
 
5 g/L BD Bacto Peptone, 1 g/L Yeast Extract (EMD), 0.1 g/L Ferric Citrate (Aldrich); 18 g/L Instant Ocean; Nanopure H2O to 1L; 
pH 7.6 ± 0.2 
 
 
M2 
 
 
Terrestrial Broth (TrB) 
Used as a medium to determine if secondary 
metabolite production can be stimulated by the 
absence of salt. 
 
5 g/L BD Bacto Peptone, 1 g/L Yeast Extract (EMD), 0.1 g/L Ferric Citrate (Aldrich); Nanopure H2O to 1L; pH 7.6 ± 0.2 
 
 
M3 
 
mMB + 0.25 g/L 
mevalonolactone (MEV) 
Mevanolactone is a growth factor in some 
bacteria; added as a precursor for terpene 
biosynthesis. 
 
5 g/L BD Bacto Peptone, 1 g/L Yeast Extract (EMD), 0.1 g/L Ferric Citrate (Aldrich); 18 g/L Instant Ocean; Nanopure H2O to 1L; 
pH 7.6 ± 0.2; Added post-sterilization: 2.5 mL of 0.25 g of mevalonolactone dissolved in 2.5 mL 95% ethanol 
 
M4 
mMB + 50 mg/L 
pravastatin (PVS) 
Pravastatin added as a bacterial growth 
promoting agent 
5 g/L BD Bacto Peptone, 1 g/L Yeast Extract (EMD), 0.1 g/L Ferric Citrate (Aldrich); 18 g/L Instant Ocean; Nanopure H2O to 1L; 
pH 7.6 ± 0.2; Added post-sterilization: 2.5 mL of 0.25 g of mevalonolactone dissolved in 2.5 mL 95% ethanol 
 
M5 
Trypticase Soy Broth 
(TSB) 
Used as a general purpose medium, notably 
for non-sporulating organisms. 
BD Difco premix: 17 g/L Pancreatic Digest of Casein; 3 g/L Papaic digest of soybean meal; 18 g/L Instant Ocean; 2.5 g/L K2HPO4; 
2.5 g/L Dextrose; Nanopure H2O to 1L 
 
 
 
M6 
 
 
 
BFM3 
Selected owing to the production of five new 
polyketides from a fermentation of 
Streptomyces sp. (Graziani et al ., 2005); 
modified to include Instant Ocean. 
0.5 g/L MgSO4∙7H2O; 0.5 g/L KCl; 3 g/L K2HPO4; 18 g/L Instant Ocean; 0.4 g/L Agar; 12 g/L Glycerol; 5 g/L Soy Peptone; 
Nanopure H2O, to 1L; pH 7.0 ± 0.2 
 
 
M7 
 
Benzoate Minimal Salt 
(BMS) 
Used as a cultivation medium for 
microorganisms which can use benzoate as a 
carbon source (ex. Pseudomonas sp.). 
0.2 g/L Citric acid sodium salt; 10 g/L K2HPO4; 0.2 g/L MgSO4∙7H2O; 3 g/L NaNH4HPO4∙7H2O; Nanopure H2O to 975 mL; 
Instant ocean 18 g/L; pH 7.0 ± 0.2; Added post-sterilization: 25 mL of Sodium Benzoate (2.5 g dissolved in 25 mL Nanopure H2O, 
filter sterilized) 
 
 
 
 
 
 
 
M8 
 
 
 
 
 
 
 
Modified mF/2 (mF/2) 
Nutrient reduction of modified F media. 1 mL NaNO3 stock solution, 1 mL NaH2PO4 stock solution, 1 mL Trace Metals solution; 0.5 mL Vitamin Stock solution; 0.25 g Proflo 
Oil; 0.09 g L-fucose; 0.09 g D-xylose; 0.09 L-arabinose; 0.09 g L-arabinose; 0.09 g D-glucosamine; 0.09 g N-acetyl-D-glucosamine; 
0.30 g Difco Cas Amino Acids; 18 g/L Instant Ocean; Nanopure H2O to 1L; pH 7.5 ± 0.2. NaH2PO4 Stock solution: (5g NaH2PO4 in 
1L Nanopure H2O). Trace metals stock solution: 4.36 g Na2EDTA, 3.15 g FeCl3·6H2O, 1.0 mL Primary trace metals, Nanopure H2O  
to 1L. Primary Trace Metals Stock Solution (added post-sterilization): 1 g CuSO4·5H2O, 2.2 g ZnSO4·7H2O, CoCl2·6H2O, 18 g 
MnCl2·4H2O, 0.63 g NaMoO4·2H2O; Nanopure H2O to 100 mL. Vitamin Stock Solution (added post-sterilization): 10 mL of 0.1 
mg/mL solution of Biotin, 1 mL of 1 mg/mL solution of Vitamin B12, 2 g Thiamine HCl. 
 
 
 
M9 
 
 
PE aqueous media 
(PEAq) 
The addition of invertebrate extract has been 
demonstrated to increase the number of novel 
cultivated isolates in sponges (Webster et al ., 
2001). 
500 mL of ground PE (100 g of ground P. elisabethae tissue was boiled and extracted with MeOH for 30 min in 1 L Nanopure dH2O 
containing 18 g/L instant ocean); 9 g/L Instant Ocean; 1 g/L Yeast Extract; 1 g/L Dextrose; Nanopure H2O to 1L; pH 7.5 ± 0.2 
 
 
M11 
 
 
mMB + HP-20 
Added to the fermentation media to adsorb 
secondary metabolites and to prevent 
feedback inhibition during fermentation. 
5 g/L peptone; 1 g/L Yeast Extract; 0.1 g/L Ferric Citrate; 18 g/L Instant Ocean; Nanopure H2O to 1L; 10% Diaion® HP-20 w/v (1 g 
into 10mL) 
 
 
 
M12 
 
 
 
modified F media (mF) 
A medium used to culture bacteria which may 
be dependent on symbiosis with the algal 
symbiont Symbiodinium sp. in P. 
elisabethae . 
2 mL NaNO3 stock solution (see mF/2); 2 mL NaH2PO4 stock solution (see mF/2); 1 mL Trace metals stock solution (see mF/2); 0.5 
g Proflo Oil; 0.2 g L-fucose; 0.2 g D-xylose; 0.2 g L-arabinose; 0.2 g D-glucosamine; 0.2 g N-acetyl-D-glucosamine; 0.6 g Difco Cas 
Amino Acids; 18 g/L Instant Ocean; Nanopure H2O to 1L; pH 7.5 ± 0.2 
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Extraction of secondary metabolites 
 
 
Cultures were removed from the rotary shaker and transferred to 50 mL centrifuge tubes. 
Activated HP-20 (10% w/v) was added to all cultures except M11, and cultures were shaken at 
250 rpm for one hour at room temperature. Resins and cells were pelleted by centrifugation for 7 
min at 4000 rpm, and supernatants were carefully removed. To wash the resins, 30 mL of 
MilliQ
® 
H2O was added to each tube. Tubes were shaken on a rotary shaker at 250 rpm for 30 
minutes, centrifuged as above, and the supernatant was removed. Next, 30 mL of 30% MeOH in 
 
H2O was added, samples were shaken at 250 rpm (30 min), and the solvent mixture was 
removed. Finally, organic metabolites were removed from the HP-20 resin by adding 7 mL of 
100% MeOH. The resins were shaken for 30 minutes, and MeOH was removed and transferred 
to a pre-weighed scintillation vial. The resins were re-extracted with 100% MeOH and 
shaken/transferred as described above, and extracts were dried using a GeneVac
® 
evaporating 
system. Dried extracts were re-suspended in H2O and extracts were partitioned using an 
equivalent amount of EtOAc. EtOAc fractions were dried and were defatted with hexane by 
partitioning with a 1:1 volume of hexane and ACN. ACN extracts were analyzed by ultra-high 
performance liquid chromatography coupled with high resolution mass spectrometry 
(UPLC/HRMS) in addition to testing for antimicrobial activities. 
 
Antimicrobial assay 
 
 
Extracts obtained from fermentations were assessed for the production of antibiotics 
against five human pathogenic microorganisms (Table 4.2). Cation Adjusted Mueller Hinton 
Broth, CAMHB, Becton-Dickinson and Company) was used to culture bacterial strains and 
Sabouraud dextrose broth (SD) was used to culture Candida albicans; stock solutions were 
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Table 4.2: List of clinical isolates investigated from P. elisabethae-associated bacterial isolates. 
 
 
Pathogen Affiliation ATCC/Strain 
No. 
Positive 
control 
Methicillin-resistant 
Staphylococcus aureus 
(MRSA) 
Gram positive ATCC 33591 Vancomycin 
Vancomycin-resistant 
Enterococcus faecalis 
(VRE) 
Gram positive 379* Rifampicin 
Pseudomonas aeruginosa 
(PA) 
Gram negative ATCC 14210 Gentamicin 
Proteus vulgaris (PrV) Gram negative ATCC 12454 Ciprofloxacin 
Candida albicans (CA) Yeast ATCC 14035 Nystatin 
*Singh et al., 2000. 
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prepared as outlined previously (Correa et al., 2011). M. Lanteigne was responsible for 
performing all bioassay experiements. 
 
Biological activities of fermentation extracts were tested using the broth microdilution 
method in 96 well microtiter plates as outlined previously (Correa et al., 2011). To each assay 
plate, three vehicle controls (blank control) were added, consisting of 2% DMSO (total volume) 
and the appropriate media. Three organism controls (negative control) containing the pathogen in 
2% DMSO were also included in each assay plate. Finally, the antibiotic control (positive 
control) was added, along with the pathogen, as a dilution series in 2% DMSO (final volume) 
with one dilution per well. Pathogens were adjusted to obtain a final cell count of 5 x 10
5
 
 
CFUs/mL. To prepare the assay plate, 10 µL of the test compound extract (prepared in 20% 
DMSO) were added into respective wells on the assay plate. In fermentation trial 1, extracts were 
not weighed, yet were transferred to the assay plate at 0.10X (e.g. 1.4 mL from a total 
fermentation volume of 14 mL was transferred and dried in assay plates). These extracts were 
tested undiluted (0.10X), at ½, ¼, and 
1
/16. The optical density was measured at an absorbance of 
600 nm (OD600) at time 0 (Tinitial) using a spectrophotometric BioTek® Synergy HT microplate 
 
reader (Vermont, USA). The plate was incubated at 37°C for 22 hours, and the final OD600 
reading (Tfinal) was obtained. To determine the antimicrobial activities of the extracts or 
compounds, the percent inhibition was calculated for each measurement, taking into account 
medium controls without inocula and media controls with inocula. Antibiotic controls were also 
performed in serial dilutions to control for variances in pathogen sensitivity (Correa et al., 2011). 
Half maximal inhibitory concentrations (IC50s) were calculated by plotting concentration (x) 
versus percent inhibition (y) and locating at which point x crosses y at 50%. Antimicrobial 
activities were initially tested using all 77 de-replicated isolates (listed with the prefix ―RKVR‖ 
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or ―RKBH‖ in Table B2). However, to confirm reproducibility and to prioritize the workload, 
fermentations were repeated by selecting 18 of the most bioactive (defined as ≥80% inhibition 
against any clinical isolate) fermentation extracts at a 10X concentration against clinical 
pathogens following the first round of bioactivity screening. For fermentation trial 2, extracts 
were tested against pathogens at 125 µg/mL. Finally, serial dilutions of RKBH-B54 fermentation 
extracts were tested against pathogens at the following concentrations: 125, 63, 31, 16, 8, 4, 2, 1, 
0.5, and 0.25 µg/mL. 
 
 
 
 
 
Chemical analysis of bioactive extracts by UPLC/HRMS 
 
All bioactive fractions and extracts were analyzed by UPLC/HRMS using electrospray 
ionization (ESI). UPLC (Thermo Scientific, Accela) was equipped with a photodiode array 
(PDA) detector (Thermo Scientific, Accela) to identify compounds which absorb UV light, an 
electron light scattering detector (ELSD; Sedere, Sedex LT-ELSD model 80LT), and a high 
resolution mass spectrometer (Thermo Scientific, Exactive plus Orbitrap) to accurately 
determine the exact molecular formula through exact mass measurements. UPLC/HRMS was 
performed in positive ion mode using a standard gradient from 5% ACN in H2O (0.1% formic 
acid in both eluents) to 100% ACN in a 10 minute run. Extracts were prepared in MeOH to a 
concentration of 500 µg/mL and reserpine (25 µg/ mL) was used as a standard for each set of 
samples. MeOH blanks were also run in each batch of samples. Chromatographic and spectral 
profiles were compared to media blank extract profiles to determine which compounds were 
produced as a result of bacterial metabolism. Pseudomolecular ions identified from the MS 
spectra were searched in natural product databases (Antibase 2007, SciFinder) to identify the 
putative novelty of the detected compounds. Antibase 2007 searches were performed by 
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searching pseudomolecular ions in positive mode ESI searching either proton adducts [M+H]
+ 
or 
sodium adducts [M+Na]
+
. Deviations of experimental values from proposed molecular formulae 
values are recorded as δ (in ppm). 
 
 
 
Large scale fermentation and extraction of RKBH-B54 
 
Streptomyces sp. RKBH-B54 (nearest GenBank representative, S. sampsonii ATCC 
25495, 99% sequence identity) was isolated and identified by B. Haltli from P. elisabethae on 
R2A media (BD Difco™, Mississauga, ON) based on partial 16S rRNA gene sequencing (refer 
to Chapter III). RKBH-B54 strongly and routinely inhibited the growth of the yeast C. albicans, 
and therefore large scale fermentation (4L) was performed in an attempt to isolate and identify 
the antifungal compound(s). A small scale fermentation and extraction (10 mL x 20 tubes = 200 
mL total) was performed in parallel to the large scale extraction to ensure biological activity was 
retained when the isolate was fermented at a larger volume, as studies have shown that feedback 
inhibition of secondary metabolites can increase when larger fermentation batch sizes are used 
(Xu et al., 1999). 
RKBH-B54 was streaked for purity on MA and was transferred using a sterile applicator 
to 10 mL of MB (seed media) containing five glass beads. Cultures were grown at 30°C for 72 
hours in seed and were shaken at 200 rpm on a rotary shaker. A small aliquot of sample growing 
in seed was used to streak for purity on MA. The remainder of RKBH-B54 growing in seed was 
transferred using a sterile pipette into 50 mL of sterile MB in a 250 mL flask, which was shaken 
at 250 rpm for 24 hours at 30°C. Cultures were again assessed for purity by streaking on agar 
plates, and 12 mL each of second stage media was transferred to 1L each of autoclaved BFM3 
into four - four liter Fernbachs covered by sterile milk filters and nitrocellulose membranes. 
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Following five days of growth in BFM3, 10% HP-20 resin (w/v) was added, and samples were 
shaken (250 rpm) at room temperature for one hour. Fermentation mixtures were transferred to 
250 mL centrifuge bottles, filling no more than 200 mL in each centrifuge. Samples were 
centrifuged for 10 min at 10,000 rpm (Beckman Coulter Allegra 25R centrifuge), and the 
supernatant was removed. Resins were washed three times using 200 mL volumes of MilliQ
® 
H2O and were subsequently washed twice with 200 mL of 20% MeOH. Resins were extracted 
three times using 200 mL of MeOH to elute adsorbed solutes, the solvent was dried using a 
rotary evaporator, and the mass of dried extracts was obtained. 
 
 
 
Bioassay guided purification of RKBH-B54 extracts 
 
MeOH extracts of RKBH-B54 were dissolved in 1L of MilliQ
® 
H2O to a concentration of 
1 g extract per L H2O which was transferred to a 4L Fernbach containing 5% each (w/v) of two 
moderately polar adsorbent resins, activated Diaion
® 
HP-20 and Amberlite
® 
XAD-7. Making a 
slurry of the resins, the broth was filtered over the resins via vacuum filtration, using 1L each of 
increasing concentrations of organic solvents: F1, H2O; F2, 80:20 H2O:MeOH; F3, 50:50 
H2O:MeOH; and F4: 100% MeOH. All fractions were evaporated under reduced pressure using a 
rotary evaporator. F4 was subjected to solid phase extraction (SPE) using a C18 Sepak cartridge 
(Waters, Milford, MA). The sample was loaded onto the column and 15 mL of each of 6 solvent 
mixtures of decreasing polarity were used to elute compounds into pre-weighed scintillation 
vials: F1, 9:1 H2O:MeOH; F2, 50:50 H2O: MeOH; F3, 2:8 H2O:MeOH; F4, 100% EtOH; F5, 
100% acetone; and F6, 1:1 DCM:MeOH. Each fraction was concentrated in vacuo using a rotary 
 
evaporator, analyzed by UPLC/HRMS, and resubmitted for biological activity screening against 
 
C. albicans. 
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Chromatographic separation of the antifungal compound produced by RKBH-B54 using 
semi-preparative reverse-phased HPLC 
Semi-preparative reverse-phased (RP)-HPLC of the bioactive C18 Sepak F3 was 
performed in an attempt to purify the antifungal compound(s) from the mixture. The sensitivity 
of the antifungal compound(s) to probable degradation was known prior to separation owing to a 
previous fermentation and RP-HPLC purification attempt (data not shown); therefore, caution 
was used by storing approximately half of the fraction F3 at -80°C (divided into ―Trial 1‖ and 
―Trial 2‖ respectively).  In Trial 1, C18-SPE F3 (~11 mg) was re-suspended to 10 mg/mL in 
H2O:MeOH (1:3), sonicated, and centrifuged to remove excess particulate material. Fractions 
were monitored and collected by RP-HPLC on a Finnigan Surveyor LC Plus pump attached to a 
PDA plus detector (Thermo Electron Corp) and a Sedex 60 LT (Sedere) ELSD. UV was 
monitored at 220, 254, and 325 nm using ChromQuest (v. 4.2.34). The mobile phases were H2O 
+ 0.1% TFA (A) and ACN (B). A C18 semi preparative column (Phenomenex Gemini
®
, 250 x 
 
10 mm, 5 µm) was used with the following elution conditions: t0 min = 50%B, t3 min =80%B; t13 min 
 
= 80%B; t13.01 min = 100% B; t23 min = 100% B; t25 min = 50% B. A 90 µL volume was injected 
onto the column with a flow rate of 2.5 mL/min. All solvents used in the purification were 
chromatography grade. 
To purify the remainder of RKBH-B54 C18 Sepak F3 (8.32 mg) for Trial 2, the sample 
was removed from storage at -80°C, resuspended in H2O:MeOH (1:3), and prepared as described 
above. Fractions were monitored and collected by RP-HPLC on a Waters HPLC (Milford, MA, 
USA) equipped with an ELS detector (Waters 2424), Binary LC pump, UV/Vis detector, and a 
fraction collector using Fractionlynx and Mass Lynx (v. 4.1) software. UV was monitored at 280 
and 325 nm, using the same semi-preparative C18 column as in Trial 1. Similarly, H2O + 0.1% 
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TFA (A) and ACN (B) were used as the mobile phase with a flow rate of 3 mL/min and injection 
volume of 100 µL. Separation was performed using the following conditions similar to those 
described from Jakobi et al. (1996): t0 min = 50%B, t24 min = 50%B; t25 min = 100%B; t31 min = 
50%B; t40 min = 50%B.  Fractions were collected in clean glass tubes and dried under reduced 
pressure.  Following separation of the entire amount of C18-SPE F3, a second HPLC separation 
on HPLC purified F3 was performed by applying a linear gradient from 10% to 60% ACN over 
40 minutes. 
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RESULTS AND DISCUSSION 
 
Antimicrobial activity of bacterial fermentation extracts 
 
The aim of this investigation was to assess the ability of P. elisabethae-associated 
bacteria to produce natural products, as measured by the ability of bacterial fermentation extracts 
to show antimicrobial activity against a panel of clinically significant pathogens. Results from 
initial screening endeavors from 77 bacteria revealed that the majority of fermentation extracts 
were active against Gram positive pathogens, where 21 fermentation extracts were strongly and 
reproducibly active against MRSA and 23 fermentation extracts were strongly and reproducibly 
active against VRE (Table 4.3). Conversely, less activity was observed against Gram negative 
bacteria, with six extracts active against P. vulgaris and no isolates active against P. aeruginosa 
at 10X concentration (Table 4.3). This concentration was equivalent to testing an extract volume 
of 1.4 mL and was used as a means to more rapidly determine antimicrobial activity. Subsequent 
extracts were tested at a minimum of 125 µg/mL. In most cases, bioactivity against P. vulgaris 
was generally observed when bacteria were fermented in TSB (Table 4.3).  The lack of 
antimicrobial activity against P. aeruginosa could suggest the coral specifically hosts bacteria 
which are incapable of competing with a potentially vital member of the coral holobiont. Only 
one coral-associated bacterial fermentation extract (Streptomyces sp. RKBH-B54) was capable 
of inhibiting the yeast C. albicans (Table 4.3). 
 
The influence of fermentation media on antimicrobial production 
 
 
Media selection is often a fundamental component in the success of microbial natural 
product production. Remarkably, features such as different media and minor variations of 
nutrients can impact the production or yield of secondary metabolites (Bills et al., 2008) or can 
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Table 4.3: Biological activity from Round 1 isolate fermentation extracts. Activities are 
 
calculated at 10X concentrates. Numbers represent percent inhibition. Red: bioactivity ≥80%; 
yellow: 60 – 80%; grey: activity not reproducible upon independently re-testing the same extract. 
 
 
B acte ria Taxonomy 
 
Fe rme ntation me dia 
 
MRSA 
 
VRE 
 
CA
1
 
 
PA
2
 
 
PrV
3
 
RKBH-B054 Streptomyces  sp.  BFM3   99   
RKBH-B054 Streptomyces  sp.  mMB 59  100   
RKBH-B054 Streptomyces  sp.  mMB + HP-20   100   
RKBH-B054 Streptomyces  sp.  mMB + Mev   100   
RKBH-B054 Streptomyces  sp.  mMB + Prav 53  100   
RKBH-B054 Streptomyces  sp.  BMS   98   
RKBH-B054 Streptomyces  sp.  mF/2   99   
RKBH-B054 Streptomyces  sp.  PEAq   98   
RKBH-B109 Micrococcus  sp.  TSB     99 
RKBH-B110 Pseudomonas  sp.  TSB 100    97 
RKVR-02 Pseudoalteromonas sp. mMB  97    
RKVR-02 Pseudoalteromonas sp. mMB+HP-20 100 100    
RKVR-02 Pseudoalteromonas sp. mMB + Mev 50     
RKVR-02 Pseudoalteromonas sp. mMB + Prav 74     
RKVR-02 Pseudoalteromonas sp. TSB 61     
RKVR-04 Pseudoalteromonas sp. TSB 54    96 
RKVR-07 Pseudoalteromonas sp. mMB+HP-20 100 100    
RKVR-07 Pseudoalteromonas sp. mMB + Mev  100    
RKVR-08 Alteromonas  sp.  BFM3 100 100    
RKVR-08 Alteromonas  sp.  mF/2 100 100    
RKVR-11 Janibacter  sp.  BFM3 100 100    
RKVR-11 Janibacter  sp.  TrB 100 98    
RKVR-11 Janibacter  sp.  PEAq 100 98    
RKVR-11 Janibacter  sp.  mMB + Mev  51    
RKVR-11 Janibacter  sp.  mF/2  61    
RKVR-19 Listonella  sp.  mF/2 100 100    
RKVR-19 Listonella  sp.  mMB + HP-20  62    
RKVR-20 Pseudoalteromonas sp. mMB+HP-20 100 100   89 
RKVR-20 Pseudoalteromonas sp. mMB + Prav     60 
RKVR-21 Vibrio sp.  mF/2 100 100    
RKVR-21 Vibrio sp.  PEAq 100 100    
RKVR-27 Paracoccus  sp.  mMB+HP-20 100 99    
RKVR-27 Paracoccus  sp.  BFM3 100 99    
RKVR-27 Paracoccus  sp.  mMB + Mev  56    
RKVR-29 Micrococcus  sp.  TSB     96 
RKVR-29 Micrococcus  sp.  mMB 100     
RKVR-30 Ruegeria  sp.  mMB 100 98    
RKVR-30 Ruegeria  sp.  TrB 100 99    
RKVR-30 Ruegeria  sp.  mMB + Prav  99    
RKVR-34 Pseudoalteromonas sp. mMB+HP-20 100 100    
RKVR-34 Pseudoalteromonas sp. mMB + Mev 100 100    
RKVR-34 Pseudoalteromonas sp. mMB + Prav  100    
RKVR-34 Pseudoalteromonas sp. TSB 54 100    
RKVR-36 Vibrio sp.  mMB 99 99    
RKVR-36 Vibrio sp.  mMB+HP-20 100 100    
RKVR-36 Vibrio sp.  TSB 100 100    
RKVR-36 Vibrio sp.  BFM3 100 91    
RKVR-39 Vibrio sp.  BFM3 100 100    
RKVR-39 Vibrio sp.  mF/2 100 98    
1 Candida albicans         2 Pseudomonas aeruginosa 
3 Proteus vulgaris 
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produce substantially different compounds (Chen et al., 2001).  It was also immediately clear 
from the present study that media selection was a critical factor in influencing the bacteria to 
produce antimicrobial extracts.  Of these, the media most successful at stimulating cultures to 
produce antimicrobial agents was BFM3 and mMB + HP-20 (Table 4.3). The latter observation 
is not surprising, since precedence in the literature suggests the addition of adsorbent resins 
during fermentation greatly increases the likelihood of detecting or increasing the yield of 
secondary metabolites (Lee et al., 2003). Specifically, Diaion
® 
HP-20 resin (matrix: styrene- 
 
divinylbenzene) was selected in this investigation as it was the most effective adsorbent resin of 
four resins (Amberlite™ XAD-16, Diaion® HP-20, charcoal, and silica gel) examined in a 
previous study, yielding a 4.2 fold increase in the quantities of the natural product teicoplanin 
(Lee et al., 2003). For example, when added at a 5% concentration during fermentation, Diaion
® 
HP-20 prevented lethal effects on bacterial growth and reduced feedback inhibition of 
teicoplanin (Lee et al., 2003). This example highlights the ability of adsorbent resins to sequester 
natural products produced during fermentation, which likely prevent their detection and 
subsequent degradation by the microorganism. However, the most versatile bacterium in the 
present study was Streptomyces sp. RKBH-B54, which demonstrated potent bioactivity against 
C. albicans when fermented in eight of the ten fermentation media tested. 
 
 
Conversely, the culture media which was the least successful at stimulating the 
production of antimicrobial metabolites production was TrB and BMS (Table 4.3). The lack of 
efficacy in the case of terrestrial broth (TrB), a culture medium devoid of salt, suggests that salts 
may be critical for natural product production. This can be shown in the example that no 
antifungal activity could be observed when this bacterium was fermented in TrB and TSB. The 
inability of RKBH-B54 to produce the antifungal agent when fermented in TrB, as was 
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characteristic for the majority of bacteria in this investigation, strongly suggests this isolate is 
dependent on salts for the production of secondary metabolites. However, although bacterial 
natural product production is strongly subject to preferred fermentation conditions (e.g. orbital 
shaking, nutrient composition, addition of adsorbent resins), the fact remains that very little is 
known regarding bacterial nutrition to promoting secondary metabolite production, and therefore 
a wide variety of conditions and/or approaches are often used as a means to compensate for our 
limited understanding. Taken together, however, it is suggested that future microbial 
fermentations from marine bacteria should incorporate HP-20 resins in a larger selection of 
fermentation media in addition to salts to increase the biological activity of cultures. 
 
 
 
 
Confirming antimicrobial reproducibility in subsequent fermentations 
 
 
Observations from antimicrobial screening from the first round of fermentation extracts 
were used to guide the selection of isolates and to select the most appropriate media at 
stimulating the production of antimicrobials in subsequent fermentations. Of the 15 isolates 
selected for re-fermentation, only five ACN extracts were active at 125 µg/mL (Table 4.4). This 
included the Gram negative bacteria Pseudoalteromonas spp. (RKVR-02, 07, 20, and 34) and a 
Gram positive bacterium Streptomyces sp. (RKBH-B54). No coral-associated bacterial extracts 
were reproducibly active against the Gram negative pathogen P. vulgaris. Specifically, ACN 
extracts from the genetically related Pseudoalteromonas spp. (RKVR-02, RKVR-07, and 
RKVR-34, 0.34 – 0.52 mg of yellow-pigmented solids) were reproducibly active against MRSA 
and VRE when fermented and extracted from mMB + HP-20 (Table 4.4). ACN extracts (0.21 
mg) from Pseudoalteromonas sp. RKVR-20 were moderately active (~60% inhibition) against 
MRSA when grown in seed media (MB) under static conditions, yet no activity was observed 
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Table 4.4: Reproducible biological activity from fermentation extracts. All extract bioactivities 
 
were calculated at 125 µg/mL and all bioactivities are reported from ACN extracts except 
RKBH-B54, which was active in the aqueous fraction. Numbers represent percent inhibition. 
Brackets represent extraction from isolates grown in TSB media. Replicates (A and B) represent 
bioactivity from fermentations performed in duplicate. 
 
Bacteria Taxonomy Media Name MRSA VRE CA PA PrV 
RKBH-B54 (A) Streptomyces  sp. BFM3   100   
RKBH-B54 (B) Streptomyces  sp. BFM3 59  100   
RKVR-02 (A) Pseudoalteromonas  sp. mMB + HP20 100 100    
RKVR-02 (B) Pseudoalteromonas  sp. mMB + HP20 100 100    
RKVR-07 (A) Pseudoalteromonas  sp. mMB + HP20 100 100   99 (TSB) 
RKVR-07 (B) Pseudoalteromonas  sp. mMB + HP20 100 100   97 (TSB) 
RKVR-20 Pseudoalteromonas  sp. MB 60     
RKVR-34 (A) Pseudoalteromonas  sp. mMB + HP20 100 100   96 (TSB) 
RKVR-34 (B) Pseudoalteromonas  sp. mMB + HP20 98 100   96 (TSB) 
 
Inhibition >80% 
Inhibition 50 - 79% 
Activity not reproducible 
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when this isolate was fermented with orbital shaking in fermentation media (data not shown). 
Aqueous extracts from Streptomyces sp. RKBH-B54 were active against C. albicans. 
 
It is intriguing to note that the aforementioned Pseudoalteromonas spp. are related 
genetically (99% sequence identity to P. piscicida (NR_040946.1), refer to Table B2), yet 
displayed different growth preferences and rates. For example, the yellow-pigmented and 
genetically related isolates Pseudoalteromonas spp. RKVR02, RKVR07, and RKVR34 (referred 
to as ―RKVR02-related isolates‖ herein) grew quickly on solid media and remained viable for up 
to one week. In addition, these isolates remained viable when grown in liquid media under 
aerobic conditions. In contrast, the maroon-pigmented isolate RKVR20 grew quickly on agar, 
yet did not remain viable for longer than 24 h on solid media. Optimum growth for this isolate 
was observed when it was fermented under static conditions, and transfer to fermentation media 
from seed resulted in a cessation of growth, pigment production, and antimicrobial activity in 
subsequent fermentations. This observation is not surprising, as previous reports have 
documented the inability of Pseudoalteromonas sp. to produce pigments during orbital shaking 
(Speitling et al., 2007). 
 
The lack of reproducibility in subsequent fermentations suggests that bacterial natural 
product production is sensitive to variations in individual fermentations. Generally, factors 
limiting natural product production are the high toxicity of secondary metabolites and self- 
inhibition of the microorganisms to their own natural product (Hua et al., 2007; Lee et al., 2003), 
a phenomenon known as feedback inhibition or autoinhibition. Feedback inhibition is a 
mechanism by which an organism controls the unnecessary production of secondary metabolites 
which are not utilized (Gerhart and Pardee, 1962). Consequently, the addition of adsorbent resins 
during fermentations theoretically mitigates feedback inhibition by sequestering secondary 
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metabolites as they are produced, ultimately preventing the producing bacterium from 
recognizing and degrading its own antibiotic (Lee et al., 2003). An alternative explanation for the 
lack of observed biological activity from P. elisabethae-associated bacterial extracts is that 
extracts may have biological activity outside of the scope of this report. For example, a previous 
report of the closely related Japanese stony coral-associated Flavobacteriaceae sp. (98% 
sequence identity to RKVR24) produced the major carotenoids (3R)-saproxanthin and (3R, 3‘R)- 
zeaxanthin, the former of which is rarely found in nature yet demonstrated significant 
antioxidative activities against lipid peroxidation and also demonstrated protective effects from 
L-glutamate toxicity (Shindo et al., 2007). The preceeding example suggests that the biological 
activity of a particular extract may have been overlooked in this investigation. 
 
 
 
 
Chemical profiling of Pseudoalteromonas spp. by UPLC/HRMS 
 
It is important to note that the high resolution mass spectrum is used to determine the 
molecular formula and molecular weight of an unknown compound through the identification of 
molecular ion peaks (Pavia et al., 2001). However, in ESI-MS, ―adducts‖ or ―pseudomolecular 
ions‖ are commonly encountered instead of the molecular ion. These species are analyte 
complexes generally formed with alkali metals and salts, and occur because the removal of salts 
from the mass spectrometer prior to analysis is virtually impossible (Schug, 2002).  In positive 
ionization mode, many of these adducts represent the addition of a proton ([M + H]
+
) or sodium 
 
([M+Na]
+
) to the molecule, which form due to the presence of an acid in the solvents (Ardrey, 
2003; Schug, 2002). The loss of water ([M+H-H2O]
+
) is also a commonly encountered molecular 
fragment. 
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UPLC/HRMS screening of ACN extracts from Pseudoalteromonas sp. RKVR02-related  
isolates (including RKVR07 and RKVR34) revealed a variety of high molecular weight [M+H]
+ 
ions were present with a m/z of 844.2943 (RT = 3.08 min; λmax(MeOH) = 374 nm), 860.3084 (RT 
= 3.24 min; λmax(MeOH) = 391 nm), 872.3093 (RT = 3.34 min; λmax(MeOH) = 391 nm) and 924.2036 
(RT = 3.34 min; λmax(MeOH) =391 nm; Figure 4.1). The mixture of compounds individually was 
abundant based on ELSD, a universal detector which measures the amount of light scattered by 
evaporated particles of eluent. Proton adducts could be confidently assigned as a result of 
detecting the corresponding [M+Na]
+ 
adducts. The equal peak intensities at m/z 844.2943 and 
m/z 846.2922 (RT = 3.06 min) matched the M+2 profile characteristic of a molecular structure 
containing bromine, where isotope peak intensities of each peak were roughly 1:1 (Pavia et al., 
2001). Based on a database search for this compound, a molecular formula of C38H50BrN7O10 
was proposed, which matched the structure for bromoalterochromide A (1, Figure 4.2). 
Bromoalterochromide A (λmax = 395 nm) was isolated from an Australian sponge-associated 
Alteromonas sp. and demonstrated cytotoxic activity against sea urchin (Strongylocentrotus 
intermedius) eggs with an MIC of 40 µg/mL (Speitling et al., 2007). However, no antibiotic 
activity was observed from this compound. Considering the taxonomic confusion regarding 
Pseudoalteromonas and Alteromonas in the literature (Bowman, 2007) in addition to the 
metabolite production from another marine invertebrate, there is a high probability that P. 
elisabethae-associated Pseudoalteromonas sp. RKVR02-related isolates are also a source of 
Bromoalterochromide A. 
 
Although Bromoalterochromide A is the likely identity of the metabolite produced by 
Pseudoalteromonas sp. RKVR02 and related isolates, the three remaining compounds (m/z 
860.3084 [M+H]
+
, 872.3093 [M+H]
+
, and 924.2036 [M+H]
+
) may be novel based on a lack of 
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Figure 4.1: UPLC/HRMS profile from Pseudoalteromonas sp. RKVR02. A variety of high molecular weight [M+H]
+
 
 
pseudomolecular ions are shown. A) UV; B) ELSD; C) MS demonstrating the presence of high molecular weight compounds. 
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Figure 4.2: The chemical structure for Bromoalterochromide A, a likely metabolite isolated from 
 
Pseudoalteromonas spp. RKVR02, RKVR07, and RKVR34. 
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plausible identities when searching nominal masses for protonated ions. For example, only four 
database matches were identified for m/z 860.3084 ([M+H]
+
; RT = 3.24 min) and 872.3093 
([M+H]
+
; RT = 3.34 min) respectively. Similarly, searching the nominal mass for m/z 924 (RT = 
3.34 min) generated six hits. However, none of the database matches were likely candidates, as 
none of the published accurate masses were within the accepted 5 ppm range to assign a putative 
structure or molecular formula (Gross, 1994). Consequently, these metabolites are currently a 
subject of biological investigation and structural characterization within the Kerr lab. 
 
In contrast to the more complex spectrum observed for RKVR02-related isolates, the 
chemical profile of RKVR20 was less complex when analyzed in positive ionization mode 
(Figure 4.3). For example, a pseudomolecular ion with m/z 817.5867 [M+H]
+ 
was most abundant 
in RKVR20 based on ELSD data (Figure 4.3). This corresponds to peaks at RT 3.42 and 3.62 
minutes (λmax(MeOH) = 533 nm, Figure 4.3). However, no hits were generated from Antibase 2007 
by searching +-ESI-H
+ 
for 817.6. Furthermore, only five hits were generated when searching the 
 
nominal mass, yet none were within the acceptable chemical shift range for HRMS (≤5 ppm; 
Gross, 1994). In this case, the compound did not appear to be brominated based on a lack of 
equal intensity peaks in the high resolution mass spectrum. Bioassay guided fractionation and 
NMR structural elucidation is required to purify and determine the structure of these metabolites. 
This is also a subject of future investigation within the Kerr lab. 
 
Pseudoalteromonas spp. as a recently described source of natural products 
 
 
A review of the literature regarding natural products from marine bacteria suggests that 
members from the recently described taxonomic group Pseudoalteromonas sp. are an 
exceptional resource of secondary metabolites (Bowman, 2007; Shnit-Orland et al., 2012) which 
have only recently begun to be investigated. These members are commonly found in 
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Figure 4.3: UPLC/HRMS profile from Pseudoalteromonas sp. RKVR20. A) UV; B) ELSD; C) MS; D) UV trace demonstrating a 
UVmax(MeOH) of 231 and 533 nm at RT = 3.34 min. The [M+H]
+ 
pseudomolecular ion at RT = 3.08 min is highlighted on the high 
resolution mass spectrum (C). 
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association with higher marine organisms and appear to play potentially symbiotic roles (Franks 
et al., 2005). For example, Pseudoalteromonas spp. isolated from Red Sea stony corals 
demonstrated extracellular Gram positive bioactivity, yet were inactive against Gram negative 
bacteria (Shnit-Orland et al., 2012). Specifically, low molecular weight compounds with 
antimicrobial activity have been published (Bowman, 2007; Isnansetyo and Kamei, 2003). For 
example, literature reports of low molecular weight compounds from Pseudoalteromonas sp. are 
active against MRSA and E. faecalis (MIC = 1 – 2 µg/mL) without any cytotoxic effects 
(Isnansetyo and Kamei, 2003). In contrast, less information is known regarding high molecular 
weight substances such as those described in the present study.  However, a dissertation reported 
brominated high molecular weight compounds ranging from 830 – 954 Da were produced by P. 
piscicida and demonstrated broad spectrum antimicrobial activity, although their structures were 
unidentified (Bowman, 2007). 
 
The complexity of the chemical profiles from Pseudoalteromonas sp. RKVR02-related 
isolates in addition to the weak antibacterial activity and the difficulties in maintaining viable 
cultures of RKVR20 made Pseudoalteromonas spp. poor candidates for bioassay guided 
fractionation. Conversely, the strong and reproducible antifungal activity from Streptomyces sp. 
RKBH-B54 extracts made this isolate a prime candidate for further purification via bioassay 
guided fractionation. Consequently, efforts were focused on the identification of novel antifungal 
compounds or novel analogues from Streptomyces sp. RKBH-B54. 
 
 
 
Bioassay guided fractionation of Streptomyces sp. RKBH-B54 
 
Crude aqueous extracts from Streptomyces sp. RKBH-B54 demonstrated remarkably 
potent and reproducible antifungal activity against C. albicans, and for this reason the extract 
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was purified further. To accomplish this, large scale (4L) fermentation and extraction was used 
to generate increased amounts of the antifungal metabolite(s). Large scale fermentations are 
necessary in microbial natural product isolation and structural elucidation efforts as a 
consequence of the often low yields of the compound of interest amongst a variety of additional 
bacterial metabolites and media components (Berrué et al., 2011). Furthermore, in this study, the 
combined small scale fermentation (200 mL) extract was less bioactive than the large scale 
fermentation extract (Table 4.5); therefore, bioassay guided purification was performed on the 
large scale fermentation extract only as summarized in Scheme 4.1. 
Following large scale fermentation, metabolites were extracted with 5% each of activated 
Diaion
® 
HP-20 and Amberlite
® 
XAD-7. These resins were selected to ensure that salts and polar 
compounds could be removed from the aqueous fraction by washing the resins with H2O, yet 
would adsorb less polar metabolites which could be easily eluted using common organic solvents 
(Ebada et al., 2008). Next, partitioning the extract with equivalent volumes of aqueous and 
organic solvents resulted in a crude brown aqueous extract (1.97 g) which was capable of 
strongly and reproducibly inhibiting C. albicans (crude bioactivity IC50 = 32.3 µg/mL). The 
presence of bioactivity in the water layer (and absence of activity in media control) suggests that 
the antifungal compound(s) contained polar groups (Buckingham, 1993). In contrast, the organic 
fractions (EtOAc, ACN, and hexane) were not biologically active at 125 µg/mL (Table 4.5). A 
major concern in purifying metabolites from aqueous extracts, particularly from marine bacteria, 
is the co-extraction of a high concentration of salt present within the fermentation media, as salts 
can interfere with downstream purification (Vizcaino, 2011). Specifically, the fermentation 
medium BFM3 contains 18g/L Instant Ocean as a salt source, and as salts are soluble in H2O 
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Table 4.5: Bioactivities of RKBH-B54 extracts. ―ls‖ refers to biological activities from large 
 
scale fermentations and ―ss‖ refers to biological activities from small scale fermentations. 
Numbers represent percent inhibition. However, C. albicans grows in clumps and although some 
values appear to be within the "hit" range, visible growth was observed in the microtiter plate. 
Consequently, these values resemble media blanks and therefore represent false positives. 
 
 
 
 
 
Fraction 
B54 Percent inhibition (µg/mL) 
250 125 62.5 31.3 15.6 7.8 3.9 
B54 ls H2O 99 99 99 96 12 6 0 
B54 ls H2O 100 99 99 96 2 1 -5 
B54 ls EtOAc 95 95 98 94 58 36 4 
B54: ls ACN 57 68 74 84 92 66 71 
B54: ss H2O 99 70 -10 -1 8 -5 -7 
B54 ss EtOAc 90 29 47 30 52 34 -3 
B54 ss ACN 76 62 28 45 52   
Blank 100 100 100     
Organism blank 3 0 -3     
 
Nystatin % inhibition 
(dilution series; µg/mL) 
 
 
6.4 
 
 
3.2 
 
 
1.6 
 
 
0.8 
 
 
0.4 
 
 
0.2 
 
 
Nystatin 
 
100 
 
100 
 
100 
 
35 
 
2 
 
7 
 
 
 
 
≥80 inhibition 
C. albicans + samples 
Media blank 
C. albicans blank 
C. albicans + Nystatin 
False positive 
  
 
 
 
 
 
 
Scheme 4.1: A summary of the workflow of the bioassay-guided fractionation employed for Streptomyces sp. RKBH-B54. 
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 (e.g. 35.85 g NaCl per 100 g H2O at 25°C), the aqueous nature of the extract suggested salt 
removal was necessary prior to chromatographic separation. Consequently, a protocol was 
designed to remove salts from the extract by washing resins containing the adsorbed metabolites 
using increasing concentrations of MeOH in H2O (refer to Materials and Methods). Biological 
activity screening of each solvent wash revealed F4 (100% MeOH) was the most active fraction 
against C. albicans with a minimum inhibitory concentration (MIC) of 0.6 µg/mL; a value 
comparable to the positive control Nystatin (Table 4.6). 
 
 
 
Chemical analysis of Streptomyces sp. RKBH-B54 by UPLC/HRMS 
 
Next, the chemical profile of fraction F4 was analyzed to assign a putative molecular 
formula for the antifungal compound(s). Media blanks and MeOH blanks were also analyzed and 
compared as negative controls to ensure that potential antifungal compounds were only detected 
in active fractions. The most abundant peaks in F4 based on ELSD (Figure 4.4B) corresponded 
to several pseudomolecular ions in the mass spectrum (Figure 4.4C). Fraction 4 contained eight 
identifiable proton adduct pseudomolecular ions with a m/z of 943.5304 ([M+H]
+
, RT = 3.08 
 
min); 511.2804 ([M+H]
+
, RT = 3.08 min); 1109.5820 ([M+H]
+
, RT = 3.11 min); 1111.5986 
 
([M+H]
+
, RT = 3.14 min); 527.2756 ([M+H]
+
, RT = 3.14 min); 513.2955 ([M+H]
+
, RT = 3.40 
 
min); 511.2805 ([M+H]
+
, RT = 3.65 min); and 497.3005 ([M+H]
+
, RT = 3.65 min; Figure 4.4). 
 
Confidence in the abilities to assign ions as the [M+H]
+ 
adduct was again assured based on the 
evidence of associated ([M+Na]
+ 
and/or ([M+H-H2O]
+ 
adducts. UV analysis indicated F4 
contained the presence of a conjugated or aromatic system, as reflected by the ability to absorb 
UV light at λmax(MeOH) = 280, 325 nm (RT = 3.31 and 3.54 min; Figure 4.4A). Additionally, a UV 
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Table 4.6: Biological activity screening of RKBH-B54 extracts against C. albicans from increasing MeOH concentrations. Values are 
 
recorded as percent inhibitions. 
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0.49 
 
 
0.24 
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Figure 4.4: UPLC/HRMS profile of 100% MeOH (F4) from RKBH-B54 showing identified 
[M+H]
+ 
pseudomolecular ions. A) UV trace showing λmax(MeOH) for each UV peak; B) ELSD 
trace showing relative abundances; C) MS highlighting identified [M+H]
+ 
pseudomolecular ions, 
and D) MS at RT 3.40 min showing the putative structure for the compound with m/z 513.2955. 
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spectrum matching the polyene group of antibiotics was identified with a λmax(MeOH) = 365, 385, 
and 408 nm (RT = 3.04 min, Figure 4.4; Jain and Jain, 2007; Seipke et al., 2011). No UV 
absorption or ELSD peaks were observed in media blanks and MeOH blanks, suggesting the 
above-mentioned compounds were the product of bacterial fermentations. 
 
 
 
Identification of metabolites from Streptomyces sp. RKBH-B54 
 
At this stage, a database search was conducted to propose molecular formulae and 
potential molecular structures for the compounds isolated from F4 (summarized in Figure 4.5 
and Table 4.7). Each [M+H]
+ 
pseudomolecular ion was compared to published compounds by 
searching positive mode proton or sodium adducts in Antibase 2007. 
 
 
 
m/z 943 
 
Thirteen database matches were recorded from searching for the nominal mass for the 
[M+H]
+ 
pseudomolecular ion at m/z 943.5304 (RT = 3.08 min), yet the closest database match 
was the fungal-derived compound Soyasaponine I (2; Figure 4.5), with a molecular formula of 
C49H78O18 (calculated [M+H]
+ 943.5268; δ = 3.8 ppm; Maul et al., 1999 ). However, it is rare for 
bacteria and fungi to share similar secondary metabolic pathways (Blodgett et al., 2010) and thus 
it is likely that the ion with m/z 943 represents a novel compound. 
 
 
 
 
m/z 1109/1111 
 
The pseudomolecular ions at [M+H]
+ 
1109/1111 (RT = 3.08 min) were proposed as 
candicidin (Levorin) analogues A2 (3) and A3 (4; Figure 4.5), with putative molecular formulae 
of C59H48N2O18 and C59H46N2O18 respectively (δ = 3 ppm). Incidentally, candicidin is an 
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Figure 4.5: Proposed compounds isolated from RKBH-B54. *Proposed compounds causing 
 
antifungal activity from RKBH-B54. 
  
Table 4.7: Summary of pseudomolecular ions detected in Streptomyces sp. RKBH-B54 fraction 4. [F]; fungi; [B]; bacteria. 
 
 
Structure 
Number 
 
 
[M+H]
+
 
 
 
[M+Na]
+
 
 
 
 
[M+H-H2O]
+
 
 
 
 
RT (min) 
Putative 
Molecular 
Formula 
 
 
 
Plausible Compound 
 
 
 
Source 
 
 
 
Bioactivity 
 
 
 
Reference 
2 943.5304 965.5118 - 3.08 C49H78O18 Soyasaponine I [F] GT 41117 None reported Maul et al ., 1999 
 
3 
 
1109.582 
 
1131.318 
 
1091.5719 
 
3.11 
 
C59H48N2O18 
 
Candicidin; Levorin-A2 
 
[B] Streptomyces griseus, S. levoris 
Antifungal; 
antibacterial; antiviral 
Kozhuharova et al ., 2008; 
Xiang-zhao et al ., 2005 
 
4 
 
1111.5986 
 
1133.581 
 
1093.5876 
 
3.14 
 
C59H46N2O18 
 
Levorin-A3 
 
[B] Streptomyces levoris, S. helvoloviolaceus 
Antifungal; 
antibacterial; antiviral 
Kozhuharova et al ., 2008; 
Xiang-zhao et al ., 2005 
5 513.2955 535.2769 - 3.40 C29H40N2O6 Dihydromaltophilin [B] Streptomyces  sp.; Lysobacter enzymogenes Antifungal Graupner et al ., 1997 
6 511.2806 533.2625 493.2701 3.65 C29H38N2O6 Maltophilin [B] Stenotrophomonas  sp. Antifungal Jakobi et al ., 1996 
 
7 
 
511.2806 
 
533.2625 
 
493.2701 
 
3.65 
 
C29H38N2O6 
 
Alteramide A 
[B] Alteromonas  sp. collected from the sponge 
Halichondria okadai 
Murine leukemia and 
lymphoma 
 
Shigemori et al ., 1992 
8 511.2806 533.2625 493.2701 3.65 C29H38N2O6 Xanthobaccatin A [B] Stenotrophomonas  sp. strain SB-K88 Antifungal Hashidoko et al ., 1999 
9 497.3005 519.2817 - 3.65 C29H40N2O5 3-deOH-HSAF [B] Lysobacter enzymogenes Inactive against fungi Li et al ., 2012 
10 527.2756 549.2575 509.2648 3.14 C29H38N2O7 Paeciloxazine [F] Paecilomyces  sp. Nematicidal Kanai et al ., 2004 
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antifungal metabolite isolated from a Streptomyces sp. from higher Attine ants (Seipke et al., 
2011), and therefore was proposed as a likely metabolite produced by Streptomyces sp. RKBH- 
B54. Furthermore, the UV spectrum of F4 at RT = 3.08 min (λmax(MeOH) = 365, 385, 408 nm) 
displayed a UV spectrum matching the polyene class of metabolites, including the UV profile of 
candicidin (λmax(MeOH) = 360, 380, 403 nm; Seipke et al., 2011). 
 
 
 
m/z 511/513 
 
The molecular ion at m/z 513.2955 [M+H]
+ 
(RT = 3.40 min) was a match to 
dihydromaltophilin (5; Figure 4.5), an antifungal compound with the molecular formula 
C29H40N2O6 (experimental [M+Na]
+ 
535.281; calc. 535.2784; δ = -1.3 ppm) from a soil- 
inhabiting Streptomyces sp. (Graupner et al., 1997). The UV profile for dihydromaltophilin 
(λmax(MeOH) = 318 nm) shared absorption characteristics of the compound with the molecular ion 
at m/z 513.2959 (λmax(MeOH) = 324 nm). A compound with a m/z 511.2804 eluted before (RT = 
3.08 min) and after (RT = 3.65 min) the compound at m/z 513, suggesting two compounds with 
identical molecular formulae were present, yet with different polarities. Consequently, three 
plausible compounds with a chemical formula of C29H38N2O6 (calculated [M+H]
+ 
511.2809; δ = 
-1.1 ppm) were proposed: maltophilin (6), alteramide A (7), and xanthobaccin A (8; Figure 4.5). 
 
Based on an inspection of the proposed structures, alteramide A (λmax(MeOH) = 347 nm) is more 
polar than maltophilin (λmax(MeOH) = 320 nm) and xanthobaccin-A (λmax(MeOH) = 321 nm), 
although it is difficult to determine whether this compound is more polar than 
dihydromaltophilin. Alteramide A was produced by a Japanese sponge-associated Alteromonas 
sp., yet no antifungal activity was reported (HR-FAB-MS m/z 533.2629 [M+Na]
+
; Shigemori et 
al., 1992). Xanthobaccin A (λmax(MeOH) = 239, 321 nm), isolated from broth cultures of 
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Stenotrophomonas sp. from sugar beet roots, also had antifungal activity against Pythium 
ultimum at an MIC of 1 µg/mL (Hashidoko et al., 1999). Maltophilin, produced by the bacterium 
Stenotrophomonas maltophilia from the rhizophere of the plant Brassica napus (λmax(MeOH) = 320 
nm, m/z 511.28120 [M+H]
+
; Jakobi et al., 1996) was the most likely compound with m/z 511 
 
eluting at RT 3.65 min (λmax(MeOH) = 325 nm). Maltophilin is also an antifungal agent active 
against a variety of fungi, including C. albicans (Jakobi et al., 1996). Structurally, 
dihydromaltophilin and maltophilin have a similar carbon skeleton, yet differ in that maltophilin 
contains a ketone moiety while dihydromaltophilin contains a hydroxyl group at position C-14 
(highlighted by red and blue respectively in Figure 4.5). 
 
 
 
m/z 497 
 
The compound with m/z at 497.3009 was a structural match to 3-deOH-heat-stable 
antifungal factor (HSAF; experimental m/z 497.3008 [M+H]
+
) (9) with a molecular formula of 
C29H41N2O5 (δ = 0.2 ppm; Li et al., 2012). It is worthwhile mentioning that this metabolite, 
which lacks the hydroxyl moiety on the ornithine residue of dihydromaltophilin, is inactive 
against fungi (Li et al., 2012). 
 
 
 
m/z 527 
 
 
 
The nearest database match to the [M+H]
+ 
pseudomolecular ion at m/z 527.2756 (RT = 
 
3.14 min) was paeciloxazine (10), a nematicidal compound isolated from the fungi Paecilomyces 
sp. (δ = -0.5 ppm; Kanai et al., 2004). This compound was the only match in the database which 
was within the accepted 5 ppm range, yet since these compounds are not biosynthetically related, 
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it is unlikely that this metabolite was produced by Streptomyces sp. RKBH-B54 and therefore 
may be a novel compound. 
 
 
 
Purification of compounds causing antifungal activity in RKBH-B54 
 
Consequently, the next logical step in the purification process was to target which 
metabolite(s) may be the most likely antifungal agent produced by Streptomyces sp. RKBH-B54. 
This was required to determine if the metabolite of interest was present in sufficient quantities to 
enable further purification. Based on database matches and a review of the literature, the 
compounds proposed to be responsible for the antifungal activity from RKBH-B54 are 
dihydromaltophilin (m/z 513, RT = 3.40 min) and/or maltophilin (m/z 511, RT = 3.65 min; 
Figure 4.5; Graupner et al., 1997; Jakobi et al., 1996). Evidently, these compounds were also the 
most abundant metabolites in F4 based on ELSD. Owing to the antifungal activity reported for 
both compounds (Graupner et al., 1997; Jakobi et al., 1996), it is possible that both compounds 
may be acting against C. albicans in a synergetic fashion. The suggestion that 
dihydromaltophilin and maltophilin were both produced by Streptomyces sp. RKBH-B54 is 
further supported by the report which also reports that a soil-isolated Streptomyces sp. is capable 
of producing both dihydromaltophilin and maltophilin simultaneously (Graupner et al., 1997). 
 
A wealth of literature also reports the production of candicidin (the proposed compound 
for [M+H]
+ 
ions at m/z 1109 and 1111), an antifungal metabolite produced by Streptomyces sp., 
(Haeder et al., 2009; Seipke et al., 2011) and therefore may also be contributing to the observed 
antifungal activity from Streptomyces sp. RKBH-B54 at least in part. However, this compound 
was not pursued further because of the complexity of the chromatographic profile at RT = 3.08 
min in addition to the lower quantities as indicated by ELSD. Although the antifungal 
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compound(s) from RKBH-B54 may have already been published, it is virtually impossible to 
determine the true identity of the compound without structural elucidation via NMR. However, 
the strong and reproducible bioactivity of the metabolite(s) in crude aqueous extracts made it an 
excellent target for downstream analysis, for example, to provide a standard for precursor 
feeding experiments. Therefore, it was rationalized that the purification of the antifungal 
compound(s) from RKBH-B54 is a worthwhile pursuit. 
The next step in the purification process was to purify the antifungal compound(s) from 
F4. Prior to HPLC separation, a C18 SPE fractionation was performed since salts were originally 
suspected to be present based on the high ELSD signal in the solvent front of this fraction 
(Figure 4.4B). Biological activity screening of the C18 SPE fractions revealed F3 (21.92 mg) 
was at least four times more active than other fractions (Table 4.8). Although the 
pseudomolecular ion for the plausible antifungal metabolite candicidin ([M+H]
+ 
= 1109/1111) 
 
could no longer be detected at this stage based on the absence of the characteristic three-peak UV 
profile, the presence of the plausible antifungal metabolites at m/z 511 and 513 could be detected 
(Figure 4.6A – C). 
An aliquot of the crude extract (―Trial 1‖) was chromatographed on a C18 column by RP- 
HPLC. In total, six fractions were generated: F1: 0.87 mg; F2: 2.21 mg; F3: 8.57 mg, yellow 
powder; F5: 1.19 mg; HPLC Tail: 1.11 mg (Figure 4.7). Following the first round of RP-HPLC 
purification in Trial 1, UPLC/HRMS analysis confirmed that HPLC F3 contained the compounds 
with m/z 513 (RT = 3.40 min) and m/z 511 (RT = 3.65 min; Figure 4.8) which eluted close in 
retention time as can be seen in the ELSD chromatogram. At this stage, the remainder of the C18 
SPE fraction F3 was purified in HPLC Trial 2 to increase the amount of material for purification. 
  
Table 4.8: Biological activity of C18 Sepak fractions from RKBH-B54 against C. albicans. Percent inhibitions are recorded in µg/mL. 
 
Dilutions from fractions 1 – 6 range from 250 to 0.2 µg/mL; 100% MeOH extract concentrations range from 250 – 7.8 µg/mL; H 
fraction bioactivities range from 1 g to 31.3 µg/mL. 
 
% 
Inhibition 
 
 100%  
MeOH 
 
MeOH 
 
MeOH 
 
MeOH 
 
MeOH d5 
B54_C18  
H2O 
 
H2O 
 
H2O 
 
H2O 
 
H2O MeOH H2O (1g) 
(100) d1 (100) d2 (100) d3 (100) d4 (100) (100) (99) d1 (93) d2 (46) d3 (17) d4 (0) d5 (0) 
F1 100 100 100 100 99 95 38 21 8 0 0 0 
F2 100 100 100 100 100 97 35 22 11 0 0 0 
F3 100 100 100 100 100 100 100 97 71 17 0 0 
F4 100 100 100 100 99 14 5 6 0 0 0 0 
F5 89 85 17 11 3 7 15 9 6 3 0 0 
F6 100 100 100 100 100 71 27 14 14 4 2 0 
µg/mL 250.0 125.0 62.5 31.3 15.6 7.8 3.9 1.95 0.98 0.49 0.24 0.12 
 100 100 100 -21 16 6 87 100 100 22 5 -16 
Nystatin 
percent 
inhibition 
6.4 3.2 1.6 0.8 0.4 0.2 
 
 
≥80% inhibition 
>60-80% inhibition 
Organism with Samples 
Blank 
Organism blank 
Organism with Antibiotic 
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Figure 4.6: UPLC/HRMS profile of RKBH-B54 (C18 Sepak SPE F3) demonstrating A) UV 
(PDA), including λmax(MeOH) values; B) ELSD; C) MS; showing [M+H]
+ 
pseudomolecular ions at 
highlighted retention times. 
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Figure 4.7: HPLC trace of purification Trial 1 of RKBH-B54 – F4. Shown are the collected 
 
fractions generated over a 25-minute run. UV (mAU) was monitored at 220 nm (blue), 254 nm 
(green), and 325 nm (red). The ELSD (mVolts) trace is shown in black. 
  
 
 
 
Figure 4.8: UPLC/HRMS profiling of HPLC fraction 3 from RKBH-B54: Trial 1. A) UV; B) ELSD; C) MS showing [M+H]
+
 
 
pseudomolecular ions. Note the abundance of the polar metabolite(s) at RT 0.47 min in (B). 
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 In total, six fractions were generated: F1: 1.79 mg (yellow powder), F2: 0.66 mg; F3: 2.05 mg; 
F4: 0.41 mg; F5: 0.28 mg (yellow powder); HPLC Tail: 0.43 mg (Figure 4.9). In this case, 
UPLC/HRMS profiling revealed that F5 contained compounds with m/z 513 [M+H]
+ 
(RT = 3.51 
min), 493 [M+H]
+ 
(RT = 3.69 min), and 511 [M+H]
+ 
(RT = 3.69 min; Figure 4.10). 
 
Unfortunately, efforts to purify the antifungal component from RKBH-B54 resulted in 
apparent compound degradation. Although extensive efforts were taken to ensure sample care 
(storage of dried extracts at -80°C in glass amber vials), the likely compounds responsible for 
antifungal activity from RKBH-B54 (m/z 513.2955 [M+H]
+ 
and/or 511.2804 [M+H]
+
) were no 
longer detected or were detected in low abundance based on UPLC/HRMS following short-term 
storage and/or RP-HPLC purification (Figure 4.8). However, ELSD and HRMS analysis from 
HPLC Trial 1 and Trial 2 showed the metabolites at m/z 511 and 513 were greatly reduced in 
quantity following short-term storage or following HPLC purification. Subsequent UPLC/HRMS 
analyses confirmed this suspicion. For example, metabolites originally abundant based on ELSD 
were subsequently located in the injection peak at a retention time of 0.46 minutes, which likely 
was the breakdown product of the proposed tetramic acid (Figure 4.9 – 4.10). In addition, the 
targeted compounds at m/z 511 and 513 (RT = 3.40 min and 3.65 min) displayed a weak 
detection based on ELSD. However, a molecular formula could not be proposed for this 
compound as the system is not calibrated to record data until 1 minute following sample 
injection. Confidence was assumed in suspecting this metabolite was the breakdown product, 
however; where the possibility that this was salts was eliminated owing to the extensive desalting 
steps (rinsing with water on two separate occasions followed by C18 SPE) employed in the 
investigation. The reduction in abundance of these compounds based on ELSD coincided with a 
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Figure 4.9: HPLC purification of RKBH-B54 100% MeOH extract: Trial 2. Fractions were collected at timed intervals as highlighted 
 
above. UV was monitored at (A) 220 nm and (B) 325 nm. ELSD (C) was used to monitor the abundance of each fraction. 
287  
 
 
 
 
 
Figure 4.10: UPLC/HRMS profile of HPLC-purified F5 from RKBH-B54. A) UV; B) ELSD; C) MS. Note the reduced abundance of 
 
the suspected tetramic acid dihydromaltophilin/maltophilin. 
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total elimination of biological activity against C. albicans.  Although the reasoning behind why 
the antifungal agent degraded so quickly cannot be comprehended at this time, the instability of 
tetramic acids has been documented previously, both dried and in solution, and appears to 
involve self-catalyzed aldol condensations (Dittmer et al., 2010). In addition, the polyenic 
chromophore of the related tetramic acid candicidin is sensitive to oxidative degradation 
(Waksman et al., 1965), which may explain the rapid degradation of the compound at least in 
part. At this stage, there was an insufficient amount of material to continue purification. 
 
 
 
Solubility is a recurring theme in the macrolactam class of antifungals 
 
In addition to instability, solubility issues were also encountered when working with this 
class of metabolite. For example, the compound was soluble only in a mixture of H2O/MeOH 
(~1:3) or DMSO and was insoluble in organic solvents (e.g. EtOAc, ACN, acetone). 
Incidentally, solubility was also a factor for dihydromaltophilin (Graupner et al., 1997), 
maltophilin (Jakobi et al., 1996), and candicidin (Waksman et al., 1965). Each compound was 
virtually insoluble in all organic solvents, yet the addition of 10 – 15% H2O to MeOH greatly 
increased the solubility (Graupner et al., 1997; Waksman et al., 1965), a feature which was also 
observed in the present report. The poor solubility of dihydromaltophilin was attributed to the 
free base, in addition to the possible presence of conformational isomers in solution (Graupner et 
al., 1997). The insolubility of the compound from RKBH-B54 in organic solvents may also 
explain some of the difficulty to establish proper HPLC conditions for their purification. 
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Dihydromaltophilin likely targets fungal sphingolipids by a novel mechanism of action 
 
Structurally, dihydromaltophilin and related compounds belong to an emerging class of 
polyketide antibiotics containing a macrolactam and a tetramic acid (Graupner et al., 1997; Lou 
et al., 2011). Tetramic acids demonstrate a variety of biological activities ranging from 
antimicrobials, to antivirals, to cytotoxic agents (Lowery et al., 2009). Some information 
regarding their mechanism of action against fungi is known. In particular, dihydromaltophilin, 
also referred to as heat-stable antifungal factor (HSAF; Li et al., 2006), appears to act by a novel 
mechanism of action which involves inducing cell wall thickening in a diverse array of fungi (Li 
et al., 2009). The thickened cell wall negatively affects fungal hyphal growth, the latter of which 
is mediated by sphingolipid biosynthesis; therefore, authors suggest that dihydromaltophilin acts 
via a disruption of the sphingolipid biosynthesis (Li et al., 2006). This is significant from a 
medical standpoint, as fungal sphingolipids appear to be absent or are distinct from mammals 
and plants and therefore offers an attractive alternative for treating fungal infectious disease (Li 
et al., 2006; Lou et al., 2011). 
 
 
 
Tetramic acids are produced by a single module hybrid PKS/NRPS 
 
On a molecular level, tetramic acids appear to be produced by an unusual hybrid iterative 
polyketide synthase-nonribosomal peptide synthase (PKS/NRPS), a feature which is not 
uncommon in fungi yet was not previously recognized in prokaryotes (Blodgett et al., 2010; Lou 
et al., 2011). Through genome mining, Clardy and co-authors determined that this single module 
hybrid PKS/NRPS was conserved in both Gram positive and Gram negative bacteria, including 
Streptomyces spp. (Blodgett et al., 2010) and Lysobacter enzymogenes strain C3 (formerly 
Stenotrophomonas maltophilia, Lou et al., 2011). Genetic evidence supports the production of 
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dihydromaltophilin by the PKS/NRPS pathway. For example, the biosynthetic genes involved in 
dihydromaltophilin contained four open reading frames, including one for a hybrid PKS/NRPS, a 
sterol desaturase, a ferredoxin reductase, and an arginase. Gene mutants devoid of ferredoxin 
reductase and arginase maintained the ability to produce dihydromaltophilin with no real impact 
on yield. Conversely, sterol desaturase-disrupted mutants did not contain dihydromaltophilin, yet 
produced two other metabolites which were active in antifungal assays (Yu et al., 2007). 
However, dihydromaltophilin could no longer be produced in PKS/NRPS-disrupted mutants (Yu 
et al., 2007). 
Bioactive tetramic acids have been identified from a variety of organisms, including 
Streptomyces spp. isolated from various terrestrial and marine sources including Attine ants 
(Blodgett et al., 2010; Haeder et al., 2009; Seipke et al., 2011), soil (Graupner et al., 1997), the 
plant-derived bacteria Stenotrophomonas maltophilia (Jakobi et al., 1997), and the marine 
sponge Discodermia dissoluta (Gunasekera et al., 1990). The wide distribution of tetramic-acid 
containing antifungal compounds in a diverse selection of microorganisms suggests that these 
molecules are an important group of compounds involved in microbial interactions (Li et al., 
2009). Furthermore, the report of a marine-isolated Streptomyces sp. described herein to likely 
produce bioactive tetramic acid(s) develops intriguing questions: was this isolate washed from 
the terrestrial environment into the sea, ingested by the coral accidentally, and maintained owing 
to its antifungal benefits? This hypothesis, where marine bacteria may be of terrestrial origin, has 
been addressed previously (Jensen and Fenical, 1994) and this report has provided evidence that 
a marine-isolated Streptomyces sp. is likely capable of producing similar antifungal compounds 
to those reported from terrestrial-isolated Streptomyces sp. This thesis is the first report to 
document that a bacterium isolated from an octocoral may be producing maltophilin derivatives. 
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CONCLUSIONS AND SIGNIFICANCE 
 
 
This thesis has demonstrated that Gammaproteobacteria and Actinobacteria isolated from 
the Bahamian octocoral P. elisabethae are capable of selectively and reproducibly inhibiting 
pathogenic Gram positive bacteria and fungi respectively. By incorporating salt and HP-20 resin, 
in fermentation media, the results have shown that the likelihood of detecting antimicrobial 
activity in fermentation extracts increased. Specifically, BFM3 and mMB + HP-20 were 
recommended as media to utilize in subsequent fermentations owing to the higher number of 
isolates with bioactivity when fermented in these media. Specifically, several genetically and 
chemically related Pseudoalteromonas spp. were cultured from P. elisabethae, where 
fermentation extracts were active against the Gram positive organisms MRSA and VRE. 
Fermentation extracts from Streptomyces sp. RKBH-B54 also demonstrated significant 
antifungal activity against C. albicans. After comparing UV spectra, HRMS data, and following 
bioassay guided fractionation, chemical profiling revealed that the most likely antifungal 
compound(s) produced by Streptomyces sp. RKBH-B54 were a series of related tetramic acids, 
notably dihydromaltophilin and maltophilin. However, owing to its rapid degradation, efforts to 
purify the antifungal component were unsuccessful. 
 
This investigation has led to the formulation of several additional questions, notably 
resolving around the perceived compound degradation – what measures can be taken to improve 
the stability of the compound? Future investigations can expand on the biological activities of 
coral-associated bacteria by including assays such as those which test for anti-algal activity, 
probiotic activity, or anticancer activity. In addition, the possible ecological role of Streptomyces 
sp. RKBH-B54 in the host could be addressed by testing extracts for activity against Aspergillus 
sydowii, the fungal pathogen which appears to be responsible for causing coral mortality via 
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aspergillosis (Alker, 2001; Rypien, 2008). Previous investigations have shown that 
dihydromaltophilin is capable of inhibiting Aspergillus nidulans, and since dihydromaltophilin 
was suspected to be an isolated product from Streptomyces sp. RKBH-B54, it is highly likely 
that the compound isolated in this investigation demonstrates additional bioactivity against 
marine fungal pathogens. Although this report has provided evidence that bacteria isolated from 
P. elisabethae are capable of producing antimicrobial agents, whether or not the natural product 
stimulation is produced in the coral‘s natural habitat is yet to be understood. 
 
Finally, feeding experiments are underway in the Kerr lab to determine if RKBH-B54 
titers can be increased by the addition of the amino acid ornithine, which is naturally 
incorporated into the lactam in dihydromaltophilin (Lou et al., 2011). Ornithine appears to be a 
significant feature involved in the biosynthesis of dihydromaltophilin and is also critical in 
antifungal activity (Lou et al., 2011; Li et al., 2012). Specifically, the hydroxyl moiety in the 
residue at the C3 position appears to be vital to bioactivity, as knock-out studies of the sterol 
desaturase gene (involved in 3-hydroxylation) demonstrated that HSAF lost antifungal activity in 
the mutant compound (Li et al., 2012). However, although the significance of the ornithine 
residue in antifungal activity has been established, it is not known whether the yield of the 
antifungal compound can be improved by the adding ornithine to the fermentation media. Hence, 
investigations of increasing the supply of the antifungal agent can dramatically affect the 
possibility of marketing the compound through clinical trials. 
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CHAPTER V 
CONCLUSIONS AND PERSPECTIVES 
The main objective of this study was to investigate the bacterial diversity and the 
biomedical potential of natural products derived from bacterial fermentation extracts from the 
alcyonacean octocoral Pseudopterogorgia elisabethae. To achieve this goal, three studies were 
performed: 1) the bacterial community was analyzed using culture-independent next generation 
pyrosequencing, 2) the cultivable bacterial diversity from P. elisabethae was assessed using a 
diverse selection of isolation media to maximize the number of phylogenetically unique isolates, 
and 3) fermentation extracts from the cultivable bacterial community were analyzed for natural 
products via antimicrobial screening, followed by bioassay-guided purification of an antifungal 
compound(s). 
 
Despite the plethora of information regarding scleractinian-associated bacterial diversity, 
very little is known regarding bacterial diversity in octocorals. Specifically, no investigation has 
studied the bacterial community of the commercially important octocoral P. elisabethae. 
Consequently, the first research objective sought to answer the following questions: is the 
bacterial diversity of P. elisabethae conserved within individuals on the same reef? How 
comparable is the bacterial community between individuals across reefs and throughout the 
Bahamas, and how do these communities compare to the surrounding seawater? Based on 
general findings from scleractinian-associated bacteria, this thesis hypothesized that the bacterial 
community of P. elisabethae would be conserved both within and between reefs in the Bahamas, 
yet would be distinct from the surrounding seawater as other studies have suggested (Rohwer et 
al., 2001; Sweet et al., 2011). To answer these questions, coral-associated bacterial communities 
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were analyzed by bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP) from triplicate 
corals each collected from four regions in the Bahamas. 
 
The results were unexpected: the 16S rRNA gene sequence community in P. elisabethae 
individuals was variable both at the class (OTU0.10) and at the species level (OTU0.03) as 
demonstrated by community composition and principal component analysis respectively. 
Contrary to the hypothesis, these results clearly suggested that bacterial communities were 
distinct both within and across reefs in the Bahamas, and therefore suggest that the coral may be 
obtaining bacteria which offer distinct physiological advantages in the local environment. In 
general, however, Gammaproteobacteria, Cyanobacteria, and Alphaproteobacteria were 
consistently dominant in both coral and water-associated bacterial libraries, while an unclassified 
bacterial phylum phylotype was particularly abundant in gDNA-derived pyrosequencing 
libraries. Interestingly, Alphaproteobacteria appeared to be the most phylogenetic diverse at the 
species level, while Gammaproteobacteria, Cyanobacteria, and Flavobacteria were dominated by 
closely related phylotypes. Dominant OTU0.03s in bTEFAP did not necessarily reflect the most 
dominant DGGE retrieved band sequences, however, and did not reflect the numerical 
abundance of Alphaproteobacteria or Gammaproteobacteria as seen in bTEFAP sequence 
libraries, although the most dominant retrieved bands were most closely related to 
Prochlorococcus marinus (NR028762.1)/Synechococcus sp. However, one DGGE band 
sequence corresponded to the bTEFAP sequence RKPE23, which due to its low sequence 
identity to its nearest cultured GenBank representative (80% sequence identity to Mycoplasma 
alkalescens) may represent a candidate bacterial phylum. Interestingly, RKPE23 was most 
closely related to an uncultured phylotype from the closely related octocoral Gorgonia ventalina 
(Gven_K23, 98% sequence identity). These appeared to be novel, octocoral-specific bacterial 
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phylotypes which have as-of-yet no cultured representative. In addition, the phylotype RKPE1 
may represent a candidate bacterial class, which shared only 91% sequence homology to the 
reference strain Endozoicomonas elysicola. Similarly, this phylotype was most similar (98% 
sequence identity) to a G. ventalina clone RKPE1. These phylotypes (RKPE1 and RKPE23) 
were particularly abundant in gDNA-derived bacterial pyrosequencing libraries from P. 
elisabethae. These phylotypes were not detected in the surrounding seawater. Based on the 
apparent novelty of these phylotypes, which have only been reported from two other octocorals 
G. ventalina and Eunicella cavolini (Sunagawa et al., 2010; unpublished), the first research 
objective demonstrated that P. elisabethae provides a uniquely specialized habitat for potentially 
novel groups of marine bacteria. Furthermore, based on the highly variable biological diversity 
of the associated prokaryotic community, it was proposed that P. elisabethae associated bacteria 
offers a new and diverse resource for natural product drug discovery. 
 
Based on the discovery that P. elisabethae harbours a diverse prokaryotic community, the 
 
second research goal aimed to cultivate P. elisabethae-associated bacteria. The goal in 
 
cultivating coral associated bacteria was to generate an isolate library suitable for subsequent 
drug discovery. This thesis hypothesized that a diverse selection of media, in combination with 
the particle filtration technique, would aid in increasing the number of phylogenetically unique 
cultivable bacteria. Furthermore, the objective was to use MALDI-TOF MS as a means to 
dereplicate cultivable isolates, a methodology which was previously conducted on sponge- 
associated bacteria but had not yet been published as a tool to dereplicate coral associated 
bacteria. It was hypothesized that MALDI-TOF MS would be a reliable and rapid means with 
which to dereplicate coral-associated bacterial isolates from P. elisabethae. Finally, the cultured 
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bacterial community of P. elisabethae was compared to the culture-independent bacterial 
community to determine the overlap of bacteria using molecular and traditional techniques. 
 
The aerobic cultivation efforts on fresh and frozen P. elisabethae homogenates yielded a 
total of approximately 826 bacterial isolates from three collection sites and two collection times. 
Owing to its rapidity, ease of use, and ability to reliably differentiate closely related isolates, it 
was demonstrated that whole-cell bacterial in-tact MALDI-TOF MS could be successfully used 
as a tool to dereplicate octocoral-associated bacteria. Numerically, Gammaproteobacteria 
represented the most abundant isolates at the class level corresponding to 55% of the total 
isolates retrieved, followed by Alphaproteobacteria (17%), Bacilli (11%), Actinobacteria (10%), 
and Flavobacteria (2%). In addition, the cultivation efforts yielded seven potentially novel 
bacterial genera based on BLAST sequence comparisons to characterized 16S rRNA gene 
sequences, thus confirming the hypothesis that P. elisabethae harbors unique bacterial species. 
According to the phylogenetic analysis, however, cultures obtained from fresh coral homogenate 
were biased towards Gram negative bacteria, while isolation efforts from frozen coral 
homogenate were more selective for isolating low GC and Gram positive bacteria. Based on 
these results, it was proposed that freezing coral homogenate prior to plating adds a unique 
benefit in increasing the number of phylogenetically distinct bacteria, allowing for the selective 
isolation of low GC and Gram positive bacteria. Conserved between year, site, and homogenate 
type (fresh vs. frozen) were isolates most closely related to Bacillus sp., Micrococcus sp., and 
Pseudomonas sp. (Figure 3.5). Their presence between collection time and across sites in the 
Bahamas indicates that these phylotypes may be important symbiotic members in the P. 
elisabethae holobiont. 
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Sequences generated from dereplicated isolates were clustered at OTU0.03 with 
pyrosequencing data, where it was hypothesized that all isolate sequences would have a 
comparable OTU0.03 generated by pyrosequencing. Although difficulties in DNA extractions 
prevented pyrosequencing of the majority of 2009-collected corals, a comparison of P. 
elisabethae cultures to pyrosequence data provides a general overview of the overlap of the 
bacterial communities described by these two techniques. Cross-correlation of bTEFAP 
sequences to bacterial isolate sequences revealed a 0.44% overlap of cultures to bTEFAP 
sequences at OTU0.03. Hence, the results clearly demonstrated bacterial diversity was 
underrepresented by cultivation. Surprisingly, the cultivable bacterial community of P. 
elisabethae demonstrated that Alphaproteobacteria were almost exclusively represented by 
Ruegeria sp., Gammaproteobacteria were represented by a more diverse group of cultured 
representatives (Alteromonas sp., Pseudoalteromonas sp., and Vibrio sp.), while no cultured 
representatives of Cyanobacteria were detected. This result contrasted with the bTEFAP 
analysis, which demonstrated Alphaproteobacteria represented the highest phylotype diversity 
while Gammaproteobacteria and Cyanobacteria were comprised of several closely-related 
phylotypes at the species level. Furthermore, the most abundant cultures from P. elisabethae did 
not have a comparable bTEFAP representative sequence. For example, although Vibrio spp. 
dominated the cultivable bacterial community, many did not have a comparable OTU0.03 in the 
pyrosequencing data generated from 14 corals. No octocoral-specific bacteria (e.g. RKPE1 and 
RKPE23-related phylotypes) were cultured using the methodologies described in this thesis. 
Although it is unusual that the most abundant bacteria from bTEFAP did not overlap with the 
most numerous bacteria from cultivation, the lack of congruence between culture-dependent and 
molecular techniques is a trend which has been repeatedly documented in the literature 
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(Galkiewicz et al., 2011; Gray et al., 2011; Meron et al., 2011), affirming that using both 
techniques is vital to uncovering the true bacterial diversity. From the second research objective, 
it was concluded that not only was MALDI-TOF MS able to suitably dereplicate coral-associated 
bacteria, but the discovery of potentially novel cultivable bacterial species suggested that P. 
elisabethae-associated bacteria are a unique resource for natural product investigations.  Isolates 
were also screened against pseudopterosin G (PsG) with the aim of determining the antimicrobial 
activity against ecologically relevant bacteria residing within the coral. This is due to the fact that 
pseudopterosins from Colombian and Bahamian collected P. elisabethae have selective activity 
against Gram positive bacteria (Ata et al., 2004; Correa et al., 2011). This investigation revealed 
that while Gram negative bacteria were largely unaffected by PsG, Gram positive bacteria were 
highly susceptible, where the growth of 88% of Gram positive bacteria were inhibited. In 
addition, isolates were tested for salinity requirements to add to the scientific understanding of 
bacteria isolated from marine invertebrates which are dependent on seawater for growth. These 
results suggested Gram negative bacteria were far more likely to require seawater to remain 
viable than Gram positive bacteria. 
Although the octocoral P. elisabethae is a well-characterized source of antibacterial 
diterpenes (Ata et al., 2004; Correa et al., 2009), its associated microbial community has not 
been assessed for natural product production.  Results from objective two led to evaluating the 
ability of P. elisabethae-associated bacteria to produce secondary metabolites. Hence, the third 
research objective was to discover new antimicrobial agents from coral-associated bacterial 
 
extracts. It was theorized that isolates from P. elisabethae will be unique to the host, and 
therefore the likelihood that finding similar microorganisms from another host will be greatly 
reduced. The ability of coral associated bacteria to produce natural products was assessed by 
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testing bacterial extracts for antimicrobial activity against a panel of clinically relevant 
pathogens. 
As expected, the majority of isolates affected by the addition of PsG to the media were 
Gram positive, with 44.7% of Gram positive isolates inhibited while 18.4% were sensitive at 50 
mg/L PsG, while Gram negative bacteria were largely unaffected at all PsG concentrations 
tested.  In contrast, the majority of isolates (57.1%) from P. elisabethae were considered 
―marine‖, based on their dependency on MA (salt-containing media) for growth. Interestingly, 
the results suggested that Gram negative bacteria were more likely to require sodium chloride for 
successful growth and viability, where 86.8% of Gram negative isolates required salt for growth 
in comparison to only 28.9% of Gram positive bacteria. These studies have increased our 
understanding of the ability of natural products to affect particular associated bacteria and have 
further enhanced our knowledge regarding salinity dependencies of bacteria isolated from marine 
sources. 
In the investigation on coral-associated bacterial extracts demonstrating antimicrobial 
activity, the results showed that Pseudoalteromonas sp. RKVR-02, RKVR-07, RKVR-20, and 
RKVR-34 and Streptomyces sp. RKBH-B54 were capable of selectively and reproducibly 
inhibiting pathogenic Gram positive bacteria and fungi respectively. Acetonitrile extracts from 
the chemically and genetically related Pseudoalteromonas sp. (RKVR-02, RKVR-07, and 
RKVR-34) demonstrated reproducible inhibition against the Gram positive bacteria MRSA and 
VRE when grown in M11. Pseudoalteromonas sp. RKVR20 (maroon pigmented) demonstrated 
moderate activity against MRSA when extracted from seed media (MB), yet extracts were 
inactive when grown in fermentation media. 
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Owing to its potent and reproducible antifungal activity against Candida albicans, 
RKBH-B54 was prioritized for large scale fermentation and bioassay guided fractionation. After 
comparing UV spectra and HRMS data, chemical profiling revealed that the most likely 
antifungal compound(s) produced by Streptomyces sp. RKBH-B54 belonged to related tetramic 
acids. For example, the pseudomolecular ion at 513.29547 [M+H]
+ 
was a match to 
dihydromaltophilin, an antifungal compound previously reported from a soil-inhabiting 
Streptomyces sp. with the molecular formula C29H40N2O6 (Graupner et al., 1997). Secondly, the 
pseudomolecular ion at m/z 511.29651 [M+H] 
+ 
was a match to maltophilin (Jakobi et al., 1996), 
 
a compound reported from a Gram negative bacterium. However, reverse-phase HPLC of these 
related metabolites was difficult owing to their virtually identical retention times. Furthermore, 
despite extensive efforts in sample care, the compound(s) likely responsible for the observed 
antifungal activity in RKBH-B54 appeared to have degraded over time, and eventually the 
compounds most likely causing bioactivity were no longer detected or were detected in low 
abundance based on ELSD following short-term storage and/or RP-HPLC purification. All 
antifungal activity was lost following the disappearance/reduction of these compounds. 
Owing to the highly potent anti-fungal activity caused by extracts of RKBH-B54, this 
bacterium was targeted for additional experiments.  Feeding experiments are currently underway 
in the Kerr lab to determine if titres of the antifungal compound can be increased by the addition 
of the amino acid ornithine to the fermentation media. Ornithine is an essential precursor to 
dihydromaltophilin biosynthesis, with the hydroxyl moiety being critical in ensuring antifungal 
activity (Li et al., 2012). Although it is clear that ornithine is incorporated into the macrolactam 
unit, no study has performed detailed analysis to determine whether yields can be improved by 
supplementing the bacterium in media containing ornithine. It is also rationalized that feeding 
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arginine to the fermentation media may increase the yield of the antifungal compound, as 
ornithine is generated from the action of the enzyme arginase from arginine (Lou et al., 2011). 
Similarly, it may be possible to generate novel analogs of dihydromaltophilin by feeding 
ornithine analogs such as L-lysine, which contains an additional CH2 group in the carbon 
skeleton. Preliminary evidence suggests that supplementing fermentation media with 0.5 mg/mL 
ornithine can significantly improve the yields of the antifungal compound by up to four times. 
In summary, the present study has investigated the bacterial community and biomedical 
activities of bacterial extracts from P. elisabethae and has demonstrated that this coral contains 
an unexpectedly diverse bacterial community. Surprisingly, bacterial communities of P. 
elisabethae individuals were variable within and between reefs in the Bahamas, which were 
generally not comparable between members at both the species level (OTU0.03) and the class 
level (OTU0.10). Fermentation extracts from select members demonstrated antimicrobial activity 
against clinically relevant pathogens. This thesis has contributed to the knowledge of octocoral- 
associated bacterial communities, which has received very little attention in the literature. In 
addition, detailed bacterial species-level classification for dominant pyrosequences have been 
provided which revealed that many closely-related, likely similar phylotypes were retrieved. 
Consequently, future investigators may consider using a less conservative taxonomic clustering 
at OTU0.04 as proposed by Kim et al. (2011). In addition, this study characterized the 
antimicrobial potential of fermentation extracts from Pseudoalteromonas spp. and Streptomyces 
sp. isolated from P. elisabethae, which were bioactive against Gram positive bacteria and yeast 
respectively.  Future studies may benefit from the information acquired from this thesis in a 
variety of ways. For example, the data generated from this investigation can be used to compare 
to other investigations of octocoral and stony coral-associated bacteria. This knowledge can be 
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used to guide culturing programs, as knowing which bacteria are present can assist targeting 
efforts for specific groups of bacteria. In addition, determining if the P. elisabethae isolates 
Pseudoalteromonas sp. and Streptomyces sp. are capable of producing their respective 
antimicrobial compounds in vivo would also suggest the ecological relevance of these bacteria in 
protecting the coral host. On-going experiments are currently being conducted in the Kerr 
laboratory to determine the location of bacteria in P. elisabethae. 
 
This study raises some intriguing biological questions. Why is the intra-individual 
variability so high in bacteria associated with P. elisabethae, and is this a trend which extends to 
other octocorals? How can we alter the global paradigm which states that less than one percent of 
bacteria can be cultured, and what information is vital to increase our ability to cultivate 
microbes? Do the cultures isolated from P. elisabethae produce natural products which have 
additional biological activities which may have been overlooked in the present investigation? 
Answers to such questions can contribute to our understanding of octocoral-associated bacterial 
communities and can provide a resource for discovering a sustainable supply of novel natural 
products. 
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Table A1: Accession numbers and nearest GenBank representatives for RKPE sequences from bTEFAP libraries. 
 
 
RKPE 
sequence 
Genbank 
Acc No 
 
 
Description 
 
 
Closest GenBank Representative 
Percent 
similarity 
RKPE1 JN411801.1 Uncultured gamma proteobacterium clone RKPE1 Uncultured bacterium clone Gven_G10 (GU118518.1) 99 
RKPE2 JN411784.1 Uncultured bacteroidetes bacterium clone RKPE2 Aquimarina sp. PSC32 (HM998909.1) 95 
RKPE3 JN411758.1 Uncultured cyanobacterium clone RKPE3 Synechococcus sp. KORDI-54 (FJ497735.1) 99 
RKPE4 JN411799.1 Uncultured proteobacterium clone RKPE4 Uncultured bacterium clone Gven_G10 (GU118518.1) 99 
RKPE5 JN411756.1 Uncultured cyanobacterium clone RKPE5 Synechococcus sp. KORDI-54 (FJ497735.1) 99 
RKPE6 JN411722.1 Uncultured proteobacterium clone RKPE6 Uncultured bacterium isolate DGGE gel band 2 (JN863712.1) 99 
RKPE7 JN411768.1 Uncultured cyanobacterium clone RKPE7 Synechococcus sp. KORDI-28 (FJ497720.1) 98 
RKPE8 JN411803.1 Uncultured gamma proteobacterium clone RKPE8 Uncultured bacterium clone Gven_PO4 (GU118455.1) 99 
RKPE9 JN411770.1 Uncultured cyanobacterium clone RKPE9 Uncultured Prochlorococcus sp. clone 97 (JN547456.1) 99 
RKPE10 JN411781.1 Uncultured bacteroidetes bacterium RKPE10 Uncultured Flavobacteriaceae bacterium clone GG101008 91 
RKPE11 JN796467.1 Uncultured alpha proteobacterium clone RKPE11 Sphingobium rhizovicinum strain CC-FH12-1 (NR_044226.1) 98 
RKPE12 JN796464.1 Uncultured alpha proteobacterium clone RKPE12 Ruegeria sp. G-M8 (JQ807219.1) 98 
 
RKPE13 
 
JX266009.1 
 
Uncultured bacterium clone RKPE13 
Uncultured bleached octocoral Rhodospirillaceae bacterium clone 
BME47 
 
99 
RKPE14 JN411798.1 Uncultured gamma proteobacterium clone RKPE14 Uncultured bacterium clone Gven_G10 (GU118518.1) 98 
RKPE15 JN411757.1 Uncultured cyanobacterium clone RKPE15 Synechococcus sp. KORDI-54 (FJ497735.1) 99 
RKPE16 JN411771.1 Uncultured cyanobacterium clone RKPE16 Uncultured Prochlorococcus sp. clone 68 (JN547449.1) 99 
RKPE17 JN411775.1 Uncultured cyanobacterium clone RKPE17 Synechococcus sp. KORDI-54 (FJ497735.1) 99 
RKPE18 JN411766.1 Uncultured cyanobacterium clone RKPE18 Uncultured bacterium clone Gven_N16 (GU118510.1) 99 
RKPE19 JN796447.1 Uncultured alphaproteobacteria bacterium RKPE19 Uncultured Brevundimonas sp. (FR657544.1) 99 
RKPE20 JN411794.1 Uncultured gamma proteobacterium clone RKPE20 Uncultured bacterium clone Gven_G10 (GU118518.1) 98 
RKPE21 JN411795.1 Uncultured proteobacterium clone RKPE21 Uncultured bacterium clone Gven_G10 (GU118518.1) 97 
RKPE22 JN796452.1 Uncultured alpha proteobacterium clone RKPE22 Uncultured bacterium clone BT60DS1BD3 (AF365701.1) 99 
 
 
RKPE23 
 
 
JN411746.1 
 
 
Uncultured bacterium clone RKPE23 
Uncultured octocoral associated bacterium clone Gven_K23 
(GU118339.1); Uncultured bacterium isolate DGGE gel band 1 
(JN863711.1) 
 
 
100 
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RKPE24 JN411767.1 Uncultured cyanobacterium clone RKPE24 Uncultured bacterium clone Gven_N16 (GU118510.1) 98 
RKPE25 JN411786.1 Uncultured proteobacterium clone RKPE25 Uncultured P. elisabethae bacterium clone PEA10 (JQ609313.1) 98 
RKPE26 JN796444.1 Uncultured alpha proteobacterium clone RKPE26 Uncultured P. elisabethae bacterium clone PEA09 (JQ609307.1) 98 
 
RKPE27 
 
JN411788.1 
 
Uncultured proteobacterium clone RKPE27 
Uncultured coral-associated bacterium clone Apal_F24 
(GU118110.1) 
 
93 
RKPE28 JN411747.1 Uncultured bacterium clone RKPE28 Uncultured bacterium clone Cyano2A11 (EU917873.1) 94 
RKPE29 JN411763.1 Uncultured bacterium clone RKPE29 Uncultured bacterium clone PoritesC32clB02 (EU636615.1) 97 
RKPE30 JN411796.1 Uncultured gamma proteobacterium clone RKPE30 Uncultured bacterium clone Gven_G10 (GU118518.1) 99 
RKPE31 JN411759.1 Uncultured cyanobacterium clone RKPE31 Synechococcus sp. KORDI-54 (FJ497735.1) 99 
RKPE32 JN411802.1 Uncultured gamma proteobacterium clone RKPE32 Uncultured bacterium clone Gven_G10 (GU118518.1) 98 
 
RKPE33 
 
JN411772.1 
 
Uncultured cyanobacterium clone RKPE33 
Prochlorococcus marinus subsp. pastoris str. PCC 9511 
(NR_028762.1) 
 
97 
RKPE34 JN796462.1 Uncultured alpha proteobacterium clone RKPE34 Ruegeria sp. MA1-6 (HQ852038.1) 99 
RKPE35 JN796455.1 Uncultured alpha proteobacterium clone RKPE35 Uncultured alpha proteobacterium (FM211779.1) 98 
RKPE36 JN411748.1 Uncultured bacterium clone RKPE36 Synechococcus sp. KORDI-54 (FJ497735.1) 99 
RKPE37 JN411724.1 Uncultured proteobacterium clone RKPE37 Pelagibius litoralis strain CL-UU02 (NR_043785.1) 97 
 
 
RKPE38 
 
 
JN411740.1 
 
 
Uncultured actinomycetales bacterium clone RKPE38 
 
Mycobacterium tuberculosis (NR_044826.1); Uncultured 
bacterium isolate DGGE gel band 4 (JN863714.1) 
 
 
99 
RKPE39 JN411726.1 Uncultured proteobacterium clone RKPE39 Uncultured bacterium isolate DGGE gel band 2 (JN863712.1) 99 
RKPE40 JN411783.1 Uncultured bacteroidetes bacterium clone RKPE40 Aquimarina sp. PSC32 (HM998909.1) 94 
RKPE41 JN411774.1 Uncultured cyanobacterium clone RKPE41 Synechococcus sp. KORDI-54 (FJ497735.1) 99 
RKPE42 JN411760.1 Uncultured cyanobacterium clone RKPE42 Synechococcus sp. KORDI-54 (FJ497735.1) 99 
 
 
RKPE43 
 
 
JN411761.1 
 
 
Uncultured cyanobacterium clone RKPE43 
 
Uncultured bacterium isolate DGGE gel band 3, 5, 7, PE3C 
(JN863718.1); Synechococcus sp. KORDI-54 (FJ497735.1) 
 
 
99 
 
RKPE44 
 
JN411728.1 
 
Uncultured alpha proteobacterium clone RKPE44 
Uncultured juvenile acroporid coral associated bacterium clone 
MC3F09 
 
99 
RKPE45 JN796460.1 Uncultured alpha proteobacterium clone RKPE45 Paracoccus zeaxanthinifaciens strain R-1506 (AF461159.1) 97 
RKPE46 JN796446.1 Uncultured alpha proteobacterium clone RKPE46 Brevundimonas terrae strain C-G-NA6 (HM755493.1) 99 
RKPE47 JN796459.1 Uncultured alpha proteobacterium clone RKPE47 Mucus bacterium from an acroporid coral (AY654761.1) 99 
RKPE48 JN411792.1 Uncultured gamma proteobacterium clone RKPE48 Pseudomonas putida (AB680123.1) 99 
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RKPE49 JN411782.1 Uncultured bacteroidetes bacterium clone RKPE49 Aquimarina sp. PSC32 (HM998909.1) 92 
RKPE50 JN411773.1 Uncultured cyanobacterium clone RKPE50 Uncultured reef water associated bacterium clone Reef_I17 99 
 
RKPE51 
 
JN411729.1 
 
Uncultured proteobacterium clone RKPE51 
Uncultured SAR11 cluster alpha proteobacterium clone 
PRTAB7855 
 
100 
RKPE52 JN411764.1 Uncultured cyanobacterium clone RKPE52 Uncultured acroporid associated bacterium clone Mfra_D07 95 
RKPE53 JN796448.1 Uncultured alpha proteobacterium clone RKPE53 Uncultured P. elisabethae bacterium clone PEA08 99 
RKPE54 JN796449.1 Uncultured alpha proteobacterium clone RKPE54 Brevundimonas vesicularis strain: NBRC 12165 (AB680247.1) 99 
 
RKPE55 
 
JX266012.1 
 
Uncultured bacterium clone RKPE55 
Uncultured marine water-associated bacterium clone 
HglFeb6H9m 
 
99 
RKPE56 JN796468.1 Uncultured alpha proteobacterium clone RKPE56 Rickettsia rhipicephali strain 3-7-6 (NR_025921.1) 99 
RKPE57 JN411727.1 Uncultured alpha proteobacterium clone RKPE57 Uncultured bacterium clone Dstr_H14 (GU118150.1) 99 
RKPE58 JN411769.1 Uncultured cyanobacterium clone RKPE58 Synechococcus sp. KORDI-28 (FJ497720.1) 98 
RKPE61 JN796445.1 Uncultured alpha proteobacterium clone RKPE61 Mycoplana bullata strain IAM 13153 (NR_025831.1) 98 
RKPE63 JN411797.1 Uncultured gamma proteobacterium clone RKPE63 Uncultured bacterium clone Gven_G10 (GU118518.1) 98 
RKPE64 JN411785.1 Uncultured bacteroidetes bacterium clone RKPE64 Aquimarina intermedia strain LMG 23204 (NR_042444.1) 94 
RKPE67 JN796465.1 Uncultured alpha proteobacterium clone RKPE67 Ruegeria sp. UloCh-03 97 
 
RKPE68 
 
JN411725.1 
 
Uncultured proteobacterium clone RKPE68 
Uncultured alpha proteobacterium clone SIMO-1536 
(AY710976.1) 
 
98 
RKPE72 JN796450.1 Uncultured alpha proteobacterium clone RKPE72 Brevundimonas vesicularis (AB680247.1) 98 
 
RKPE73 
 
JN411733.1 
 
Uncultured alpha proteobacterium clone RKPE73 
Uncultured coral associated bacterium clone Mfra_E05 
(GU118700.1) 
 
99 
RKPE78 JN411734.1 Uncultured alpha proteobacterium clone RKPE78 Uncultured bacterium clone 47-S-68 (JN018674.1) 99 
 
RKPE99 
 
JN411730.1 
 
Uncultured bacterium clone RKPE99 
Uncultured South Atlantic bacterium clone ST13_70m 
(HQ015557.1) 
 
98 
 
RKPE81 
 
JN411735.1 
 
Uncultured bacterium clone RKPE81 
Uncultured coral-associated bacterium clone Past_N22 
(GU118960.1) 
 
95 
 
RKPE82 
 
JN411723.1 
 
Uncultured proteobacterium clone RKPE82 
Uncultured Bahamian thrombolite proteobacterium clone 
Pink_2F06 (GQ483965.1) 
 
97 
RKPE84 JN796461.1 Uncultured alpha proteobacterium clone RKPE84 Uncultured coral reef sand bacterium clone Si06 94 99 
 
RKPE87 
 
JN411741.1 
 
Uncultured actinomycetales bacterium clone RKPE87 
Mycobacterium tuberculosis (NR_044826.1); Uncultured 
bacterium isolate DGGE gel band 4 (JN863714.1) 
 
99 
RKPE88 JN411732.1 Uncultured bacterium clone RKPE88 Uncultured bacterium clone S23_1425 99 
RKPE90 JN796463.1 Uncultured alpha proteobacterium clone RKPE90 Uncultured sponge associated bacterium clone en1492-89 99 
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RKPE91 JN411800.1 Uncultured gamma proteobacterium clone RKPE91 Uncultured bacterium clone Gven_G10 (GU118518.1) 98 
 
RKPE93 
 
JX266014.1 
 
Uncultured bacterium clone RKPE93 
Uncultured Hawaiian water-associated SAR11 bacterium clone 
HF0010_09016 
 
99 
RKPE95 JN796453.1 Uncultured alpha proteobacterium clone RKPE95 Uncultured alpha proteobacterium (AB294937) 97 
RKPE96 JX266010.1 Uncultured bacterium clone RKPE96 Uncultured marine bacterium clone SC5-101 (FN43560.1) 99 
 
RKPE98 
 
JN411742.1 
 
Uncultured actinomycetales bacterium clone RKPE98 
Mycobacterium tuberculosis (NR_044826.1); (Uncultured 
bacterium isolate DGGE gel band 4 (JN863714.1)) 
 
99 
RKPE99 JN411730.1 Uncultured bacterium clone RKPE99 Uncultured bacterium clone ST13_70m_clone1 (HQ015557.1) 98 
RKPE100 JN411744.1 Uncultured actinomycetales bacterium RKPE100 Streptomyces flavovirens strain CGMCC 4.575 (JQ924389.1) 99 
RKPE101 JN411731.1 Uncultured proteobacterium clone RKPE101 Uncultured SAR11 cluster alpha proteobacterium clone 124 99 
 
RKPE103 
 
JN411749.1 
 
Uncultured bacterium clone RKPE103 
Uncultured coral-associated bacterium clone Apal_K23 
(GU118137.1) 
 
94 
RKPE105 JN411790.1 Uncultured proteobacterium clone RKPE105 Uncultured bacterium clone Reef_P09 (GU119233.1) 97 
RKPE110 JN411804.1 Uncultured proteobacterium clone RKPE110 Uncultured bacterium clone Gven_G10 (GU118518.1) 98 
RKPE112 JN411779.1 Uncultured firmicutes bacterium clone RKPE112 Staphylococcus pseudointermedius LMG 22219 (NR_042284.1) 99 
RKPE114 JN411737.1 Uncultured proteobacterium clone RKPE114 Uncultured coral associated bacterium clone BT60DS1BE12 94 
RKPE115 JN411736.1 Uncultured proteobacterium clone RKPE115 Uncultured healthy coral associated bacterium clone SHFH663 98 
RKPE120 JN796466.1 Uncultured alpha proteobacterium clone RKPE120 Uncultured bacterium clone SHFH457 (FJ203421.1) 96 
RKPE121 JN411762.1 Uncultured bacterium clone RKPE121 Uncultured organism clone Apal_J16 (GU119563.1) 94 
 
RKPE091 
 
JN411800.1 
 
Uncultured gamma proteobacterium clone RKPE91 
Uncultured octocoral associated bacterium clone C9 
(JQ691583.1) 
 
98 
RKPE107 JX266011.1 Uncultured bacterium clone RKPE107 Uncultured stony coral associated bacterium JQ347383.1 99 
RKPE123 JN411789.1 Uncultured proteobacterium clone RKPE123 Uncultured hard coral bacterium clone AP37 (JQ347329.1) 99 
RKPE128 JN796454.1 Uncultured alpha proteobacterium clone RKPE128 Uncultured microbial mat bacterium (FN663015.1) 98 
RKPE130 JN411780.1 Uncultured bacteroidetes bacterium RKPE130 Uncultured coral associated bacterium cl. MHH03 (FJ216111.1) 95 
RKPE132 JN411765.1 Uncultured cyanobacterium clone RKPE132 Uncultured bacterium clone BM89PA1BbC9 97 
RKPE138 JN796457.1 Uncultured alpha proteobacterium clone RKPE138 Porphyrobacter dokdonensis (NR_043469.1) 99 
RKPE143 JN796456.1 Uncultured alpha proteobacterium clone RKPE143 Uncultured microbial mat bacterium ( FN663015.1) 98 
 
RKPE144 
 
JN411743.1 
 
Uncultured actinomycetales bacterium clone RKPE144 
Mycobacterium tuberculosis (NR_044826.1); (Uncultured 
bacterium isolate DGGE gel band 4 (JN863714.1) 
 
99 
RKPE145 JN411791.1 Uncultured proteobacterium clone RKPE145 Uncultured bacterium clone 6C232341 (EU804424.1) 99 
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RKPE150 JN411750.1 Uncultured bacterium clone RKPE150 Uncultured surface marine bacterium (FM214293.1) 90 
RKPE152 JN411751.1 Uncultured bacterium clone RKPE152 Uncultured bacterium clone APM21 (JQ347383.1) 98 
 
RKPE153 
 
JN411745.1 
 
Uncultured bacterium clone RKPE153 
Uncultured sponge associated bacterium clone BAC-E110 
(JN113072.1) 
 
97 
 
RKPE157 
 
JN411787.1 
 
Uncultured proteobacterium clone RKPE157 
Uncultured coral associated bacterium clone Apal_N19 
(GU118096.1) 
 
98 
RKPE168 JN796458.1 Uncultured alpha proteobacterium clone RKPE168 Uncultured hard coral associated bacterium clone SHFG464 98 
 
RKPE170 
 
JN796469.1 
 
Uncultured alpha proteobacterium clone RKPE170 
Uncultured diseased stony coral tissue bacterium clone SHFG464 
(FJ203077.1) 
 
98 
RKPE176 JN796470.1 Uncultured alpha proteobacterium clone RKPE176 Rickettsia rhipicephali strain 3-7-6 (NR_025921.1) 99 
 
RKPE185 
 
JN411738.1 
 
Uncultured alpha proteobacterium clone RKPE185 
Uncultured coral associated bacterium clone BT60DS1BB10 
(AF365685.1) 
 
99 
 
RKPE219 
 
JN411777.1 
 
Uncultured firmicutes bacterium clone RKPE219 
Staphylococcus aureus subsp. aureus strain S33 R 
(NR_037007.1) 
 
99 
RKPE221 JN411739.1 Uncultured actinomycetales bacterium clone RKPE221 Brevibacterium sp. EP11 (AM398220.1) 99 
 
RKPE223 
 
JN411752.1 
 
Uncultured bacterium clone RKPE223 
Uncultured bacterium clone Gven_K23 (GU118339.1); 
Uncultured bacterium isolate DGGE gel band 1 (JN863711.1) 
 
99 
 
RKPE225 
 
JN411776.1 
 
Uncultured firmicutes bacterium clone RKPE225 
Uncultured coral associated bacterium clone BM89DS6BbE6 
(AF365668.1) 
 
99 
RKPE230 JN796451.1 Uncultured alpha proteobacterium clone RKPE230 Bradyrhizobium betae strain PL7HG1 (NR_029104.1) 98 
RKPE245 JN411793.1 Uncultured gamma proteobacterium clone RKPE245 Pseudomonas aeruginosa strain R1-73 (JQ659528.1) 99 
 
RKPE250 
 
JN411753.1 
 
Uncultured bacterium clone RKPE250 
Uncultured bacterium clone Gven_K23 (GU118339.1); 
Uncultured bacterium isolate DGGE gel band 1 (JN863711.1) 
 
98 - 99 
RKPE253 JN411778.1 Uncultured firmicutes bacterium clone RKPE253 Streptococcus salivarius strain ATCC 7073 (NR_042776.1) 98 
RKPE259 JN796471.1 Uncultured alpha proteobacterium clone RKPE259 Rickettsia rhipicephali strain 3-7-6 (NR_025921.1) 99 
RKPE280 JX266015.1 Uncultured firmicutes clone RKPE280 Uncultured bacterium clone ncd2286g06c1 (JF196886.1) 99 
RKPE289 JN411754.1 Uncultured bacterium clone RKPE289 Coxiella endosymbiont of American tick (AY939824.1) 98 
 
RKPE290 
 
JN796472.1 
 
Uncultured alpha proteobacterium clone RKPE290 
Uncultured disease coral associated tissue bacterium clone 
SHFG464 (FJ203077.1) 
 
98 
RKPE311 JN411755.1 Uncultured bacterium clone RKPE311 Uncultured bacterium clone ncd763f02c1 (HM299723.1) 94 
 Indicates high sequence identity (≥98% sequence similarity) to other octocoral-associated 16S rRNA gene sequences in GenBank 
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Table B1: List of dilutions used for P. elisabethae samples for A) Bimini Site 1 and B) Bimini site 2. BS1 refers to Bimini Site 1 
 
(Victory Reef), and BS2 refers to Bimini Site 2 (Tuna Alley); A, B, and C refer to coral replicates collected at each site, while 104 and 
51 refer to screen sizes, and PF refers to particle filtrate. 
 
A) 
 
Sample Dilution 1 Dilution 2 µL/well Comments 
PE-BS1-A – 104µm Undiluted 1/10 20  
PE-BS1-A – 51 µm Undiluted 1/2 20 
PE-BS1-A-PF 1/10 1/1000 20 
PE-BS1-B – 104 µm Undiluted Undiluted 20  
PE-BS1-B – 51 µm Undiluted Undiluted 20 
PE-BS1-B-PF 1/10 1/1000 20 
PE-BS1-C – 104 µm Undiluted 1/2 20 Greater mucus content than other samples 
PE-BS1-C – 51 µm Undiluted 1/2 20 
PE-BS1-C-PF 1/10 1/1000 20 
B) 
 
Sample Dilution 1 Dilution 2 µL/well Comments 
PE-BS2-A – 104µm Undiluted 1/50 10  
PE-BS2-A – 51 µm 1/10 1/500 10 
PE-BS2-A-PF 1/100 1/1000 10 
PE-BS2-B – 104 µm Undiluted 1/50 10 Greater mucus content than other samples 
PE-BS2-B – 51 µm 1/10 1/500 10 
PE-BS2-B-PF 1/100 1/1000 10 
PE-BS2-C – 104 µm Undiluted 1/50 10  
PE-BS2-C – 51 µm 1/10 1/500 10 
PE-BS2-C-PF 1/100 1/1000 10 
 
 
 
 
 
321 
322  
Table B2: GenBank accession numbers for bacteria cultivated from P. elisabethae. Replicate and 
 
Filters and replicates are applicable only to 2009-collected corals. Site 1, Victory Reef; Site 2, 
Tuna Alley. (2009); SS, San Salvador (2008). 
 
Isolate Organism Acc No. Site Replicate 
(2009) 
Particle 
size 
(2009) 
V8 Microbacterium sp. isolate RKVR_V8 JX317705 1 A PF 
RKVR37 Bacillus sp. isolate RKVR37 JX317714 1 B 51 
B20 Vibrio sp. isolate B20 JX407128 1 C 51 
B27 Pseudoalteromonas sp. isolate B27 JX407132 1 C 51 
B3 Pseudoalteromonas sp. isolate B3 JX407133 1 B 51 
B30 Ruegeria sp. isolate B30 JX407134 1 B PF 
B36 Pseudoalteromonas sp. isolate B36 JX407135 1 C 51 
B48 Alteromonas sp. isolate B48 JX407136 1 A 51 
B6 Pseudoalteromonas sp. isolate B6 JX407138 1 A PF 
B9-1 Pseudoalteromonas sp. isolate B9-1 JX407141 1 C 104 
B9-2 Pseudoalteromonas sp. isolate B9-2 JX407142 1 C 104 
C8 Alteromonas sp. isolate C8 JX407147 1 A 51 
D1 Ruegeria sp. isolate D1 JX407149 1 C 51 
D2 Vibrio sp. isolate D2 JX407160 1 B PF 
D27 Ruegeria sp. isolate D27 JX407162 1 A PF 
D28 Ruegeria sp. isolate D28 JX407163 1 B PF 
D3 Vibrio sp. isolate D3 JX407164 1 B 51 
D41 Vibrio sp. isolate D41 JX407170 1 A 51 
D42 Pseudoalteromonas sp. isolate D42 JX407171 1 C 51 
D47 Vibrio sp. isolate D47 JX407172 1 A PF 
D50_W Ruegeria sp. isolate D50_W JX407175 1 B 51 
D55 Vibrio sp. isolate D55 JX407180 1 B 51 
D59 Vibrio sp. isolate D59 JX407181 1 A 51 
D6 Vibrio sp. isolate D6 JX407182 1 C PF 
D62 Ruegeria sp. isolate D62 JX407184 1 B 51 
D68 Vibrio sp. isolate D68 JX407186 1 B 51 
D7 Vibrio sp. isolate D7 JX407187 1 B PF 
D74 Vibrio sp. isolate D74 JX407190 1 B 51 
D77 Vibrio sp. isolate D77 JX407192 1 B 51 
D78 Vibrio sp. isolate D78 JX407193 1 C PF 
D81 Pseudoalteromonas sp. isolate D81 JX407195 1 B 51 
G11 Ruegeria sp. isolate G11 JX407197 1 C PF 
G20 Pseudoalteromonas sp. isolate G20 JX407200 1 C 51 
G24 Ruegeria sp. isolate G24 JX407202 1 A 51 
323  
 
G29 Ruegeria sp. isolate G29 JX407205 1 C 51 
G3 Vibrio sp. isolate G3 JX407206 1 B 51 
G5 Pseudoalteromonas sp. isolate G5 JX407207 1 A 104 
G6 Ruegeria sp. isolate G6 JX407208 1 A PF 
G7 Ruegeria sp. isolate G7 JX407209 1 C PF 
G8 Ruegeria sp. isolate G8 JX407210 1 B PF 
U1 Pseudoalteromonas sp. isolate U1 JX407216 1 A 51 
U5 Ruegeria sp. isolate U5 JX407217 1 A PF 
U11 Shewanella sp. isolate U11 JX407218 1 B 51 
V5 Pseudoalteromonas sp. isolate V5 JX407221 1 B 51 
V1 Vibrio sp. isolate V1 JX407222 1 A PF 
RKVR02 Pseudoalteromonas sp. isolate RKVR02 JX407229 1 C PF 
RKVR03 Pseudoalteromonas sp. isolate RKVR03 JX407230 1 A PF 
RKVR04 Pseudoalteromonas sp. isolate RKVR04 JX407231 1 A  
RKVR07 Pseudoalteromonas sp. isolate RKVR07 JX407233 1 A 51 
RKVR13 Pseudoalteromonas sp. isolate RKVR13 JX407238 1 C 51 
RKVR16 Ruegeria sp. isolate RKVR16 JX407240 1 C 51 
RKVR30 Ruegeria sp. isolate RKVR30 JX407244 1 A 51 
RKVR33 Ruegeria sp. isolate RKVR33 JX407245 1 C 51 
RKVR34 Pseudoalteromonas sp. isolate RKVR34 JX407246 1 C 51 
RKVR36 Bacillus sp. isolate RKVR36 JX407247 1 A PF 
RKVR39 Vibrio sp. isolate RKVR39 JX407248 1 B 51 
RKVR40 Pseudoalteromonas sp. isolate RKVR40 JX407249 1 C 51 
RKVR41 Pseudooidiomarina sp. isolate RKVR41 JX407250 1 A 51 
RKVR42 Microbacterium sp. isolate RKVR42 JX407251 1 A PF 
Ps1E1 Arthrobacter sp. isolate RKVR_Ps1E1 JX317703 1 NA PF 
B28 Bacillus sp. isolate RKVR_B28 JX317686 2 A PF 
G2 Aquimarina sp. isolate RKVR_G2 JX317687 2 B 51 
E3 Aquimarina sp. isolate RKVR_E3 JX317688 2 B 51 
B16-1 Bacillus sp. isolate RKVR_B16-1 JX317689 2 A PF 
D43 Kytococcus sp. isolate RKVR_D43 JX317690 2 C 51 
E5 Macrococcus sp. isolate RKVR_E5 JX317691 2 A 51 
F1 Bacillus sp. isolate RKVR_F1 JX317692 2 A PF 
F3 Bacillus sp. isolate RKVR_F3 JX317693 2 A PF 
F4 Bacillus sp. isolate RKVR_F4 JX317694 2 A PF 
F5 Bacillus sp. isolate RKVR_F5 JX317695 2 C PF 
D22 Microbacterium sp. isolate RKVR_D22 JX317696 2 C PF 
D73 Marinilactibacillus sp. isolate RKVR_D73 JX317697 2 B 51 
D69 Bacillus sp. isolate RKVR_D69 JX317698 2 B 104 
G17 Bacillus sp. isolate RKVR_G17 JX317699 2 A 51 
U3 Bacillus sp. isolate RKVR_U3 JX317700 2 B PF 
L1 Microbacterium sp. isolate RKVR_L1 JX317701 2 C 51 
L3 Micrococcus sp. isolate RKVR_L3 JX317702 2 C PF 
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V2 Bacillus sp. isolate RKVR_V2 JX317704 2 A PF 
V12 Janibacter sp. isolate RKVR_V12 JX317706 2 A PF 
RKVR11 Janibacter sp. isolate RKVR11 JX317707 2 A PF 
RKVR17 Micrococcus sp. isolate RKVR17 JX317708 2 B 104 
RKVR18 Bacillus sp. isolate RKVR18 JX317709 2 B 104 
RKVR25 Aquimarina sp. isolate RKVR25 JX317710 2 C 51 
RKVR26 Macrococcus sp. isolate RKVR26 JX317711 2 A 51 
RKVR38 Bacillus sp. isolate RKVR38 JX317715 2 C PF 
RKVR31 Paraliobacillus sp. isolate RKVR31 JX317716 2 A PF 
RKVR24 Aquimarina sp. isolate RKVR24 JX317743 2 A PF 
RKVR35 Sphingopyxis sp. isolate RKVR35 JX407110 2 A PF 
RKVR_B7 Amphritea sp. isolate B7 JX407111 2 A 51 
RKVR_L4 Amphritea sp. isolate L4 JX407112 2 A 51 
RKVR_C15 Sphingopyxis sp. isolate C15 JX407113 2 A PF 
RKVR_V14 Sphingomonas sp. isolate V14 JX407114 2 B 51 
RKVR21 Vibrio sp. isolate RKVR21 JX407116 2 B PF 
A10 Vibrio sp. isolate A10 JX407117 2 A PF 
A12 Vibrio sp. isolate A12 JX407118 2 A PF 
A2 Vibrio sp. isolate A2 JX407119 2 A PF 
A4 Vibrio sp. isolate A4 JX407120 2 A PF 
A5 Vibrio sp. isolate A5 JX407121 2 A PF 
A6 Vibrio sp. isolate A6 JX407122 2 A PF 
A7 Vibrio sp. isolate A7 JX407123 2 A PF 
A8 Vibrio sp. isolate A8 JX407124 2 A 51 
B10 Pseudoalteromonas sp. isolate B10 JX407125 2 A 51 
B14 Pseudoalteromonas sp. isolate B14 JX407126 2 B 51 
B2 Pseudoalteromonas sp. isolate B2 JX407127 2 B 51 
B23 Vibrio sp. isolate B23 JX407129 2 B 104 
B24 Pseudoalteromonas sp. isolate B24 JX407131 2 B 104 
B5 Pseudoalteromonas sp. isolate B5 JX407137 2 B 51 
B7-1 Ruegeria sp. isolate B7-1 JX407139 2 A 51 
B7-2 Pseudoalteromonas sp. isolate B7-2 JX407140 2 A 51 
C13 Alteromonas sp. isolate C13 JX407143 2 B 51 
C2 Alteromonas sp. isolate C2 JX407144 2 C PF 
C4 Alteromonas sp. isolate C4 JX407146 2 B 51 
C9 Pseudoalteromonas sp. isolate C9 JX407148 2 B PF 
D10 Pseudoalteromonas sp. isolate D10 JX407150 2 B 104 
D12 Vibrio sp. isolate D12 JX407152 2 B 51 
D13 Vibrio sp. isolate D13 JX407153 2 B 104 
D14 Vibrio sp. isolate D14 JX407154 2 A 104 
D15 Vibrio sp. isolate D15 JX407155 2 B PF 
D16 Vibrio sp. isolate D16 JX407156 2 B PF 
D17 Vibrio sp. isolate D17 JX407157 2 B 51 
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D18 Vibrio sp. isolate D18 JX407158 2 B PF 
D19 Vibrio sp. isolate D19 JX407159 2 B 51 
D20 Vibrio sp. isolate D20 JX407161 2 B 51 
D33 Pseudoalteromonas sp. isolate D33 JX407166 2 C PF 
D37 Vibrio sp. isolate D37 JX407167 2 B 51 
D48 Alteromonas sp. isolate D48 JX407173 2 A 51 
D5 Vibrio sp. isolate D5 JX407174 2 B 51 
D51_W Pseudoalteromonas sp. isolate D51-W JX407176 2 B 51 
D51_Y Pseudoalteromonas sp. isolate D51_Y JX407177 2 B 51 
D52 Alteromonas sp. isolate D52 JX407178 2 A PF 
D53 Pseudoalteromonas sp. isolate D53 JX407179 2 C PF 
D66 Vibrio sp. isolate D66 JX407185 2 A PF 
D71 Photobacterium sp. isolate D71 JX407188 2 A PF 
D72 Vibrio sp. isolate D72 JX407189 2 B PF 
D75 Vibrio sp. isolate D75 JX407191 2 B 51 
D80 Alteromonas sp. isolate D80 JX407194 2 A PF 
D9 Vibrio sp. isolate D9 JX407196 2 B PF 
G18 Vibrio sp. isolate G18 JX407199 2 B PF 
G22 Ruegeria sp. isolate G22 JX407201 2 A PF 
G25 Xanthomonadaceae isolate G25 JX407203 2 B 51 
G28 Ruegeria sp. isolate G28 JX407204 2 A 51 
H2 Vibrio sp. isolate H2 JX407212 2 C PF 
H3 Vibrio sp. isolate H3 JX407213 2 B 104 
H5 Vibrio sp. isolate H5 JX407215 2 B PF 
V3 Pseudoalteromonas sp. isolate V3 JX407219 2 B 51 
V4 Pseudoalteromonas sp. isolate V4 JX407220 2 B 51 
V7 Alteromonas sp. isolate V7 JX407223 2 C PF 
V9 Pseudoalteromonas sp. isolate V9 JX407224 2 B 51 
V10 Rhodobacteraceae sp. isolate V10 JX407225 2 A PF 
V11 Photobacterium sp. isolate V11 JX407226 2 C PF 
V13 Alteromonas sp. isolate V13 JX407227 2 B 51 
RKVR01 Vibrio sp. isolate RKVR01 JX407228 2 A PF 
RKVR05 Pseudoalteromonas sp. isolate RKVR05 JX407232 2 A 51 
RKVR08 Alteromonas sp. isolate RKVR08 JX407234 2 A 104 
RKVR09 Alteromonas sp. isolate RKVR09 JX407235 2 B 51 
RKVR15 Photobacterium sp. isolate RKVR15 JX407239 2 A PF 
RKVR19 Vibrio sp. isolate RKVR19 JX407241 2 C PF 
RKVR20 Pseudoalteromonas sp. isolate RKVR20 JX407242 2 C PF 
RKVR27 Paracoccus sp. isolate RKVR27 JX407243 2 B 51 
RKVR43 Vibrio sp. isolate RKVR43 JX407252 2 A PF 
RKVR14 Pseudoalteromonas sp. isolate RKVR14 JX407253 2 A 51 
RKVR06 Vibrio sp. isolate RKVR06 JX407254 2 A PF 
RKVR22 Shewanella sp. isolate RKVR22 JX407255 2 A 51 
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RKVR23 Alteromonas sp. isolate RKVR23 JX407256 2 C PF 
RKVR28 Marinilactibacillus sp. isolate RKVR28 JX407257 2 A PF 
RKVR29 Micrococcus sp. isolate RKVR29 JX317712 2 NA PF 
RKVR32 Janibacter sp. isolate RKVR32 JX317713 2 B 51 
RKVR_L5 Pseudoalteromonas sp. isolate L5 JX407115 2 C 51 
D30 Vibrio sp. isolate D30 JX407165 2 A 51 
G13 Alteromonas sp. isolate G13 JX407198 2 A 51 
RKVR10 Alteromonas sp. isolate RKVR10 JX407236 2 C 51 
C3 Alteromonas sp. isolate C3 JX407145 2 A PF 
D11 Vibrio sp. isolate D11 JX407151 2 A PF 
D61 Alteromonas sp. isolate D61 JX407183 2 A PF 
H4 Vibrio sp. isolate H4 JX407214 2 A PF 
RKVR12 Pseudoalteromonas sp. isolate RKVR12 JX407237 2 A PF 
D39 Vibrio sp. isolate D39 JX407168 NA A PF 
D40 Vibrio sp. isolate D40 JX407169 NA A PF 
H1 Vibrio sp. isolate H1 JX407211 PEA A PF 
SS1 Staphylococcus sp. isolate RKVR_SS1 JX317679 SS   
SS2 Nocardioides sp. isolate RKVR_SS2 JX317680 SS   
SS3 Micrococcus sp. isolate RKVR_SS3 JX317681 SS   
SS5 Nocardioides sp. isolate RKVR_SS5 JX317682 SS   
SS12 Oceanobacillus sp. isolate RKVR_SS12 JX317683 SS   
SS14 Bacillus sp. isolate RKVR_SS14 JX317684 SS   
SS12 Staphylococcus sp. isolate RKVR_SS12 JX317685 SS   
RKBH-B54 Streptomyces sp. isolate RKBH-B54 JX317717 SS   
RKBH- 
B109 
Micrococcus sp. isolate RKBH-B109 JX317718 SS   
RKBH- 
B100 
Microbacterium sp. isolate RKBH-B100 JX317719 SS   
RKBH-B58 Brevibacterium sp. isolate RKBH-B58 JX317720 SS   
RKBH-B62 Nocardiopsis sp. isolate RKBH-B62 JX317721 SS   
RKBH- 
B150 
Terribacillus sp. isolate RKBH-B150 JX317722 SS   
RKBH- 
B102 
Rhodococcus sp. isolate RKBH-B102 JX317723 SS   
RKBH-B86 Pseudonocardia sp. isolate RKBH-B86 JX317724 SS   
RKBH- 
B104 
Rhodococcus sp. isolate RKBH-B104 JX317725 SS   
RKBH-B74 Staphylococcus sp. isolate RKBH-B74 JX317726 SS   
RKBH- 
B106 
Bacillus sp. isolate RKBH-B106 JX317727 SS   
RKBH- 
B108 
Planococcus sp. isolate RKBH-B108 JX317728 SS   
RKBH- 
B152 
Streptomyces sp. isolate RKBH-B152 JX317729 SS   
RKBH- Bacillus sp. isolate RKBH-B153 JX317730 SS   
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B153  
RKBH-B55 Bacillus sp. isolate RKBH-B55 JX317731 SS 
RKBH-B75 Microbacterium sp. isolate RKBH-B75 JX317732 SS 
RKBH-B65 Staphylococcus sp. isolate RKBH-B65 JX317733 SS 
RKBH- 
B113 
Gordonia sp. isolate RKBH-B113 JX317734 SS 
RKBH- 
B114 
Bacillus sp. isolate RKBH-B114 JX317735 SS 
RKBH-B80 Exiguobacterium sp. isolate RKBH-B80 JX317736 SS 
RKBH-B56 Staphylococcus sp. isolate RKBH-B56 JX317737 SS 
RKBH- 
B115 
Kytococcus sp. isolate RKBH-B115 JX317738 SS 
RKBH- 
B116 
Bacillus sp. isolate RKBH-B116 JX317739 SS 
RKBH-B57 Micrococcus sp. isolate RKBH-B57 JX317740 SS 
RKBH- 
B155 
Micrococcus sp. isolate RKBH-B155 JX317741 SS 
RKBH- 
B156 
Staphylococcus sp. isolate RKBH-B156 JX317742 SS 
RKBH- 
B103 
Roseomonas sp. isolate RKBH-B103 JX407130 SS 
RKBH- 
B110 
Pseudomonas sp. isolate RKBH-B110 JX407258 SS 
RKBH- 
B105 
Salinicola sp. isolate RKBH-B105 JX407259 SS 
RKBH- 
B107 
Enterobacter sp. isolate RKBH-B107 JX407260 SS 
RKBH- 
B001 
Paracoccus sp. isolate RKBH-B001 JX407261 SS 
SS9 Ruegeria sp. isolate SS9 JX407262 SS 
SS17 Cohaesibacter sp. isolate SS17 JX407263 SS 
 
